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Abstract 
This thesis is divided into four chapters in which one-pot processes have been 
developed and utilised for the synthesis of biologically active compounds. The 
work in the first chapter outlines the 13-step total synthesis of D-ribo- and L-
arabino-phytosphingosine from D-ribose. This process employed a microwave 
promoted Overman rearrangement of an allylic trichloroacetimidate to install the 
amine functionality. 
 
 
In the second and third chapters, the development of a one-pot, two-step 
Overman/ring closing metathesis process is detailed. The synthesis of three 
different classes of starting material is also shown. This one-pot process was used 
as the key step in the synthesis of four oxybenzo[c]phenanthridine natural 
products and the partial synthesis of an ACAT inhibitor. The potential for further 
functionalisation of the products by oxidation and reduction was also explored. 
 
 
In the final chapter, a one-pot allylboration/Heck process for the synthesis of 
indan-1-ols is described. Optimisation and an investigation of the scope of the 
process are also presented. The process was then altered to allow the use of a 
chiral phosphoric acid catalyst for the asymmetric synthesis of these compounds. 
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Chapter 1 The Synthesis of D-ribo- and L-arabino-
Phytosphingosine 
1.1 Introduction 
1.1.1 The Overman rearrangement 
Sigmatropic rearrangements are a valuable class of reactions in the synthetic 
chemists’ toolbox. Carbon-carbon and carbon-nitrogen bond forming 
rearrangements are especially important and reactions such as the Claisen and 
Cope rearrangements are commonly used in many areas of synthetic chemistry.1,2 
The [3,3]-sigmatropic rearrangement of an allylic imidate to an allylic amide is 
known as an aza-Claisen reaction and is a very efficient method for the installation 
of a protected amine functionality. The conversion of an imidate to an amide is 
essentially irreversible as the reaction is exothermic by approximately 15 kcal 
mol−1.3,4 A number of types of imidate have been used for the aza-Claisen with 
varying degrees of success. It was the discovery by Overman in 1974 of the [3,3]-
rearrangement of allylic trihaloacetimidates to their corresponding amides that 
allowed the field to grow dramatically. This was due to the wide scope and 
comparatively milder conditions of this sub-set of the aza-Claisen.5–7 This reaction 
has subsequently become known as the Overman rearrangement. 
The trichloroacetimidates that can be used in the Overman rearrangement are 
easily synthesised by the base-promoted reaction between an allylic alcohol and 
trichloroacetonitrile. This base can either be stoichiometric and strong enough to 
irreversibly deprotonate the allylic alcohol and imidate until work-up (e.g. sodium 
hydride)7 or can be used catalytically as a proton transfer agent, as in the case of 
DBU.8 
The Overman rearrangement can be carried out under either thermal or metal-
catalysed conditions. The reaction rate is highly dependent on the electronics and 
sterics of the allylic system. In general, the more substituted the allylic position of 
the chain, the more rapid the reaction. This can be rationalised by the formation of 
a partial positive charge in the transition state of the rearrangement. The reaction 
is slowed by a second or bulky substituents on the β-position of the allylic system 
due to steric hindrance. In addition, electron-donating groups which stabilise the 
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partial positive charge on the allylic position, enhance the reaction rate further. As 
with all sigmatropic rearrangements, the Overman rearrangement is highly 
concerted and consequently there is complete transfer of chirality, if present, from 
the allylic imidate (Scheme 1, R ≠ H). The highly ordered, chair transition state of 
the reaction was proposed by Shimoda and co-workers in 1976.9 
 
 
Scheme 1: The chair transition state of the Overman rearrangement. 
 
The most common conditions for the thermal Overman rearrangement employ 
heating the imidate in toluene or xylenes in the presence of small quantities of 
potassium carbonate. Isobe and co-workers first reported the addition of small 
quantities of base to thermal Overman rearrangements in 1998.10 It was found 
that, at the elevated temperatures necessary for the rearrangement to proceed, 
small amounts of acidic by-products or impurities could cause decomposition of 
the starting imidate. By the addition of a small quantity of base, this problem was 
alleviated and yields were greatly improved (Scheme 2). 
 
 
Scheme 2: Work by Isobe and co-workers showing beneficial addition of K2CO3. 
 
The Overman rearrangement can also be performed using transition metal 
catalysis. This has the benefits, in some cases, of increasing the yield, 
stereoselectivity or cleanliness of the reaction. The original metal-catalysed 
Overman rearrangements were performed using mercury(II)-catalysts, for which a 
dramatic acceleration in rate is observed.5 These vast increases in rate allow for 
the reactions to be carried out at room temperature or even at −78 °C. The 
conditions are much milder than those used for the thermal rearrangement and so 
also broaden the scope of the reaction. Palladium(II)-catalysts are now preferred 
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over mercury(II) based systems as they have been shown to equilibrate with the 
substrate at a greater rate than other transition metal catalysts and so, generally, 
will provide a faster reaction in higher yield. This, in turn, allows lower catalyst 
loadings to be used without detriment to the results.  
A common impurity in metal-catalysed Overman rearrangements is the [1,3]-
rearranged product. This is postulated to form via a palladium(0)-catalysed, non-
concerted [1,3]-rearrangement of the acetimidate. The metal-catalysed 
rearrangements of allylic imidates have been studied by the groups of Ikariya and 
Bosnich.11,12 They found that the oxidation state of the palladium complex used in 
the rearrangement process had a direct impact on the product formed. 
Palladium(II) predominantly formed the [3,3]-product while palladium(0) formed the 
[1,3]- through a non-concerted ionisation pathway (Scheme 3). It has been shown 
that the addition of p-benzoquinone (p-BQ) can counteract this reaction pathway 
by oxidising any palladium(0)13,14 formed back to the catalytically active 
palladium(II) species.15  
 
 
Scheme 3: Difference in mechanism between [1,3]- and [3,3]-rearrangements. 
 
Studies into the mechanism of the palladium(II)-catalysed rearrangement have 
shown that it is likely to proceed through a similar mechanism to that proposed by 
Henry for palladium-catalysed allylic acetate rearrangements.16 As with the 
thermal rearrangement, a chair transition state is proposed, in which the palladium 
adopts an equatorial position. This chair transition state again explains the 
complete suprafacial transfer of chirality that is observed in these reactions. It is 
postulated that the mechanism proceeds through coordination of palladium to the 
olefin, which is then activated to intramolecular nucleophilic attack by the nitrogen 
of the acetimidate. The alkene is then reinstalled with the decyclisation and 
regeneration of the palladium(II)-catalyst (Figure 1). 
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Figure 1: Proposed mechanism for palladium(II)-catalysed Overman rearrangement. 
 
Since the first reports of transition metal-catalysed Overman rearrangements, a 
number of chiral ligand-bearing palladium catalysts have been developed in an 
effort to perform an asymmetric Overman rearrangement on an achiral starting 
material. The first chiral diamine ligands were successful only on N-
arylbenzimidates, gave only modest enantioselectivity and formed a significant 
amount of the unwanted [1,3]-rearrangement side-product (Scheme 4).17 
 
Scheme 4: [1,3]- vs [3,3]-rearrangement in the first asymmetric aza-Claisen 
rearrangement. 
 
The next generation of asymmetric catalysts were designed to reduce the quantity 
of [1,3]-rearrangement side-product. The ferrocenyl palladacycles reported by 
Overman and co-workers were compatible with only N-arylbenzimidates and still 
yielded only modest enantioselectivity but the [1,3]-product was no longer 
observed and the yield of [3,3]-rearranged product was much improved (Scheme 
5).18 
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Scheme 5: The ferrocenyl palladacycle first reported by Overman in 1997. 
 
The ferrocenyl oxazoline palladacycle (FOP) catalysts further improved upon the 
closely related, original palladacycle catalysts (Scheme 6).19 The FOP catalysts 
provided higher enantioselectivity and, as was shown by Overman, would tolerate 
N-aryltrifluoroacetimidate substrates as well as N-arylbenzimidates.20 This was an 
important result as it was the first time a prochiral trihaloacetimidate had been 
rearranged to give an enantioenriched allylic amide in good yield. Although the 
reaction proceeds at room temperature with a good catalyst loading, the addition 
of four equivalents of silver trifluoroacetate — necessary to preactivate the catalyst 
as its TFA salt — and the use of strong oxidants to remove the p-methoxyphenyl 
group after the rearrangement, limited the utility of this process and catalyst. 
 
Scheme 6: First report of an asymmetric trihaloacetimidate aza-Claisen rearrangement. 
 
The more recently developed cobalt oxazoline palladacycle (COP) catalysts 1 are, 
as yet, the most synthetically useful. They encompass the widest range of 
substrates and provide high enantioselectivities with E-allylic trichloroacetimidates 
(Scheme 7).21 The scope of the COP-catalysed process includes various Lewis 
basic groups, moderately bulky substituents and even free alcohols and does not 
require an aryl group on the imidate nitrogen. However, the system will still not 
tolerate unprotected primary or secondary amines, directly conjugated aromatic 
systems or very bulky olefin substituents such as tert-butyl groups. In the case of a 
conjugated system derived from a cinnamyl alcohol or a bulky tert-butyl group, the 
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reaction slowed so drastically that the [1,3]-process was observed and yields 
decreased to around 10%. 
 
 
Scheme 7: Highly enantioselective (S)-COP-Cl catalysed Overman rearrangement. 
 
1.1.2 Previous work within the Sutherland group 
Within the Sutherland group, the Overman rearrangement has been used for the 
synthesis of a large number of small molecule and natural product targets. The 
first target studied by the group was (2S,3S,4R)-γ-hydroxyisoleucine (4).22 In 5 
steps and 61% total yield, the necessary allylic alcohol 2 was synthesised from 
poly-(R)-hydroxybutanoate. The corresponding trichloroacetimidate was then 
formed by the reaction with sodium hydride and trichloroacetonitrile. Exposing the 
imidate to 10 mol% of palladium(II) dichloride bisbenzonitrile in THF at room 
temperature caused rearrangement to the desired (3R)-trichloroacetamide 3 in just 
3 hours. The steric bulk of the TBDPS protecting group is thought to encourage 
binding of the palladium catalyst to the less hindered face through the reduction of 
1,3-allylic strain in the chair transition state. This is supported by the reversal of 
selectivity observed upon use of thermal rearrangement conditions. Under these 
conditions, a 3:2 ratio in favour of the (S)-isomer is observed. Ozonolysis followed 
by acidic deprotection of both the amine and alcohol functionalities delivered 
(2S,3S,4R)-γ-hydroxyisoleucine (4) in a 19% overall yield over 10 steps (Scheme 
8). 
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Scheme 8: The first enantioselective synthesis of (2S,3S,4R)-γ-hydroxyisoleucine. 
 
Following this successful synthesis, the group went on to develop a highly 
selective ether-directed Overman rearrangement.23 In the synthesis of (2S,3S,4R)-
γ-hydroxyisoleucine (4), the TBDPS protecting group had caused direction by 
inducing 1,3-allylic strain on the system. The ether-directed system used a γ-
hydroxy allylic alcohol with a protecting group such as MOM or MEM to coordinate 
the palladium catalyst to the same face as the protected alcohol. This directed the 
Overman rearrangement to the least hindered face of the molecule: anti- to the 
alcohol and gave the major product (Scheme 9, top pathway). In the case of larger 
protecting groups such as trityl or TBDPS, the coordination still occurred but, due 
to the steric hindrance of the protecting group causing 1,3-allylic strain, the effect 
was less pronounced  (Scheme 9, bottom pathway). This in turn yielded a lower 
diastereoselectivity (3:1 vs 10:1). This methodology allowed the synthesis of 
protected, anti-1,2-amino alcohols in high yields and selectivities (78% yield and 
28:1 d.r. in one example).24 
 
 
Scheme 9: Proposed transition states for the ether-directed rearrangement. 
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Using this methodology as the key step, a number of amino alcohol-derived 
natural products have been synthesised. A recent example of this is the synthesis 
of three members of the clavaminol family of natural products.25 In seven steps 
and an overall yield of 85% the allylic alcohol 5 was synthesised from (R)-glycidol. 
Using standard conditions with catalytic DBU, the imidate 6 was formed.8 It was 
then used crude in the palladium-catalysed Overman rearrangement to give the 
key intermediate 7 in a high yield (Scheme 10). As mentioned earlier, it is 
necessary in some cases to add p-BQ to metal-catalysed Overman 
rearrangements to stop the formation of the [1,3]-rearrangement product. This 
intermediate allowed access to clavaminols A and C in 14 steps and 29% yield 
each and clavaminol H in 12 steps and 48% overall yield. 
 
Scheme 10: Overman rearrangement step in the synthesis of clavaminols A, C and H. 
 
1.1.3 Introduction to sphingoid bases 
Sphingolipids are found in almost all plants, animals, fungi and some prokaryotic 
organisms and viruses.26 Sphingolipids are comprised of two sections: a fatty acid 
or lipid chain, attached through an amide bond, and a sphingoid base such as 
sphingosine. The sphingoid bases are a family of long chain amino alcohols 
ranging from 12 to 22 carbons in length. The long chain can contain unsaturation 
and various hydroxyl and/or methyl substituents at other sites along the chain.27,28 
Sphingolipids are important as structural components of skin, membranes, 
lipoproteins, and as cell signalling mediators and modulators.26 Glycosylated 
sphingolipids, also called glycosphingolipids (GSLs), containing a number of 
saccharide units, such as iGB3 8 (Figure 2), are characteristic components of the 
cell membrane of eukaryotic cells.29,30 
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Figure 2: iGB3, a linear tri-saccharide containing GSL. 
 
Sphingolipids and GSLs are involved in a number of higher-order physiological 
processes31 such as inflammation32 and vasculogenesis33 and, over the last two 
decades, have also been investigated in relation to a wide range of diseases. Most 
recently GSLs have been implicated in a number of important human diseases 
such as HIV,34 microbial infections,35 cancer,36 diabetes37 and neurological 
diseases.38 In addition to the sphingolipids, the more structurally simple sphingoid 
bases also have potent biological activities. For example, D-erythro-sphingosine 
(9) strongly inhibits protein kinase C,39 while D-ribo-phytosphingosine (10a) is a 
potential heat-stress signal in yeast cells.40,41 
The principal sphingoid bases in the majority of sphingolipids present in 
mammalian cells are sphingosine (9) or dihydrosphingosine (11), otherwise known 
as sphinganine, with the minority being comprised mainly of 4-hydroxysphinganine 
(10a), also named phytosphingosine (Figure 3).26 
 
Figure 3: The three most common mammalian sphingoid bases. 
 
1.1.4 Aims 
The aim of this project was to complete the total synthesis of D-ribo- and L-
arabino-phytosphingosine from the chiral pool starting material D-ribose. The 
proposed synthesis utilised cross metathesis to attach the long alkyl chain of the 
products and a diastereoselective Overman rearrangement from a primary allylic 
alcohol to install the amine functionality at C-2 (Figure 4). 
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Figure 4: Retrosynthesis of D-ribo-phytosphingosine. 
 
1.2 Results and discussion 
1.2.1 Synthesis of long chain triol 
Protection of D-ribose (12) as the di-acetal 13, following a modified version of the 
procedure used by Bailey and co-workers proceeded in high yield, with no 
purification necessary (Scheme 11).42 The protection of the hemiacetal of D-ribose 
leads to the isolation of only the 1,2-anti-furan. This was confirmed by the 1H NMR 
spectrum of the compound, in which a 3J-coupling is not observed between the 
two hydrogens at these positions. This can only be accounted for by there being 
around a 90° dihedral torsional angle between these hydrogens, which would not 
occur in the 1,2-syn-furan. This was followed by iodination of the primary alcohol 
under Appel-like conditions. 
 
 
Scheme 11: Protection and iodination of D-ribose. 
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Ring opening of the iodide 14 under Vasella fragmentation conditions yielded the 
aldehyde 15, however purification of this compound was complicated by its lack of 
stability during silica column chromatography (Scheme 12).43 Previous syntheses 
utilising this aldehyde had purified it by vacuum distillation.42 To circumvent this 
problem and allow for simpler purification, the aldehyde 15 was reduced with 
sodium borohydride in ethanol to yield the primary alcohol 16. Although this initially 
caused racemisation of the α-position stereocenter when attempted at room 
temperature, the problem was solved by dropwise addition of the borohydride 
solution at 0 °C. This improved, two-step procedure allowed isolation of the triol-
olefin in a high yield with no further purification necessary after filtration and an 
extractive work-up  
 
 
Scheme 12: Vasella fragmentation and subsequent reduction. 
 
Cross metathesis of the protected triol-olefin 16 was proposed as a key feature of 
the synthesis. The use of cross metathesis with this easily obtained intermediate 
would allow the length and substitution pattern of the long alkyl chain to be altered. 
This could make the methodology of use to chemists interested in preparing 
related analogues for medicinal chemistry or drug design. 
Cross metathesis between 16 and tetradec-1-ene (17) should proceed rapidly and 
selectively, as 16 is categorised as a type II olefin, while tetradec-1-ene (17) is a 
type I.44 While it was broadly true that this was a selective process, separation of 
remaining starting material 16 from product 18, especially on a small scale was 
very challenging. For this reason, conversion to product, as measured by 1H NMR 
spectroscopy, was used in place of isolated yield as a measure of reaction 
efficiency during optimisation (Table 1). 
Two solvents and three temperatures were identified to start optimisation of this 
process. Initial attempts at metathesis showed that dichloromethane was a better 
solvent for the reaction; however the extended reaction times caused 
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decomposition of the starting material and product and this lead to some of the 
problems in purification of the products. It was found that at raised temperatures, a 
shorter reaction time and single addition of catalyst were sufficient to isolate the 
product in a 63% yield. 
 
 
Entry Solvent 
Catalyst loading 
/mol% 
Temperature 
/°C 
Time 
/h 
Conversion to 18 
/%a 
1 CH2Cl2 2 × 5 rt 120 61 
2 CH2Cl2 2 × 5 35 48 24 
3 Toluene 2 × 5 35 48 16 
4 Toluene 2 × 5 45 48 37 
5 CH2Cl2 2 × 5 45 48 76 (43)
b 
6 CH2Cl2 5 45 10 66 (63)
b 
Table 1: Reactions performed with 1.5 eq of tetradec-1-ene (17) and the stated amount 
of Grubbs II catalyst. 
a
Measured by 
1
H NMR spectroscopy of crude material. 
b
Isolated yield 
of 18 in brackets. 
 
Due to the problems with purification it was decided to proceed with the crude 
product through the next step before purification, as this would possibly allow a 
higher yield over the two steps. Initially hydrogenation in methanol was attempted, 
however, this caused deprotection of the diol. Changing to ethyl acetate, a less 
acidic solvent, alleviated this problem. By using the optimised metathesis 
conditions, then washing the homocoupled side-product, hexacos-13-ene, out of 
the mixture before hydrogenating the crude product, it was possible to increase 
the yield of 19 to 82% across the two steps (Scheme 13).  
 
Scheme 13: Optimised cross metathesis and hydrogenation. 
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An investigation of the minimum catalyst loading that could be used for metathesis 
was also undertaken when the process was scaled up. It was found that, on one 
gram scale, the catalyst loading could be reduced to 1 mol%. However, the slightly 
extended reaction times, and high concentrations necessary for the reaction to 
proceed to complete conversion, caused a lower isolated yield over the two steps 
(Table 2). 
Entry 
Scale 
/g 
Catalyst loading 
/mol% 
Concentration of 
16 /M 
Time /h 
Isolated yield  
(2 steps) /% 
1 0.10 5.0 0.08 16 82 
2 0.25 0.5 0.16 24 27 
3 0.25 0.5 0.32 24 27 
4 0.25 0.5 0.80 24 39 
5 0.25 0.5 1.6 24 33 
6 1.0 0.5 3.2 24 43 
7 1.0 1.0 3.2 24 52 
Table 2: Attempts to lower catalyst loading in scaled up metathesis and 
hydrogenation. Reactions carried out in CH2Cl2 at 45 °C with 1.5 eq of tetradec-1-ene (17). 
 
1.2.2 Primary Overman rearrangement route 
Having accessed the important intermediate 19, a one-pot Swern/Horner-
Wadsworth-Emmons reaction, developed within the Sutherland group, was applied 
to access the α,β-unsaturated ester 22 (Scheme 14).23 In this process, the 
aldehyde 20 formed in the Swern oxidation was concentrated in vacuo and used 
directly in the subsequent Horner-Wadsworth-Emmons (HWE) reaction with 
triethyl phosphonoacetate (TEPA, 21). This process was developed to alleviate 
problems with purification of volatile or sensitive aldehydes. Epimerisation of the α-
stereocenter of the shorter chain, olefin-containing analogue of 20 had been 
observed during attempts at reduction during the Vasella fragmentation (Scheme 
12). By using this one-pot process and employing the mild Masamune-Roush 
conditions in the HWE step, the α,β-unsaturated ester 22 was synthesised in a 
high yield over two steps with no epimerisation and entirely as the E-isomer.45 
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Scheme 14: One-pot Swern/Horner-Wadsworth-Emmons reaction. 
 
Access to the primary allylic alcohol required for the key Overman rearrangement 
was gained by DIBAL-H reduction of the α,β-unsaturated ester 22 at −78 °C 
(Scheme 15). This reduction method has been utilised many times within the 
Sutherland group for the synthesis of allylic alcohols for Overman 
rearrangements.23 Reduction of the α,β-unsaturated ester 22 to alcohol 23 
proceeded in a high yield. 
 
 
Scheme 15: DIBAL-H reduction of α,β-unsaturated ethyl ester 22. 
 
With the allylic alcohol 23 in hand, the next step was to perform a palladium 
catalysed diastereoselective Overman rearrangement to install the C-2 amine 
functionality of phytosphingosine. Previous work within the group had shown that 
this was possible on a simplified analogue of allylic alcohol 23 that was lacking the 
long alkyl chain (24, Scheme 16).46 This work did, however, highlight some 
potential issues that could arise in the use of these catalytic systems when 
rearranging from acetonide-protected triols. 
In the previous work on allylic alcohol 24 the use of a simple palladium(II) catalyst 
such as bisacetonitrile dichloropalladium(II) yielded a mixture of syn- and anti-
diastereomers (25a and 25b respectively) as well as the undesirable [1,3]-
rearrangement-hydrolysis product, 26. The use of the more complex (S)- and (R)-
COP-Cl catalysts 1 had shown that greater levels of diastereoselectivity could be 
induced, and that the increased stability of these catalysts could also lower the 
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quantity of [1,3]-rearrangement-hydrolysis product 26. In the case of (R)-COP-Cl 
(R)-1, the observed diastereoselectivity was considerably lower and a small 
amount of undesired [1,3]-product was still formed. This result is postulated to 
come from a mismatch between the catalyst and the chiral substrate which slows 
the reaction and allows time for the catalyst to be reduced. 
 
Scheme 16: Previous work toward a similar diastereoselective Overman rearrangement. 
 
For allylic alcohol 23, a thermal rearrangement was first investigated. The results 
from the thermal rearrangement showed that the allylic trichloroacetimidate 27 was 
more stable than might be expected (Table 3). It was observed that at 
temperatures of 140 °C or lower, extended reaction periods were necessary to 
effect full conversion. The use of longer reaction times resulted in increased 
degradation, which could be minimised by increasing the temperature and 
reducing the duration of heating. The thermal rearrangement was also performed 
under microwave irradiation conditions. These conditions allowed for shorter 
reaction times but also appeared to cause greater degradation of the products. 
The best results were obtained at 160 °C in p-xylene over three days and yielded 
a mixture of diastereomers that were separated by column chromatography. The 
crude ratio of diasteromers after work-up did not, however, translate to isolated 
products. It was observed that upon separation of the two diastereomers, a lower 
quantity of the desired, anti-isomer 28a was obtained. 
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Entry Solvent 
Heating 
method 
Temperature 
/°C 
Time 28a:28ba 
Yieldb /% 
28a 28b 
1 Toluene Oil bath 120 7 days 2:1 Incomplete 
2 Toluene Oil bath 140 5 days 1:1 Incomplete 
3 Toluene Oil bath 140 14 days 1:1 17 33 
4 p-Xylene Oil bath 160 3 days 1:1 26 44 
5 Toluene μW 180 1 h 1:1 12 33 
6 Toluene μW 180 1.5 h - Decomposed 
Table 3: Results of thermal Overman rearrangement. Reactions performed in a sealed 
tube. 
a
d.r. measured from 
1
H NMR spectrum of crude material. 
b
Isolated yield of individual 
diastereomers. 
 
The use of achiral palladium catalysts such as PdCl2(MeCN)2 was also explored. 
Previous work within the group on similar reactions had shown that the use of this 
catalyst could cause the formation of the undesired and deprotected [1,3]-
product.46 This is postulated to form via the palladium(II)-catalysed hydrolysis of 
the acetonide and the palladium(0)-catalysed, non-concerted [1,3]-rearrangement 
of the acetimidate. The deprotection of acetonides by this catalyst complex had 
previously been reported in wet THF and acetone, but was unexpected in dry 
toluene or dichloromethane.47 
It has been shown that the addition of p-BQ can counteract this reaction pathway 
by oxidising any palladium(0) formed back to the catalytically active palladium(II) 
species.15 Upon investigation of the reaction, it was observed that, after 16 hours, 
29 was the only product in all cases (Table 4). 
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Entry Solvent Catalyst loading /mol% Additive Isolated yield /% (29) 
1 Toluene 7 - 16 
2 CH2Cl2 7 - 18 
3 CH2Cl2 10 p-BQ
a 13 
Table 4: Results of the Pd(MeCN)2Cl2 catalysed Overman rearrangement. All reactions 
carried out at room temperature over 16 h. 
a
3 mol% p-benzoquinone added. 
 
The use of the chiral COP-Cl catalysts was then investigated (Table 5). The (R)-
COP-Cl catalyst (R)-1, due to its mismatch with the substrate, was expected to 
require longer reaction periods and give lower yields. However, it was observed 
that after prolonged reaction times or under increased temperatures the (R)-COP-
Cl catalyst (R)-1 failed to produce either of the products, 28a or 28b (Table 5, 
entries 1–3). 
The use of (S)-COP-Cl (S)-1 allowed the isolation of diastereomerically pure 28b 
in low yields (entries 4–7). From the optimisation results, it was observed that high 
initial catalyst loadings yielded a greater ratio of 29 to 28b and that increasing the 
temperature had no beneficial effect on the ratio. Various conditions were 
screened in an attempt to inhibit the formation of [1,3]-product. These poor results 
can be attributed to the steric bulk of both the catalyst and the substrate, at the 
position adjacent to the alkene. Poor yields and loss of selectivity have both been 
observed when using palladium(II) catalysts with sterically demanding substrates 
in work on ether-directed Overman rearrangements.15,23 
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Entry Solvent Catalyst 
Loading 
/mol% 
Temperature 
/°C 
Time 28b:29a 
1 CH2Cl2 (R)-COP-Cl 6 38 19 days NR 
2 MeCN (R)-COP-Cl 6 70 6 days NR 
3 Toluene (R)-COP-Cl 6 70 4 days NR 
4 CH2Cl2 (S)-COP-Cl 9
b 38 14 days 2:1 (17%)c 
5 CH2Cl2 (S)-COP-Cl 9
d 38 16 days 1:1 (22%)c 
6 CH2Cl2 (S)-COP-Cl 10
e 38 4 days 1:4 (7%)c 
7 Toluene (S)-COP-Cl 9c 60 10 days 1:2 (27%)c 
8 MeCN (S)-COP-Cl 6 70 6 days NR 
Table 5: Optimisation of COP-Cl-catalysed Overman. 
a
Calculated from 
1
H NMR 
spectrum of crude material. 
b
Added as 3 mol% initially and 3 mol% at 3 and 6 days. 
c
Isolated 
yield of 28b in brackets. 
d
Added as 3 mol% initially and 3 mol% at 2 and 4 days. 
e
Added as 
10 mol% initially. 
 
Having observed the sub-optimal results yielded by both thermal rearrangement 
and palladium catalysis in this system, it was decided that to improve the route, a 
secondary Overman rearrangement could be utilised to install the desired 
stereocenter. Before embarking on this modification to the route, the synthesis 
was completed with the separated products of the thermal Overman 
rearrangement. This was to ensure that the final two steps of the proposed route 
would work. 
Ozonolysis with a reductive work-up of compounds 28a and 28b afforded the 
desired, protected phytosphingosines 30a and 30b in high yields. These could 
then be deprotected in a simple two-step procedure to afford, D-ribo-
phytosphingosine (10a) and L-arabino-phytosphingosine (10b) (Scheme 17 and 
Scheme 18). 
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Scheme 17: Ozonolysis and deprotection to D-ribo-phytosphingosine, 10a. 
 
 
Scheme 18: Ozonolysis and deprotection to L-arabino-phytosphingosine, 10b. 
 
1.2.3 Secondary Overman rearrangement route 
An alternative, diastereoselective route to D-ribo- and L-arabino-phytosphingosine 
from the intermediate alcohol 19 was proposed. This used an HWE reaction with 
dimethyl 2-oxopropylphosphonate followed by a reagent-controlled 
diastereoselective reduction of the α,β-unsaturated ketone 31 (Scheme 19). 
 
Scheme 19: Diastereoselective route to secondary allylic alcohols. 
 
Upon synthesis of the α,β-unsaturated ketone 31, a number of trial reactions with 
the (R)-(+)-2-methyl-CBS-oxazaborolidine, (R)-CBS reagent were attempted 
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(Table 6). It had been shown by prior work within the group that for α,β-
unsaturated ketones, stoichiometric quantities of the CBS reagent were necessary 
to produce high yields as well as e.e. and/or d.r.48 For this reason, a stoichiometric 
amount of CBS reagent was used in this study. At between −45 °C and −20 °C, 
the reaction proceeded extremely slowly with a low d.r. The reaction produced 
only one diastereomer when the temperature was increased to 0 °C. It has been 
reported in the literature that, at temperatures below −30 °C, there is a sufficient 
alteration in the equilibria, between borane, the stabilising ligand (eg. THF), the 
CBS catalyst and the coordinated ketone, to allow intervention by competing, non-
selective reduction pathways.49  
 
 
Entry (R)-CBS/Eq BH3∙THF/Eq 
Temperature 
/°C 
Time 
/h 
Conversiona 32a:32ba 
1 1.0 1.1 −45 3 28 3:1 
2 1.1 3.0 −40 6 93 2:1 
3 1.1 3.0+3.0 −20 24 81 2:1 
4 1.1 3.0 0 6 99b 32a only 
Table 6: Diastereoselective reduction condition screen results. aCalculated from 1H 
NMR spectra of crude material. bIsolated yield of 32a after purification. 
 
There are a number of examples in the literature where the enantio- and/or 
diastereoselectivity of CBS reductions reach a maximum between the 
temperatures of 30 and 50 °C.50–52 The exact point at which this occurs is 
substrate and CBS-analogue dependent. Having achieved near quantitative yields 
of a single diastereomer at 0 °C, warming the reaction was not attempted. 
An additional problem was also identified during the screening of reaction 
conditions. The most common method for removal of the CBS catalyst by-product 
is washing with a weak solution of an acid, such as hydrochloric acid. In the case 
of products 32a and 32b, this would cause serious problems due to the lability of 
the acetonide protecting group. This protecting group had also caused problems in 
the purification of previous intermediates due to its decomposition during silica 
chromatography. In response to this problem, a dilute solution of citric acid was 
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used instead. The use of this work-up allowed the removal of the majority of the 
amino alcohol while minimising the loss of product. 
With the optimised conditions for CBS reduction in hand, these were then applied 
to the synthesis of the unnatural diastereomer 32b (Scheme 20). It was observed 
that in the case of the (S)-CBS reduction to 32b, a considerably lower yield was 
obtained. This may be due to a mismatch between the catalyst and substrate 
causing the diastereoselective reaction to slow down, which would allow a slower 
side process to become more prevalent. This hypothesis is supported by the lack 
of any 32a, which would be the product formed by a non-selective reduction 
pathway, or any 31 remaining after the reaction. 
 
Scheme 20: Diastereoselective reduction to each diastereomer of 32. 
 
The Overman rearrangement of secondary, allylic trichloroacetimidates is known 
to proceed under thermal conditions at around 110 °C or, at higher temperatures, 
over much shorter time scales than for a primary rearrangement.53 As this is less 
forcing than the rearrangement of similar, primary compounds, a short screen of 
conditions under which the Overman rearrangement of 33a and 33b might 
proceed was undertaken (Table 7). 
Initially, a trial of three different temperatures was conducted (Table 7, entries 1–
3). Performing the reaction at 160 °C for 18 hours, a very low yield of 34a was 
obtained as the only product. An improved yield was observed when conducting 
the reaction at 140 °C. However, when the temperature was further lowered to 110 
°C, a portion of the intermediate trichloroacetimidate was recovered. As it had 
been observed in the primary rearrangement, that longer reaction times tended to 
cause decomposition of the product, the reaction was attempted at 140 °C for 8 
hours (entry 4). This gave a much improved yield of the desired product but the 1H 
NMR spectrum of the crude mixture still showed incomplete conversion of the 
imidate. An intermediate duration of 10 hours provided an optimised yield of 71% 
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(entry 6). Using this result as a starting point, it was shown that the reaction at 160 
°C was completed in 3 hours with an almost identical yield (entry 7). Applying the 
group’s knowledge of microwave chemistry, it was shown that the reaction could 
be accelerated using microwave irradiation to finish in only 15 minutes at 140 °C 
(entry 8). The microwave conditions required the addition of a silicon carbide 
passive heating element to the reaction vessel to allow heating, as p-xylene does 
not absorb microwave radiation. Attempting the reaction under each of the three 
conditions produced high yields of diastereomerically pure 34a. Applying the 
optimised conditions to the rearrangement of 33b produced similarly high yields of 
diastereomerically pure 34b (entries 9 and 10). 
 
 
Entry Substrate 
Temperature 
/°C 
Time 
/h 
Solvent 
Heat 
source 
Yield /% 
1 33a 160 18 p-Xylene Oil bath 7 
2 33a 140 18 Toluene Oil bath 36 
3 33a 110 18 Toluene Oil bath 22 (+15% 33a) 
4 33a 140 8 p-Xylene Oil bath 53 (+13% 33a) 
5 33a 140 8 DMF Oil bath Decomposed 
6 33a 140 10 p-Xylene Oil bath 71 
7 33a 160 3 p-Xylene Oil bath 72 
8 33a 140 0.25 p-Xylene µW 72 
9 33b 160 3 p-Xylene Oil bath 77 
10 33b 140 0.25 p-Xylene µW 71 
Table 7: Conditions for Overman rearrangement of allylic imidates 33a and 33b. 
 
With the allylic trichloroacetamides 34a and 34b in hand, repetition of the 
ozonolysis conditions utilised previously allowed access to the same, protected 
phytosphingosines, 30a and 30b. The ozonolysis and reductive work-up again 
proceeded in a good yield for each analogue (Scheme 21 and Scheme 22). 
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Scheme 21: Overman rearrangement and ozonolysis to protected D-ribo-phytosphingosine 
30a. 
 
 
Scheme 22: Overman rearrangement and ozonolysis to protected L-arabino-
phytosphingosine 30b. 
 
1.3 Conclusions 
A 13-step, diastereoselective synthesis of both D-ribo- and L-arabino-
phytosphingosine from the chiral pool starting material D-ribose has been 
developed. This synthesis included the use of cross metathesis to install the long 
chain alkane of the natural products and an Overman rearrangement to install the 
C-2 amine functionality in a diastereoselective manner. Having experienced 
problems with the initial route, via a primary Overman rearrangement, an 
alternative strategy using CBS-reduction of an α,β-unsaturated methyl ketone to 
access each of the chiral secondary allylic alcohols was developed. This method 
allowed the total synthesis of D-ribo- and L-arabino-phytosphingosine in 19% and 
12% yields, respectively. 
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Chapter 2 Development of a One-Pot Multi-
Reaction Process: The Total Synthesis of 
Oxybenzo[c]phenanthridine Natural Products 
2.1 Introduction 
2.1.1 One-pot multi-reaction processes 
In recent years the study of one-pot, multi-reaction, tandem, domino and cascade 
processes has grown rapidly.54–58 The utilisation of multiple transformations within 
a single reaction vessel has a number of advantages over traditional step-wise 
chemistry. These include the minimisation of solvent and other chemical waste by 
the elimination of purification steps for intermediates and potential gains in yield, 
where intermediates are sensitive or volatile. Tandem catalysis processes, in 
particular, where one or more catalysts may perform multiple isolated 
transformations during a single reaction, can reduce the time needed to synthesise 
compounds, as well as the quantity of waste created.56 This can lead to more 
efficient and more environmentally-friendly synthetic routes to compounds. 
There has been a large amount of discussion in the literature over the proper use 
of the terms cascade, domino and tandem. As defined by Nicolaou, in all 
variations of cascade, domino or tandem processes, all reagents or catalysts must 
be present at the initiation of the first reaction.54 A further expansion on this by 
Fogg and dos Santos details that a one-pot process in which:56 
“Modification of an organic moiety via two catalytic elaborations, with 
addition of the second catalyst only after the first catalytic 
transformation is complete, is not a [sic] tandem catalysis, but a one-pot 
(bicatalytic) reaction.”  
In addition, Fogg and dos Santos specify that, for reactions in which there is only a 
single catalytic step in addition to a stoichiometric one, these cannot fall under the 
category of tandem but, may be classed as domino only if all reagents are present 
at the start. As such, in this thesis, where multiple additions and changes in 
reaction conditions are used in the key processes of the projects that will be 
detailed below, the processes will be defined as one-pot multi-reaction, and not as 
cascade, tandem or domino processes. 
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2.1.2 Previous work within the group 
Within the Sutherland group a number of recent projects have focused on the use 
of an Overman-RCM/RCEYM one-pot process. The initial ideas for this process 
came about in 2007 as an extension of the group’s previous work on ether-
directed Overman rearrangements (see section 1.1.2 for information on the ether-
directed process).59 Having demonstrated that the Overman rearrangement could 
be efficiently controlled by an allylic, ether-protected alcohol, the group set about 
synthesising a number of natural products using this methodology. Included in 
these was the piperidine alkaloid, α-conhydrine (Scheme 23).60 In the synthesis of 
α-conhydrine, a deprotection-acylation strategy was utilised to install a second 
alkene in the molecule before using RCM to form the six-membered ring of the 
natural product.  
 
 
Scheme 23: Key steps of the Sutherland group’s synthesis of α-conhydrine in 2007. 
 
This methodology was complicated by the necessity of changing the protecting 
group and the difficulties in attaching the olefin-containing chain. Later in the same 
year, the group published initial attempts at a one-pot Overman-RCM process to 
overcome the limitations observed in the conhydrine synthesis.59 Having reported 
in an intermediate paper that ruthenium-based catalysts had no detrimental effect 
on allylic trichloroacetimidates, the initial idea had been to perform an orthogonal 
tandem-catalysis reaction. In such a reaction both the palladium and ruthenium 
catalysts would be present at the initiation of the reaction. The palladium catalyst 
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would first perform the Overman rearrangement before the ruthenium catalyst 
performed RCM. However, a set-back was encountered in this plan — it appeared 
that the ruthenium metathesis catalysts were decomposing through a side-reaction 
with the palladium(II) catalyst before the completion of the Overman step — and in 
all cases only the intermediate trichloroacetamide-diene was isolated. To 
circumvent this problem, a step-wise addition procedure was utilised that involved 
performing the palladium-catalysed Overman rearrangement at room temperature 
before addition of the ruthenium catalyst and warming to 45 °C to effect the RCM 
(Scheme 24). This allowed access to the desired cyclic allylic amides in high 
yields. The use of chiral (S)-COP-Cl catalyst (S)-1 in this methodology showed 
that it was also possible to obtain high enantioselectivities (94:6 e.r. prior to 
crystallisation) in the one-pot two-step process. 
 
 
Scheme 24: One-pot Overman rearrangement ring closing metathesis reaction. 
aPerformed using Grubbs II. 
 
Having developed a one-pot multi-reaction process for the synthesis of cyclic 
allylic trichloroacetamides, the group utilised this methodology for the total 
synthesis of a number of natural products and drug-like compounds such as 
analogues of (+)-7-deoxypancratistatin.61 This project combined the ether-directed 
Overman rearrangement strategy with the one-pot multi-reaction process. Starting 
from (S)-glycidol (35), in seven steps and an impressive 86% overall yield, the 
allylic alcohol 36 was synthesised (Scheme 25). Using this in the one-pot multi-
reaction process allowed access to the cyclic allylic amide 37 as a single 
stereoisomer. Deprotection of the amide and coupling with 6-bromopiperonylic 
acid gave aryl bromide 38 which was then used in a Heck reaction to close the 
final ring. This compound was then deprotected under acidic conditions to give the 
precursor to the (+)-7-deoxypancratistatin analogues 39. With this compound in 
hand, the synthesis of three analogues of (+)-7-deoxypancratistatin by oxidation or 
reduction of the 1,2-alkene was completed. 
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Scheme 25: The key steps in the synthesis of analogues of (+)-7-deoxypancratistatin using 
a one-pot multi-reaction process. 
 
An obvious extension of this project was the incorporation of an alkyne in place of 
the terminal alkene. This allowed the process to be expanded and the use of 
RCEYM furnished a 1,3-diene which was then used in a Diels-Alder reaction.62 
Again, a short synthetic route to the necessary allylic alcohol was developed. After 
optimising the step-wise process, it was applied as a one-pot three-step procedure 
(Scheme 26). Performing the Overman rearrangement under thermal conditions 
and the RCEYM at 75 °C with Grubbs 1st generation catalyst yielded the required 
1,3-enyne. At this point a number of different dienophiles were used in a Diels-
Alder reaction to form bi- and tri-cyclic compounds. 
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Scheme 26: One-pot three-step reaction sequence allowing access to substituted 
octahydroamidonaphthalenes and hexahydroamidoindenes. 
 
The scope of this methodology was then expanded to include Diels-Alder 
reactions with alkynes and dienes containing heteroatoms in their backbone.63 
This process formed 1,4-dienes, which could then be aromatised using either DDQ 
or manganese dioxide to yield amidoindanes and amidotetralins (Scheme 27). 
This project ignited interest within the Sutherland group in developing new one-pot 
processes that could access these amidoindanes and amidotetralins in a different 
and complimentary manner.  
 
Scheme 27: One-pot two-step process for the synthesis of amidoindanes and 
amidotetralins. 
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2.1.3 The oxybenzo[c]phenanthridine natural products 
The first reported isolation of a member of the benzophenanthridine alkaloids 
dates back to the early 1800s.64 Since then a large number of related 
benzophenanthridine natural products have been isolated and characterised.65 
These natural products have gained significant attention due to their potent 
biological activities. Of particular interest are the fully aromatised 
oxybenzo[c]phenanthridine natural products. A major source of these alkaloids are 
plants of the genus Zanthoxylum. This genus includes around 250 evergreen and 
deciduous shrubs, which grow in temperate and subtropical areas of the globe. 
The bark of a number of these shrubs was historically used for treatment of pain 
and inflammation, amongst other ailments.66 For example Zanthoxylum nitidum, 
which has been used as an anti-inflammatory and analgesic in Chinese medicine 
for over 1000 years, contains a number of benzophenanthridine natural products 
including nitidine (40), dihydrochelerythrine (41), 8-methoxychelerythrine (42) and 
oxyavicine (43) (Figure 5).67 These compounds have been shown to have 
analgesic and anti-inflammatory effects comparable with those of hydrocortisone.67 
 
 
Figure 5: Four of the alkaloid natural products obtained from Zanthoxylum nitidum. 
 
Other members of this family of alkaloids show efficacy against a diverse range of 
biological targets. Examples include oxychelerythrine (44), which displays 
cytotoxic effects against P-388 and HT-29 tumour cell lines,68 oxysanguinarine 
(45) which inhibits platelet aggregation69 and oxynitidine (46) which inhibits DNA 
replication in hepatitis B virus.70 Due to the potent biological activity of a large 
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number of these alkaloids, and the relatively low quantities that can be extracted 
from plant sources, they have been the focus of a large number of syntheses.65 
 
 
Figure 6: Other members of the family of oxybenzo[c]phenanthridine natural products. 
 
2.1.4 Aims 
The aim of this project was to optimise a previously developed one-pot multi-
reaction process for the synthesis of a series of C-1 amido substituted indenes 
and dihydronaphthalenes. This one-pot process would then be applied as the key 
step in the total synthesis of a number of natural products from the 
oxybenzo[c]phenanthridine family. To this end, a rapid and versatile synthesis of 
the 2’-substituted cinnamyl alcohols would also have to be developed (Scheme 
28). 
 
Scheme 28: Proposed access to allylic alcohols and use in one-pot process to form bicyclic 
systems.  
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2.2 Results and discussion 
2.2.1 A rapid synthesis of 2’-vinylcinnamyl alcohols 
2.2.1.1  Stille route to allylic alcohols 
The initial route proposed to gain access to the required 2’-vinylcinnamyl alcohols 
involved the use of a palladium-catalysed Stille coupling between 2-bromobenzyl 
alcohol (47) and vinyl tributyltin (Scheme 29).71–73 It was then necessary to oxidise 
the alcohol 48 to the corresponding benzaldehyde 49a. This oxidation was carried 
out using manganese dioxide. 
 
 
Scheme 29: Initial reactions to access 2’-vinylbenzaldehyde (49a). 
 
Although the Stille coupling was an extremely efficient reaction, giving full 
conversion to the product, by 1H NMR analysis, with no protodehalogenation 
products or starting material returned after the reaction, it was very difficult to 
remove all the by-products derived from the vinyl tributyltin. A number of different 
work-ups and column conditions were investigated. The initial conditions were 
based upon reacting the tributyltin bromide by-product of the reaction with 
potassium fluoride to form the polymeric tributyltin fluoride and potassium bromide, 
then removal of the polymeric compound by filtration or column 
chromatography.74,75 Although a large quantity of the by-products could be 
removed in this way, a significant amount always remained inseparable from the 
desired compound. Differences in the concentration or solvent that the potassium 
fluoride was introduced in made no difference to the outcome of purification. 
Heating with the potassium fluoride or prolonged stirring also had no effect. After 
consultation of the literature, a number of other possibilities were apparent; these 
included filtration through a Celite® or silica and potassium fluoride mixture,76 
repeated washing of the organic liquors with 1 M aqueous potassium fluoride 
solution and column chromatography in a ~2–5% triethylamine elution solvent 
mixture.  
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Upon attempting a procedure by Renaud et al,77 in which 1 M aqueous sodium 
hydroxide was used to form tributyltin hydroxide and bis(tributyltin) ether, which 
are too polar to elute from silica gel under low polarity solvent mixtures, an 
unexpected reaction occurred. Having used the Stille coupling to access benzyl 
alcohol 48, it was observed that the 2-vinylbenzaldehyde 49a had formed. This 
reaction probably goes through the widely accepted mechanism for palladium-
catalysed aerobic oxidation of alcohols.78,79  
By progressing the crude 2’-vinylbenzaldehyde (49a) through an HWE reaction 
with triethyl phosphonoacetate (21), under the Masamune-Roush conditions,45 
then reducing the resulting ester 50a with DIBAL-H, the required cinnamyl alcohol 
51a was formed (Scheme 30). Having carried large quantities of the tributyltin 
side-product through these two steps, it was impossible to gain good 
characterisation data or yields for these reactions. It was, however, possible to 
purify the cinnamyl alcohol at this stage. 
 
 
Scheme 30:  Initial route to 2’-vinylcinnamyl alcohols. 
 
An amended process using benzaldehydes as substrates for the Stille coupling 
was also investigated (Scheme 31). 4,5-Piperonyl-derived analogue 51b and the 
5-fluoro analogue 51c were chosen for their differing electronic properties. In both 
cases it was impossible to separate the products from the tributyltin-related 
impurity until the final step.  
 
Scheme 31: First synthesis of 4,5-piperonyl- and 5-fluoro-derived cinnamyl alcohols. 
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Although the Stille coupling route provided enough material to start optimising the 
one-pot multi-reaction process, it was decided to attempt a different approach to 
synthesising the key 2’-vinylcinnamyl alcohols. There had also been a number of 
other complications in the synthesis of the 2’-allylcinnamyl alcohols through this 
route. These problems will be detailed in section 2.2.3.1. 
2.2.1.2  Suzuki-Miyaura route to allylic alcohols 
Following the problems encountered with the Stille coupling route, it was clear that 
the first step of the sequence had to be efficient, general, simple and high yielding. 
Following a literature search, it was decided to attempt a Suzuki-Miyaura coupling 
of 2-bromobenzaldehyde (52a) and potassium vinyltrifluoroborate with 
palladium(II) dichloride diphenylphosphinoferrocene as the catalyst (Scheme 32).80 
Gratifyingly, this reaction worked in high yield and with no issues with purification 
and little optimisation required. 
 
 
Scheme 32: Suzuki-Miyaura coupling of potassium vinyltrifluoroborate and 2-
bromobenzaldehyde (52a). 
 
Having synthesised the required 2’-vinylbenzaldehydes 49a–f cleanly and in high 
yields using the Suzuki-Miyaura coupling, they were used in an HWE reaction 
using Masamune-Roush conditions (Table 8). This reaction yielded only the E-
ethyl cinnamates 50a–f in very high yields and could be purified by filtration 
through a silica plug. DIBAL-H reduction of the esters gave the desired 2’-
vinylcinnamyl alcohols 51a–f. This methodology allowed the generation of a 
reasonable range of substrates in overall yields of between 71% and 89% over the 
three-step synthesis. 
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Entry 52 49 (%) 50 (%) 51 (%) 
1 
R = H 
52a 
49a (84) 50a (98) 51a (97) 
2 
 
52b 
49b (96) 50b (94) 51b (99) 
3 
R = 5-F 
52c 
49c (91) 50c (89) 51c (97) 
4 
R = 4-Me 
52d 
49d (90) 50d (100) 51d (92) 
5 
R = 5-OMe 
52e 
49e (89) 50e (99) 51e (89) 
6 
 
52f 
49f (89) 50f (87) 51f (92) 
Table 8: Yields for the three-step synthesis of the (E)-2’-vinylcinnamyl alcohols 51a−f. 
 
2.2.2 A one-pot multi-reaction process to form amidoindenes 
Initially, replication of the results previously obtained within the group was the main 
aim (Scheme 33). If these could be replicated then this would form the basis for 
optimisation of the one-pot multi-reaction process.  
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Scheme 33: Previous attempt at one-pot process by Fiona McGonagle in the group.81 
 
Acid-catalysed elimination of the trichloroacetimidate group during purification of 
intermediate 53a on silica had previously been observed to occur on a related 
series of compounds.81 To prevent this, the purification method in this project was 
changed to use Brockman V neutral alumina. 
After a single attempt at the Overman rearrangement, it was noticed that the 
reaction duration needed to be increased to 36 hours as there was still a small 
quantity of the imidate present. Over the course of five reactions, it was found that 
the optimised conditions required to form the desired RCM product, in the fastest 
time with the least catalyst loading, were marginally different from the previous 
conditions. At the end of the RCM reaction (36 h), the reaction mixture was passed 
through a pad of Celite®. The crude material obtained appeared to contain only 
product 54a and the phosphine ligand from the Grubbs I catalyst. 
However, when any of the reaction mixtures were further purified by silica column 
chromatography, a new set of peaks appeared within the 1H NMR spectra (Figure 
7). The quantity of this side-product varied with the length of silica column that was 
used in the purification and so, in some cases, appeared in less than 2% of the 
purified product, while in other cases it was the only recovered compound. Full 
characterisation of this compound could not be obtained but 1H and 13C NMR 
spectroscopy showed that it appeared to be closely related to the desired product. 
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Figure 7: 1H NMR spectrum of isolated, unknown impurity. 
 
Purification of the reaction mixture through neutral alumina gave a small quantity 
of a different compound and a complex mixture of unknown decomposition 
products. At this time, it was decided to investigate if the use of higher temperature 
or a different catalyst might lead to a reaction mixture that could be purified by 
filtration through a very short pad of silica. To this end, the one-pot process was 
repeated in a stepwise fashion (Scheme 34). The optimised conditions for the 
step-wise process showed that, similar to the results for the synthesis of 
phytosphingosine, a higher temperature and shorter reaction duration gave higher 
yields in the Overman rearrangement. In addition, Grubbs 2nd generation catalyst 
gave a marginal improvement in yield for the RCM process and could be used at 
just one third of the loading required for Grubbs 1st generation. It was also found 
that increasing the temperature during the RCM reaction from room temperature to 
50 °C improved the conversion. 
 
Scheme 34: Optimisation of step-wise Overman rearrangement and RCM process. 
 
These optimised conditions were then applied as a one-pot process to the small 
family of 2’-vinylcinnamyl alcohols previously synthesised (Scheme 35). Despite 
achieving a very high yield of 82%, over the three steps for the unsubstituted 
analogue 54a, the yields were lower for the other analogues. Although the reaction 
is tolerant of electron-donating and withdrawing substituents, even a slightly 
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electron-donating group such as the 4-methyl substituent, 54d, began to affect the 
yield adversely. The lowering of yield became more pronounced on the addition of 
more electron-donating substituents such as a 5,6-methylenedioxy 54b or 5-
methoxy 54e. Electron-poor compounds, such as 5-fluoro-substituted analogue 
54c, were also tolerated, but again in slightly lower yield than the unsubstituted 
substrate. In the case of the naphthyl-derived analogue, 54f, the reduced yield 
was due to isomerisation of the product to the enamide under the reaction 
conditions of the RCM step. It was observed that by reducing the reaction time to 
12 hours, a better ratio of products could be obtained in the crude mixture (6:1 vs 
2:1), as observed by 1H NMR spectroscopy, and this led to the desired product 
being obtained in a higher yield (56% vs 14% yields). 
 
 
Scheme 35: Optimised yields for the one-pot multi-reaction process. aRCM reaction 
carried out for 12 hours. 
 
2.2.3 A rapid synthesis of 2’-allylcinnamyl alcohols 
2.2.3.1  Stille route to allylic alcohols 
As for the synthesis of the vinylcinnamyl alcohols, initial attempts at synthesising 
the 2’-allylcinnamyl alcohols focused on using Stille methodology. However, upon 
attempting the Stille coupling, it was observed that a mixture of isomers was 
forming (Scheme 36). This had been previously observed in the original work on 
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these systems within the group where an inseparable mixture that ranged from 2:1 
to 30:1 had been reported.81 
 
 
Scheme 36: Initial attempts at Stille coupling with allyl tributyltin. 
 
It was observed that under reflux conditions, the palladium(0)-catalysed 
isomerisation of the double bond occurred at a comparable rate to that of the Stille 
coupling itself. Reduction of the reaction time resulted in the isolation of only a 
mixture of starting material and both isomers. Lowering the temperature to 80 °C 
allowed the reaction to progress to a single, non-isomerised product. 
Unfortunately, the same problems encountered in the vinyl Stille coupling, with 
regards to removal of the tin by-products were experienced here. It was at this 
point that the change to using a Suzuki-Miyaura coupling for the synthesis of the 
vinyl systems was made. Having observed that using Suzuki-Miyaura chemistry 
greatly simplified the process of preparing vinylcinnamyl alcohols, similar 
methodology was investigated for the synthesis of 2’-allylcinnamyl alcohols. 
2.2.3.2  Suzuki-Miyaura route to allylic alcohols 
Examining the literature around the planned allyl-Suzuki-Miyaura coupling 
highlighted two points. Firstly, using the potassium allyltrifluoroborate would most 
likely yield the internal isomer of the olefin 5582 and secondly, that performing the 
Suzuki-Miyaura coupling before the HWE reaction would give a competing side 
reaction between the allyl borate and the aldehyde and lead to homoallylic 
alcohols such as 56 (Scheme 37).83–85 
 
 
Scheme 37: Expected problems with performing the Suzuki-Miyaura reaction as the 1st 
step of synthesis. 
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To circumvent these issues it was decided that the HWE reaction would be 
performed first, followed by the Suzuki-Miyaura reaction using allylboronic acid 
pinacol ester (58). This boronate ester is both commercially available and easily 
synthesised.86,87 
The HWE reaction proceeded in high yields under the same conditions used for 
the 2’-vinylcinnamyl alcohol synthesis, with no optimisation necessary, and again 
yielded the E-isomers as the sole product (Scheme 38). The starting material, 52h, 
for the furan-derived analogue 57h was synthesised in a single step by the 
formylation, under Rieche conditions, of 3-bromofuran with dichloromethyl methyl 
ether and titanium tetrachloride, in a 96% yield.88 
 
 
Scheme 38: Results of the HWE reaction of various 2-bromobenzaldehydes. 
 
Under the initial conditions, the Suzuki-Miyaura coupling proceeded in a high yield 
for electron-poor bromides such as the fluorine containing analogue 57c (Scheme 
39).89,90 However, optimisation was needed before it could be applied to electron-
rich substrates. It was observed that, under the conditions utilised for the electron-
poor analogues, an inseparable mixture of product 59e and proto-dehalogenated 
side-product 60 was obtained (Scheme 40 and Table 9, entry 1).  
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Scheme 39: Suzuki-Miyaura coupling of electron-poor aryl bromide. 
 
 
 
Scheme 40:  Initial problems with Suzuki-Miyaura coupling on electron-rich aryl bromide 
57e. 
 
Initially, changing the catalyst to dichloropalladium(II) diphenylphosphinoferrocene 
was attempted; this gave both an increase in yield and a decrease in 
debromination (entry 2). It was then observed that at lower temperatures, 
debromination was completely halted with either catalyst, but that the reaction now 
no longer proceeded to completion (entries 3 and 4). The number of equivalents of 
allylboronic acid pinacol ester (58) was then increased, raising the conversion to 
59e and the yield to near quantitative levels (entries 5 and 6). 
Entry Catalyst 
Equivalents 
of 58 
Temperature 
/°C 
Time 
/h 
Yield 
/%a 
Ratio of 
57e:59e:60b 
1 Pd(PPh3)4 1.5 101 18 44 0:2:1 
2 PdCl2(dppf) 1.5 101 18 85 0:10:1 
3 Pd(PPh3)4 1.5 85 24 84 2:3:0 
4 PdCl2(dppf) 1.5 85 24 86 3:7:0 
5 PdCl2(dppf) 4.0 85 24 98 0:1:0 
6 PdCl2(dppf) 2.0 85 24 99 0:1:0 
Table 9: Optimisation of Suzuki-Miyaura chemistry for 59e. 
a
Yield of mixture of 
products 59e and 60. 
b
Calculated from 
1
H NMR spectra of purified mixture. 
 
These optimised conditions were then applied to the synthesis of the other 
analogues (Table 10). Performing the Suzuki-Miyaura coupling and then reducing 
the ester with DIBAL-H allowed access to a group of nine 2’-allylcinnamyl alcohols 
in very high yields over the three steps. A small amount of modification of the 
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optimised conditions was required for the synthesis of the naphthyl-derived 
analogue 59f (Table 10, entry 6). Performing the Suzuki-Miyaura coupling at 101 
°C and increasing the number of equivalents of 58 to 2.5 gave a quantitative yield 
of 59f. This was necessary due to the extra steric hinderance of the second ring. 
The pyridine-derived analogue 57i did not perform as well in the Suzuki-Miyaura 
coupling and suffered from increased proto-dehalogenation (entry 9). However, 
unlike the other analogues, the desired product 59i could be separated from the 
side-products by column chromatography.  
 
Entry 57 59 (%) 61 (%) 
1 
R = H 
57a 
59a (100) 61a (81) 
2 
 
57b 
59b (100) 61b (97) 
3 
R = 5-F 
57c 
59c (98) 61c (92) 
4 
R = 4-Me 
57d 
59d (99) 61d (88) 
5 
R = 5-OMe 
57e 
59e (99) 61e (82) 
6 
 
57f 
59f (98)a 61f (93) 
7 
R = 4-CF3 
57g 
59g (100) 61g (93) 
8 
 
57h 
59h (100) 61h (96) 
9 
 
57i 
59i (77) 61i (88) 
Table 10: Optimised yields for the synthesis of 2’-allylcinnamyl alcohols. aReaction 
performed at 100 °C with 2.5 eq of 58. 
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2.2.4 A one-pot multi-reaction process to form 
amidodihydronaphthalenes 
The initial attempts at performing the one-pot multi-reaction process on the 2’-
allylcinnamyl alcohols were based around the optimised conditions for the 
synthesis of amidoindenes. However, while optimising these conditions, a side-
*product was formed in as much as a 2:1 ratio versus the desired product. The 1H 
NMR spectra of this side-product showed that it was closely related to both the 
allylic alcohol 61e and the allylic imidate 62e and was always accompanied by a 
broad doublet corresponding to the NH2 group of trichloroacetamide (64). It was 
thought that this impurity could be one of two compounds: the product of [1,3]-
rearrangement, the allylic trichloroacetamide 63 (Scheme 41, top path); or the 
product of hydrolysis of the imidate back to the allylic alcohol 61e and 
trichloroacetamide (64) (Scheme 41, bottom path).  
 
 
Scheme 41: Possible decomposition routes in Overman rearrangement. 
 
The [1,3]-rearrangement is a known reaction under palladium(0)-catalysed 
Overman conditions or in the presence of catalytic quantities of acid.10 However, 
isolation of a [1,3]-product under thermal Overman conditions in the presence of 
potassium carbonate is unprecedented; this meant a metal contaminant would 
have had to be present for the [1,3]-reaction to have occurred. To minimise the 
chances of the side-product coming from small quantities of metal contaminants 
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on the Schlenk tubes, the reaction was carried out in a previously unused 
microwave vial. This had no effect on the ratio of product to side-product. 
To investigate the possibility of the side-product coming from hydrolysis of the 
imidate, 5 Å molecular sieves were added to the Overman rearrangement step. 
This improved the ratio of product to side-product from 1:2 to 2:1. Following this 
observation, a fresh bottle of anhydrous p-xylene was purchased. It was also 
observed, during this investigation, that the imidate formation was complete in only 
one hour and that, especially in the case of the electron-rich analogues, prolonging 
this step or not using the imidate quickly after its synthesis, gave a lower ratio 
between [3,3]-product and the side-product. In the optimised process, the allylic 
alcohol was dried under high vacuum before use, the imidate formation was 
carried out in one hour and the imidates were kept dry and used rapidly. These 
changes prevented hydrolysis of the imidate and hence greatly improved the yield 
of the reaction. 
Using the optimised conditions for the imidate formation and one-pot process, it 
was possible to synthesise eight of the target molecules (Scheme 42). The 
process tolerates both electron-rich and -poor systems with little change in yield. In 
the case of the piperonyl-derived analogue 65b it was shown that, upon scaling up 
the reaction to 9 mmol, the catalyst loading for this reaction could be lowered to 
2.5 mol%. The trifluoromethyl substituted analogue 65g required two additions of 5 
mol% of catalyst over a 48 hour period and heating to 50 °C before the reaction 
reached completion. 
In the case of the pyridine-derived analogue, two problems were encountered. 
After the Overman rearrangement step it was observed that the alkene of the allyl 
chain had isomerised to give 65i. This problem was not investigated further, 
however, as when RCM was attempted on this compound, the reaction failed. This 
is due to the nitrogen of the pyridine ligating the Grubbs 2nd generation catalyst. 
This is well precedented and can be avoided by using the N-alkyl salt, or by 
making the hydrochloride salt of the pyridine.91,92 These methods would have 
required protection of the pyridine at the start of the synthesis as the N-alkyl 
species or the addition of hydrochloric acid between the Overman rearrangement 
and RCM steps. 
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Scheme 42: Optimised yields for the one-pot multi-reaction process. aThe RCM step was 
performed using 2.5 mol% of Grubbs 2nd generation catalyst. bThe RCM step required 10 mol% 
of Grubbs second generation catalyst and was performed at 50 °C over 48 h. 
 
2.2.5 The total synthesis of four oxybenzo[c]phenanthridines 
Having demonstrated that a scalable, robust one-pot process had been 
developed, the next goal was the total synthesis of a number of 
oxybenzo[c]phenanthridine natural products. Initially, deprotection of the piperonyl-
derived product 65b under the standard acidic or basic conditions was envisioned 
(Scheme 43). This would then be followed by an amide coupling with a substituted 
2-bromobenzoyl chloride and N-methylation of this amide. This would give an aryl 
bromide for use in an intramolecular Heck coupling to give a precursor that could 
be aromatised to yield oxysanguinarine (45). 
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Scheme 43: Initial approach to oxybenzo[c]phenanthridine natural products. 
 
The proposed first step was to deprotect the amido-dihydronaphthalene 65b. 
Under the mildest basic conditions attempted, elimination of the trichloroacetamide 
moiety was the major product (Table 11). Changing to a more nucleophilic base, 
such as barium hydroxide, caused a larger quantity of elimination to be observed. 
However, using acidic deprotection conditions, elimination was the only process 
observed. Under reductive conditions, that have rarely been used, the elimination 
process was also the only observed process.93 
 
 
Entry Reagent Conditions 66:(67+64) 
1 6 M NaOH 65 °C, 48 h 1:1 
2 Ba(OH)2.8H2O 65 °C, 72 h 1:14 
3 6 M HCl 65 °C, 48 h 0:1 
4 DIBAL-H −78 °C, 2 h 0:1 
Table 11: Results for basic, acidic and reductive deprotections. 
 
As it was clear that there was a significant driving force for 65b to become 
aromatic, the synthetic route was altered. By first aromatising 65b to 68, it was 
assumed that the deprotection step would become trivial. Deprotection would now 
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yield a substituted naphthylamine 70 which could then be coupled with a variety of 
2-bromobenzoyl chlorides before using a Heck coupling to close the final ring and 
yield four oxybenzo[c]phenanthridine natural products, through a similar route to 
that reported by Harayama and co-workers.94–100  
Indeed, aromatisation of the one-pot process product 65b proceeded in a high 
yield with the remainder of the mass made up of the product of benzylic oxidation 
69 (Scheme 44). This side-product could not be eliminated, even under strictly 
degassed conditions or by changing the temperature of the reaction, but was 
easily separated by column chromatography. Deprotection to the naphthylamine 
70 occurred under acidic conditions. The milder basic conditions were not 
attempted as the acidic conditions gave an almost quantitative yield from the first 
attempt. 
 
 
Scheme 44: Aromatisation and deprotection of the one-pot process product. 
 
Four benzoic acids were needed to acess the four oxybenzo[c]phenanthridine 
targets. Two of these were commercially available, while two had to be 
synthesised (Scheme 45). The first of these was prepared by ortho-bromination101 
of benzoic acid 71 and the other through Pinnick oxidation,102 from its 
corresponding 2-bromobenzaldehyde 52b. 
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Scheme 45: Syntheses of the two commercially unavailable 2-bromobenzoic acids. 
 
With the amine 70 and acids 72a–d in hand, the use of a number of coupling 
agents for the formation of the amides was investigated (Table 12). Optimisation 
was initially performed with acid 72b. Using either HBTU or CDI coupling agents 
returned only starting materials (Table 12, entries 1 and 2) while both EDCI and 
the triphenylphosphine/DDQ conditions103 gave low yields (entries 3 and 4). All of 
these results were attributed to the amine not being sufficiently nucleophilic. Acid 
chloride formation, followed by reaction with the amine 70 was then investigated. 
Initially, oxalyl chloride and DMF were tried, but also gave a poor yield (entry 5). It 
is believed that the DMF may not have been sufficiently dry for these conditions 
as, when acid chloride formation with thionyl chloride was attempted as the 
activation step, a yield of 89% was obtained (entry 6). 
 
 
Entry Conditions Yield /% 
1 HBTU, DIPEA, 50 °C, 8 days NR 
2 CDI, NEt3, 70 °C, 19 h NR 
3 EDCI, DMAP, 60 °C, 18 h 18 
4 PPh3, DDQ, rt, 10 mins 20 
5 (COCl)2, DMF, NEt3, 0 °C to rt then 50 °C, 2 h 5 
6 SOCl2, DIPEA, 0 °C to rt, 2 h 89 
Table 12: Screened conditions for amide coupling. 
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Having optimised the conditions for amide coupling, they were then applied to the 
set of four benzoic acids, 72a–d that would ultimately allow the preparation of four 
oxybenzo[c]phenanthridine natural products. The amide couplings were then 
performed under the optimised conditions before methylation with sodium hydride 
and methyl iodide (Scheme 46). 
 
Scheme 46: Amide formation and N-methylation steps. 
 
The group of Harayama has published a number of papers on the intramolecular 
Heck coupling of similar aryl halides (Scheme 47).94–100 In their system bromides 
and iodides, as well as a triflate on one occasion, were used.95–97 They showed 
that aryl halides containing a 6-position substituent on the halogenated phenyl ring 
can undergo the Heck reaction with 20 mol% of palladium(II) acetate and 40 mol% 
of tri-ortho-tolyl phosphine in very high yields.96 However, in the case of systems 
that are lacking this 6-position substituent, they were forced to use stoichiometric 
quantities of palladium and two equivalents of ligand, even when using the more 
reactive iodide.97 This marked change in reactivity can be explained by envisioning 
the conformation that these compounds must adopt for the reaction to occur. In 
the case of the 6-substituted compounds, such as those leading to 
oxychelerythrine (44), there will be steric repulsion between the 2-position- or the 
6-position-substituent and the hydrogen at the reaction centre of the other ring. 
This must be overcome for the reaction to occur, hence the high temperatures. 
However, in the case of the substrates lacking in a 6-position substituent, the 6-
position is now, relative to the 2-position, unhindered. This leads to an 
unfavourable pre-organisation within the molecule, where the halide is 
preferentially kept away from the naphthyl ring system, resulting in the lower 
reactivity of these substrates. 
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Scheme 47: Work by Harayama and co-workers on the Heck reaction for the synthesis of 
oxybenzo[c]phenanthridine natural products.96–98 
 
Early attempts in this project followed the precedent of Harayama and co-workers 
closely.96–98 For the synthesis of oxychelerythrine (44), from 74a, it was possible to 
use the palladium(II) acetate and tri-ortho-tolyl phosphine conditions and achieve a 
yield of 97%. However, upon attempting Harayama’s conditions for the synthesis 
of oxynitidine (46), using the less reactive bromide 72d, no product was obtained. 
It was clear that the bromides, lacking a 6-position substituent, could not be used 
with Harayama’s conditions while obtaining a good yield of product. 
Instead, it was decided to change the catalyst. One of the problems that had been 
noted, upon attempts at using Harayama’s conditions for the synthesis of 
oxynitidine, was that palladium black was precipitating from the solution within 30 
minutes of the mixture reaching reaction temperature. With this in mind, a catalyst 
with similar properties to the tri-o-tolyl phosphine/palladium(II) acetate mixture, that 
would have better longevity at high temperatures, was desirable. The Herrmann-
Beller palladacycle fits these traits (Figure 8).104,105 This palladacycle catalyst has 
been used for sterically congested Heck and Suzuki-Miyaura couplings at high 
temperature, has a slower release of the active palladium(0) species and has been 
shown to have a greater stability at these increased temperatures than the 
palladium(II) acetate/tri-o-tolyl phosphine combination system that it derives from. 
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Figure 8: The structure of the Herrmann-Beller palladacycle. 
 
Using this catalyst, the desired biaryl Heck coupling with all four of the aryl 
bromides was performed (Scheme 48). These reactions took a varying amount of 
time and, in the case of the two analogues lacking a 6-position substituent, 
required a slightly higher catalyst loading. This allowed access to oxyavicine (43), 
oxychelerythrine (44), oxysanguinarine (45) and oxynitidine (46) in 11 steps and 
38%, 46%, 42% and 38% overall yields, respectively. 
 
 
Scheme 48: Final step in the synthesis of oxyavicine, oxychelerythrine, oxysanguinarine 
and oxynitidine. a20 mol% of the Herrmann-Beller palladacycle used. 
  
2.2.6 Conclusions 
A highly efficient and easily scalable three step synthesis of 2’-vinyl and 2’-
allylcinnamyl alcohols has been developed. These cinnamyl alcohols have been 
used to prepare the corresponding allylic trichloroacetimidates which are the 
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starting materials for a one-pot multi-reaction process involving an Overman 
rearrangement and ring closing metathesis. This one-pot process has been 
optimised to allow the high yielding synthesis of six amidoindenes and eight 
amido-1,4-dihydronaphthalenes. One of these amido-1,4-dihydronaphthalenes has 
then been progressed through a divergent five-step route to allow the synthesis of 
four oxybenzo[c]phenanthridine natural products in a total of 11-steps and 
between a 38% and 46% overall yield. 
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Chapter 3 Development of a One-Pot Multi-
Reaction Process: The Synthesis of Amido 
Benzoxepine scaffolds 
3.1 Introduction 
3.1.1 Benzoxepines in drug molecules 
The benzoxepine framework is found in a number of natural products and 
biologically active molecules.106–109 One example of this is pterulone (75), which 
was shown to have antibiotic qualities (Figure 9).106–108 The 5-amino-1-
benzoxepines are a pharmaceutically relevant sub-class of the benzoxepines 
containing compounds such as pyrrolidin-2-one substituted benzoxepine 76, which 
is a weak potassium channel activator and smooth muscle relaxant.110 Other 
examples include an inhibitor of human cytomegalovirus (HCMV) 77,111 which is 
active at micromolar levels, a class of acyl-CoA, cholesterol O-acyl transferase 
(ACAT) inhibitors based around the core 78 and a sub-micromolar Src homology 2 
domain binder 79.112 
 
 
Figure 9: Examples of the benzoxepine scaffold in natural products and biologically 
active compounds. 
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3.1.2 Previous work within the group on heterocyclic scaffolds 
As previous work within the Sutherland group had developed a rapid route to 
cyclic allylic amides with an all-carbon ring system, an obvious extension was to 
include a heteroatom in the backbone of the compounds. To synthesise the 
required allylic alcohols for this one-pot process, a different route had to be utilised 
(Scheme 49).113 Starting from 2-aminoethanol (80) and selectively alkylating the 
amine gave alcohol 81. This alcohol was then protected as the TBDPS ether to 
allow Boc protection of the secondary amine, granting access to compound 82. 
Deprotection of the alcohol with TBAF returned primary alcohol 83, which was 
then used in a one-pot Swern/Wittig reaction to yield the α,β-unsaturated aldehyde 
84. This was reduced with sodium borohydride in methanol to give the desired 
allylic alcohol 85. The standard approach within the group of using a one-pot 
Swern/HWE with triethyl phosphonoacetate (21) followed by DIBAL-H reduction of 
the resulting ester was attempted, but gave a complex mixture of compounds. This 
was attributed to a 1,4-addition competing with the 1,2-reduction of the α,β-
unsaturated ester, which could occur through complexation of the metal hydride 
with the heteroatom.114 
 
Scheme 49: Synthesis of the allylic alcohol 85 for a heterocyclic variant of the one-pot 
process. 
 
Having successfully synthesised the heteroatom containing allylic alcohol 85 it was 
then transformed to the corresponding allylic trichloroacetimidate using 
trichloroacetonitrile and DBU in dichloromethane (Scheme 50). The imidate was 
then used in a one-pot palladium(II)-catalysed Overman rearrangement and RCM 
sequence to form the 7-membered nitrogen containing cyclic allylic amide 86.  
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Scheme 50: Heteroatom containing variant of one-pot Overman/RCM process. 
 
As cyclic allylic amides are known to be good substrates for directed epoxidation 
and dihydroxylation reactions, the further functionalisation of the one-pot 
Overman/RCM products was investigated. Starting from the Boc-protected one-pot 
process product 86, epoxidation using m-CPBA yielded the cis-epoxide 87.115 This 
was then treated with lithium aluminium hydride to open the epoxide and form the 
cis-oxazolidinone 88. Without further purification the oxazolidinone was hydrolysed 
and the Boc protecting group removed with hydrochloric acid in methanol to give 
the cis-3-aminoazepin-4-ol 89. To form the cis-diol, directed dihydroxylation of the 
one-pot process product 86 under the Donohoe conditions with OsO4 and TMEDA 
was used.116 This gave the all cis-diol amide 90. This was deprotected by 
hydrolysis under basic conditions to cleave the trichloroacetamide and then acidic 
conditions to remove the Boc group, to give the cis-3-aminoazepin-4,5-diol 91. 
 
 
Scheme 51: Previous work on oxidation of one-pot Overman/RCM process products. 
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3.1.3 Aims 
The aim of this project was to optimise the previously developed one-pot multi-
reaction process to allow the synthesis of a series of amido-substituted 
dihydrobenzoxepines (Scheme 52). This methodology would then be applied to 
the synthesis of a benzoxepine-containing ACAT inhibitor and a number of 
biologically active hydroxylated amidotetrahydrobenzoxepine scaffolds. 
 
 
Scheme 52: Proposed access to 2’-allyloxy cinnamyl alcohols and use in one-pot multi-
reaction process to form 5-amido-2,5-dihydrobenzoxepines. 
 
3.2 Results and discussion 
3.2.1 A rapid synthesis of 2’-allyloxycinnamyl alcohols 
As for the 5- and 6-membered ring forming processes (Section 2.2), a rapid route 
to the 2’-substituted cinnamyl alcohols was necessary. For the formation of the 
oxygen-containing 7-membered ring, a 2’-allyloxy substituent was required. To 
attach this, allylation of a range of 2-hydroxybenzaldehydes 92a–h with allyl 
bromide was carried out (Scheme 53).117 This method of allylation is fast, high 
yielding and requires only an aqueous work-up to isolate the product. The chosen 
analogues allowed testing of the scope of the synthesis and the one-pot process. 
They included a very electron-poor, nitro-substituted analogue 93b and a very 
electron-rich diethylamine-substituted analogue 93h. Analogues 93c and 93d were 
included as they would allow for further functionalization of the ring system after 
the one-pot process. The three methoxy-substituted analogues 93e–g were used 
to probe if there would be a difference in the synthesis, or the one-pot process, if 
the substituents were moved between the ortho-, meta- or para-positions. 
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Scheme 53: Allylation of 2-hydroxybenzaldehydes. 
 
Having synthesised a number of 2-allyloxybenzaldehydes 93a–h in very high 
yields, an HWE reaction under the Masamune-Roush conditions was used to form 
the E-cinnamates 94a–h (Table 13). With these in hand, DIBAL-H reduction 
yielded the desired 2’-allyloxy cinnamyl alcohols 95a–h. This methodology allowed 
extremely rapid access to the eight desired compounds in very high yields. 
 
 
Entry 93 94 (%) 95 (%) 
1 R = H, 93a 94a (95) 95a (87) 
2 R = 5-NO2, 93b 94b (91) 95b (88) 
3 R = 5-Cl, 93c 94c (92) 95c (95) 
4 R = 5-Br, 93d 94d (97) 95d (90) 
5 R = 4-OMe, 93e 94e (100) 95e (100) 
6 R = 5-OMe, 93f 94f (100) 95f (83) 
7 R = 6-OMe, 93g 94g (85) 95g (90) 
8 R = 4-NEt2, 93h 94h (95) 95h (92) 
Table 13: Optimised yields for the synthesis of 2’-allyloxy cinnamyl alcohols. 
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3.2.2 A one-pot multi-reaction process to form 5-amido-2,5-
dihydrobenzoxepines 
Although results previously obtained within the group provided a good basis for the 
optimisation of the one-pot process, there was still the opportunity for further 
improvement (Scheme 54).81 In particular, the 30 mol% loading of Grubbs 1st 
generation catalyst and the five day reaction time for the RCM step were seen as 
points for optimisation. 
 
Scheme 54: Previous attempt at one-pot process (McGonagle, unpublished data).81 
 
In the development of the one-pot process for the synthesis of amidoindenes, it 
had been observed that raising the temperature of the Overman rearrangement 
reaction to 160 °C contributed to a much higher yield than had been previously 
reported (Scheme 34, Section 2.2.2). Attempting to increase the temperature to 
160 °C with the first three analogues synthesised (95b, 95e and 95h) resulted in 
the decomposition of all three (Scheme 55). In the case of 95h, the imidate 
decomposed as soon as it was synthesised. The imidates of 95b and 95e were 
both found to be more stable. However, after heating to 160 °C for 18 hours then 
performing RCM with Grubbs 2nd generation catalyst at room temperature 
overnight, nothing could be isolated from the reaction of 95e, while 95b had ring-
closed to form a six-membered ring containing compound 97. In both cases this 
was presumably the result of the imidate starting materials and amide products of 
the Overman rearrangement being unstable at the reaction temperature, while the 
imidate of 95b rearranges and decomposes at a slower rate and so is still present 
after 18 hours and is ring closed to form 97. 
Chapter 3 The Synthesis of Amido Benzoxepine Scaffolds 68 
 
 
Scheme 55: First attempts at optimising the one-pot process for the synthesis of 
benzoxepines. 
 
At this point, 95h was abandoned as the imidate was too unstable to use. For the 
two other analogues the Overman rearrangement was performed at 140 °C 
(Scheme 56). It was observed that there was a very strong relationship between 
the electronics of the aryl ring and the rate of the Overman rearrangement. In the 
case of the nitro-containing analogue 96b, the reaction required 59 hours at 140 
°C to proceed to completion, while the methoxy-substituted compound 96e needed 
only 18 hours at the same temperature. It was also found that increasing the 
temperature of the RCM step from room temperature to 50 °C improved the 
cleanliness of the reaction. 
 
Scheme 56: Optimisation of one-pot process for amidobenzoxepine synthesis. 
 
During the optimisation of this process, it was noticed that when the imidate 
formation was left for any longer than three hours, there was a large decrease in 
overall yield. Following this observation, the duration of the imidate formation was 
reduced to one hour and the yields for all analogues increased (Scheme 57). In 
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particular, the yields for the electron-rich analogues showed the greatest 
increases. It was found that all of the electron-poor analogues, 96b–d, required 
longer reaction times and, to drive the nitro-substituted analogue to completion, a 
second addition of Grubbs 2nd generation catalyst was necessary. 
 
 
 
Scheme 57: Optimised yields for the one-pot multi-reaction process. aPerformed by 
Salaheddin Sharif in the group, included for completeness. bThe Overman rearrangement 
required an extended reaction time (59 h, 96b and 96c, 48 h, 96d). c7.5 mol % of Grubbs 2nd 
generation catalyst was used for the RCM step. 
 
3.2.3 An altered route for the partial synthesis of a drug target 
Having shown the generality of this process, the next aim was to apply it to the 
synthesis of a biologically relevant molecule. The target chosen was the ACAT 
inhibitor 102 (Scheme 58). It was initially proposed that Suzuki-Miyaura coupling of 
a halogen-containing product of the one-pot process 98 would allow direct, late-
stage formation of the biaryl system, 99. This could then be followed by selective 
hydrogenation to remove the alkene without dechlorinating the trichloroacetamide. 
The amine would be deprotected to give 100 before being reductively aminated 
with heptaldehyde to give 101 and coupled with an isocyanate to give the target 
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compound 102. This method would allow a great deal of flexibility in the groups 
attached to the core and would therefore be of interest for the synthesis of a family 
of compounds related to the ACAT inhibitor 102. 
 
Scheme 58: Proposed synthesis of ACAT inhibitor 102. 
 
As the 7-bromo-substituted compound 96d had already been made, a few 
attempts at this reaction sequence were carried out using it as a model substrate 
(Scheme 59). However, it was found that under all conditions attempted, the 
Suzuki-Miyaura coupling would not proceed and only returned starting materials, 
protodehalogenated starting material or complex mixtures.  
 
 
Scheme 59: Attempted Suzuki-Miyaura coupling of 96d and 4-fluorophenylboronic acid. 
 
Instead the synthetic route was redesigned to place the formation of the biaryl 
system near the start of the route, hopefully leading to fewer complications in the 
later parts of the project. The new route required the synthesis of 2-hydroxy-4-
iodobenzaldehyde (104a) by formylation of 3-iodophenol (103, Scheme 60).118–120 
Although this method of synthesising 104a showed some promising initial results, 
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the formation of the 1,2,3-substituted isomer 104b in significant quantities, which 
could not be separated from the desired product 104a without significant loss 
(isolated yields of 104a were less than 25%), led to this route being abandoned. 
 
 
Scheme 60: Formylation of 3-iodophenol 103. 
 
Instead, starting from the commercially available methyl 2-hydroxy-4-iodobenzoate 
(105) and performing a Suzuki-Miyaura coupling with 4-fluorophenylboronic acid 
gave quantitative access to biaryl compound 106 (Scheme 61).121 This was then 
reduced with lithium aluminium hydride to the corresponding benzyl alcohol 107 in 
quantitative yield. 
 
 
Scheme 61: Suzuki-Miyaura coupling and LiAlH4 reduction to synthesise benzyl alcohol 
107. 
 
Mono-allylation under a modified version of the allylation conditions used for the 
synthesis of the 2-allyloxybenzaldehydes 93a–h, then allowed access to the 2-
allyloxy-substituted benzyl alcohol 108 (Scheme 62). Selectivity for the phenolic 
alcohol over the benzyl alcohol was achieved here due to the relative pKas of the 
two alcohols (~10 vs ~16). Under these conditions only the phenol was 
deprotonated. The catalytic quantity of sodium iodide was used to enhance the 
rate of reaction. This rate enhancement occurs through the Finkelstein reaction122 
of sodium iodide and allyl bromide to form allyl iodide, which is more susceptible to 
SN2 attack by the deprotonated phenol. The SN2 reaction releases the iodide anion 
back into solution where it can perform another Finkelstein reaction. This method 
leads to high yield of the mono-allylated benzyl alcohol 108. The benzyl alcohol 
was then used in a one-pot Swern/HWE reaction to form the E-ethyl cinnamate 
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109 in a high yield. Reduction of the ester with DIBAL-H then gave the 2’-allyloxy 
cinnamyl alcohol 110 required for the one-pot Overman/RCM process. 
 
Scheme 62: Synthesis of 2’-allyloxy cinnamyl alcohol 110. 
 
The one-pot process was performed using allylic alcohol 110 at 140 °C for 18 
hours and gave the desired 8-aryl-benzoxepine 99 in an almost quantitative yield 
over three steps (Scheme 63). The greatly increased yield with respect to the 
other analogues could be due to the stabilisation of the intermediate imidate by the 
electron-withdrawing fluorine substituent. However, as this stabilisation and 
increase in yield by an 8-position electron-withdrawing group was not observed in 
the case of the 8-chloro-substituted analogue synthesised by Salaheddin in the 
group, and as no other biaryl analogues were synthesised, this explanation 
remains speculative.123 
 
Scheme 63: One-pot process for the synthesis of the 8-aryl-benzoxepine 99. 
 
With the core of the compound now synthesised, the next goal was to hydrogenate 
the alkene and deprotect the amine to allow reductive amination and urea 
formation (Scheme 58). First of all, hydrogenation was performed on a model 
system. Using the 7-bromo analogue 96d it was possible to selectively reduce the 
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alkene to 111, without removing any of the chlorines from the trichloroacetamide 
nor the aromatic bromide under the standard palladium on carbon conditions. 
These were then applied to the biaryl system 99 (Scheme 64). Unfortunately, 
under these conditions a 38% yield of mono-dehalogenated product 113 was 
isolated in addition to an inseparable 1:7 mixture of starting material 99 and 
product 112. 
 
 
Scheme 64: Hydrogenations of 96d and 99. aCalculated from 1H NMR spectrum of isolated 
mixture of starting material 99 and product 112. 
 
Instead of trying to optimise this reaction or use a different catalyst, an alternative 
method of hydrogenation was pursued. Metal-free hydrogenation conditions 
provided an attractive route and can be achieved using diimide.124,125 There are 
three main methods for the in situ generation of diimide. These are: oxidation of 
hydrazine with oxygen in the presence of a copper(II) catalyst and/or a carboxylic 
acid;126 decarboxylation of dipotassium azodicarboxylate in the presence of an 
acid;127–130 and thermal decomposition of sulfonylhydrazides.131 As a metal-free 
process was desired, the first of these options was not explored. Although it was 
possible to generate dipotassium azodicarboxylate relatively easily, through the 
basic deamination of azodicarboxamide, its handling and use proved to be too 
problematic due to the sensitivity of the compound. Basic, thermal decomposition 
of tosyl hydrazine to form diimide was therefore investigated (Scheme 65). 
Although this process gave a high yield of the desired product 112, ten equivalents 
of tosyl hydrazine and potassium acetate were necessary to affect the reduction. 
In addition, a small but significant quantity of the mono-dehalogenated product 113 
was also isolated. It is not fully understood how this dehalogenation occurs, as 
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there is no precedent for the reduction of carbon-halogen bonds under diimide 
conditions. One possible explanation could be dehalogenation by potassium p-
tolylsulfinate, derived from tosyl hydrazine. Dehalogenation of α-bromo and -iodo 
sulfones with sodium arenesulfinates has been reported.132 It is suggested that 
this reaction proceeds through nucleophilic displacement on the halogen atom and 
formation of a stabilised carbanion. 
 
Scheme 65: Diimide reduction of 99. 
 
Having gained access to the selectively reduced product 112, the next step was to 
deprotect the amine. There are a number of methods for cleaving 
trichloroacetamides, the most common of which are basic hydrolysis24,133 and the 
more forcing, acidic hydrolysis.123,134 Less common methods include reductive 
conditions with DIBAL-H93,135,136 or sodium borohydride.137,138 Initially, deprotection 
under basic conditions was attempted on the pre-hydrogenation compound 99. 
However, this resulted in isolation of only decomposition products (Table 14, entry 
1). Attempts at removing the trichloroacetamide of 112 under basic conditions 
(entries 2 and 3) were unsuccessful and returned only starting material, even 
when the reaction was heated. One attempt was made at deprotecting with 
DIBAL-H (entry 4), but this led to the formation of a complex mixture of side-
products, which could not be adequately separated or characterised. As a small 
amount of the dichloroacetamide compound 113 had also been isolated, 
deprotection of this compound was also attempted (entries 5–8). Under refluxing, 
highly acidic conditions, no reaction was observed, the only exception being when 
the reaction was carried out in 1,4-dioxane (entry 8). However, although the 
desired product could be observed by 1H NMR spectroscopy of the reaction 
mixture, there was no way to separate it from a contaminant formed when using 
these conditions. This contaminant appeared to be formed by polymerisation of 
the dioxane solvent and is a known reaction when performed in tetrahydrofuran.139 
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Entry X Conditions Result 
1 99, X = Cl 6 M NaOH, MeOH, 60 °C, 24 h Decomposed 
2 113, X = Cl 6 M NaOH, MeOH, rt, 72 h No reaction 
3 113, X = Cl 6 M NaOH, MeOH, 50 °C, 120 h No reaction 
4 113, X = Cl DIBAL-H, CH2Cl2, −78 °C, 4 h Decomposed 
5 112, X = H 46% HBr, MeOH, 80 °C, 72 h No reaction 
6 112, X = H 10% H2SO4, AcOH, 110 °C, 24 h No reaction 
7 112, X = H 12 M HCl, (CH2Cl)2, IPA, 85 °C, 18 h No reaction 
8 112, X = H 12 M HCl, 1,4-Dioxane, 90 °C, 18 h Not purifieda 
Table 14: Conditions used for attempted cleavage of tri- and di-chloroacetamide. 
aProduct inseparable from polymerised dioxane. 
 
Unfortunately, due to time constraints and the difficulties encountered in 
deprotecting the amine for further functionalisation, no further work was carried out 
on the synthesis of this target.  
3.2.4 Oxidations of 5-amido-2,5-dihydrobenzoxepines 
Some of the biologically active benzoxepine-based drugs contain additional 
functionalisation around the 7-membered ring in the form of hydroxyl groups (76, 
Figure 9 and 114,140 Figure 10). As these compounds have a diverse range of 
biological properties, they were desirable targets for synthesis.  
 
 
Figure 10: An Eli-Lily patented hydroxy-amido-benzoxepine-derived compound for use 
as a Cathepsin S inhibitor. 
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As epoxides are a versatile functional group for the installation of single hydroxyl 
groups and 1,2-anti-diols, as well as various other 1,2-anti-functionalities, such as 
1,2-anti-amino-alcohols (via opening of the epoxide with an azide), their synthesis 
was investigated first. Directed epoxidation of the 7-chloro-substituted 
benzoxepine 96c under the conditions published by the O’Brien group, gave an 
inseperable 12:1 ratio of cis:trans-epoxide products 115 (Scheme 66).115 The ratio 
of diastereomers was determined by 1H NMR spectroscopy while the relative 
geometry of the major diastereomer was proven by NOE experiments (See 
Chapter 5: Experimental for NOE effect values). 
 
Scheme 66: Epoxidation and subsequent ring opening of one-pot process product 96c. 
 
The good diastereoselectivity in this reaction is due to a hydrogen bonding 
interaction between m-CPBA and the N–H bond of the trichloroacetamide (Figure 
11). Due to the curved shape of the molecule however, the cis-face is sterically 
hindered. This causes the reaction to be slower than would otherwise be expected 
and, because of this, the m-CPBA also reacts on the trans-face. This competition 
between the sterics of the molecule and the reduction in energy granted by the 
hydrogen bond leads to lower diastereoselectivity than has been reported for 
similar molecules (19:1 on a cyclohexene-derived allylic trichloroacetamide).115 
 
 
Figure 11: The two transition states showing the formation of the two diastereomeric 
epoxides. 
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Without major purification, the mixture of epoxides was ring-opened under acidic 
conditions, resulting in the isolation of 3,4-trans-diol 116 in a good yield over two 
steps (Scheme 66). The minor diastereomer could not be isolated after column 
chromatography. The product is formed through attack of a molecule of water on 
the 3-position of the benzoxepine, opening the protonated epoxide (Blue route, 
Scheme 67). This route is favoured as attack on the 4-position of the benzoxepine 
would force the reaction to proceed to a twist-boat-like conformation (Red route). 
This conformation is generally energetically disfavoured due to 1,3-diaxial strain. 
This epoxide could also have been opened to yield the 4-hydroxy derivative using 
lithium aluminium hydride, as has been reported previously on a similar system.113  
 
 
Scheme 67: Two different routes for epoxide opening. 
 
Dihydroxylation of the 6-methoxy-substituted benzoxepine 96g with osmium 
tetraoxide under the conditions of Donohoe and co-workers also gave a good yield 
of the cis-diol 117 (Scheme 68).116 The dihydroxylation reaction gives a single 
diastereomer, as opposed to the 12:1 ratio observed with epoxidation conditions. 
Again NOE was utilised to determine the relative geometry of the product 117. The 
dihydroxylation is also directed by hydrogen bonding between the N–H of the 
amide and the osmium tetraoxide/TMEDA complex. However, as the reaction is 
Chapter 3 The Synthesis of Amido Benzoxepine Scaffolds 78 
 
performed at −78 °C, the rate enhancement gained through hydrogen bonding is 
able to compensate fully for the increased steric hindrance of the curved molecule. 
 
 
Scheme 68: Directed dihydroxylation of one-pot process product 96g. 
 
3.2.5 Conclusions 
A rapid and highly efficient three-step synthesis of 2’-allyloxy cinnamyl alcohols 
has been developed. The cinnamyl alcohols were then transformed to the 
corresponding allylic trichloroacetimidates, which were subsequently used in a 
one-pot two-step, Overman/RCM process that allowed access to 5-amido-2,5-
dihydrobenzoxepines. Having optimised this process, a total of eight 
amidobenzoxepines were synthesised. One of these benzoxepines was then used 
for the synthesis of the core structure of an ACAT inhibitor via selective 
hydrogenation. Further functionalisation of two of the 5-amido-2,5-
dihydrobenzoxepines was explored, leading to syn- and anti-diol derivatives with 
high selectivity and in good yields. 
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Chapter 4 A One-Pot Allylboration/Heck Process 
for the Asymmetric Synthesis of 3-Methylene-indan-
1-ols 
4.1 Introduction 
4.1.1 3-Methylene-indan-1-ols 
Functionalised indanes and indanols are important scaffolds for drug design and 
have been used as key intermediates in the synthesis of a variety of biologically 
active compounds.141 In particular, an indanol forms the core of a monoamine re-
uptake blocker for the treatment of cocaine abuse (Figure 12, 118).142 The indanol 
scaffold has also been a key intermediate (119) in the synthesis of the muscarinic 
receptor antagonist (R)-tolterodine143 and in the formal total synthesis of the 
sesquiterpene toxin, anisatin (intermediate 120).144  
 
 
Figure 12: Key indanol intermediates in the synthesis of biologically active compounds. 
 
Due to their importance as synthetic intermediates, a considerable number of 
papers have been published on their synthesis. The most common strategy for the 
racemic synthesis of these compounds involves addition of allylmagnesium,145 
allylzinc,146 allyllithium146 or allylindium147 species to a benzaldehyde or 
acetophenone followed by an intramolecular Heck reaction to close the five-
membered ring (Scheme 69). These processes are often limited in scope due to 
functional group incompatibility and isomerisation of the exo-methylene compound 
to the more stable endocyclic alkene-containing compound. 
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Scheme 69: Sequential allylation/Heck process for the synthesis of indanols.146 
 
An alternative method, more tolerant of various functional groups, was 
demonstrated by Mirabdolbaghi and Dudding in their use of a 
Sakurai−Hosomi−Yamamoto allylation of 2-halobenzaldehydes to form the 
homoallylic alcohol intermediates (Scheme 70).148 In this synthesis they used a 
chiral (R)-BINAP-derived silver fluoride salt to form the (R)-homoallylic alcohol 
intermediate in a 64–81% yield and 81:19–90:10 e.r. Attempting to perform the 
Heck reaction in one-pot with the Sakurai−Hosomi−Yamamoto allylation was 
reported to afford an “intractable mixture of products”. Instead, they were forced to 
perform the reaction as two separate steps. In the case of both the methoxy- and 
fluoro-substituted analogues, a reduction in yield was seen for both steps 
compared to the unsubstituted example. In particular, for the fluoro-substituted 
analogue they observed a drop in yield from 73% to 40% and 87:13 e.r. to 81:19 
e.r., while having to raise the temperature of the Heck step to 130 °C. It can be 
inferred from our own work149 that the remainder of the product in their Heck 
reactions could have been isomerised to the corresponding indanone product, 
although no mention of this is made in their paper.148 
 
 
Scheme 70: Mirabdolbaghi and Dudding’s work on the asymmetric synthesis of indanols. 
 
A recent advance in the synthesis of indanols was achieved by Schmalz and co-
workers; while attempting a Stille coupling on a 2-bromo-6-iodobenzaldehyde, they 
serendipitously discovered a one-pot, domino allylstannylation/Heck reaction 
(Scheme 71).150 They proposed that the oxidative addition of palladium activated 
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the benzaldehyde to allylstannylation by allyl tributyltin. This process was then 
demonstrated on another electron-rich bromobenzaldehyde and an electron-poor 
bromopyridine-derived aldehyde, while the electron-rich substrate still gave good 
yields the pyridine-derived aldehyde gave a much lower yield. In a subsequent 
study, an asymmetric variant of the reaction was demonstrated, although only on 
unsubstituted 2-iodobenzaldehydes and ortho-formylphenyl triflates.151 Although 
they were able to achieve either high yields (80%, 75:25 er) or high 
enantioselectivity (52%, 98:2 er) they were unable to achieve both high yield and 
selectivity for the same substrate. 
 
Scheme 71: Work by Schmalz on the electrophilic activation of benzaldehydes through 
ortho-palladation. 
 
This trade off in yield and selectivity was investigated by Fukuzawa and co-
workers (Scheme 72).152 They developed a palladium/clickferrophos catalyst 
system 122 to improve on the procedure of Schmalz and co-workers. Their 
methodology allowed access to chiral indanols in both high yield and 
enantioselectivity for unsubstituted or electron-rich analogues (64–81%, 86:14–
98:2 e.r.). However, their system still has disadvantages: two equivalents of the 
highly toxic allyl tin reagent are necessary for their reaction and their preferred 
substrates, the ortho-formylphenyl triflates, have “pronounced air sensitivity”.150 
Electron-poor systems are not well tolerated and while high enantioselectivities 
were still possible, very large reductions in yield were observed. In the case of a 
very electron-poor nitro-substituted analogue, the reaction gave no product. 
When attempting to utilise 4-bromo-2-formylphenyl triflate 121 with their optimised 
conditions of two equivalents of allyl tributyltin, they observed a 35% yield of the 
double addition product 123 (Scheme 72). Upon halving the equivalence of allyl 
tributyltin, a maximum yield of only 48% of their desired product 124 was 
observed. Electron-donating 5-position substituents also begin to direct the 
reaction pathway towards Stille coupling with the triflate rather than electrophilic 
activation and allylstannylation. 
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Scheme 72: Different products in allylstannylation/Heck process. 
 
4.1.2 Aims 
The aim of this project was to develop a one-pot allylboration/Heck method for the 
synthesis of 3-methylene-indan-1-ols from readily available 2-
bromobenzaldehydes and allylboronic acid pinacol ester (58, Scheme 73). It was 
hoped that by drawing upon the large literature surrounding allylboration reactions, 
a more general process, that would also replace the highly toxic tin reagents with 
the non-toxic boronic pinacol ester 58, could be developed. As there is precedent 
for asymmetric allylboration reactions, the scope of this method would first be 
examined before the development of an asymmetric variant. 
 
 
Scheme 73: Proposed allylboration/Heck process for the synthesis of 3-methylene-indan-
1-ols. 
 
4.2 Results and discussion 
4.2.1 Racemic one-pot allylboration/Heck reaction 
While working on the development of a route to 2’-allylcinnamyl alcohols for the 
one-pot process towards amido-dihydronaphthalenes, a problem was observed in 
coupling of the allyl chain to 2-bromobenzaldehydes. When coupling allylboronic 
acid pinacol ester (58) with 2-bromo-5-fluorobenzaldehyde (52c) was attempted, it 
was observed that, while the major product of this reaction was 2-
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allylbenzaldehyde 125, a considerable amount of 6-fluoro-3-methylene-indan-1-ol 
(126c) and ketone product 127c were present in the 1H NMR spectrum of the 
crude reaction mixture (Scheme 74).  
 
 
Scheme 74: Initial observation of one-pot allylboration/Heck process occurring. aYields 
calculated from 1H NMR spectrum of crude products. 
 
Following this observation, it was proposed that this could occur through a two-
step process in which addition of the boronate 58 across the aldehyde would form 
homoallylic alcohol 128c, which would then undergo a Heck coupling to form the 
five-membered ring and the exocyclic alkene 126c (Scheme 75). The formation of 
the cyclopentanone product 127c is unprecedented from intramolecular Heck 
cyclizations of homoallylic-derived aryl halides. It is believed, however, that under 
the reaction conditions, heating in a polar solvent with a relatively strong base, 
palladium chain-walking via successive β-hydride eliminations and migratory 
insertions could occur. This is known as a redox-relay process and is well 
precedented in the literature.153–157 The allylboration/Heck process was obviously 
in competition with the Suzuki-Miyaura coupling. As a method of making 2-
allylbenzaldehydes this was abandoned, but it seemed attractive as a new one-pot 
process which could be developed for the synthesis of useful chemical building 
blocks. 
 
 
Scheme 75: Proposed mechanism for allylboration/Heck process. 
 
It was clear that attempting this as a tandem process, in which all reagents are 
added at the outset of the reaction, would not prevent the Suzuki-Miyaura coupling 
from occurring in competition with the desired allylboration reaction. To overcome 
this obstacle, the process was performed as a one-pot, two-step reaction with 
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addition of the palladium catalyst after the allylboration had already occurred. Early 
on in the optimisation process, it was observed that if the reaction was carried out 
in anhydrous acetonitrile, the intermediate species containing a boron-oxygen 
bond was clearly visible by 1H NMR spectroscopy recorded before addition of the 
palladium catalyst (Figure 13). It was also noted that these reactions gave 
incomplete conversion and lower yields. For this reason, acetonitrile was used as 
supplied and an additional four equivalents of water were added to the reaction to 
promote hydrolysis of this B–O bond. On addition of the potassium carbonate after 
the allylboration reaction, the solution effervesces and a large quantity of an 
extremely fine powdered solid precipitates from the solution. This is thought to be 
the potassium salt of pinacol boronic acid or, if the pinacol-boron bonds are 
hydrolysed too, potassium borate. It was decided to add the potassium carbonate 
at the start of the reaction and this was shown to have no impact on the 
allylboration.  
 
 
Figure 13:  Excerpt from a 1H NMR spectrum of a 2:1 mixture of the intermediates 56 and 
128a 
 
Optimisation of the one-pot, two-step reaction continued with an investigation of 
the most suitable catalyst for the Heck stage of the process (Table 15, entries 1–
3). As the product was not easily separated from some of the impurities, the initial 
optimisation used conversion, as measured by 1H NMR spectroscopy, of the crude 
product mixture after passing through a short pad of silica. Attempting the one-pot 
process with palladium(II)dichloride diphenylphosphinoferrocene resulted in a 1:1 
ratio of the desired product 126a and the isomerised product 3-methyl-indan-1-one 
(127a, entry 1). Changing to a palladium(0) species increased the ratio of product 
126a to indanone 127a, however a considerable quantity of the homoallylic alcohol 
intermediate 56 was also observed in the 1H NMR spectrum (entry 2). Changing to 
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a combination of palladium(II) dichloride bistriphenylphosphine with hydrazine 
monohydrate as an in situ reductant, as reported by Dudding, gave a better 
conversion to product, but an increase in isomerisation (entry 3).148 Increasing the 
temperature to 100 °C, which required the reactions to be performed in a sealed 
tube, pushed the reaction to completion, but again increased the quantity of 
indanone product that was observed (entry 4). This change gave a reaction that 
could easily be purified and a 75% yield of the desired product 126a was isolated. 
To examine if the hydrazine monohydrate was necessary for the reaction to 
proceed in good yields and selectivity, a reaction was performed in which it was 
not added (entry 5). However, a 3:1 ratio of product 126a and indanone 127a was 
observed at the end of this reaction and yielded only 18% of the isolated product. 
 
 
Entry Catalyst 
Cat loading/ 
mol% 
Temp/
°C 
Crude ratio of 
56:126a:127aa 
Conversion 
to 126aa 
1 PdCl2(dppf) 5 80 0:1:1 54% 
2 Pd(PPh3)4 5 80 9:23:1 53% 
3b PdCl2(PPh3)2 7.5 80 2:16:1 83% 
4b PdCl2(PPh3)2 7.5 100 0:8:1 89% (75%)
c 
5 PdCl2(PPh3)2 7.5 100 0:3:1 (18%)
c 
Table 15: Optimisation of one-pot two-step allylboration/Heck process. Unless 
otherwise noted, all reactions were performed with 58 (1.1 equiv), K2CO3 (5.0 equiv), and 
H2O (4.0 equiv). 
aRatio and yield determined through analysis of 1H NMR spectra of crude 
reaction mixtures and recovered mass. bN2H4.H2O (0.4 equiv) was added with the Pd cat. 
cIsolated yield of 126a in brackets. 
 
Having successfully developed a one-pot allylboration/Heck process it was then 
applied to a number of 2-bromobenzaldehydes (Scheme 76). A large range of 
substrates was chosen to fully explore the scope of the reaction. The ratios and 
yields for compounds 126a–e, 126g and 126k, which contain both electron-
donating groups and electron-withdrawing groups, are all reasonably constant. 
The chlorine containing 126k requires a slightly higher catalyst loading for the 
reaction to proceed to completion. 
The naphthyl-derived compound 126f appeared to rapidly isomerise to the ketone, 
1-methyl-cyclopenta[a]naphthalen-3-one, 127f. More interestingly however, an 
inseparable impurity was observed by 1H NMR spectroscopy (Figure 14). This 
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impurity appeared to be 1,2-dihydrophenanthren-1-ol, the product of an endo-
cyclic Heck reaction which should not occur. It is postulated that this product may 
occur due to steric effects forcing the palladium catalyst to rearrange to the usually 
less favoured internal position of the alkene before elimination. 
The pyridine-containing analogue 126i was a good substrate for the one-pot 
reaction, despite concerns that it could chelate the palladium catalyst and slow or 
halt the reaction. The most electron-poor analogue, nitro-containing 126j, gave a 
single product with none of the indanone observed by 1H NMR spectroscopy. In a 
slight change of conditions, it required less hydrazine monohydrate to be added. 
This is due to competing reduction of the nitro group under the 
palladium/hydrazine conditions; when the usual quantity of hydrazine was used a 
31% yield was obtained.158,159 The high yield of 126j is in direct contrast to the 
domino allylstannylation/Heck process developed by Fukuzawa and co-workers, 
where no indanol is observed, making this a more general process.152  
 
 
Scheme 76: Optimised conditions, yields and ratios of product 126 to indanone 127 for 
the synthesis of methylene-indanols 126a–g, i–k. aRatios calculated from 1H NMR spectrum of 
crude reaction mixture. b126f was isolated as an inseparable mixture of 126f and the 6-endo-
product 1,2-dihydrophenanthren-1-ol. cReaction performed with N2H4.H2O (0.15 equiv). 
dReaction performed with PdCl2(PPh3)2 (10 mol%). 
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Figure 14: Expansion of 1H NMR spectrum showing key peaks attributed to 126f and 1,2-
dihydrophenanthren-1-ol. 
 
The other heterocyclic compound attempted, furan based 52h, underwent the 
allylboration reaction perfectly, but the Heck reaction would not go to completion, 
with the best conversion observed being 25% (Scheme 77). This is probably due 
to the difficulties of forming a 5,5-bicyclic system through sp2-sp2 bond formation. 
Many reactions which precedent this type of Heck coupling are performed at over 
120 °C and/or give low yields.160–162 Increasing the catalyst loading and 
temperature only led to decomposition of the homoallylic alcohol intermediate.  
Changing to the dibromobenzaldehyde 52l completely inhibited the Heck reaction 
with only the homoallylic alcohol recovered even at higher catalyst loadings. The 
reaction may be able to tolerate bromide functionality if 5-bromo-2-
iodobenzaldehyde was used. This would rely on the difference in reactivity 
between the two halides, in much the same manner as the chloride-containing 
compound, 52k. 2’-Bromoacetophenone (52m), did not undergo the allylboration 
step: a Lewis basic indium catalyst is nessecary for this reaction.163 
 
 
Scheme 77: Substrates that failed to react during optimisation. 
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4.2.2 Asymmetric one-pot allylboration/Heck reaction 
With a robust one-pot, two-step method for the synthesis of racemic 3-methylene-
indan-1-ols developed, the next step was to extend this method to allow the 
synthesis of chiral 3-methylene-indan-1-ols. Building on the substantial quantity of 
literature detailing chiral Brønsted acid-catalysed asymmetric allylboration 
procedures,164–170 and wishing to avoid using tin-based chiral acids, the work by 
the groups of Antilla168 and Hu169 seemed most attractive. Specifically, the work of 
Jain and Antilla on asymmetric allylboration of benzaldehydes with the 
commercially available (R)-TRIP phosphoric acid catalyst (129a, Figure 15) was of 
most interest. Although high yields and excellent enantioselectivities were 
observed by Antilla for meta- and para-substituted benzaldehydes, lower levels 
were obtained with the single ortho-substituted analogue investigated in this study. 
More recent papers by Hu169 and Kotora170 have attempted to address this lower 
selectivity in ortho-substituted analogues with some success. The work by Hu and 
co-workers, however uses the (R)-SPINOL phosphoric acid (130), which is not 
commercially available. 
 
Figure 15: Chiral phosphoric acids used in this project and by the Antilla and Hu groups. 
 
As these catalysts had been shown to be most effective in non-coordinating 
solvents such as dichloromethane and toluene,168 the first step towards developing 
an enantioselective variant of the one-pot process was to ensure that the racemic 
process worked just as well in toluene (Scheme 78). In addition, as the catalyst is 
a phosphoric acid, the addition of potassium carbonate and water would need to 
be performed after the allylboration. These conditions worked as well as before, 
giving 126a in 80% yield. However, in place of the indanone 127a, a different side-
product was observed in a similar ratio. Due to the small scale that the reactions 
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were performed on and the small amount of this impurity that was formed, it could 
only be observed in the 1H NMR spectrum before purification by column 
chromatography. 
 
 
Scheme 78: One-pot allylboration/Heck process performed in toluene. 
 
The next goal was to optimise the asymmetric allylboration reaction for the 2-
bromobenzaldehydes. Using the work by Jain and Antilla as a starting point for the 
allylboration conditions,168 the reaction mixture was cooled to −30 °C before 
addition of the allylboronic acid pinacol ester (58). The screening of a series of 
catalysts was carried out, starting with the unsubstituted (S)-BINOL-PA (S)-129c 
(Table 16). As expected, the unsubstituted catalyst (S)-129c provided no 
enantioinduction but did give an improved yield over the uncatalysed process 
(Table 16, entry 1). Attempting the reaction with the (R)-ditrifluoromethylphenyl-
substituted catalyst (R)-129b showed similarly high yields and began to provide 
some enantioselectivity (entry 2). The (R)-TRIP catalyst (R)-129a, showed 
considerably better enantioselectivity with only a marginal reduction in yield (entry 
3). The octahydro-catalyst with para-chlorophenyl substituents (R)-131 appeared 
to be the least effective of the catalysts used, giving a lower yield than the 
unsubstituted catalyst (S)-129c and a lower level of enantioinduction than (R)-
TRIP (R)-129a (entry 4). As the enantioselectivity for the reaction of 2-
bromobenzaldehyde (52a) was lower than expected, it was decided that 
racemisation in the Heck reaction should be eliminated as a possibility. To this 
end, a reaction was performed and stopped at the homoallylic alcohol stage (entry 
5). This showed that the enantiomeric ratios were not degraded by the later steps 
and that the 2-bromobenzaldehydes were just poor substrates for this reaction. A 
reaction without the catalyst was also performed (entry 6), to prove that the lower 
enantiomeric ratio was due to the slower, uncatalysed racemic process proceeding 
in the background. As this was clearly the case, and as Brown and co-workers 
have shown that no reaction occurs between benzaldehydes and allyl borates at 
−78 °C in dichloromethane, two lower temperatures were attempted.171 At −50 °C 
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(entry 7), both the yield and enantioselectivity of the reaction improved; however, 
when the temperature was reduced to −80 °C (entry 8), in an attempt to eliminate 
the racemic reaction entirely, both the yield and e.r. began to drop. This was due 
to poor solubility of both the catalyst and the benzaldehydes below −60 °C. While 
this could possibly be circumvented by using dichloromethane instead of toluene, 
this was not explored, as it would have involved switching solvent after the first 
step of the reaction sequence. The solubility of the SPINOL catalysts 130 (Figure 
15) used by Hu and co-workers is much improved at −78 °C, however this would 
not solve the benzaldehyde solubility problems. 
 
 
Entry Catalyst Temp/°C Yield/%a erb 
1 (S)-129c −30 90 50:50 
2 (R)-129b −30 88 55:45 
3 (R)-129a −30 83 77:23 
4 (R)-131 −30 82 52:48 
5c (R)-129a −30 97d 75:25d 
6e – −30 51 – 
7 (R)-129a −50 91 86:14 
8f (R)-129a −80 59f 80:20 
Table 16: Unless otherwise noted, all reactions were performed with 58 (1.2 eq), PA-
catalyst (5 mol%), K2CO3 (6.0 eq), and H2O (10.0 eq). 
aIsolated yield of 126a. ber was 
determined using chiral HPLC analysis (see Appendix 1). cReaction was stopped after the 
allylboration step, and the homoallylic alcohol 56 was isolated. dYield and e.r. for 
homoallylic alcohol 56. eNo PA-catalyst present. fReaction performed with 52e and yielded 
126e. 
 
Having optimised the asymmetric conditions as far as possible, they were next 
applied to a range of substrates (Scheme 79). As the naphthyl-derived aldehyde 
52f had not performed well in the racemic process, it was not included in the 
asymmetric screen. Similarly, compounds which had not undergone the Heck step 
in the racemic screen were discarded (52h, 52l, 52m). As the catalyst was a 
phosphoric acid, the pyridine-aldehyde 52i could not be used as it would 
deprotonate the catalyst and, as has been shown by List and co-workers, salts of 
the phosphoric acid catalysts are not as effective in many reactions.172 It was 
found that benzaldehydes 52b and 52d were not soluble below −30 °C, so these 
were also excluded. It is thought that the poor result obtained for the 
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trifluoromethyl substituted analogue (R)-126g is also due to reduced solubility. As 
2-bromo-4-trifluoromethylbenzaldehyde (52g) is a colourless oil, it was not 
possible to be certain that it was fully dissolved at −50 °C. The asymmetric 
process gave higher yields than the racemic process. This was in part due to a 
reduction in quantity of side-products formed, with all analogues showing 
selectivity towards the desired indanol product over the unknown side-product in 
the region of 40:1. The asymmetric process showed greater yields and selectivities 
for electron-poor analogues (R)-126c, (R)-126j and (R)-126k. This is probably due 
to the fact that the background, racemic allylboration reaction proceeds more 
slowly on these substrates. This selectivity on electron-poor analogues makes the 
process highly complementary to the asymmetric allylstannylation reactions of 
Fukuzawa and co-workers.152 
 
 
 
Scheme 79: Optimised yields and enantiomeric ratios for the asymmetric one-pot 
allylboration/Heck process. 
 
4.2.3 Conclusions 
A high yielding one-pot allylboration/Heck process has been developed for the 
racemic and asymmetric synthesis of 3-methylene-indan-1-ols. The racemic 
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process was shown to be broad in scope and a more general process than those 
previously reported for the synthesis of 3-methylene-indan-1-ols. This process was 
then altered to allow the asymmetric synthesis of the same compounds. The 
asymmetric process has been shown to be higher yielding and shows promising 
selectivity. However, this process could possibly be improved through altering the 
catalyst or by performing the first step in dichloromethane, before changing to 
toluene for the second step of the process. 
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Chapter 5 Experimental 
General Experimental 
All reagents and starting materials were obtained from commercial sources and 
used as received. All dry solvents were purified using a PureSolv 500 MD solvent 
purification system. All reactions were performed under an atmosphere of argon 
unless otherwise mentioned. Flash column chromatography was carried out using 
Fisher matrix silica 60. Macherey-Nagel aluminium-backed plates pre-coated with 
silica gel 60 (UV 254) were used for thin layer chromatography and were 
visualised by staining with KMnO4. 
1H NMR and 13C NMR spectra were recorded 
on a Bruker DPX 400 or 500 MHz spectrometer with chemical shift values in ppm 
relative to TMS (δH 0.00 and δC 0.0) or residual chloroform (δH 7.26 and δC 77.16), 
dimethylsulfoxide (δH 2.50 and δC 39.52), or methanol (δH 3.31 and δC 49.00) as 
standar as standard. Proton and carbon assignments are based on two-
dimensional COSY and DEPT experiments, respectively. NOe were recorded on a 
500 MHz spectrometer with a D8 delay of 0.30000001 seconds. Mass spectra 
were obtained using a JEOL JMS-700 spectrometer for EI and CI or Bruker 
Microtof-q for ESI. Infrared spectra were obtained neat using a Shimadzu IR 
Prestige-21 spectrometer. Melting points were determined on a Reichert platform 
melting point apparatus. Microwave reactions were conducted using a CEM 
Discover TM Synthesis Unit (CEM Corp., Matthews, NC) and performed in glass 
vessels (capacity 10 mL) sealed with a septum. Optical rotations were determined 
as solutions irradiating with the sodium D line (λ= 589 nm) using an Autopol V 
polarimeter. [D values are given in units 10
–1 deg cm2 g–1. The chiral HPLC 
methods were calibrated with their corresponding racemic mixtures. 
2,3-Isopropylidine-1-methoxy-D-ribofuranoside (13)173  
 
Concentrated hydrochloric acid (34–36%, 0.02 mL) was added to a stirred solution 
of D-ribose (12) (0.200 g, 1.34 mmol) in acetone (3 mL) and methanol (3 mL). The 
solution was heated under reflux for 2 h, before cooling to room temperature. The 
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reaction was neutralised by addition of a saturated solution of sodium hydrogen 
carbonate (10 mL), then extracted with ethyl acetate (2 × 50 mL). The organic 
layers were combined and washed with water (40 mL), brine (40 mL), then dried 
(MgSO4), filtered and concentrated in vacuo to yield 2,3-isopropylidine-1-methoxy-
D-ribofuranoside (13) (0.228 g, 84%) as a colourless oil. Spectroscopic data as 
reported in literature.173  [D
25 −52.8 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 1.32 
(3H, s, C(CH3)(CH3)), 1.48 (3H, s, C(CH3)(CH3)), 3.24 (1H, dd, J 10.5, 2.7 Hz, 
OH), 3.43 (3H, s, OCH3), 3.61 (1H, ddd, J 12.8, 10.5, 2.7 Hz, 5-HH), 3.70 (1H, dt, 
J 12.8, 2.7 Hz, 5-HH), 4.43 (1H, t, J 2.7 Hz, 4-H), 4.59 (1H, d, J 5.9 Hz, 2-H), 4.84 
(1H, d, J 5.9 Hz, 3-H), 4.97 (1H, s, 1-H); δC (101 MHz, CDCl3) 24.7 (CH3), 26.3 
(CH3), 55.5 (CH3), 64.0 (CH2), 81.5 (CH), 85.8 (CH), 88.4 (CH), 110.0 (CH), 112.1 
(C); m/z (CI) 205 (MH+, 14%), 173 (100), 113 (5), 85 (10), 69 (14). 
5-Deoxy-5-iodo-2,3-isopropylidine-1-methoxy-D-ribofuranoside (14)174  
 
Iodine (0.341 g, 1.34 mmol) was added to a stirred solution of 2,3-isopropylidine-1-
methoxy-D-ribofuranoside (13) (0.228 g, 1.12 mmol), imidazole (0.114 g, 1.68 
mmol) and triphenylphosphine (0.352 g, 1.34 mmol) in toluene (15 mL) and 
acetonitrile (5 mL). The solution was heated under reflux for 0.1 h before cooling to 
room temperature. Iodine was then added in 10 mg portions until the solution 
remained dark-brown in colour. The solution was diluted with diethyl ether (40 mL) 
and washed with a saturated solution of sodium thiosulfate (80 mL), water (100 
mL) and brine (70 mL). The organic layer was dried (MgSO4), filtered, 
concentrated in vacuo and filtered through a short plug of silica (ethyl 
acetate/petroleum ether, 1:20) to yield 5-deoxy-5-iodo-2,3-isopropylidine-1-
methoxy-D-ribofuranoside (14) (0.330 g, 94%) as a clear oil. [D
25 −65.7 (c 1.0, 
CHCl3), lit.
174  [D
25 −68.3 (c 0.1, CHCl3); δH (400 MHz, CDCl3) 1.33 (3H, d, J 0.4 
Hz, C(CH3)(CH3)), 1.48 (3H, d, J 0.4 Hz, C(CH3)(CH3)), 3.16 (1H, t, J 10.0 Hz, 5-
HH), 3.29 (1H, dd, J 10.0, 6.0 Hz, 5-HH), 3.37 (3H, s, OCH3), 4.44 (1H, ddd, J 
10.0, 6.0, 0.7 Hz, 4-H), 4.63 (1H, d, J 5.9 Hz, 2-H), 4.76 (1H, dd, J 5.9, 0.7 Hz, 3-
H), 5.05 (1H, s, 1-H); δC (101 MHz, CDCl3) 6.8 (CH2), 25.2 (CH3), 26.6 (CH3), 55.4 
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(CH3), 83.2 (CH), 85.5 (CH), 87.6 (CH), 109.9 (CH), 112.8 (C); m/z (CI) 315 (MH
+, 
8%), 279 (7), 127 (8), 113 (38), 85 (52), 73 (100). 
(2S,3R)-2,3-(O-Isopropylidene)pent-4-en-1,2,3-triol (16)175  
 
Zinc (2.44 g, 35.7 mmol) was added to a solution of 5-deoxy-5-iodo-2,3-
isopropylidine-1-methoxy-D-ribofuranoside (14) (2.24 g, 7.14 mmol) and a catalytic 
amount of glacial acetic acid (0.06 mL) in methanol (40 mL). The suspension was 
heated under reflux for 1 h before cooling to 0 °C. A saturated solution of sodium 
borohydride in ethanol (140 mL) was added dropwise with stirring to the reaction 
mixture and stirred at 0 °C for 0.5 h before warming to room temperature over 3 h. 
The mixture was concentrated in vacuo. The resulting residue was dissolved in 
diethyl ether (50 mL) and filtered through Celite®. The filtrate was washed with 
water (2 × 50 mL), brine (2 × 50 mL), dried (MgSO4), filtered and concentrated in 
vacuo to yield (2S,3R)-2,3-(O-isopropylidene)pent-4-en-1,2,3-triol (16) (1.01 g, 
89%) as a colourless oil. [D
25
 −40.0 (c 1.5, CHCl3); lit.
175 [D
25 −45.7 (c 1.0, 
CHCl3); δH (400 MHz, CDCl3) 1.40 (3H, d, J 0.4 Hz, C(CH3)(CH3)), 1.51 (3H, d, J 
0.4 Hz, C(CH3)(CH3)), 1.81 (1H, t, J 6.2 Hz, OH), 3.59 (2H, dd, J 6.2, 5.9 Hz, 1-
H2), 4.26 (1H, dt, J 6.6, 5.9 Hz, 2-H), 4.65 (1H, tt, J 6.6, 1.1 Hz, 3-H), 5.28 (1H, 
ddd, J 10.3, 1.5, 1.1 Hz, 5-HH), 5.40 (1H, ddd, J 17.5, 1.5, 1.1 Hz, 5-HH), 5.87 
(1H, ddd, J 17.5, 10.3, 6.6 Hz, 4-H); δC (101 MHz, CDCl3) 25.3 (CH3), 27.8 (CH3), 
62.1 (CH2), 78.3 (CH), 78.4 (CH), 108.9 (C), 119.0 (CH2), 133.1 (CH); m/z (CI) 159 
(MH+, 71%), 141 (11), 101 (100), 83 (12). 
(2S,3R)-2,3-(O-Isopropylidene)heptadecan-1,2,3-triol (19) 
 
A solution of Grubbs second generation catalyst (0.145 g, 0.172 mmol) in 
dichloromethane (20 mL) was added to a solution of (2S,3R)-2,3-(O-
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isopropylidene)pent-4-en-1,2,3-triol (16) (0.540 g, 3.41 mmol) and 1-tetradecene 
(17) (1.30 mL, 5.14 mmol) in dichloromethane (20 mL) and heated under reflux for 
16 h. The reaction mixture was then concentrated in vacuo and filtered through a 
plug of silica with first petroleum ether (500 mL) and then 25% ethyl acetate in 
petroleum ether (1000 mL). The second wash was concentrated in vacuo to yield 
the cross metathesis product 18 as a clear oil, which was used without further 
purification. The alkene was dissolved in ethyl acetate (40 mL) and a suspension 
of 10% palladium on carbon (0.150 g, 15% w/w) in ethyl acetate (10 mL) was 
added. The mixture was degassed, purged with hydrogen gas and left to stir at 
room temperature under a hydrogen atmosphere for 2 h. The suspension was 
filtered through Celite® with ethyl acetate (100 mL) and purified by column 
chromatography (ethyl acetate/petroleum ether, 1:5) to yield (2S,3R)-2,3-(O-
isopropylidene)heptadecan-1,2,3-triol (19) (0.921 g, 82% over two steps) as a 
colourless oil. νmax (neat)/cm
–1 3437 (OH), 2923 (CH), 2854 (CH), 1466, 1379, 
1217, 1042; [D
24
 −10.4 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 0.87 (3H, t, J 6.8 Hz, 
17-H3), 1.21–1.53 (32H, m, 4-H2, 5-H2, 6-H2, 7-H2, 8-H2, 9-H2, 10-H2, 11-H2, 12-H2, 
13-H2, 14-H2, 15-H2, 16-H2 and C(CH3)2), 1.95 (1H, br s, OH), 3.55–3.63 (2H, m, 1-
H2), 4.10–4.19 (2H, m, 2-H and 3-H); δC (101 MHz, CDCl3) 14.3 (CH3), 22.8 (CH2), 
25.7 (CH3), 26.8 (CH3), 28.4 (CH2), 29.0 (CH2), 29.5 (CH2), 29.6 (CH2), 29.7 (CH2), 
29.8 (3 × CH2), 29.8 (2 × CH2), 29.8 (CH2), 32.1 (CH2), 62.0 (CH2), 77.2 (CH), 78.1 
(CH), 108.2 (C); m/z (CI) 329.3051 (MH+. C20H41O3 requires 329.3056), 313 
(13%), 271 (60), 253 (10), 235 (5), 159 (3), 69 (7). 
Ethyl (2E,4S,5R)-4,5-(O-isopropylidene)-4,5-dihydroxynonadec-2-enoate (22) 
 
Dimethyl sulfoxide (0.61 mL, 8.6 mmol) was slowly added to a stirred solution of 
oxalyl chloride (0.38 mL, 4.5 mmol) in dichloromethane (15 mL) at −78 °C. The 
reaction was stirred for 0.3 h before (2S,3R)-2,3-(O-isopropylidene)heptadecan-
1,2,3-triol (19) (0.95 g, 2.9 mmol) in dichloromethane (15 mL) was added 
dropwise. The reaction mixture was then stirred for a further 0.3 h before 
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triethylamine (2.0 mL, 15 mmol) was added. The temperature was maintained at 
−78 °C for 0.5 h then allowed to warm to room temperature over 2 h. Meanwhile, a 
solution of lithium chloride (0.24 g, 5.8 mmol), triethyl phosphonoacetate (21) (0.73 
mL, 3.7 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (0.97 mL, 6.5 mmol) in 
acetonitrile (30 mL) was prepared and stirred for 1 h. The Swern solution was 
concentrated in vacuo to give a yellow residue 20 to which the Horner–
Wadsworth–Emmons solution was added. The reaction mixture was stirred at 
room temperature for 20 h then quenched by the addition of a saturated solution of 
ammonium chloride (20 mL), concentrated to give an orange residue and 
extracted with diethyl ether (2 × 30 mL). The organic layers were combined, 
washed with water (50 mL), brine (50 mL) then dried (MgSO4), filtered and 
concentrated in vacuo to give a yellow oil. Purified by filtration through a pad of 
silica (elution with 20% ethyl acetate:petroleum ether) to yield ethyl (2E,4S,5R)-
4,5-(O-isopropylidene)-4,5-dihydroxynonadec-2-enoate (22) (0.95 g, 83%) as a 
clear yellow oil. (Found: C, 72.5; H, 11.3. C29H44O4 requires C, 72.7; H, 11.2%); 
max (neat)/cm
−1 2853 (CH), 1722 (CO), 1661 (C=C), 1466, 1370, 1252, 1161, 
1038; [𝛼]𝐷
26 −5.1 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 0.88 (3H, t, J 6.9 Hz, 19-H3), 
1.25–1.53 (35H, m, OCH2CH3, 6-H2, 7-H2, 8-H2, 9-H2, 10-H2, 11-H2, 12-H2, 13-H2, 
14-H2, 15-H2, 16-H2, 17-H2, 18-H2 and C(CH3)2), 4.17–4.24 (3H, m, 5-H and 
OCH2CH3), 4.63 (1H, td, J 6.3, 1.4 Hz, 4-H), 6.06 (1H, dd, J 15.6, 1.4 Hz, 2-H), 
6.84 (1H, dd, J 15.6, 6.3 Hz, 3-H); δC (101 MHz, CDCl3) 14.3 (CH3), 14.4 (CH3), 
22.9 (CH2), 25.7 (CH3), 26.5 (CH2), 28.3 (CH3), 29.5 (CH2), 29.7 (CH2), 29.7 (CH2), 
29.7 (CH2), 29.8 (CH2), 29.8 (2 × CH2), 29.8 (2 × CH2), 30.6 (CH2), 32.1 (CH2), 
60.6 (CH2), 77.6 (CH), 78.7 (CH), 108.9 (C), 123.2 (CH), 144.0 (CH), 166.2 (CH); 
m/z (CI) 397.3312 (MH+. C29H45O4 requires 397.3318), 379 (12%), 339 (100), 143 
(13), 81 (12). 
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(2E,4S,5R)-4,5-(O-Isopropylidene)nonadec-2-en-1,4,5-triol (23) 
 
Diisobutylaluminium hydride (0.55 mL, 1 M in hexanes) was added dropwise to a 
stirred solution of ethyl (2E,4S,5R)-4,5-(O-isopropylidene)-4,5-dihydroxynonadec-
2-enoate (22) (0.95 g, 2.4 mmol) in diethyl ether (50 mL) at −78 °C. The solution 
was stirred at −78 °C for 3 h then allowed to return to room temperature over 18 h. 
The reaction was quenched with saturated ammonium chloride solution (30 mL), 
filtered through a pad of Celite® then extracted with diethyl ether (30 mL) and 
washed with water (50 mL) and brine (50 mL). The organic layer was dried 
(MgSO4), filtered and concentrated in vacuo. Purified by column chromatography 
(elution with 20% ethyl acetate:petroleum ether) to yield (2E,4S,5R)-4,5-(O-
isopropylidene)nonadec-2-en-1,4,5-triol (23) (0.71 g, 83%) as a clear oil. max 
(neat)/cm−1 3417 (OH), 2922 (CH), 1456, 1369, 1216, 1095, 1027; [𝛼]𝐷
24 −42.0 (c 
1.1, CHCl3); δH (500 MHz, CDCl3) 0.87 (3H, t, J 7.0 Hz, 19-H3), 1.22–1.48 (32H, m, 
6-H2, 7-H2, 8-H2, 9-H2, 10-H2, 11-H2, 12-H2, 13-H2, 14-H2, 15-H2, 16-H2, 17-H2, 18-
H2 and C(CH3)2), 1.62 (1H, br s, OH), 4.12 (1H, ddd, J 8.7, 6.3, 4.7 Hz, 5-H), 4.16 
(2H, dd, J 5.2, 1.5 Hz, 1-H2), 4.50 (1H, dd, J 7.9, 6.3 Hz, 4-H), 5.68 (1H, ddt, J 
15.5, 7.9, 1.5 Hz, 3-H), 5.88 (1H, dtd, J 15.5, 5.2, 0.6 Hz, 2-H); δC (126 MHz, 
CDCl3) 14.3 (CH3), 22.8 (CH2), 25.8 (CH3), 26.4 (CH2), 28.4 (CH3), 29.5 (CH2), 
29.7 (CH2), 29.7 (CH2), 29.8 (CH2), 29.8 (2 × CH2), 29.8 (3 × CH2), 30.5 (CH2), 
32.1 (CH2), 63.0 (CH2), 78.5 (CH), 79.1 (CH), 108.2 (C), 127.5 (CH), 133.5 (CH); 
m/z (CI) 355.3211 (MH+. C22H43O3 requires 355.3212), 337 (20%), 297 (41), 279 
(100), 225 (90). 
 Experimental 99 
 
(3R,4S,5R)-3-(Trichloromethylcarbonylamino)-4,5-(O-
isopropylidene)nonadec-1-en-4,5-diol (28b) and (3S,4S,5R)-3-
(trichloromethylcarbonylamino)-4,5-(O-isopropylidene)nonadec-1-en-4,5-diol 
(28a) 
  
1,8-Diazabicyclo[5.4.0]undec-7-ene (0.070 mL, 0.47 mmol) was added to a stirred 
solution of (2E,4S,5R)-4,5-(O-isopropylidene)nonadec-2-en-1,4,5-triol (23) (0.19 g, 
0.54 mmol) and trichloroacetonitrile (0.080 mL, 0.80 mmol), at 0 °C, in 
dichloromethane (28 mL). The solution was stirred at 0 °C for 0.5 h, warmed to 
room temperature over 3 h then filtered through a pad of silica with 
dichloromethane (200 mL) and concentrated in vacuo to yield the crude 
trichloroacetimidate as a yellow oil which was used without further purification. The 
crude trichloroacetimidate 27 was dissolved in p-xylene (4 mL) and added to a 
pressure tube loaded with a stirrer bar and potassium carbonate (0.012 g, 0.087 
mmol). The tube was sealed under argon and heated, with stirring, to 160 °C for 
60 h. The reaction mixture was filtered through Celite® to yield a crude mixture of 
diastereomers (d.r. 1:1). Purification by column chromatography (elution with 5% 
ethyl acetate:petroleum ether) yielded (3R,4S,5R)-3-
(trichloromethylcarbonylamino)-4,5-(O-isopropylidene)nonadec-1-en-4,5-diol (28b) 
(0.12 g, 44%) as a clear, colourless oil and (3S,4S,5R)-3-
(trichloromethylcarbonylamino)-4,5-(O-isopropylidene)nonadec-1-en-4,5-diol (28a) 
(0.071 g, 26%) as a clear, colourless oil. Data for 28b: max (neat)/cm
−1 3427 (NH), 
2922 (CH), 2853 (CH), 1721 (CO), 1496, 1211, 819; [𝛼]𝐷
27 −10.5 (c 1.4, CHCl3); δH 
(500 MHz, CDCl3) 0.88 (3H, t, J 7.0 Hz, 19-H3), 1.25–1.55 (32H, m, 6-H2, 7-H2, 8-
H2, 9-H2, 10-H2, 11-H2, 12-H2, 13-H2, 14-H2, 15-H2, 16-H2, 17-H2 , 18-H2 and 
C(CH3)2), 4.22–4.26 (2H, m, 4-H, 5-H), 4.38–4.41 (1H, m, 3-H), 5.27 (1H, d, J 10.4 
Hz, 1-HH), 5.30 (1H, d, J 17.1 Hz, 1-HH), 5.83 (1H, ddd, J 17.1, 10.4, 5.8 Hz, 2-H), 
7.19 (1H, d, J 7.7 Hz, NH); δC (126 MHz, CDCl3) 14.3 (CH3), 22.9 (CH2), 24.3 
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(CH3), 27.2 (CH3), 27.3 (CH2), 29.4 (CH2), 29.5 (CH2), 29.6 (CH2), 29.6 (CH2), 29.7 
(2 × CH2), 29.8 (2 × CH2), 29.8 (CH2), 29.9 (CH2), 32.1 (CH2), 53.2 (CH), 77.6 
(CH), 78.4 (CH), 92.9 (C), 108.1 (C), 117.2 (CH2), 134.8 (CH), 160.8 (C); m/z (CI) 
498.2307 (MH+. C24H43NO3Cl3 requires 498.2309), 440 (31%), 406 (28), 161 (35), 
113 (52), 73 (100); Data for 28a: max (neat)/cm
−1 3324 (NH), 2922 (CH), 2853 
(CH), 1694 (CO), 822; [𝛼]𝐷
27 −48.0 (c 0.8, CHCl3); δH (500 MHz, CDCl3) 0.88 (3H, t, 
J 7.0 Hz, 19-H3), 1.26–1.50 (32H, m, 6-H2, 7-H2, 8-H2, 9-H2, 10-H2, 11-H2, 12-H2, 
13-H2, 14-H2, 15-H2, 16-H2, 17-H2, 18-H2 and C(CH3)2), 4.13 (1H, dd, J 6.3, 3.8 Hz, 
4’-H), 4.23 (1H, ddd, J 9.7, 6.3, 3.7 Hz, 5’-H), 4.55 (1H, dddt, J 8.7, 5.2, 3.8, 1.7 
Hz, 3’-H), 5.28–5.32 (2H, m, 1’-H2), 6.01 (1H, ddd, J 17.4, 10.5, 5.2 Hz, 2’-H), 6.91 
(1H, d, J 8.7 Hz, NH); δC (126 MHz, CDCl3) 14.3 (CH3), 22.8 (CH2), 25.3 (CH3), 
27.0 (CH3), 27.1 (CH2), 29.0 (CH2), 29.5 (CH2), 29.6 (CH2), 29.7 (CH2), 29.7 (CH2), 
29.8 (CH2), 29.8 (2 × CH2), 29.8 (CH2), 29.9 (CH2), 32.1 (CH2), 54.2 (CH), 77.6 
(CH), 79.0 (CH), 92.8 (C), 108.7 (C), 118.0 (CH2), 134.0 (CH), 161.2 (C); m/z (CI) 
498.2304 (MH+. C24H43NO3Cl3 requires 498.2309), 464 (13%), 440 (100), 406 
(81), 394 (22), 329 (21). 
(2S,3S,4R)-2-(Trichloromethylcarbonylamino)-3,4-(O-
isopropylidene)octadecan-1,3,4-triol (30a) 
 
(3S,4S,5R)-3-(Trichloromethylcarbonylamino)-4,5-(O-isopropylidene)nonadec-1-
en-4,5-diol (28a) (0.053 g, 0.11 mmol) was dissolved in a mixture of 
dichloromethane (10 mL) and methanol (10 mL) and cooled to −78 °C. Ozone was 
bubbled through the reaction mixture until the solution turned deep blue. After 
excess ozone was purged with oxygen gas, a solution of sodium borohydride 
(0.013 g, 0.32 mmol) in ethanol (10 mL) was added dropwise with vigorous 
stirring. The reaction mixture was then allowed to slowly return to room 
temperature over 5 h. The reaction mixture was quenched with a saturated 
solution of ammonium chloride (10 mL) then concentrated in vacuo to an aqueous 
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solution and extracted with diethyl ether (3 × 15 mL). The combined organic layers 
were then washed with water (20 mL) and brine (20 mL), then dried (MgSO4), 
filtered and concentrated in vacuo to yield the crude product. Purification by 
column chromatography (diethyl ether/petroleum ether, 1:1) gave (2S,3S,4R)-2-
(trichloromethylcarbonylamino)-3,4-(O-isopropylidene)octadecan-1,3,4-triol (30a) 
(0.038 g, 71%) as a colourless oil. νmax (neat)/cm
–1 3307 (NH), 2918 (CH), 2849 
(CH), 1687 (CO), 1533, 1221, 1047, 822; [D
20 +4.8 (c 1.1, CHCl3); δH (500 MHz, 
CDCl3) 0.89 (3H, t, J 7.0 Hz, 18-H3), 1.17–1.33 (24H, m, 6-H2, 7-H2, 8-H2, 9-H2, 
10-H2, 11-H2, 12-H2, 13-H2, 14-H2, 15-H2, 16-H2 and 17-H2), 1.36 (3H, s, 
C(CH3)(CH3)), 1.49 (3H, s, C(CH3)(CH3)), 1.52–1.58 (2H, m, 5-H2), 3.75 (1H, dd, J 
11.4, 3.2 Hz, 1-HH), 4.01 (1H, dd, J 11.4, 3.2 Hz, 1-HH), 4.05 (1H, ddt, J 8.4, 5.6, 
3.2 Hz, 2-H), 4.19–4.26 (2H, m, 3-H and 4-H), 7.18 (1H, d, J 8.4 Hz, NH); δC (126 
MHz, CDCl3) 14.2 (CH3), 22.8 (CH2), 25.1 (CH3), 26.9 (CH2), 27.6 (CH3), 29.4 
(CH2), 29.5 (CH2), 29.6 (CH2), 29.6 (CH2), 29.7 (CH2), 29.8 (CH2), 29.8 (CH2), 29.8 
(CH2), 29.8 (2 × CH2), 32.1 (CH2), 52.1 (CH), 62.5 (CH2), 77.8 (CH), 77.8 (CH), 
92.7 (C), 108.6 (C), 161.7 (C); m/z (CI) 502.2264 (MH+. C23H43
35Cl3NO4 requires 
502.2258), 444 (100%), 410 (41), 329 (80), 313 (60), 271 (46), 257 (38), 219 (31), 
172 (27), 148 (26), 73 (59). 
(2R,3S,4R)-2-(Trichloromethylcarbonylamino)-3,4-(O-
isopropylidene)octadecan-1,3,4-triol (30b) 
 
The reaction was carried out according to the procedure described for (2S,3S,4R)-
2-(trichloromethylcarbonylamino)-3,4-(O-isopropylidene)octadecan-1,3,4-triol (30a) 
using (2R, 3S, 4R)-2-(trichloromethylcarbonylamino)-3,4-(O-
isopropylidene)octadecan-1,3,4-triol (28b) (0.046 g, 0.18 mmol). This yielded 
(2R,3S,4R)-2-(trichloromethylcarbonylamino)-3,4-(O-isopropylidene)octadecan-
1,3,4-triol (30b) (0.036 g, 77%) as a colourless oil. νmax (neat)/cm
–1 3419 (NH), 
2922 (CH), 2853 (CH), 1717 (CO), 1502, 1211, 1050, 820; [D
26 −20.5 (c 1.0, 
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CHCl3); δH (500 MHz, CDCl3) 0.88 (3H, t, J 6.9 Hz, 18-H3), 1.21–1.33 (26H, m, 5-
H2, 6-H2, 7-H2, 8-H2, 9-H2, 10-H2, 11-H2, 12-H2, 13-H2, 14-H2, 15-H2, 16-H2 and 17-
H2), 1.38 (3H, s, C(CH3)(CH3)), 1.53 (3H, s, C(CH3)(CH3)), 3.74 (1H, dd, J 11.1, 
6.4 Hz, 1-HH), 3.80 (1H, dd, J 11.1, 5.1 Hz, 1-HH), 3.90–3.98 (1H, m, 2-H), 4.21–
4.29 (1H, m, 4-H), 4.41 (1H, dd, J 7.1, 1.4 Hz, 3-H), 7.25 (1H, d, J 7.4 Hz, NH); δC 
(126 MHz, CDCl3) 14.2 (CH3), 22.8 (CH2), 24.5 (CH3), 27.2 (CH2), 27.2 (CH3), 29.4 
(CH2), 29.5 (CH2), 29.5 (CH2), 29.6 (CH2), 29.6 (CH2), 29.7 (CH2), 29.7 (CH2), 29.8 
(CH2), 29.8 (CH2), 29.8 (CH2), 32.1 (CH2), 52.7 (CH), 63.9 (CH2), 76.0 (CH), 77.7 
(CH), 92.9 (C), 108.3 (C), 161.9 (C); m/z (CI) 502.2252 (MH+. C23H43
35Cl3NO4 
requires 502.2258), 486 (14), 444 (100), 419 (34), 391 (42), 342 (37), 297 (68), 
149 (11). 
D-ribo-Phytosphingosine hydrochloride (10a)176 
 
(2S,3S,4R)-2-(Trichloromethylcarbonylamino)-3,4-(O-isopropylidene)octadecan-
1,3,4-triol (30a) (0.026 g, 0.052 mmol) was dissolved in a mixture of 
dichloromethane (2 mL) and methanol (2 mL). 4 M Sodium hydroxide (4 mL) was 
added and the reaction mixture stirred for 60 h. The solution was extracted with 
dichloromethane (3 × 20 mL), washed with water (3 × 20 mL) and concentrated in 
vacuo. The crude oil was then dissolved in a mixture of dichloromethane (2 mL) 
and methanol (2 mL). To this solution, 6 M hydrochloric acid (2 mL) was added 
and stirred for 3 h. The reaction was concentrated in vacuo and washed with 
petroleum ether (3 × 10 mL) to yield D-ribo-phytosphingosine hydrochloride (10a) 
as a white solid (0.015 g, 82%). Spectroscopic data as reported in literature.176 
[D
21 +4.8 (c 0.8, MeOH); δH (500 MHz, CD3OD) 0.90 (3H, t, J 7.0 Hz, 18-H3), 
1.28–1.42 (24H, m, 6-H2, 7-H2, 8-H2, 9-H2, 10-H2, 11-H2, 12-H2, 13-H2, 14-H2, 15-
H2, 16-H2 and 17-H2), 1.50–1.57 (1H, m, 5-HH), 1.63–1.73 (1H, m, 5-HH), 3.38–
3.45 (2H, m, 3-H and 4-H), 4.11 (1H, ddd, J 8.8, 5.9, 3.2 Hz, 2-H), 4.39 (1H, t, J 
8.8 Hz, 1-HH), 4.46 (1H, dd, J 8.8, 5.9 Hz, 1-HH); δC (126 MHz, CD3OD) 14.3 
(CH3), 23.6 (CH2), 26.6 (CH2), 30.4 (CH2), 30.7 (2 × CH2), 30.7 (5 × CH2), 30.8 
(CH2), 33.0 (CH2), 34.8 (CH2), 55.6 (CH), 67.4 (CH2), 74.0 (CH), 75.8 (CH); m/z 
(ESI) 318.2990 (MH+. C18H40NO3 requires 318.3003). 
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L-arabino-Phytosphingosine hydrochloride (10b)176 
 
The reaction was carried out as described for D-ribo-phytosphingosine 
hydrochloride (10a) using (2R,3S,4R)-2-(trichloromethylcarbonylamino)-3,4-(O-
isopropylidene)octadecan-1,3,4-triol (30b) (0.033 g, 0.066 mmol). This gave L-
arabino-phytosphingosine hydrochloride (10b) as a white solid (0.020 g, 87%). 
Spectroscopic data as reported in literature.176 [D
20
 −12.2 (c 0.9, MeOH); δH (500 
MHz, CD3OD) 0.90 (3H, t, J 7.0 Hz, 18-H3), 1.27–1.40 (24H, m, 6-H2, 7-H2, 8-H2, 
9-H2, 10-H2, 11-H2, 12-H2, 13-H2, 14-H2, 15-H2, 16-H2 and 17-H2), 1.49–1.58 (1H, 
m, 5-HH), 1.76 (1H, td, J 9.4, 3.4 Hz, 5-HH), 3.20 (1H, dd, J 8.1, 4.2 Hz, 3-H), 3.42 
(1H, td, J 8.1, 3.4 Hz, 4-H), 4.13 (1H, ddd, J 8.9, 6.3, 4.2 Hz, 2-H), 4.29 (1H, dd, J 
8.9, 6.3 Hz, 1-HH), 4.48 (1H, t, J 8.9 Hz, 1-HH); δC (126 MHz, CD3OD) 14.3 (CH3), 
23.6 (CH2), 26.5 (CH2), 30.4 (CH2), 30.7 (CH2), 30.7 (CH2), 30.7 (5 × CH2), 30.8 
(CH2), 33.0 (CH2), 35.1 (CH2), 55.9 (CH), 69.2 (CH2), 73.9 (CH), 76.3 (CH); m/z 
(ESI) 318.2990 (MH+. C18H40NO3 requires 318.3003).  
(3E,5S,6R)-5,6-(O-Isopropylidene)-5,6-dihydroxyicos-3-en-2-one (31) 
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E,4S,5R)-4,5-(O-isopropylidene)-4,5-dihydroxynonadec-2-enoate (22) 
using (2S,3R)-2,3-(O-isopropylidene)heptadecan-1,2,3-triol (19) (0.050 g, 0.15 
mmol) and dimethyl 2-oxopropylphosphonate (0.040 mL, 0.29 mmol). This yielded 
(3E,5S,6R)-5,6-(O-isopropylidene)-5,6-dihydroxyicos-3-en-2-one (31) (0.043 g, 
79%) as a colourless oil. νmax (neat)/cm
–1 2916 (CH), 2848 (CH), 1697 (CO), 1676 
(C=C), 1632, 1373, 1246, 1217, 1102, 1036; [D
21
 –2.3 (c 1.3, CHCl3); δH (400 
MHz, CDCl3) 0.87 (3H, t, J 6.9 Hz, 20-H3), 1.21–1.34 (24H, m, 8-H2, 9-H2, 10-H2, 
11-H2, 12-H2, 13-H2, 14-H2, 15-H2, 16-H2, 17-H2, 18-H2 and 19-H2), 1.38 (3H, s, 
C(CH3)(CH3)), 1.41–1.49 (2H, m, 7-H2), 1.51 (3H, s, C(CH3)(CH3)), 2.28 (3H, s, 1-
 Experimental 104 
 
H3), 4.24 (1H, ddd, J 8.7, 6.4, 4.6 Hz, 6-H), 4.64 (1H, td, J 6.4, 1.3 Hz, 5-H), 6.28 
(1H, dd, J 15.9, 1.3 Hz, 3-H), 6.65 (1H, dd, 15.9, 6.4 Hz, 4-H); δC (101 MHz, 
CDCl3) 14.3 (CH3), 22.8 (CH2), 25.6 (CH3), 26.4 (CH2), 27.7 (CH3), 28.2 (CH3), 
29.5 (CH2), 29.6 (CH2), 29.7 (CH2), 29.7 (CH2), 29.8 (CH2), 29.8 (2 × CH2), 29.8 (2 
× CH2), 30.7 (CH2), 32.1 (CH2), 77.8 (CH), 78.6 (CH), 109.0 (C), 131.8 (CH), 142.6 
(CH), 198.0 (C); m/z (CI) 367.3216 (MH+. C23H43O3 requires 367.3212), 349 
(17%), 309 (45), 239 (4), 141 (100), 113 (16), 81 (16). 
(3E,2S,5S,6R)-5,6-(O-Isopropylidene)-icos-3-en-2,5,6-triol (32a) 
 
(R)-(+)-2-Methyl-CBS-oxazaborolidine (0.60 mL, 0.60 mmol, 1 M solution in 
toluene) was added dropwise with stirring to a solution of (3E,5S,6R)-5,6-(O-
isopropylidene)-5,6-dihydroxyicos-3-en-2-one (31) (0.20 g, 0.55 mmol) in dry 
tetrahydrofuran (20 mL) at 0 °C. The solution was stirred for 0.5 h at 0 °C before 
borane (1.6 mL, 1.6 mmol, 1 M in tetrahydrofuran) was added dropwise and 
stirring was continued at 0 °C for 7.5 h. The reaction was quenched with methanol 
(10 mL), then warmed to room temperature and concentrated in vacuo. The 
resulting residue was dissolved in diethyl ether (30 mL) and washed with 1 M citric 
acid (3 × 50 mL), water (50 mL) and brine (50 mL). The organic layer was dried 
(MgSO4), filtered and purified by column chromatography (ethyl acetate/petroleum 
ether, 1:6, 1% triethylamine) to yield (3E,2S,5S,6R)-5,6-(O-isopropylidene)-icos-3-
en-2,5,6-triol (32a) (0.20 g, 99%) as a clear, colourless oil. νmax (neat)/cm
–1 3397 
(OH), 2982 (CH), 2922 (CH), 1456, 1368, 1215, 1032; [D
22
 +4.5 (c 1.1, CHCl3); 
δH (500 MHz, CDCl3) 0.88 (3H, t, J 7.0 Hz, 20-H3), 1.23–1.32 (27H, m, 1-H3, 8-H2, 
9-H2, 10-H2, 11-H2, 12-H2, 13-H2, 14-H2, 15-H2, 16-H2, 17-H2, 18-H2 and 19-H2), 
1.36 (3H, s, C(CH3)(CH3)), 1.38–1.46 (2H, m, 7-H2), 1.48 (3H, s, C(CH3)(CH3)), 
4.12 (1H, ddd, J 8.6, 6.3, 4.7 Hz, 6-H), 4.35 (1H, quin, J 5.9 Hz, 2-H), 4.49 (1H, dd, 
J 7.9, 6.3 Hz, 5-H), 5.65 (1H, ddd, J 15.5, 7.9, 1.2 Hz, 4-H), 5.81 (1H, ddd, J 15.5, 
5.9, 0.7 Hz, 3-H); δC (126 MHz, CDCl3) 14.3 (CH3), 22.8 (CH2), 23.4 (CH3), 25.8 
(CH3), 26.3 (CH2), 28.4 (CH3), 29.5 (CH2), 29.7 (CH2), 29.7 (CH2), 29.8 (CH2), 29.8 
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(2 × CH2), 29.8 (CH2), 29.8 (2 × CH2), 30.6 (CH2), 32.1 (CH2), 68.2 (CH), 78.5 
(CH), 79.0 (CH), 108.2 (C), 125.9 (CH), 138.4 (CH); m/z (ESI) 391.3169 (MNa+. 
C23H44NaO3 requires 391.3183). 
(3E,2R,5S,6R)-5,6-(O-Isopropylidene)-icos-3-en-2,5,6-triol (32b) 
 
The reaction was carried out according to the procedure described above for 
(3E,2S,5S,6R)-5,6-(O-isopropylidene)-icos-3-en-2,5,6-triol (32a) using (3E,5S,6R)-
5,6-(O-isopropylidene)-5,6-dihydroxyicos-3-en-2-one (31) (0.10 g, 0.28 mmol) and 
(S)-(−)-2-methyl-CBS-oxazaborolidine (0.30 mL, 0.30 mmol, 1 M solution in 
tetrahydrofuran). This yielded (3E,2R,5S,6R)-5,6-(O-isopropylidene)-icos-3-en-
2,5,6-triol (32b) (0.065 g, 64%) as a colourless oil. νmax (neat)/cm
–1 3414 (OH), 
2922 (CH), 2853 (CH), 1458, 1370, 1217, 1044, 756; [D
24 −3.7 (c 1.0, CHCl3); δH 
(500 MHz, CDCl3) 0.88 (3H, t, J 6.9 Hz, 20-H3), 1.20–1.31 (29H, m, 1-H3, 7-H2, 8-
H2, 9-H2, 10-H2, 11-H2, 12-H2, 13-H2, 14-H2, 15-H2, 16-H2, 17-H2, 18-H2 and 19-
H2), 1.35 (3H, s, C(CH3)(CH3)), 1.47 (3H, s, C(CH3)(CH3)), 4.08–4.15 (1H, m, 6-H), 
4.33 (1H, quintet of doublets, J 6.5, 0.9 Hz, 2-H), 4.47 (1H, dd, J 8.0, 6.2 Hz, 5-H), 
5.62 (1H, ddd, J 15.5, 8.0, 0.9 Hz, 4-H), 5.78 (1H, ddd, J 15.5, 6.5, 0.6 Hz, 3-H); 
δC (126 MHz, CDCl3) 14.3 (CH3), 22.8 (CH2), 23.3 (CH3), 25.8 (CH3), 26.2 (CH2), 
28.4 (CH3), 29.5 (CH2), 29.7 (CH2), 29.7 (CH2), 29.8 (3 × CH2), 29.8 (CH2), 29.8 
(CH2), 30.4 (CH2), 30.5 (CH2), 32.1 (CH2), 68.3 (CH), 78.5 (CH), 79.0 (CH), 108.2 
(C), 126.1 (CH), 138.5 (CH); m/z (CI) 369.3366 (MH+. C23H45O3 requires 
369.3369), 351 (37%), 309 (14), 293 (100), 225 (28), 183 (39), 125 (88). 
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 (2E,4S,5S,6R)-4-(Trichloromethylcarbonylamino)-5,6-(O-isopropylidene)-
icos-2-en-5,6-diol (34a) 
 
1,8-Diazabicycloundec-7-ene (0.011 g, 0.07 mmol) was added to a stirred solution 
of (3E,2S,5S,6R)-5,6-(O-isopropylidene)-icos-3-en-2,5,6-triol (32a) (0.053 g, 0.14 
mmol) and trichloroacetonitrile (0.031 g, 0.21 mmol) at 0 °C in dichloromethane (3 
mL). The solution was stirred at 0 °C for 0.5 h then warmed to room temperature 
over 3 h. The solution was filtered through a pad of silica with dichloromethane 
(200 mL) and concentrated in vacuo to yield the allylic trichloroacetimidate 33a as 
a yellow oil, which was used without further purification. The allylic 
trichloroacetimidate was dissolved in p-xylene (2 mL) and added to a microwave 
vial loaded with a silicon carbide bar and potassium carbonate (0.012 g, 6 mg/mL). 
The vial was sealed under argon and heated to 140 °C for 0.25 h in a microwave 
reactor. After cooling to room temperature, the reaction mixture was concentrated 
in vacuo. Purification by column chromatography (diethyl ether/petroleum ether, 
1:10) gave (2E,4S,5S,6R)-4-(trichloromethylcarbonylamino)-5,6-(O-
isopropylidene)-icos-2-en-5,6-diol (34a) (0.053 g, 72%) as a white solid. Mp 53–58 
°C; νmax (neat)/cm
–1 3356 (NH), 2918 (CH), 2851 (CH), 1688 (CO), 1516, 1219, 
959, 818; [D
22 −28.5 (c 1.0, CHCl3); δH (500 MHz, CDCl3) 0.81 (3H, t, J 6.9 Hz, 
20-H3), 1.17–1.31 (27H, m, 8-H2, 9-H2, 10-H2, 11-H2, 12-H2, 13-H2, 14-H2, 15-H2, 
16-H2, 17-H2, 18-H2, 19-H2 and C(CH3)(CH3)), 1.41 (3H, s, C(CH3)(CH3)), 1.50–
1.64 (2H, m, 7-H2), 1.67 (3H, dd, J 6.4, 1.4 Hz, 1-H3), 4.04 (1H, dd, J 6.3, 3.8 Hz, 
5-H), 4.14 (1H, ddd, J 9.6, 6.3, 3.7 Hz, 6-H), 4.40–4.44 (1H, m, 4-H), 5.53 (1H, 
ddd, J 15.5, 5.7, 1.4 Hz, 3-H), 5.64 (1H, dqd, J 15.5, 6.4, 1.1 Hz, 2-H), 6.83 (1H, d, 
J 8.7 Hz, NH); δC (126 MHz, CDCl3) 14.3 (CH3), 18.2 (CH3), 22.9 (CH2), 25.3 
(CH3), 27.0 (CH3), 27.1 (CH2), 29.0 (CH2), 29.5 (CH2), 29.6 (CH2), 29.7 (CH2), 29.7 
(CH2), 29.8 (CH2), 29.8 (2 × CH2), 29.9 (2 × CH2), 32.1 (CH2), 53.8 (CH), 77.6 
(CH), 79.1 (CH), 92.9 (C), 108.5 (C), 126.7 (CH), 129.4 (CH), 161.0 (C); m/z (ESI) 
534.2265 (MH+. C25H44
35Cl3NNaO3 requires 534.2279). 
 Experimental 107 
 
(2E,4R,5S,6R)-4-(Trichloromethylcarbonylamino)-5,6-(O-isopropylidene)-icos-
2-en-5,6-diol (34b) 
 
The reaction was carried out according to the procedure described for 
(2E,4S,5S,6R)-4-(trichloromethylcarbonylamino)-5,6-(O-isopropylidene)-icos-2-en-
5,6-diol (34a) using (3E,2R,5S,6R)-5,6-(O-isopropylidene)-icos-3-en-2,5,6-triol 
(32b) (0.029 g, 0.079 mmol). This yielded (2E,4R,5S,6R)-4-
(trichloromethylcarbonylamino)-5,6-(O-isopropylidene)-icos-2-en-5,6-diol (34b) 
(0.029 g, 71%) as a yellow oil. νmax (neat)/cm
–1 3426 (NH), 2922 (CH), 2853 (CH), 
1719 (CO), 1495, 1213, 964, 820; [D
22
 −12.6 (c 0.9, CHCl3); δH (500 MHz, 
CDCl3) 0.88 (3H, t, J 7.0 Hz, 20-H3), 1.20–1.33 (24H, m, 8-H2, 9-H2, 10-H2, 11-H2, 
12-H2, 13-H2, 14-H2, 15-H2, 16-H2, 17-H2, 18-H2 and 19-H2), 1.38 (3H, s, 
C(CH3)(CH3)), 1.45–1.51 (2H, m, 7-H2), 1.54 (3H, s, C(CH3)(CH3)), 1.72 (3H, ddd, 
J 6.5, 1.6, 0.9 Hz, 1-H3), 4.16–4.24 (2H, m, 5-H and 6-H), 4.30–4.37 (1H, m, 4-H), 
5.45 (1H, ddq, J 15.3, 7.3, 1.6 Hz, 3-H), 5.75 (1H, dqd, J 15.3, 6.5, 0.9 Hz, 2-H), 
7.18 (1H, d, J 7.0 Hz, NH); δC (126 MHz, CDCl3) 14.3 (CH3), 18.0 (CH3), 22.9 
(CH2), 24.4 (CH3), 27.2 (CH3), 27.3 (CH2), 29.3 (CH2), 29.5 (CH2), 29.6 (CH2), 29.6 
(CH2), 29.7 (CH2), 29.8 (2 × CH2), 29.8 (CH2), 29.8 (CH2), 29.8 (CH2), 32.1 (CH2), 
52.8 (CH), 77.6 (CH), 78.9 (CH), 93.0 (C), 108.0 (C), 127.8 (CH), 129.0 (CH), 
160.6 (C); m/z (CI) 512.2458 (MH+. C25H45
35Cl3NO3 requires 512.2465), 478 
(84%), 442 (100), 408 (55), 297 (20), 189 (34), 113 (14). 
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(2S,3S,4R)-2-(Trichloromethylcarbonylamino)-3,4-(O-
isopropylidene)octadecan-1,3,4-triol (30a) 
 
(2E,4S,5S,6R)-4-(Trichloromethylcarbonylamino)-5,6-(O-isopropylidene)-icos-2-
en-5,6-diol (32a) (0.057 g, 0.11 mmol) was dissolved in a mixture of 
dichloromethane (10 mL) and methanol (10 mL) and cooled to −78 °C. Ozone was 
bubbled through the reaction mixture until the solution turned deep blue. After 
excess ozone was purged with oxygen gas, a solution of sodium borohydride 
(0.013 g, 0.32 mmol) in ethanol (10 mL) was added dropwise with vigorous 
stirring. The reaction mixture was then allowed to slowly return to room 
temperature over 5 h. The reaction mixture was quenched with a saturated 
solution of ammonium chloride (10 mL) then concentrated in vacuo to an aqueous 
solution and extracted with diethyl ether (3 × 15 mL). The combined organic layers 
were then washed with water (20 mL) and brine (20 mL), then dried (MgSO4), 
filtered and concentrated in vacuo to yield the crude product. Purification by 
column chromatography (diethyl ether/petroleum ether, 1:1) gave (2S,3S,4R)-2-
(trichloromethylcarbonylamino)-3,4-(O-isopropylidene)octadecan-1,3,4-triol (30a) 
(0.041 g, 73%) as a colourless oil. νmax (neat)/cm
–1 3307 (NH), 2918 (CH), 2849 
(CH), 1687 (CO), 1533, 1221, 1047, 822; [D
20 +4.8 (c 1.1, CHCl3); δH (500 MHz, 
CDCl3) 0.89 (3H, t, J 7.0 Hz, 18-H3), 1.17–1.33 (24H, m, 6-H2, 7-H2, 8-H2, 9-H2, 
10-H2, 11-H2, 12-H2, 13-H2, 14-H2, 15-H2, 16-H2 and 17-H2), 1.36 (3H, s, 
C(CH3)(CH3)), 1.49 (3H, s, C(CH3)(CH3)), 1.52–1.58 (2H, m, 5-H2), 3.75 (1H, dd, J 
11.4, 3.2 Hz, 1-HH), 4.01 (1H, dd, J 11.4, 3.2 Hz, 1-HH), 4.05 (1H, ddt, J 8.4, 5.6, 
3.2 Hz, 2-H), 4.19–4.26 (2H, m, 3-H and 4-H), 7.18 (1H, d, J 8.4 Hz, NH); δC (126 
MHz, CDCl3) 14.2 (CH3), 22.8 (CH2), 25.1 (CH3), 26.9 (CH2), 27.6 (CH3), 29.4 
(CH2), 29.5 (CH2), 29.6 (CH2), 29.6 (CH2), 29.7 (CH2), 29.8 (CH2), 29.8 (CH2), 29.8 
(CH2), 29.8 (2 × CH2), 32.1 (CH2), 52.1 (CH), 62.5 (CH2), 77.8 (CH), 77.8 (CH), 
92.7 (C), 108.6 (C), 161.7 (C); m/z (CI) 502.2264 (MH+. C23H43
35Cl3NO4 requires 
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502.2258), 444 (100%), 410 (41), 329 (80), 313 (60), 271 (46), 257 (38), 219 (31), 
172 (27), 148 (26), 73 (59). 
(2R,3S,4R)-2-(Trichloromethylcarbonylamino)-3,4-(O-
isopropylidene)octadecan-1,3,4-triol (30b) 
 
The reaction was carried out according to the procedure described for (2S,3S,4R)-
2-(trichloromethylcarbonylamino)-3,4-(O-isopropylidene)octadecan-1,3,4-triol (30a) 
using (2E,4R,5S,6R)-4-(trichloromethylcarbonylamino)-5,6-(O-isopropylidene)-
icos-2-en-5,6-diol (32b) (0.090 g, 0.18 mmol). This yielded (2R,3S,4R)-2-
(trichloromethylcarbonylamino)-3,4-(O-isopropylidene)octadecan-1,3,4-triol (30b) 
(0.058 g, 66%) as a colourless oil. νmax (neat)/cm
–1 3419 (NH), 2922 (CH), 2853 
(CH), 1717 (CO), 1502, 1211, 1050, 820; [D
26 −20.5 (c 1.0, CHCl3); δH (500 
MHz, CDCl3) 0.88 (3H, t, J 6.9 Hz, 18-H3), 1.21–1.33 (26H, m, 5-H2, 6-H2, 7-H2, 8-
H2, 9-H2, 10-H2, 11-H2, 12-H2, 13-H2, 14-H2, 15-H2, 16-H2 and 17-H2), 1.38 (3H, s, 
C(CH3)(CH3)), 1.53 (3H, s, C(CH3)(CH3)), 3.74 (1H, dd, J 11.1, 6.4 Hz, 1-HH), 3.80 
(1H, dd, J 11.1, 5.1 Hz, 1-HH), 3.90–3.98 (1H, m, 2-H), 4.21–4.29 (1H, m, 4-H), 
4.41 (1H, dd, J 7.1, 1.4 Hz, 3-H), 7.25 (1H, d, J 7.4 Hz, NH); δC (126 MHz, CDCl3) 
14.2 (CH3), 22.8 (CH2), 24.5 (CH3), 27.2 (CH2), 27.2 (CH3), 29.4 (CH2), 29.5 (CH2), 
29.5 (CH2), 29.6 (CH2), 29.6 (CH2), 29.7 (CH2), 29.7 (CH2), 29.8 (CH2), 29.8 (CH2), 
29.8 (CH2), 32.1 (CH2), 52.7 (CH), 63.9 (CH2), 76.0 (CH), 77.7 (CH), 92.9 (C), 
108.3 (C), 161.9 (C); m/z (CI) 502.2252 (MH+. C23H43
35Cl3NO4 requires 502.2258), 
486 (14), 444 (100), 419 (34), 391 (42), 342 (37), 297 (68), 149 (11). 
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2-Vinylbenzaldehyde (49a)177 
  
Potassium vinyltrifluoroborate (0.904 g, 6.75 mmol) and [1,1'-
bis(diphenylphosphino)ferrocene]palladium(II) dichloride (0.276 g, 0.337 mmol) 
were added to a degassed solution of 2-bromobenzaldehyde (52a) (0.624 g, 3.37 
mmol) and triethylamine (1.40 mL, 10.1 mmol) in propan-2-ol (34 mL). The 
solution was then heated to 80 °C for 18 h. The reaction mixture was cooled to 
room temperature, concentrated in vacuo and purified by filtration through a pad of 
silica (elution with 20% diethyl ether:petroleum ether) to yield 2-vinylbenzaldehyde 
(49a) (0.374 g, 84%) as a yellow oil. Spectroscopic data was in accordance with 
literature values.177 δH (400 MHz, CDCl3) 5.52 (1H, dd, J 11.0, 1.2 Hz, 2’-HH), 5.71 
(1H, dd, J 17.4, 1.2 Hz, 2’-HH), 7.40–7.48 (1H, m, ArH), 7.49–7.60 (3H, m, 1’-H 
and 2 × ArH), 7.81–7.86 (1H, m, ArH), 10.30 (1H, s, CHO); δC (101 MHz, CDCl3) 
119.6 (CH2), 127.6 (CH), 128.1 (CH), 131.4 (CH), 133.1 (C), 133.5 (CH), 133.9 
(CH), 140.7 (C), 192.6 (CH); m/z (EI) 132 (M+, 60%), 131 (20), 104 (53), 103 (52), 
86 (92), 84 (100), 78 (42). 
4,5-Methylenedioxy-2-vinylbenzaldehyde (49b)178 
 
The reaction was carried out according to the previously described procedure for 
2-vinylbenzaldehyde (49a) using 2-bromo-4,5-methylenedioxybenzaldehyde (52b) 
(0.400 g, 1.75 mmol). This gave 4,5-methylenedioxy-2-vinylbenzaldehyde (49b) 
(0.296 g, 96%) as a yellow solid. Mp 50–53 °C (lit.,178 52–54 °C); δH (500 MHz, 
CDCl3) 5.48 (1H, dd, J 10.9, 0.8 Hz, 2’-HH), 5.62 (1H, dd, J 17.3, 0.8 Hz, 2’-HH), 
6.05 (2H, s, OCH2O), 6.98 (1H, s, 3-H), 7.31 (1H, s, 6-H), 7.41 (1H, dd, J 17.3, 
10.9 Hz, 1’-H), 10.21 (1H, s, CHO); δC (126 MHz, CDCl3) 102.2 (CH2), 106.8 (CH), 
108.1 (CH), 119.2 (CH2), 128.2 (C), 132.4 (CH), 138.5 (C), 148.1 (C), 152.7 (C), 
189.6 (CH); m/z (EI) 176 (M+, 100%), 147 (91), 84 (90), 49 (68). 
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5-Fluoro-2-vinylbenzaldehyde (49c)177 
 
The reaction was carried out according to the previously described procedure for 
2-vinylbenzaldehyde (49a) using 2-bromo-5-fluorobenzaldehyde (52c) (0.500 mg, 
2.46 mmol) and potassium vinyltrifluoroborate (0.396 g, 2.96 mmol). This gave 5-
fluoro-2-vinylbenzaldehyde (49c) (0.336 g, 91%) as a yellow oil. Spectroscopic 
data was in accordance with literature values.177 δH (400 MHz, CDCl3) 5.50 (1H, d, 
J 11.0 Hz, 2’-HH), 5.62 (1H, d, J 17.4 Hz, 2’-HH), 7.18–7.26 (1H, m, ArH), 7.38 
(1H, dd, J 17.4, 11.0 Hz, 1’-H), 7.44–7.54 (2H, m, 2 × ArH), 10.24 (1H, s, CHO); δC 
(101 MHz, CDCl3) 116.1 (CH, d, 
2JCF 22.1 Hz), 119.9 (CH2), 121.1 (CH, d, 
2JCF 
21.9 Hz), 129.7 (CH, d, 3JCF 7.3 Hz), 132.0 (CH), 134.4 (C, d, 
3JCF 5.9 Hz), 137.0 
(C, d, 4JCF 3.4 Hz), 162.3 (C, d, 
1JCF 249.5 Hz), 190.6 (CHO); m/z (EI) 150 (M
+, 
79%), 122 (100), 121 (63), 101 (61), 96 (52), 75 (32). 
4-Methyl-2-vinylbenzaldehyde (49d)177 
 
The reaction was carried out according to the previously described procedure for 
2-vinylbenzaldehyde (49a) using 2-bromo-4-methylbenzaldehyde (52d) (0.400 g, 
2.01 mmol). This gave 4-methyl-2-vinylbenzaldehyde (49d) (0.264 g, 90%) as a 
yellow oil. Spectroscopic data was in accordance with literature values.177 δH (400 
MHz, CDCl3) 2.43 (3H, s, 4-CH3), 5.49 (1H, dd, J 11.0, 1.2 Hz, 2’-HH), 5.69 (1H, 
dd, J 17.4, 1.2 Hz, 2’-HH), 7.24 (1H, d, J 7.9 Hz, 5-H), 7.37 (1H, s, 3-H), 7.53 (1H, 
dd, J 17.4, 11.0 Hz, 1’-H), 7.73 (1H, d, J 7.9 Hz, 6-H), 10.23 (1H, s, CHO); δC (101 
MHz, CDCl3) 22.0 (CH3), 119.2 (CH2), 128.2 (CH), 128.9 (CH), 130.9 (C), 131.7 
(CH), 133.7 (CH), 140.7 (C), 144.9 (C), 192.2 (CH); m/z (EI) 146 (M+, 100%), 117 
(71), 115 (37), 91 (25), 84 (11). 
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5-Methoxy-2-vinylbenzaldehyde (49e) 
 
The reaction was carried out according to the previously described procedure for 
2-vinylbenzaldehyde (49a) using 2-bromo-5-methoxybenzaldehyde (52e) (0.400 g, 
1.86 mmol). This gave 5-methoxy-2-vinylbenzaldehyde (49e) (0.269 g, 89%) as a 
yellow oil. max (neat)/cm
−1 2943 (CH), 2838 (CH), 1686 (CO), 1605 (C=C), 1494, 
1317, 1246, 1164, 1024; δH (400 MHz, CDCl3) 3.87 (3H, s, OCH3), 5.45 (1H, dd, J 
10.9, 1.1 Hz, 2’-HH), 5.61 (1H, dd, J 17.3, 1.1 Hz, 2’-HH), 7.13 (1H, dd, J 8.6, 2.8 
Hz, 4-H), 7.34 (1H, d, J 2.8 Hz, 6-H), 7.42 (1H, dd, J 17.3, 10.9 Hz, 1’-H), 7.51 
(1H, d, J 8.6 Hz, 3-H), 10.32 (1H, s, CHO); δC (101 MHz, CDCl3) 55.7 (CH3), 113.0 
(CH), 118.3 (CH2), 121.3 (CH), 129.0 (CH), 132.4 (CH), 133.9 (C), 134.0 (C), 
159.5 (C), 191.8 (CH); m/z (EI) 162.0680 (M+, C10H10O2 requires 162.0681), 134 
(100%), 119 (42), 91 (41), 84 (39), 49 (28). 
1-Vinyl-2-naphthaldehyde (49f)177 
 
The reaction was carried out according to the previously described procedure for 
2-vinylbenzaldehyde (49a) using 1-bromo-2-naphthaldehyde (52f) (0.400 g, 1.70 
mmol). This gave 1-vinyl-2-naphthaldehyde (49f) (0.275 g, 89%) as a yellow solid. 
Spectroscopic data was in accordance with literature values.177 Mp 68–70 °C; δH 
(400 MHz, CDCl3) 5.49 (1H, dd, J 17.5, 1.6 Hz, 2’-HH), 6.01 (1H, dd, J 11.3, 1.6 
Hz, 2’-HH), 7.38 (1H, dd, J 17.5, 11.3 Hz, 1’-H), 7.58 (1H, ddd, J 8.4, 6.9, 1.4 Hz, 
ArH), 7.63 (1H, ddd, J 8.4, 6.9, 1.3 Hz, ArH), 7.83 (1H, d, J 8.4 Hz, ArH), 7.87 (1H, 
dd, J 8.4, 1.3 Hz, ArH), 8.00 (1H, d, J 8.4 Hz, ArH), 8.18 (1H, dd, J 8.4, 0.7 Hz, 3-
H), 10.46 (1H, d, J 0.7 Hz, CHO); δC (101 MHz, CDCl3) 123.1 (CH2), 126.0 (CH), 
126.2 (CH), 127.1 (CH), 128.2 (CH), 128.6 (CH), 129.0 (CH), 130.8 (CH), 131.5 
(C), 131.7 (C), 135.9 (C), 143.4 (C), 192.8 (CH); m/z (EI) 182 (M+, 57%), 153 
(100), 152 (52), 127 (14), 84 (11), 76 (13). 
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Ethyl (2E)-3-(2’-vinylphenyl)prop-2-enoate (50a)179 
 
Lithium bromide (0.583 g, 6.70 mmol) was added to a solution of triethyl 
phosphonoacetate (21) (1.13 mL, 5.69 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-
ene (0.848 mL, 5.69 mmol) in acetonitrile (25 mL) and stirred at room temperature 
for 0.5 h. 2-Vinylbenzaldehyde (49a) (0.221 g, 1.67 mmol) was added and the 
solution was stirred at room temperature for 18 h. The reaction was quenched by 
the addition of a saturated solution of ammonium chloride (30 mL), concentrated to 
half volume in vacuo and extracted with diethyl ether (3 × 30 mL). The combined 
organic layers were washed with water (100 mL), brine (100 mL), dried (MgSO4), 
filtered and concentrated in vacuo. Purification by filtration through a pad of silica 
(elution with 20% diethyl ether:petroleum ether) gave ethyl (2E)-3-(2’-
vinylphenyl)prop-2-enoate (50a) (0.331 g, 98%) as a yellow oil. Spectroscopic data 
was in accordance with literature values.179 δH (400 MHz, CDCl3) 1.34 (3H, t, J 7.2 
Hz, OCH2CH3), 4.27 (2H, q, J 7.2 Hz, OCH2CH3), 5.43 (1H, dd, J 11.0, 1.2 Hz, 2”-
HH), 5.64 (1H, dd, J 17.4, 1.2 Hz, 2”-HH), 6.35 (1H, d, J 15.9 Hz, 2-H), 7.07 (1H, 
dd, J 17.4, 11.0 Hz, 1”-H), 7.29 (1H, td, J 7.5, 1.2 Hz, ArH), 7.36 (1H, td, J 7.5, 1.2 
Hz, ArH), 7.46–7.55 (2H, m, ArH), 8.04 (1H, d, J 15.9 Hz, 3-H); δC (101 MHz, 
CDCl3) 14.5 (CH3), 60.7 (CH2), 118.2 (CH2), 120.5 (CH), 127.1 (CH), 127.2 (CH), 
128.1 (CH), 130.1 (CH), 132.7 (C), 134.4 (CH), 138.1 (C), 142.5 (CH), 167.0 (C); 
m/z (EI) 202 (M+, 10%), 173 (4), 157 (10), 129 (100), 128 (58), 102 (5), 83 (12). 
Ethyl (2E)-3-(4’,5’-methylenedioxy-2’-vinylphenyl)prop-2-enoate (50b) 
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-vinylphenyl)prop-2-enoate (50a) using 4,5-methylenedioxy-2-
vinylbenzaldehyde (49b) (0.279 g, 1.59 mmol). This gave ethyl (2E)-3-(4’,5’-
methylenedioxy-2-vinylphenyl)prop-2-enoate (50b) (0.367 g, 94%) as an off-white 
solid. Mp 82–84 °C; max (neat)/cm
−1 2904 (CH), 1714 (CO), 1614 (C=C), 1500, 
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1489, 1284, 1177; δH (500 MHz, CDCl3) 1.33 (3H, t, J 7.1 Hz, OCH2CH3), 4.26 
(2H, q, J 7.1 Hz, OCH2CH3), 5.35 (1H, dd, J 10.9, 1.0 Hz, 2”-HH), 5.53 (1H, dd, J 
17.2, 1.0 Hz, 2”-HH), 5.98 (2H, s, OCH2O), 6.21 (1H, d, J 15.7 Hz, 2-H), 6.95 (1H, 
s, 3’-H), 7.00 (1H, s, 6’-H), 7.03 (1H, dd, J 17.2, 10.9 Hz, 1”-H), 7.98 (1H, d, J 15.7 
Hz, 3-H); δC (126 MHz, CDCl3) 13.5 (CH3), 59.6 (CH2), 100.7 (CH2), 105.1 (CH), 
105.6 (CH), 115.9 (CH2), 117.6 (CH), 125.9 (C), 132.8 (C), 132.9 (CH), 140.7 
(CH), 147.1 (C), 148.8 (C), 166.1 (C); m/z (EI) 246.0889 (M+, C14H14O4 requires 
246.0892), 217 (30%), 201 (30), 173 (100), 143 (38), 115 (96). 
Ethyl (2E)-3-(5’-fluoro-2’-vinylphenyl)prop-2-enoate (50c) 
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-vinylphenyl)prop-2-enoate (50a) using 5-fluoro-2-
vinylbenzaldehyde (49c) (0.190 g, 1.27 mmol). This gave ethyl (2E)-3-(5’-fluoro-2’-
vinylphenyl)prop-2-enoate (50c) (0.247 g, 89%) as a yellow oil. max (neat)/cm
−1 
2982 (CH), 2932 (CH), 1712 (CO), 1636 (C=C), 1486, 1316, 1237, 1176, 1034; δH 
(400 MHz, CDCl3) 1.33 (3H, t, J 7.1 Hz, OCH2CH3), 4.26 (2H, q, J 7.1 Hz, 
OCH2CH3), 5.38 (1H, dd, J 10.9, 0.7 Hz, 2”-HH), 5.56 (1H, dd, J 17.2, 0.7 Hz, 2”-
HH), 6.31 (1H, d, J 15.9 Hz, 2-H), 6.92–7.06 (2H, m, 1”-H and 6’-H), 7.18 (1H, dd, 
J 9.2, 4JHF 2.7 Hz, 3’-H), 7.43 (1H, dd, J 9.2, 
3JHF 5.7 Hz, 4’-H), 7.94 (1H, dd, J 
15.9, 5JHF 1.3 Hz, 3-H); δC (126 MHz, CDCl3) 14.4 (CH3), 60.8 (CH2), 113.2 (CH, d, 
2JCF 22.3 Hz), 117.1 (CH, d, 
2JCF 21.6 Hz), 118.0 (CH2), 121.4 (CH), 128.9 (CH, d, 
3JCF 8.1 Hz), 133.3 (CH), 134.3 (C, d, 
4JCF 3.2 Hz), 134.4 (C, d, 
3JCF 7.6 Hz), 141.1 
(CH, d, 4JCF 2.3 Hz), 162.3 (C, d, 
1JCF 247.3 Hz), 166.5 (C); m/z (ESI) 243.0789 
(MNa+, C13H13FNaO2 requires 243.0792), 236 (35%), 218 (5), 147 (8), 135 (4). 
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Ethyl (2E)-3-(4’-methyl-2’-vinylphenyl)prop-2-enate (50d) 
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-vinylphenyl)prop-2-enoate (50a) using 4-methyl-2-
vinylbenzaldehyde (49d) (0.258 g, 1.77 mmol). This gave ethyl (2E)-3-(4’-methyl-
2’-vinylphenyl)prop-2-enoate (50d) (0.385 g, 100%) as a yellow oil. max 
(neat)/cm−1 2980 (CH), 1710 (CO), 1631 (C=C), 1313, 1266, 1176, 1158, 1037; δH 
(400 MHz, CDCl3) 1.34 (3H, t, J 7.1 Hz, OCH2CH3), 2.37 (3H, s, 4’-CH3), 4.26 (2H, 
q, J 7.1 Hz, OCH2CH3), 5.40 (1H, dd, J 11.0, 1.3 Hz, 2”-HH), 5.62 (1H, dd, J 17.3, 
1.3 Hz, 2”-HH), 6.32 (1H, d, J 15.9 Hz, 2-H), 7.06 (1H, dd, J 17.3, 11.0 Hz, 1”-H), 
7.09–7.12 (1H, m, 5’-H), 7.30 (1H, s, 3’-H), 7.45 (1H, d, J 8.0 Hz, 6’-H), 8.01 (1H, 
d, J 15.9 Hz, 3-H); δC (126 MHz, CDCl3) 14.5 (CH3), 21.5 (CH3), 60.6 (CH2), 117.9 
(CH2), 119.4 (CH), 127.1 (CH), 127.7 (CH), 129.0 (CH), 129.9 (C), 134.5 (CH), 
138.1 (C), 140.3 (C), 142.3 (CH), 167.2 (C); m/z (ESI) 239.1035 (MNa+, 
C14H16NaO2 requires 239.1043). 
Ethyl (2E)-3-(5’-methoxy-2’-vinylphenyl)prop-2-enoate (50e) 
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-vinylphenyl)prop-2-enoate (50a) using 5-methoxy-2-
vinylbenzaldehyde (49e) (0.266 g, 1.64 mmol). This gave ethyl (2E)-3-(5’-methoxy-
2’-vinylphenyl)acrylate (50e) (0.376 g, 99%) as a yellow oil. max (neat)/cm
–1 2980 
(CH), 1709 (CO), 1634 (C=C), 1603, 1493, 1314, 1236, 1167, 1035, 980; δH (500 
MHz, CDCl3) 1.35 (3H, t, J 7.1 Hz, OCH2CH3), 3.83 (3H, s, OCH3), 4.27 (2H, q, J 
7.1 Hz, OCH2CH3), 5.32 (1H, dd, J 11.0, 1.1 Hz, 2”-HH), 5.54 (1H, dd, J 17.3, 1.1 
Hz, 2”-HH), 6.33 (1H, d, J 15.8 Hz, 2-H), 6.92 (1H, dd, J 8.6, 2.7 Hz, 4’-H), 7.00 
(1H, dd, J 17.3, 11.0 Hz, 1”-H), 7.02 (1H, d, J 2.7 Hz, 6’-H), 7.43 (1H, d, J 8.6 Hz, 
3’-H), 8.01 (1H, d, J 15.8 Hz, 3-H); δC (126 MHz, CDCl3) 14.5 (CH3), 55.5 (CH3), 
60.7 (CH2), 111.3 (CH), 116.3 (CH2), 116.6 (CH), 120.6 (CH), 128.3 (CH), 131.1 
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(C), 133.7 (CH), 133.7 (C), 142.4 (CH), 159.3 (C), 166.9 (C); m/z (EI) 232.1099 
(M+, C14H16O3 requires 232.1099), 203 (47%), 187 (24), 159 (100), 144 (83), 115 
(53). 
Ethyl (2E)-3-(1’-vinylnaphthalen-2’-yl)prop-2-enoate (50f) 
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-vinylphenyl)prop-2-enoate (50a) using 1-vinyl-2-naphthaldehyde 
(49f) (0.271 g, 1.49 mmol). This gave ethyl (2E)-3-(1’-vinylnaphthalen-2’-yl)prop-2-
enoate (50f) (0.327 g, 87%) as a yellow oil. max (neat)/cm
−1 2978 (CH), 1711 
(CO), 1627 (C=C), 1293, 1256, 1175, 1038; δH (500 MHz, CDCl3) 1.35 (3H, t, J 7.1 
Hz, OCH2CH3), 4.28 (2H, q, J 7.1 Hz, OCH2CH3), 5.43 (1H, dd, J 17.7, 1.8 Hz, 2”-
HH), 5.93 (1H, dd, J 11.4, 1.8 Hz, 2”-HH), 6.48 (1H, d, J 16.0 Hz, 2-H), 7.21 (1H, 
dd, J 17.7, 11.4 Hz, 1”-H), 7.49–7.55 (2H, m, 2 × ArH), 7.71 (1H, d, J 8.7 Hz, 4’-H), 
7.77 (1H, d, J 8.7 Hz, 3’-H), 7.80–7.85 (1H, m, ArH), 8.10–8.14 (1H, m, ArH), 8.24 
(1H, d, J 16.0 Hz, 3-H); δC (126 MHz, CDCl3) 14.5 (CH3), 60.6 (CH2), 119.1 (CH2), 
123.6 (CH), 124.4 (CH), 126.2 (CH), 126.8 (CH), 127.1 (CH), 128.0 (CH), 128.4 
(CH), 129.6 (C), 131.9 (C), 132.7 (CH), 134.1 (C), 138.2 (C), 144.0 (CH), 167.3 
(C); m/z (ESI) 275.1037 (MNa+, C17H16NaO2 requires 275.1043). 
(2E)-3-(2’-Vinylphenyl)prop-2-en-1-ol (51a) 
 
Diisobutylaluminium hydride (3.33 mL, 1 M solution in hexanes) was added 
dropwise with stirring, to a solution of ethyl (2E)-3-(2’-vinylphenyl)prop-2-enoate 
(50a) (0.269 g, 1.33 mmol), in diethyl ether (27 mL) at −78 °C. The solution was 
stirred at −78 °C for 3 h then allowed to return to room temperature over 15 h. The 
reaction was quenched with 10% aqueous potassium sodium tartrate solution (30 
mL), extracted with diethyl ether (2 × 20 mL), washed with water (100 mL), brine 
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(100 mL), dried (MgSO4), filtered and concentrated in vacuo. Purification by 
column chromatography (elution with 50% diethyl ether/petroleum ether) yielded 
(2E)-3-(2’-vinylphenyl)prop-2-en-1-ol (51a) (0.207 g, 97%) as a colourless oil. max 
(neat)/cm–1 3329 (OH), 2922 (CH), 1624 (C=C), 1476, 1414, 1099, 966; δH (500 
MHz, CDCl3) 1.54 (1H, br s, OH), 4.35 (2H, d, J 5.4 Hz, 1-H2), 5.34 (1H, dd, J 
11.0, 1.2 Hz, 2”-HH), 5.63 (1H, dd, J 17.4, 1.2 Hz, 2”-HH), 6.24 (1H, dt, J 15.7, 5.4 
Hz, 2-H), 6.92 (1H, d, J 15.7 Hz, 3-H), 7.02 (1H, dd, J 17.4, 11.0 Hz, 1”-H), 7.23–
7.27 (2H, m, ArH), 7.41–7.47 (2H, m, ArH); δC (126 MHz, CDCl3) 64.0 (CH2), 
116.5 (CH2), 126.5 (CH), 126.7 (CH), 127.9 (CH), 128.0 (CH), 128.9 (CH), 131.2 
(CH), 135.0 (CH), 135.1 (C), 136.3 (C); m/z (EI) 160.0882 (M+, C11H12O requires 
160.0888), 141 (13%), 129 (100), 115 (21), 91 (9). 
(2E)-3-(4’,5’-Methylenedioxy-2’-vinylphenyl)prop-2-en-1-ol (51b) 
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-vinylphenyl)prop-2-en-1-ol (51a) using ethyl (2E)-3-(4’,5’-
methylenedioxy-2-vinylphenyl)prop-2-enoate (50b) (0.357 g, 1.45 mmol). This 
gave (2E)-3-(4’,5’-methylenedioxy-2’-vinylphenyl)prop-2-en-1-ol (51b) (0.292 g, 
99%) as a white solid. Mp 73–76 °C; max (neat)/cm
−1 3332 (OH), 2896 (CH), 1622 
(C=C), 1501, 1478, 1245, 1039; δH (500 MHz, CDCl3) 1.65 (1H, s, OH), 4.30 (2H, 
dd, J 5.7, 1.5 Hz, 1-H2), 5.23 (1H, dd, J 10.9, 1.0 Hz, 2”-HH), 5.49 (1H, dd, J 17.3, 
1.0 Hz, 2”-HH), 5.93 (2H, s, OCH2O), 6.10 (1H, dt, J 15.6, 5.7 Hz, 2-H), 6.84 (1H, 
dt, J 15.6, 1.5 Hz, 3-H), 6.89 (1H, s, ArH), 6.93 (1H, s, ArH), 6.94 (1H, dd, J 17.3, 
10.9 Hz, 1”-H); δC (126 MHz, CDCl3) 62.9 (CH2), 100.2 (CH2), 105.0 (CH), 105.2 
(CH), 113.9 (CH2), 127.6 (CH), 128.5 (C), 128.8 (CH), 129.7 (C), 133.4 (CH), 
146.8 (C), 146.8 (C); m/z (EI) 204.0790 (M+, C12H12O3 requires 204.0786), 173 
(78%), 115 (41), 82 (100). 
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(2E)-3-(5’-Fluoro-2’-vinylphenyl)prop-2-en-1-ol (51c) 
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-vinylphenyl)prop-2-en-1-ol (51a) using ethyl (2E)-3-(5’-fluoro-2’-
vinylphenyl)prop-2-enoate (50c) (0.223 g, 1.01 mmol). This gave (2E)-3-(5’-fluoro-
2’-vinylphenyl)prop-2-en-1-ol (51c) (0.174 g, 97%) as a colourless oil. max 
(neat)/cm−1 3329 (OH), 2868 (CH), 1605 (C=C), 1574, 1483, 1096, 964, 912; δH 
(500 MHz, CDCl3) 1.48 (1H, br s, OH), 4.35 (2H, dd, J 5.4, 1.5 Hz, 1-H2), 5.31 (1H, 
dd, J 11.0, 0.9 Hz, 2”-HH), 5.55 (1H, dd, J 17.4, 0.9 Hz, 2”-HH), 6.24 (1H, dt, J 
15.8, 5.4 Hz, 2-H), 6.87 (1H, dd, J 15.8, 1.5 Hz, 3-H), 6.91–6.98 (2H, m, 1”-H and 
6’-H), 7.11 (1H, dd, J 9.3, 4JHF 2.7 Hz, 3’-H), 7.41 (1H, dd, J 9.3, 
3JHF 5.9 Hz, 4’-H); 
δC (126 MHz, CDCl3) 63.7 (CH2), 112.9 (d, 
2JCF 22.0 Hz, CH), 114.9 (d, 
2JCF 21.6 
Hz, CH), 116.4 (CH2), 127.6 (d, 
4JCF 2.2 Hz, CH), 128.3 (d, 
3JCF 8.3 Hz, CH), 132.2 
(CH), 132.5 (d, 4JCF 3.1 Hz, C), 133.9 (CH), 137.0 (d, 
3JCF 7.7 Hz, C), 162.6 (d, 
1JCF 246.2 Hz, C); m/z (EI) 178.0791 (M
+, C11H11FO requires 178.0794), 160 (11), 
147 (100), 133 (13), 127 (10), 84 (5).  
(2E)-3-(4’-Methyl-2’-vinylphenyl)prop-2-en-1-ol (51d) 
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-vinylphenyl)prop-2-en-1-ol (51a) using ethyl (2E)-3-(4’-methyl-2’-
vinylphenyl)prop-2-enoate (50d) (0.286 g, 1.32 mmol). This gave (2E)-3-(4’-
methyl-2’-vinylphenyl)prop-2-en-1-ol (51d) (0.213 g, 92%) as a colourless oil. max 
(neat)/cm−1 3333 (OH), 2921 (CH), 1488, 1238, 1201, 1005, 910; δH (500 MHz, 
CDCl3) 1.41 (1H, t, J 5.7 Hz, OH), 2.34 (3H, s, 4’-CH3), 4.33 (2H, td, J 5.7, 1.0 Hz, 
1-H2), 5.31 (1H, dd, J 11.0, 1.4 Hz, 2”-HH), 5.61 (1H, dd, J 17.4, 1.4 Hz, 2”-HH), 
6.20 (1H, dt, J 15.7, 5.7 Hz, 2-H), 6.88 (1H, d, J 15.7 Hz, 3-H), 7.00 (1H, dd, J 
17.4, 11.0 Hz, 1”-H), 7.06 (1H, d, J 7.9 Hz, ArH), 7.26 (1H, s, 3’-H), 7.33 (1H, d, J 
7.9 Hz, ArH); δC (126 MHz, CDCl3) 21.3 (CH3), 64.2 (CH2), 116.3 (CH2), 126.7 
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(CH), 127.1 (CH), 128.9 (CH), 128.9 (CH), 130.3 (CH), 132.3 (C), 135.0 (CH), 
136.2 (C), 137.6 (C); m/z (CI) 157.1021 (MH+−H2O, C12H13 requires 157.1017), 
113 (31%), 97 (38), 85 (85), 71 (100), 69 (90). 
(2E)-3-(5’-Methoxy-2’-vinylphenyl)prop-2-en-1-ol (51e) 
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-vinylphenyl)prop-2-en-1-ol (51a) using ethyl (2E)-3-(5’-methoxy-2’-
vinylphenyl)prop-2-enoate (50e) (0.321 g, 1.38 mmol). This gave (2E)-3-(5’-
methoxy-2’-vinylphenyl)prop-2-en-1-ol (51e) (0.233 g, 89%) as a clear oil. max 
(neat)/cm–1 3345 (OH), 2936 (CH), 1603 (C=C), 1491, 1288, 1246, 1167, 1105, 
1024; δH (500 MHz, CDCl3) 1.96 (1H, br s, OH), 3.81 (3H, s, OCH3), 4.33 (2H, d, J 
5.4 Hz, 1-H2), 5.22 (1H, dd, J 11.0, 1.3 Hz, 2”-HH), 5.52 (1H, dd, J 17.4, 1.3 Hz, 
2”-HH), 6.22 (1H, dt, J 15.7, 5.4 Hz, 2-H), 6.81 (1H, dd, J 8.6, 2.7 Hz, 4’-H), 6.89 
(1H, d, J 15.7 Hz, 3-H), 6.91–6.98 (2H, m, 1”-H and 6’-H), 7.40 (1H, d, J 8.6 Hz, 3’-
H); δC (126 MHz, CDCl3) 55.5 (CH3), 63.9 (CH2), 111.4 (CH), 114.1 (CH), 114.7 
(CH2), 127.7 (CH), 128.9 (CH), 129.3 (C), 131.4 (CH), 134.3 (CH), 136.3 (C), 
159.4 (C); m/z (EI) 190.0991 (M+, C12H14O2 requires 190.0994), 172 (8%), 159 
(100), 144 (48), 115 (28), 83 (21). 
(2E)-3-(1’-Vinylnaphthalen-2’-yl)prop-2-en-1-ol (51f) 
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-vinylphenyl)prop-2-en-1-ol (51a) using ethyl (2E)-3-(1’-vinylnaphthalen-
2’-yl)prop-2-enoate (50f) (0.325 g, 1.29 mmol). This gave (2E)-3-(1’-
vinylnaphthalen-2’-yl)prop-2-en-1-ol (51f) (0.248 g, 92%) as a yellow oil. max 
(neat)/cm−1 3327 (OH), 3056 (CH), 2859 (CH), 1508, 1418, 1094, 994, 970; δH 
(500 MHz, CDCl3) 1.49 (1H, t, J 5.7 Hz, OH), 4.38 (2H, t, J 5.7 Hz, 1-H2), 5.43 (1H, 
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dd, J 17.8, 2.0 Hz, 2”-HH), 5.84 (1H, dd, J 11.4, 2.0 Hz, 2”-HH), 6.41 (1H, dt, J 
15.9, 5.7 Hz, 2-H), 7.07–7.15 (2H, m, 3-H and 1”-H), 7.43–7.50 (2H, m, 2 × ArH), 
7.69 (1H, d, J 8.7 Hz, 4’-H), 7.74 (1H, d, J 8.7 Hz, 3’-H), 7.79–7.82 (1H, m, ArH), 
8.08–8.11 (1H, m, ArH); δC (126 MHz, CDCl3) 64.3 (CH2), 122.9 (CH2), 123.8 
(CH), 125.9 (CH), 125.9 (CH), 126.4 (CH), 127.6 (CH), 128.2 (CH), 129.6 (CH), 
130.4 (CH), 131.5 (C), 132.0 (C), 133.1 (C), 133.5 (CH), 134.8 (C); m/z (EI) 
210.1049 (M+, C15H14O requires 210.1045), 179 (100%), 165 (29), 152 (19), 139 
(6), 115 (5), 67 (21). 
1-(2’,2’,2’-Trichloromethylcarbonylamino)-1H-indene (54a) 
 
(2E)-3-(2’-Vinylphenyl)prop-2-en-1-ol (51a) (0.051 g, 0.32 mmol) was dissolved in 
dry dichloromethane (8 mL) and cooled to 0 °C under argon with stirring. 
Trichloroacetonitrile (0.048 mL, 0.48 mmol) was added to the solution, followed by 
1,8-diazabicyclo[5.4.0]undec-7-ene (0.024 mL, 0.16 mmol) and the reaction was 
allowed to return to room temperature over 1.5 h. The reaction mixture was filtered 
through a short pad of alumina (neutral, Brockman V) with diethyl ether (150 mL) 
and concentrated in vacuo to yield the crude allylic trichloroacetimidate as a yellow 
oil which was used without further purification. The allylic trichloroacetimidate 53a 
was transferred to a dry Schlenk tube containing a stirrer bar and potassium 
carbonate (15 mg, 3 mg/mL) to which p-xylene (5 mL) was then added. The tube 
was purged with argon, sealed and heated to 160 °C for 18 h. The reaction was 
allowed to cool to room temperature, Grubbs 2nd generation catalyst (0.011 g, 
0.013 mmol) was added and the reaction was heated to 50 °C for 20 h. The 
reaction mixture was concentrated in vacuo and purified by filtration through a 
short pad of silica (elution with 20% diethyl ether/petroleum ether) to yield 1-
(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54a) (0.072 g, 82%) as a white 
solid. Mp 73–75 °C; max (neat)/cm
–1 3325 (NH), 2927 (CH), 1697 (CO), 1506, 
1235, 819; δH (400 MHz, CDCl3) 5.62–5.68 (1H, m, 1-H), 6.42 (1H, dd, J 5.6, 1.9 
Hz, 2-H), 6.66 (1H, br d, J 5.2 Hz, NH), 6.91 (1H, ddd, J 5.6, 1.9, 0.8 Hz, 3-H), 
7.23–7.28 (1H, m, ArH), 7.33–7.36 (2H, m, ArH), 7.47–7.51 (1H, m, ArH); δC (126 
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MHz, CDCl3) 58.5 (CH), 92.5 (C), 122.0 (CH), 123.7 (CH), 126.7 (CH), 129.0 (CH), 
134.0 (CH), 134.8 (CH), 142.9 (C), 143.2 (C), 162.8 (C); m/z (CI) 275.9753 (MH+, 
C11H9
35Cl3NO requires 275.9750), 242 (62%), 208 (32), 172 (10), 85 (17), 69 (27). 
5,6-Methylenedioxy-1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene 
(54b) 
 
The reaction was carried out according to the previously described procedure for 
1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54a) using (2E)-3-(4’,5’-
methylenedioxy-2’-vinylphenyl)prop-2-en-1-ol (51b) (0.057 mg, 0.28 mmol). This 
gave 5,6-methylenedioxy-1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene 
(54b) (0.050 g, 57%) as an off-white solid. Mp 106–108 °C; max (neat)/cm
−1 3325 
(NH), 2901 (CH), 1696 (CO), 1502, 1472, 1337, 1276, 1039, 939, 838, 820; δH 
(500 MHz, CDCl3) 5.47–5.52 (1H, m, 1-H), 5.95 (1H, d, J 1.4 Hz, OCHHO), 5.96 
(1H, d, J 1.4 Hz, OCHHO), 6.30 (1H, dd, J 5.6, 2.0 Hz, 2-H), 6.71 (1H, br d, J 8.4 
Hz, NH), 6.76 (1H, dd, J 5.6, 1.3 Hz, 3-H), 6.78 (1H, s, 4-H), 6.96 (1H, s, 7-H); δC 
(126 MHz, CDCl3) 58.1 (CH), 92.5 (C), 101.5 (CH2), 103.0 (CH), 105.4 (CH), 132.8 
(CH), 134.4 (CH), 136.8 (C), 137.0 (C), 147.0 (C), 148.3 (C), 162.7 (C); m/z (EI) 
320.9539 (M+, C12H8
35Cl2
37ClNO3 requires 320.9542), 284 (68%), 248 (100), 218 
(21), 202 (32), 174 (80), 159 (61), 116 (52), 103 (58), 89 (58). 
6-Fluoro-1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54c) 
 
The reaction was carried out according to the previously described procedure for 
1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54a) using (2E)-3-(5’-fluoro-
2’-vinylphenyl)prop-2-en-1-ol (51c) (0.048 g, 0.27 mmol). This gave 6-fluoro-1-
(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54c) (0.052 g, 65%) as an off-
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white solid. Mp 92–94 °C; max (neat)/cm
−1 3321 (NH), 2916 (CH), 1695 (CO), 
1506, 1477, 1270, 1234, 839, 821; δH (500 MHz, CDCl3) 5.58–5.64 (1H, m, 1-H), 
6.38 (1H, dd, J 5.6, 2.0 Hz, 2-H), 6.69 (1H, br s, NH), 6.87 (1H, dd, J 5.6, 1.6 Hz, 
3-H), 7.03 (1H, ddd, 3JHF 8.4, J 8.4, 2.4 Hz, 5-H), 7.21 (1H, dd, 
3JHF 8.4, J 2.4 Hz, 
7-H), 7.26 (1H, dd, J 8.4, 4JHF 4.9 Hz, 4-H); δC (126 MHz, CDCl3) 58.4 (CH, d, 
4JCF 
2.1 Hz), 92.4 (C), 112.0 (CH, d, 2JCF 24.1 Hz), 115.7 (CH, d, 
2JCF 22.8 Hz), 122.7 
(CH, d, 3JCF 8.6 Hz), 133.7 (CH, d, 
5JCF 4.1 Hz), 134.2 (CH), 138.9 (C, d, 
4JCF 2.6 
Hz), 145.2 (C, d, 3JCF 8.3 Hz), 162.3 (C, d, 
1JCF 246.5 Hz), 162.8 (C); m/z (ESI) 
315.9461 (MNa+, C11H7
35Cl3FNNaO requires 315.9469). 
5-Methyl-1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54d) 
 
The reaction was carried out according to the previously described procedure for 
1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54a) using (2E)-3-(4’-methyl-
2’-vinylphenyl)prop-2-en-1-ol (51d) (0.063 g, 0.36 mmol). This gave 5-methyl-1-
(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54d) (0.072 g, 68%) as a white 
solid. Mp 88–92 °C; max (neat)/cm
−1 3321 (NH), 2923 (CH), 1695 (CO), 1505, 
1239, 837, 809; δH (500 MHz, CDCl3) 2.39 (3H, s, 5-CH3), 5.58–5.63 (1H, m, 1-H), 
6.40 (1H, dd, J 5.6, 2.0 Hz, 2-H), 6.65 (1H, br d, J 6.1 Hz, NH), 6.86 (1H, ddd, J 
5.6, 1.8, 0.6 Hz, 3-H), 7.07 (1H, d, J 7.5 Hz, 6-H), 7.16 (1H, s, 4-H), 7.37 (1H, d, J 
7.5 Hz, 7-H); δC (126 MHz, CDCl3) 21.6 (CH3), 58.2 (CH), 92.5 (C), 122.8 (CH), 
123.5 (CH), 127.3 (CH), 134.2 (CH), 134.8 (CH), 139.0 (C), 140.0 (C), 143.5 (C), 
162.8 (C); m/z (ESI) 311.9707 (MNa+, C12H10
35Cl3NNaO requires 311.9720). 
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6-Methoxy-1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54e) 
 
The reaction was carried out according to the previously described procedure for 
1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54a) using (2E)-3-(5’-
methoxy-2’-vinylphenyl)prop-2-en-1-ol (51e) (0.049 g, 0.26 mmol). This gave 6-
methoxy-1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54e) (0.048 g, 61%) 
as an off-white solid. Mp 69–71 °C; max (neat)/cm
–1 3314 (NH), 2940 (CH), 1697 
(CO), 1505, 1234, 1026, 818, 737; δH (400 MHz, CDCl3) 3.82 (3H, s, OCH3), 5.58–
5.63 (1H, m, 1-H), 6.27 (1H, dd, J 5.6, 2.1 Hz, 2-H), 6.67 (1H, br d, J 7.8 Hz, NH), 
6.80–6.88 (2H, m, 3-H and 5-H), 7.07 (1H, d, J 2.1 Hz, 7-H), 7.23 (1H, d, J 8.2 Hz, 
4-H); δC (126 MHz, CDCl3) 55.8 (CH3), 58.5 (CH), 92.5 (C), 110.7 (CH), 113.9 
(CH), 122.4 (CH), 131.7 (CH), 134.5 (CH), 135.9 (C), 145.0 (C), 159.3 (C), 162.8 
(C); m/z (EI) 306.9751 (M+, C12H10
35Cl2
37ClNO2 requires 306.9749), 270 (82%), 
234 (48), 192 (15), 160 (60), 145 (64), 130 (40), 115 (42), 83 (100), 77 (21). 
3-(2’,2’,2’-Trichloromethylcarbonylamino)-3H-benz[e]indene (54f) 
 
The reaction was carried out according to the previously described procedure for 
1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54a) using (2E)-3-(1’-
vinylnaphth-2’-yl)prop-2-en-1-ol (51f) (0.055 g, 0.26 mmol). This gave 3-(2’,2’,2’-
trichloromethylcarbonylamino)-3H-benz[e]indene (54f) (0.048 g, 56%) as an off-
white solid. Mp 130–134 °C (decomposition); max (neat)/cm
−1 3270 (NH), 3050 
(CH), 1698 (CO), 1685, 1533, 1514, 1260, 841, 822; δH (500 MHz, CDCl3) 5.79–
5.84 (1H, m, 3-H), 6.61 (1H, dd, J 5.6, 1.8 Hz, 2-H), 6.72 (1H, br d, J 6.7 Hz, NH), 
7.47–7.59 (3H, m, 1-H and 2 × ArH), 7.63 (1H, d, J 8.2 Hz, ArH), 7.79 (1H, d, J 8.2 
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Hz, ArH), 7.91 (1H, d, J 7.9 Hz, ArH), 8.06 (1H, d, J 7.9 Hz, ArH); δC (126 MHz, 
CDCl3) 59.4 (CH), 92.5 (C), 121.3 (CH), 123.9 (CH), 126.3 (CH), 126.7 (CH), 
127.2 (CH), 127.8 (C), 128.8 (CH), 132.1 (CH), 134.1 (C), 134.3 (CH), 139.7 (C), 
140.4 (C), 163.0 (C); m/z (EI) 324.9829 (M+, C15H10
35Cl3NO requires 324.9828), 
290 (54%), 254 (91), 208 (46), 180 (91), 165 (100), 152 (83), 88 (40), 70 (70), 61 
(57). 
Ethyl (2E)-3-(2’-bromophenyl)prop-2-enoate (57a)180 
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-vinylphenyl)prop-2-enoate (50a) using 2-bromobenzaldehyde 
(52a) (0.492 g, 2.66 mmol). This gave ethyl (2E)-3-(2’-bromophenyl)prop-2-enoate 
(57a) (0.558 g, 82%) as a colourless oil. Spectroscopic data was in accordance 
with literature values.180 δH (500 MHz, CDCl3) 1.35 (3H, t, J 7.1 Hz, OCH2CH3), 
4.28 (2H, q, J 7.1 Hz, OCH2CH3), 6.39 (1H, d, J 15.9 Hz, 2-H), 7.22 (1H, td, J 7.6, 
1.6 Hz, ArH), 7.32 (1H, t, J 7.6 Hz, ArH), 7.60 (1H, dd, J 7.6, 1.6 Hz, ArH), 7.61 
(1H, dd, J 7.6, 1.6 Hz, ArH), 8.05 (1H, d, J 15.9 Hz, 3-H); δC (126 MHz, CDCl3) 
14.5 (CH3), 60.8 (CH2), 121.3 (CH), 125.4 (C), 127.8 (CH), 127.9 (CH), 131.3 
(CH), 133.6 (CH), 134.7 (C), 143.1 (CH), 166.5 (C); m/z (EI) 254 (M+, 25%), 209 
(45), 175 (86), 147 (100), 102 (62), 83 (31), 75 (21). 
Ethyl (2E)-3-(2’-bromo-4’,5’-methylenedioxyphenyl)prop-2-enoate (57b) 
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-vinylphenyl)prop-2-enoate (50a) using 2-bromo-4,5-
methylenedioxybenzaldehyde (52b) (0.600 g, 2.62 mmol). This gave ethyl (2E)-3-
(2’-bromo-4’,5’-methylenedioxyphenyl)prop-2-enoate (57b) (0.781 g, 100%) as a 
white solid. Mp 101–105 °C; max (neat)/cm
−1 3072 (CH), 1695 (CO), 1501 (C=C), 
1476, 1289, 1256, 1228, 1113, 1027, 972; δH (400 MHz, CDCl3) 1.32 (3H, t, J 7.1 
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Hz, OCH2CH3), 4.25 (2H, q, J 7.1 Hz, OCH2CH3), 6.01 (2H, s, OCH2O), 6.22 (1H, 
d, J 15.9 Hz, 2-H), 7.03 (1H, s, ArH), 7.04 (1H, s, ArH), 7.96 (1H, d, J 15.9 Hz, 3-
H); δC (101 MHz, CDCl3) 14.4 (CH3), 60.7 (CH2), 102.3 (CH2), 106.5 (CH), 113.2 
(CH), 117.9 (C), 119.1 (CH), 127.8 (C), 142.8 (CH), 148.0 (C), 150.1 (C), 166.7 
(C); m/z (EI) 297.9837 (M+, C12H11
79BrO4 requires 297.9841), 219 (83%), 191 
(100), 174 (41), 133 (27), 84 (10). 
Ethyl (2E)-3-(2’-bromo-5’-fluorophenyl)prop-2-enoate (57c) 
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-vinylphenyl)prop-2-enoate (50a) using 2-bromo-5-
fluorobenzaldehyde (52c) (0.300 g, 1.48 mmol). This gave ethyl (2E)-3-(2’-bromo-
5’-fluorophenyl)prop-2-enoate (57c) (0.384 g, 95%) as a colourless oil. max 
(neat)/cm−1 2984 (CH), 1709 (CO), 1638 (C=C), 1464, 1316, 1271, 1161, 1030; δH 
(400 MHz, CDCl3) 1.35 (3H, t, J 7.1 Hz, OCH2CH3), 4.29 (2H, q, J 7.1 Hz, 
OCH2CH3), 6.37 (1H, d, J 15.9 Hz, 2-H), 6.97 (1H, ddd, J 8.8, 7.7, 3.0 Hz, 4’-H), 
7.30 (1H, dd, J 9.3, 3.0 Hz, 6’-H), 7.57 (1H, dd, J 8.8, 5.3 Hz, 3’-H), 7.97 (1H, dd, J 
15.9, 1.5 Hz, 3-H); δC (101 MHz, CDCl3) 14.4 (CH3), 61.0 (CH2), 114.6 (d, 
2JCF 
23.7 Hz, CH), 118.6 (d, 2JCF 22.7 Hz, CH), 119.6 (C), 122.4 (CH), 134.8 (d, 
3JCF 
7.9 Hz, CH), 136.4 (d, 3JCF 7.7 Hz, C), 142.1 (d, 
4JCF 1.9 Hz, CH), 162.1 (d, 
1JCF 
247.4 Hz, C), 166.2 (C); m/z (EI) 271.9854 (M+, C11H10
79BrFO2 requires 
271.9848), 229 (23%), 193 (36), 165 (100), 120 (47), 84 (20). 
Ethyl (2E)-3-(2’-bromo-4’-methylphenyl)prop-2-enoate (57d)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-vinylphenyl)prop-2-enoate (50a) using 2-bromo-4-
methylbenzaldehyde (52d) (0.500 g, 2.51 mmol). This gave ethyl (2E)-3-(2’-
bromo-4’-methylphenyl)prop-2-enoate (57d) (0.648 g, 96%) as an off-white solid. 
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Mp 37–41 °C; max (neat)/cm
−1 2980 (CH), 1709 (CO), 1634 (C=C), 1603, 1312, 
1263, 1165, 1040, 978, 814; δH (400 MHz, CDCl3) 1.34 (3H, t, J 7.1 Hz, 
OCH2CH3), 2.34 (3H, s, 4’-CH3), 4.27 (2H, q, J 7.1 Hz, OCH2CH3), 6.35 (1H, d, J 
15.9 Hz, 2-H), 7.12 (1H, d, J 7.9 Hz, 5’-H), 7.44 (1H, s, 3’-H), 7.50 (1H, d, J 7.9 Hz, 
6’-H), 8.02 (1H, d, J 15.9 Hz, 3-H); δC (101 MHz, CDCl3) 14.5 (CH3), 21.1 (CH3), 
60.8 (CH2), 120.2 (CH), 125.4 (C), 127.5 (CH), 128.8 (CH), 131.7 (C), 134.0 (CH), 
142.1 (C), 143.0 (CH), 166.7 (C); m/z (ESI) 290.9981 (MNa+, C12H13
79BrNaO2 
requires 290.9991), 271 (6%), 236 (22), 223 (64), 144 (19). 
Ethyl (2E)-3-(2’-bromo-5’-methoxyphenyl)prop-2-enoate (57e)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-vinylphenyl)prop-2-enoate (50a) using 2-bromo-5-
methoxybenzaldehyde (52e) (0.500 g, 2.33 mmol). This gave ethyl (2E)-3-(2’-
bromo-5’-methoxyphenyl)prop-2-enoate (57e) (0.619 g, 93%) as a yellow oil. max 
(neat)/cm−1 2987 (CH), 1710 (CO), 1637 (C=C), 1465, 1288, 1177, 1017; δH (500 
MHz, CDCl3) 1.35 (3H, t, J 7.1 Hz, OCH2CH3), 3.81 (3H, s, OCH3), 4.28 (2H, q, J 
7.1 Hz, OCH2CH3), 6.37 (1H, d, J 15.9 Hz, 2-H), 6.81 (1H, dd, J 8.8, 3.0 Hz, 4’-H), 
7.11 (1H, d, J 3.0 Hz, 6’-H), 7.49 (1H, d, J 8.8 Hz, 3’-H), 8.00 (1H, d, J 15.9 Hz, 3-
H); δC (126 MHz, CDCl3) 14.5 (CH3), 55.7 (CH3), 60.9 (CH2), 112.7 (CH), 116.1 
(C), 117.8 (CH), 121.4 (CH), 134.1 (CH), 135.4 (C), 143.2 (CH), 159.2 (C), 166.5 
(C); m/z (ESI) 306.9936 (MNa+, C12H13
79BrNaO3 requires 306.9940), 285 (6%), 
264 (32), 239 (43), 160 (100). 
Ethyl (2E)-3-(1’-bromonaphthalen-2’-yl)prop-2-enoate (57f)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-vinylphenyl)prop-2-enoate (50a) using 1-bromo-2-naphthaldehyde 
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(52f) (0.500 g, 2.13 mmol). This gave ethyl (2E)-3-(1’-bromonaphthalen-2’-yl)prop-
2-enoate (57f) (0.647 g, 100%) as a white solid. Mp 117–119 °C; max (neat)/cm
−1 
2976 (CH), 1707 (CO), 1632 (C=C), 1308, 1283, 1180, 1157, 980; δH (400 MHz, 
CDCl3) 1.37 (3H, t, J 7.1 Hz, OCH2CH3), 4.32 (2H, q, J 7.1 Hz, OCH2CH3), 6.50 
(1H, d, J 15.9 Hz, 2-H), 7.53–7.69 (3H, m, 3 × ArH), 7.77–7.88 (2H, m, 2 × ArH), 
8.35–8.43 (2H, m, 3-H and ArH); δC (101 MHz, CDCl3) 14.5 (CH3), 60.9 (CH2), 
121.8 (CH), 124.1 (CH), 126.9 (C), 127.9 (CH), 128.1 (CH), 128.2 (CH), 128.3 
(CH), 128.4 (CH), 132.4 (C), 132.8 (C), 135.1 (C), 144.1 (CH), 166.7 (C); m/z (EI) 
304.0101 (M+, C15H13
79BrO2 requires 304.0099), 225 (100%), 197 (43), 152 (15), 
76 (4). 
Ethyl (2E)-3-(2’-bromo-4’-trifluoromethylphenyl)prop-2-enoate (57g)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-vinylphenyl)prop-2-enoate (50a) using 2-bromo-4-
trifluoromethylbenzaldehyde (52g) (0.500 g, 1.98 mmol). This gave ethyl (2E)-3-
(2’-bromo-4’-trifluoromethylphenyl)prop-2-enoate (57g) (0.562 g, 88%) as a yellow 
oil. max (neat)/cm
−1 2984 (CH), 1717 (CO), 1640 (C=C), 1393, 1316, 1265, 1171, 
1125, 1078; δH (400 MHz, CDCl3) 1.35 (3H, t, J 7.1 Hz, OCH2CH3), 4.30 (2H, q, J 
7.1 Hz, OCH2CH3), 6.45 (1H, d, J 16.0 Hz, 2-H), 7.58 (1H, br d, J 8.2 Hz, 5’-H), 
7.69 (1H, d, J 8.2 Hz, 6’-H), 7.87 (1H, br s, 3’-H), 8.01 (1H, d, J 16.0 Hz, 3-H); δC 
(126 MHz, CDCl3) 14.4 (CH3), 61.1 (CH2), 123.0 (C, q, 
1JCF 272.7 Hz), 123.6 (CH), 
124.7 (CH, q, 3JCF 3.6 Hz), 125.2 (C), 128.2 (CH), 130.5 (CH, q, 
3JCF 3.9 Hz), 
132.9 (C, q, 2JCF 33.4 Hz), 138.3 (C), 141.6 (CH), 166.0 (C); m/z (ESI) 344.9693 
(MNa+, C12H10
79BrF3NaO2 requires 334.9708), 301 (65%), 275 (40), 258 (26), 243 
(19), 236 (49), 201 (28). 
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3-Bromofuran-2-carboxaldehyde (52h)181 
 
Titanium tetrachloride (17.0 mL, 1.0 M in dichloromethane, 17.0 mmol) was added 
to dichloromethane (70 mL) and cooled to −78 °C. Dichloromethyl methyl ether 
(1.53 mL, 17.0 mmol) was added dropwise and stirred for 0.1 h before 3-
bromofuran (0.300 mL, 3.39 mmol) was added dropwise with vigorous stirring. The 
reaction mixture was stirred at −78 °C for 2 h then warmed to 0 °C, quenched with 
water (20 mL) and stirred as a slurry for a further 1 h. A saturated solution of 
sodium hydrogen carbonate was added until gas evolution ceased. The biphasic 
reaction mixture was filtered through a pad of celite then extracted with 
dichloromethane (3 × 30 mL). The combined organic layers were washed with 
water (50 mL) then brine (50 mL), dried (MgSO4), filtered and concentrated in 
vacuo to yield 3-bromofuran-2-carboxaldehyde (52h) (0.567 g, 96%) as a light 
brown oil. Spectroscopic data was in accordance with literature values.181 δH (400 
MHz, CDCl3) 6.66 (1H, dd, J 1.8, 0.7 Hz, 4-H), 7.63 (1H, dd, J 1.8, 0.7 Hz, 5-H), 
9.71–9.73 (1H, m, CHO); δC (126 MHz, CDCl3) 112.8 (C), 116.8 (CH), 148.1 (CH), 
148.3 (C), 176.5 (CH); m/z (EI) 175 (M+, 95%), 173 (74), 149 (39), 111 (53), 97 
(72), 85 (78), 71 (98), 57 (100). 
Ethyl (2E)-3-(3’-bromofuran-2’-yl)prop-2-enoate (57h) 
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-vinylphenyl)prop-2-enoate (50a) using 3-bromofuran-2-
carboxaldehyde (52h) (0.550 g, 3.14 mmol). This gave ethyl (2E)-3-(3’-
bromofuran-2’-yl)prop-2-enoate (57h) (0.718 g, 93%) as an orange solid. Mp 44–
46 °C; max (neat)/cm
−1 2986 (CH), 1713 (CO), 1636 (C=C), 1304, 1258, 1173, 
1026, 964; δH (500 MHz, CDCl3) 1.32 (3H, t, J 7.1 Hz, OCH2CH3), 4.25 (2H, q, J 
7.1 Hz, OCH2CH3), 6.39 (1H, d, J 15.8 Hz, 2-H), 6.53 (1H, d, J 2.0 Hz, 4’-H), 7.42 
(1H, d, J 2.0 Hz, 5’-H), 7.48 (1H, d, J 15.8 Hz, 3-H); δC (126 MHz, CDCl3) 14.4 
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(CH3), 60.8 (CH2), 105.5 (C), 116.0 (CH), 117.7 (CH), 128.1 (CH), 144.7 (CH), 
148.2 (C), 166.83 (C); m/z (ESI) 266.9628 (MNa+, C9H9
79BrNaO3 requires 
266.9627), 242 (8%), 236 (36), 200 (4), 171 (4). 
Ethyl (2E)-3-(2’-bromopyridin-3’-yl)prop-2-enoate (57i)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-vinylphenyl)prop-2-enoate (50a) using 2-bromopyridine-3-
carboxaldehyde (52i) (0.500 g, 2.69 mmol). This gave ethyl (2E)-3-(2’-
bromopyridin-3’-yl)prop-2-enoate (57i) (0.639 g, 93%) as a white solid. Mp 43–46 
°C; max (neat)/cm
−1 2980 (CH), 1709 (CO), 1636 (C=C), 1553, 1389, 1310, 1267, 
1177, 1051, 972, 800; δH (400 MHz, CDCl3) 1.35 (3H, t, J 7.1 Hz, OCH2CH3), 4.29 
(2H, q, J 7.1 Hz, OCH2CH3), 6.41 (1H, d, J 16.0 Hz, 2-H), 7.31 (1H, dd, J 7.7, 4.7 
Hz, 5’-H), 7.86 (1H, dd, J 7.7, 1.9 Hz, 4’-H), 7.94 (1H, d, J 16.0 Hz, 3-H), 8.37 (1H, 
dd, J 4.7, 1.9 Hz, 6’-H); δC (101 MHz, CDCl3) 14.4 (CH3), 61.1 (CH2), 123.2 (CH), 
123.3 (CH), 132.3 (C), 135.7 (CH), 141.1 (CH), 144.4 (C), 150.9 (CH), 165.9 (C); 
m/z (ESI) 255.9961 (MH+, C10H11
79BrNO2 requires 255.9968), 228 (89%), 148 
(100), 120 (19). 
Ethyl (2E)-3-(2’-allylphenyl)prop-2-enoate (59a)182 
 
Caesium fluoride (0.238 g, 1.57 mmol), [1,1'-
bis(diphenylphosphino)ferrocene]palladium(II) dichloride (0.032 g, 0.0392 mmol) 
and allylboronic acid pinacol ester (58) (0.147 mL, 0.784 mmol) were added to a 
degassed solution of ethyl (2E)-3-(2’-bromophenyl)prop-2-enoate (57a) (0.100 g, 
0.392 mmol) in 1,4-dioxane (5 mL). The solution was heated to 85 °C for 18 h, 
cooled to room temperature and concentrated in vacuo. The reaction was purified 
by filtration through a pad of silica (elution with 20% diethyl ether:petroleum ether) 
to yield ethyl (2E)-3-(2’-allylphenyl)prop-2-enoate (59a) (0.0844 g, 100%) as a 
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yellow oil. Spectroscopic data was in accordance with literature values.182 max 
(neat)/cm–1 2980 (CH), 1712 (CO), 1635 (C=C), 1483, 1367, 1313, 1267, 1174, 
1036, 980, 915, 764; δH (500 MHz, CDCl3) 1.34 (3H, t, J 7.1 Hz, OCH2CH3), 3.53 
(2H, br d, J 6.2 Hz, 1’'-H2), 4.27 (2H, q, J 7.1 Hz, OCH2CH3), 5.00 (1H, dq, J 17.1, 
1.6 Hz, 3’'-HH), 5.09 (1H, dq, J 10.1, 1.6 Hz, 3’'-HH), 5.96 (1H, ddt, J 17.1, 10.1, 
6.2 Hz, 2’'-H), 6.36 (1H, d, J 15.8 Hz, 2-H), 7.20–7.27 (2H, m, 2 × ArH), 7.32 (1H, 
td, J 7.5, 1.3 Hz, ArH), 7.58 (1H, dd, J 7.5, 1.3 Hz, ArH), 7.99 (1H, d, J 15.8 Hz, 3-
H); δC (126 MHz, CDCl3) 14.4 (CH3), 37.6 (CH2), 60.6 (CH2), 116.5 (CH2), 119.8 
(CH), 126.7 (CH), 127.0 (CH), 130.2 (CH), 130.4 (CH), 133.6 (C), 136.7 (CH), 
139.4 (C), 142.3 (CH), 167.1 (C); m/z (EI) 216.1147 (M+, C14H16O2 requires 
216.1150), 187 (24%), 171 (30), 143 (100), 142 (99), 128 (94), 115 (97), 84 (42). 
Ethyl (2E)-3-(2’-allyl-4’,5’-methylenedioxyphenyl)prop-2-enoate (59b)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-allylphenyl)prop-2-enoate (59a) using ethyl (2E)-3-(2’-bromo-4’,5’-
methylenedioxyphenyl)prop-2-enoate (57b) (0.270 g, 0.903 mmol). This gave ethyl 
(2E)-3-(2’-allyl-4’,5’-methylenedioxyphenyl)prop-2-enoate (59b) (0.235 g, 100%) 
as a white solid. Mp 63–67 °C; max (neat)/cm
−1 2982 (CH), 1694 (CO), 1499 
(C=C), 1476, 1256, 1036, 974; δH (400 MHz, CDCl3) 1.32 (3H, t, J 7.1 Hz, 
OCH2CH3), 3.45 (2H, dt, J 6.2, 1.5 Hz, 1’’-H2), 4.24 (2H, q, J 7.1 Hz, OCH2CH3), 
4.99 (1H, dq, J 17.0, 1.5 Hz, 3’’-HH), 5.07 (1H, dq, J 10.1, 1.5 Hz, 3’’-HH), 5.91 
(1H, ddt, J 17.0, 10.1, 6.2 Hz, 2’’-H), 5.97 (2H, s, OCH2O), 6.21 (1H, d, J 15.7 Hz, 
2-H), 6.68 (1H, s, 3’-H), 7.05 (1H, s, 6’-H), 7.89 (1H, d, J 15.7 Hz, 3-H); δC (101 
MHz, CDCl3) 14.5 (CH3), 37.4 (CH2), 60.5 (CH2), 101.5 (CH2), 105.8 (CH), 110.3 
(CH), 116.4 (CH2), 117.4 (CH), 126.8 (C), 134.9 (C), 136.7 (CH), 141.6 (CH), 
146.9 (C), 149.6 (C), 167.3 (C); m/z (ESI) 283.0935 (MNa+, C15H16NaO4 requires 
283.0941). 
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Ethyl (2E)-3-(2’-allyl-5’-fluorophenyl)prop-2-enoate (59c)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-allylphenyl)prop-2-enoate (59a) using ethyl (2E)-3-(2’-bromo-5’-
fluorophenyl)prop-2-enoate (57c) (0.254 g, 0.930 mmol). This gave ethyl (2E)-3-
(2’-allyl-5’-fluorophenyl)prop-2-enoate (59c) (0.214 g, 98%) as a yellow oil. max 
(neat)/cm−1 2982 (CH), 1711 (CO), 1636 (C=C), 1489, 1314, 1269, 1233, 1173, 
1034, 976, 860; δH (400 MHz, CDCl3) 1.34 (3H, t, J 7.1 Hz, OCH2CH3), 3.48 (2H, 
br d, J 6.1 Hz, 1’’-H2), 4.27 (2H, q, J 7.1 Hz, OCH2CH3), 4.96 (1H, dq, J 17.1, 1.6 
Hz, 3’’-HH), 5.09 (1H, dq, J 10.1, 1.6 Hz, 3’’-HH), 5.93 (1H, ddt, J 17.1, 10.1, 6.1 
Hz, 2’’-H), 6.33 (1H, d, J 15.8 Hz, 2-H), 7.02 (1H, td, J 8.3, 2.7 Hz, 4’-H), 7.18 (1H, 
dd, J 8.3, 5.8 Hz, 3’-H), 7.26 (1H, dd, J 9.8, 2.7 Hz, 6’-H), 7.90 (1H, dd, J 15.8, 1.6 
Hz, 3-H); δC (101 MHz, CDCl3) 14.5 (CH3), 36.9 (CH2), 60.8 (CH2), 113.1 (d, 
2JCF 
22.1 Hz, CH), 116.7 (CH2), 117.1 (d, 
2JCF 21.2 Hz, CH), 120.9 (CH), 132.0 (d, 
3JCF 
7.9 Hz, CH), 135.1 (d, 4JCF 3.3 Hz, C), 135.3 (d, 
3JCF 7.5 Hz, C), 136.5 (CH), 141.1 
(d, 4JCF 2.2 Hz, CH), 161.7 (d, 
1JCF 244.9 Hz, C), 166.8 (C); m/z (EI) 234.1053 (M
+, 
C14H15FO2 requires 234.1056), 205 (12%), 189 (15), 161 (95), 146 (100), 133 (54), 
84 (16), 69 (20). 
Ethyl (2E)-3-(2’-allyl-4’-methylphenyl)prop-2-enoate (59d)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-allylphenyl)prop-2-enoate (59a) using ethyl (2E)-3-(2’-bromo-4’-
methylphenyl)prop-2-enoate (57d) (0.050 g, 0.19 mmol). This gave ethyl (2E)-3-
(2’-allyl-4’-methylphenyl)prop-2-enoate (59d) (0.042 g, 99%) as a colourless oil. 
max (neat)/cm
−1 2980 (CH), 1709 (CO), 1632 (C=C), 1609, 1312, 1173, 1155; δH 
(400 MHz, CDCl3) 1.33 (3H, t, J 7.1 Hz, OCH2CH3), 2.34 (3H, s, 4’-CH3), 3.50 (2H, 
br d, J 6.2 Hz, 1’’-H2), 4.26 (2H, q, J 7.1 Hz, OCH2CH3), 5.00 (1H, dq, J 17.0, 1.6 
Hz, 3’’-HH), 5.08 (1H, dq, J 10.1, 1.6 Hz, 3’’-HH), 5.95 (1H, ddt, J 17.0, 10.1, 6.2 
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Hz, 2’’-H), 6.33 (1H, d, J 15.8 Hz, 2-H), 7.03 (1H, s, 3’-H), 7.06 (1H, d, J 7.9 Hz, 5’-
H), 7.49 (1H, d, J 7.9 Hz, 6’-H), 7.96 (1H, d, J 15.8 Hz, 3-H); δC (101 MHz, CDCl3) 
14.5 (CH3), 21.5 (CH3), 37.6 (CH2), 60.5 (CH2), 116.4 (CH2), 118.6 (CH), 126.7 
(CH), 127.8 (CH), 130.6 (C), 131.1 (CH), 136.8 (CH), 139.4 (C), 140.6 (C), 142.2 
(CH), 167.3 (C); m/z (ESI) 253.1198 (MNa+, C15H18NaO2 requires 253.1199), 236 
(8%), 157 (36), 142 (28). 
Ethyl (2E)-3-(2’-allyl-5’-methoxyphenyl)prop-2-enoate (59e)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-allylphenyl)prop-2-enoate (59a) using ethyl (2E)-3-(2’-bromo-5’-
methoxyphenyl)prop-2-enoate (57e) (0.619 g, 2.17 mmol). This gave ethyl (2E)-3-
(2’-allyl-5’-methoxyphenyl)prop-2-enoate (59e) (0.529 g, 99%) as a yellow oil. max 
(neat)/cm−1 2980 (CH), 1709 (CO), 1634 (C=C), 1495, 1233, 1165, 1036; δH (500 
MHz, CDCl3) 1.34 (3H, t, J 7.1 Hz, OCH2CH3), 3.46 (2H, br d, J 6.2 Hz, 1’’-H2), 
3.81 (3H, s, OCH3), 4.27 (2H, q, J 7.1 Hz, OCH2CH3), 4.97 (1H, dq, J 17.1, 1.6 Hz, 
3’’-HH), 5.06 (1H, dq, J 10.0, 1.6 Hz, 3’’-HH), 5.93 (1H, ddt, J 17.1, 10.0, 6.2 Hz, 
2’’-H), 6.34 (1H, d, J 15.8 Hz, 2-H), 6.89 (1H, dd, J 8.4, 2.7 Hz, 4’-H), 7.09 (1H, d, 
J 2.7 Hz, 6’-H), 7.12 (1H, d, J 8.4 Hz, 3’-H), 7.94 (1H, d, J 15.8 Hz, 3-H); δC (126 
MHz, CDCl3) 14.5 (CH3), 36.8 (CH2), 55.5 (CH3), 60.6 (CH2), 111.4 (CH), 116.1 
(CH2), 116.4 (CH), 119.9 (CH), 131.5 (CH), 131.8 (C), 134.4 (C), 137.2 (CH), 
142.3 (CH), 158.5 (C), 167.0 (C); m/z (ESI) 269.1141 (MNa+, C15H18NaO3 requires 
269.1148). 
Ethyl (2E)-3-(1’-allylnaphthalen-2’-yl)prop-2-enoate (59f)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-allylphenyl)prop-2-enoate (59a) using ethyl (2E)-3-(1’-
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bromonaphthalen-2’-yl)prop-2-enoate (57f) (0.415 g, 1.36 mmol) and allylboronic 
acid pinacol ester (58) (0.636 mL, 3.41 mmol) at 100 °C. This gave ethyl (2E)-3-
(1’-allylnaphthalen-2’-yl)prop-2-enoate (59f) (0.355 g, 98%) as a yellow oil. max 
(neat)/cm−1 2978 (CH), 1707 (CO), 1626 (C=C), 1256, 1173, 1153, 1036, 812; δH 
(500 MHz, CDCl3) 1.36 (3H, t, J 7.1 Hz, OCH2CH3), 4.01 (2H, br d, J 5.6 Hz, 1’’-
H2), 4.30 (2H, q, J 7.1 Hz, OCH2CH3), 4.93 (1H, dq, J 17.1, 1.7 Hz, 3’’-HH), 5.08 
(1H, dq, J 10.2, 1.7 Hz, 3’’-HH), 6.08 (1H, ddt, J 17.1, 10.2, 5.6 Hz, 2’’-H), 6.48 
(1H, d, J 15.8 Hz, 2-H), 7.48–7.56 (2H, m, 2 × ArH), 7.67 (1H, d, J 8.7 Hz, 4’-H), 
7.74 (1H, d, J 8.7 Hz, 3’-H), 7.80–7.85 (1H, m, ArH), 8.08 (1H, d, J 8.1 Hz, ArH), 
8.22 (1H, d, J 15.8 Hz, 3-H); δC (126 MHz, CDCl3) 14.5 (CH3), 32.3 (CH2), 60.7 
(CH2), 116.6 (CH2), 120.5 (CH), 123.8 (CH), 125.1 (CH), 126.8 (CH), 126.8 (CH), 
127.6 (CH), 128.8 (CH), 130.8 (C), 132.5 (C), 134.5 (C), 136.0 (CH), 136.1 (C), 
142.7 (CH), 167.2 (C); m/z (ESI) 289.1190 (MNa+, C18H18NaO2 requires 
289.1199), 236 (6%), 193 (3), 178 (2). 
Ethyl (2E)-3-(2’-allyl-4’-trifluoromethylphenyl)prop-2-enoate (59g)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-allylphenyl)prop-2-enoate (59a) using ethyl (2E)-3-(2’-bromo-4’-
trifluoromethylphenyl)prop-2-enoate (57g) (0.321 g, 1.00 mmol). This gave ethyl 
(2E)-3-(2’-allyl-4’-trifluoromethylphenyl)prop-2-enoate (59g) (0.282 g, 100%) as a 
yellow oil. max (neat)/cm
−1 2984 (CH), 1715 (CO), 1638 (C=C), 1333, 1314, 1279, 
1163, 1123, 1078; δH (500 MHz, CDCl3) 1.34 (3H, t, J 7.1 Hz, OCH2CH3), 3.56 
(2H, br d, J 6.2 Hz, 1’’-H2), 4.28 (2H, q, J 7.1 Hz, OCH2CH3), 5.01 (1H, dq, J 16.8, 
1.5 Hz, 3’’-HH), 5.14 (1H, dq, J 10.3, 1.5 Hz, 3’’-HH), 5.94 (1H, ddt, J 16.8, 10.3, 
6.2 Hz, 2’’-H), 6.40 (1H, d, J 15.9 Hz, 2-H), 7.47 (1H, s, 3’-H), 7.50 (1H, d, J 8.2 
Hz, 5’-H), 7.65 (1H, d, J 8.2 Hz, 6’-H), 7.95 (1H, d, J 15.9 Hz, 3-H); δC (126 MHz, 
CDCl3) 14.4 (CH3), 37.5 (CH2), 60.9 (CH2), 117.4 (CH2), 122.2 (CH), 123.8 (CH, q, 
3JCF 3.7 Hz), 124.0 (C, q, 
1JCF 272.3 Hz), 127.1 (CH, q, 
3JCF 3.8 Hz), 127.2 (CH), 
131.8 (C, q, 2JCF 32.5 Hz), 135.6 (CH), 137.2 (C), 139.9 (C), 140.8 (CH), 166.5 
(C); m/z (ESI) 307.0907 (MNa+, C15H15F3NaO2 requires 307.0916), 301 (43%), 
236 (36), 209 (72). 
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Ethyl (2E)-3-(3’-allylfuran-2’-yl)prop-2-enoate (59h)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-allylphenyl)prop-2-enoate (59a) using ethyl (2E)-3-(3’-bromofuran-
2’-yl)prop-2-enoate (57h) (0.230 g, 0.939 mmol). This gave ethyl (2E)-3-(3’-
allylfuran-2’-yl)prop-2-enoate (59h) (0.193 g, 100%) as a yellow oil. max 
(neat)/cm−1 2924 (CH), 1705 (CO), 1636 (C=C), 1304, 1258, 1165, 1042, 972; δH 
(500 MHz, CDCl3) 1.32 (3H, t, J 7.1 Hz, OCH2CH3), 3.29 (2H, br d, J 6.3 Hz, 1’’-
H2), 4.24 (2H, q, J 7.1 Hz, OCH2CH3), 5.06–5.11 (2H, m, 3’’-H2), 5.88 (1H, ddt, J 
16.2, 10.0, 6.3 Hz, 2’’-H), 6.27 (1H, d, J 15.6 Hz, 2-H), 6.35 (1H, d, J 1.6 Hz, 4’-H), 
7.40 (1H, d, J 1.6 Hz, 5’-H), 7.47 (1H, d, J 15.6 Hz, 3-H); δC (126 MHz, CDCl3) 
14.5 (CH3), 29.4 (CH2), 60.5 (CH2), 113.9 (CH), 114.9 (CH), 116.5 (CH2), 128.0 
(C), 129.1 (CH), 135.6 (CH), 144.3 (CH), 147.1 (C), 167.5 (C); m/z (ESI) 229.0838 
(MNa+, C12H14NaO3 requires 229.0835). 
Ethyl (2E)-3-(2’-allylpyridin-3’-yl)prop-2-enoate (59i)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-allylphenyl)prop-2-enoate (59a) using ethyl (2E)-3-(2’-
bromopyridin-3’-yl)prop-2-enoate (57i) (0.346 g, 1.35 mmol). Purification by 
column chromatography (elution with 50% diethyl ether:petroleum ether) yielded 
ethyl (2E)-3-(2’-allylpyridin-3’-yl)prop-2-enoate (59i) (0.226 g, 77%) as a yellow oil. 
max (neat)/cm
−1 2980 (CH), 1713 (CO), 1636 (C=C), 1429, 1308, 1167; δH (500 
MHz, CDCl3) 1.34 (3H, t, J 7.1 Hz, OCH2CH3), 3.74 (2H, br d, J 6.4 Hz, 1’’-H2), 
4.27 (2H, q, J 7.1 Hz, OCH2CH3), 5.08 (1H, dq, J 17.0, 1.5 Hz, 3’’-HH), 5.13 (1H, 
dq, J 10.2, 1.5 Hz, 3’’-HH), 6.03 (1H, ddt, J 17.0, 10.2, 6.4 Hz, 2’’-H), 6.36 (1H, d, J 
15.9 Hz, 2-H), 7.19 (1H, dd, J 7.9, 4.8 Hz, 5’-H), 7.82 (1H, dd, J 7.9, 1.6 Hz, 4’-H), 
7.93 (1H, d, J 15.9 Hz, 3-H), 8.55 (1H, dd, J 4.8, 1.6 Hz, 6’-H); δC (126 MHz, 
CDCl3) 14.4 (CH3), 40.5 (CH2), 60.9 (CH2), 117.0 (CH2), 121.7 (CH), 122.1 (CH), 
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129.2 (C), 134.2 (CH), 135.0 (CH), 140.4 (CH), 150.6 (CH), 158.6 (C), 166.5 (C); 
m/z (ESI) 218.1185 (MH+, C13H16NO2 requires 218.1176), 190 (100%), 170 (10), 
144 (78), 130 (54). 
(2E)-3-(2’-Allylphenyl)prop-2-en-1-ol (61a)183 
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-vinylphenyl)prop-2-en-1-ol (51a) using ethyl (2E)-3-(2’-allylphenyl)prop-
2-enoate (59a) (0.700 g, 3.24 mmol). This gave (2E)-3-(2’-allylphenyl)prop-2-en-1-
ol (61a) (0.456 g, 81%) as a colourless oil. Spectroscopic data was in accordance 
with literature values.183 δH (400 MHz, CDCl3) 1.48 (1H, t, J 5.4 Hz, OH), 3.45 (2H, 
dt, J 6.2, 1.7 Hz, 1’'-H2), 4.30–4.35 (2H, m, 1-H2), 4.97 (1H, dq, J 17.1, 1.7 Hz, 3’'-
HH), 5.06 (1H, dq, J 10.1, 1.7 Hz, 3’'-HH), 5.97 (1H, ddt, J 17.1, 10.1, 6.2 Hz, 2’'-
H), 6.26 (1H, dt, J 15.7, 5.7 Hz, 2-H), 6.85 (1H, dt, J 15.7, 1.5 Hz, 3-H), 7.14–7.23 
(3H, m, ArH), 7.46–7.49 (1H, m, ArH); δC (101 MHz, CDCl3) 37.6 (CH2), 64.1 
(CH2), 116.0 (CH2), 126.3 (CH), 126.8 (CH), 128.0 (CH), 128.9 (CH), 129.9 (CH), 
130.4 (CH), 135.9 (C), 137.0 (CH), 137.3 (C); m/z (EI) 174 (M+, 8%), 156 (31), 143 
(62), 128 (100), 115 (70), 91 (23), 84 (12), 74 (5). 
(2E)-3-(2’-Allyl-4’,5’-methylenedioxyphenyl)prop-2-en-1-ol (61b)  
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-vinylphenyl)prop-2-en-1-ol (51a) using ethyl (2E)-3-(2’-allyl-4’,5’-
methylenedioxyphenyl)prop-2-enoate (59b) (1.14 g, 4.37 mmol). This gave (2E)-3-
(2’-allyl-4’,5’-methylenedioxyphenyl)prop-2-en-1-ol (61b) (0.920 g, 97%) as a white 
crystalline solid. Mp 45–49 °C; max (neat)/cm
−1 3262 (OH), 2866 (CH), 1636 
(C=C), 1503, 1481, 1244, 1165, 1044, 1017, 995; δH (400 MHz, CDCl3) 3.30 (2H, 
dt, J 6.1, 1.5 Hz, 1’’-H2), 3.68 (1H, br s, OH), 4.25 (2H, br d, J 5.7 Hz, 1-H2), 4.95 
(1H, dq, J 17.0, 1.5 Hz, 3’’-HH), 5.02 (1H, dq, J 10.1, 1.5 Hz, 3’’-HH), 5.85 (2H, s, 
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OCH2O), 5.88 (2H, ddt, J 17.0, 10.1, 6.1 Hz, 2’’-H), 6.08 (1H, dt, J 15.6, 5.7 Hz, 2-
H), 6.60 (1H, s, ArH), 6.71 (1H, dt, J 15.6, 1.2 Hz, 3-H), 6.94 (1H, s, ArH); δC (101 
MHz, CDCl3) 37.4 (CH2), 64.1 (CH2), 101.1 (CH2), 106.0 (CH), 109.9 (CH), 116.0 
(CH2), 128.6 (CH), 128.7 (CH), 129.2 (C), 131.4 (C), 137.0 (CH), 146.6 (C), 147.5 
(C); m/z (EI) 218.0945 (M+, C13H14O3 requires 218.0943), 200 (20%), 173 (80), 
160 (44), 149 (23), 115 (48), 103 (19), 83 (73), 77 (12).  
(2E)-3-(2’-Allyl-5’-fluorophenyl)prop-2-en-1-ol (61c)  
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-vinylphenyl)prop-2-en-1-ol (51a) using ethyl (2E)-3-(2’-allyl-5’-
fluorophenyl)prop-2-enoate (59c) (0.190 g, 0.812 mmol). This gave (2E)-3-(2’-allyl-
5’-fluorophenyl)prop-2-en-1-ol (61c) (0.144 g, 92%) as a colourless oil. max 
(neat)/cm−1 3300 (OH), 2857 (CH), 1609 (C=C), 1582, 1489, 1267, 1155, 964, 
912, 870; δH (400 MHz, CDCl3) 1.46 (1H, br t, J 5.8 Hz, OH), 3.41 (2H, br d, J 6.1 
Hz, 1’’-H2), 4.34 (2H, td, J 5.8, 1.6 Hz, 1-H2), 4.94 (1H, dq, J 17.0, 1.6 Hz, 3’’-HH), 
5.07 (1H, dq, J 10.1, 1.6 Hz, 3’’-HH), 5.93 (1H, ddt, J 17.0, 10.1, 6.1 Hz, 2’’-H), 
6.25 (1H, dt, J 15.7, 5.8 Hz, 2-H), 6.80 (1H, dq, J 15.7, 1.6 Hz, 3-H), 6.90 (1H, td, J 
8.3, 2.7, Hz, 4’-H), 7.10 (1H, dd, J 8.3, 5.9 Hz, 3’-H), 7.16 (1H, dd, J 10.2, 2.7 Hz, 
6’-H); δC (101 MHz, CDCl3) 36.8 (CH2), 63.7 (CH2), 112.6 (CH, d, 
2JCF 21.9 Hz), 
114.6 (CH, d, 2JCF 21.2 Hz), 116.2 (CH2), 127.7 (CH, d, 
4JCF 2.2 Hz), 131.4 (CH, d, 
3JCF 8.7 Hz), 131.5 (CH), 132.9 (C, d, 
4JCF 3.0 Hz), 136.8 (CH), 137.7 (C, d, 
3JCF 
7.5 Hz), 161.8 (C, d, 1JCF 243.7 Hz); m/z (CI) 175.0919 (MH
+−H2O, C12H12F 
requires 175.0923), 147 (25%), 113 (6), 85 (5), 73 (14). 
(2E)-3-(2’-Allyl-4’-methylphenyl)prop-2-en-1-ol (61d)  
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-vinylphenyl)prop-2-en-1-ol (51a) using ethyl (2E)-3-(2’-allyl-4’-
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methylphenyl)prop-2-enoate (59d) (0.483 g, 2.10 mmol). This gave (2E)-3-(2’-allyl-
4’-methylphenyl)prop-2-en-1-ol (61d) (0.348 g, 88%) as a colourless oil. max 
(neat)/cm−1 3325 (OH), 2918 (CH), 1638 (C=C), 1611 (C=C), 1495, 1086, 995, 
966; δH (500 MHz, CDCl3) 1.39 (1H, t, J 5.9 Hz, OH), 2.32 (3H, s, 4’-CH3), 3.42 
(2H, dt, J 6.2, 1.6 Hz, 1’’-H2), 4.32 (2H, td, J 5.9, 1.5 Hz, 1-H2), 4.98 (1H, dq, J 
17.0, 1.6 Hz, 3’’-HH), 5.06 (1H, dq, J 10.1, 1.6 Hz, 3’’-HH), 5.95 (1H, ddt, J 17.0, 
10.1, 6.2 Hz, 2’’-H), 6.22 (1H, dt, J 15.7, 5.9 Hz, 2-H), 6.81 (1H, d, J 15.7 Hz, 3-H), 
6.97 (1H, br s, 3’-H), 7.02 (1H, d, J 7.9 Hz, 5’-H), 7.38 (1H, d, J 7.9 Hz, 6’-H); δC 
(126 MHz, CDCl3) 21.3 (CH3), 37.6 (CH2), 64.2 (CH2), 115.9 (CH2), 126.2 (CH), 
127.6 (CH), 128.9 (CH), 129.4 (CH), 130.6 (CH), 133.0 (C), 137.1 (CH), 137.2 (C), 
137.8 (C); m/z (ESI) 211.1096 (MNa+, C13H16NaO requires 211.1093), 190 (22%), 
171 (29), 143 (100), 128 (46). 
(2E)-3-(2’-Allyl-5’-methoxyphenyl)prop-2-en-1-ol (61e)  
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-vinylphenyl)prop-2-en-1-ol (51a) using ethyl (2E)-3-(2’-allyl-5’-
methoxyphenyl)prop-2-enoate (59e) (0.461 g, 1.87 mmol). This gave (2E)-3-(2’-
allyl-5’-methoxyphenyl)prop-2-en-1-ol (61e) (0.313 g, 82%) as a yellow oil. max 
(neat)/cm−1 3228 (OH), 2909 (CH), 1605 (C=C), 1572, 1495, 1285, 1198, 1163, 
1040, 964; δH (500 MHz, CDCl3) 1.46 (1H, t, J 5.3 Hz, OH), 3.39 (2H, dt, J 6.2, 1.7 
Hz, 1’’-H), 3.81 (3H, s, OCH3), 4.33 (2H, t, J 5.3 Hz, 1-H2), 4.95 (1H, dq, J 16.9, 
1.7 Hz, 3’’-HH), 5.04 (1H, dq, J 10.2, 1.7 Hz, 3’’-HH), 5.94 (1H, ddt, J 16.9, 10.2, 
6.2 Hz, 2’’-H), 6.25 (1H, dt, J 15.7, 5.3 Hz, 2-H), 6.78 (1H, dd, J 8.4, 2.8 Hz, 4’-H), 
6.81 (1H, dt, J 15.7, 1.6 Hz, 3-H), 7.02 (1H, d, J 2.8 Hz, 6’-H), 7.07 (1H, d, J 8.4 
Hz, 3’-H); δC (126 MHz, CDCl3) 36.8 (CH2), 55.4 (CH3), 64.0 (CH2), 111.4 (CH), 
113.7 (CH), 115.7 (CH2), 128.9 (CH), 129.7 (C), 130.5 (CH), 131.0 (CH), 136.9 
(C), 137.4 (CH), 158.4 (C); m/z (EI) 204.1152 (M+, C13H16O2 requires 204.1150), 
173 (100%), 159 (74), 158 (73), 115 (53), 103 (18), 91 (23), 77 (13), 51 (10). 
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(2E)-3-(1’-Allylnaphthalen-2’-yl)prop-2-en-1-ol (61f)  
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-vinylphenyl)prop-2-en-1-ol (51a) using ethyl (2E)-3-(1’-allylnaphthalen-
2’-yl)prop-2-enoate (59f) (0.326 g, 1.23 mmol). This gave (2E)-3-(1’-
allylnaphthalen-2’-yl)prop-2-en-1-ol (61f) (0.256 g, 93%) as a yellow oil. max 
(neat)/cm−1 3320 (OH), 3055 (CH), 2859 (CH), 1636 (C=C), 1510, 1449, 1373, 
1090, 966, 739; δH (400 MHz, CDCl3) 1.58 (1H, br s, OH), 3.92 (2H, dt, J 5.5, 1.8 
Hz, 1’’-H2), 4.40 (2H, d, J 5.7, 1-H2), 4.91 (1H, dq, J 17.2, 1.8 Hz, 3’’-HH), 5.06 
(1H, dq, 10.2, 1.8 Hz, 3’’-HH), 6.08 (1H, ddt, J 17.2, 10.2, 5.5 Hz, 2’’-H), 6.39 (1H, 
dt, J 15.7, 5.7 Hz, 2-H), 7.07 (1H, d, J 15.7 Hz, 3-H), 7.45 (1H, ddd, J 8.0, 7.0, 1.1 
Hz, ArH), 7.50 (1H, ddd, J 8.4, 7.0, 1.2 Hz, ArH), 7.63 (1H, d, J 8.7 Hz, ArH), 7.72 
(1H, d, J 8.7 Hz, ArH), 7.81 (1H, dd, J 8.0, 1.2 Hz, ArH), 8.03 (1H, d, J 8.4 Hz, 
ArH); δC (101 MHz, CDCl3) 32.3 (CH2), 64.2 (CH2), 116.1 (CH2), 124.5 (CH), 124.6 
(CH), 125.6 (CH), 126.4 (CH), 127.2 (CH), 128.6 (CH), 129.4 (CH), 131.2 (CH), 
132.5 (C), 132.6 (C), 133.0 (C), 133.5 (C), 136.2 (CH); m/z (ESI) 247.1093 (MNa+, 
C16H16NaO requires 247.1093), 236 (49%), 227 (40), 207 (29), 179 (100), 166 
(17), 159 (11). 
(2E)-3-(2’-Allyl-4’-trifluoromethylphenyl)prop-2-en-1-ol (61g)  
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-vinylphenyl)prop-2-en-1-ol (51a) using ethyl (2E)-3-(2’-allyl-4’-
trifluoromethylphenyl)prop-2-enoate (59g) (0.326 g, 1.23 mmol). This gave (2E)-3-
(2’-allyl-4’-trifluoromethylphenyl)prop-2-en-1-ol (61g) (0.256 g, 93%) as a 
colourless oil. max (neat)/cm
−1 3320 (OH), 2928 (CH), 1640 (C=C), 1616, 1420, 
1332, 1160, 1118, 1091; δH (500 MHz, CDCl3) 1.98 (1H, br s, OH), 3.48 (2H, dt, J 
6.2, 1.5 Hz, 1’’-H2), 4.36 (2H, dd, J 5.4, 1.6 Hz, 1-H2), 4.98 (1H, dq, J 16.7, 1.5 Hz, 
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3’’-HH), 5.11 (1H, dq, J 10.1, 1.5 Hz, 3’’-HH), 5.94 (1H, ddt, J 16.7, 10.1, 6.2 Hz, 
2’’-H), 6.32 (1H, dt, J 15.8, 5.4 Hz, 2-H), 6.86 (1H, d, J 15.8 Hz, 3-H), 7.41 (1H, s, 
3’-H), 7.44 (1H, d, J 8.2 Hz, 5’-H), 7.54 (1H, d, J 8.2 Hz, 6’-H); δC (126 MHz, 
CDCl3) 37.4 (CH2), 63.7 (CH2), 117.0 (CH2), 123.6 (CH, q, 
3JCF 3.8 Hz), 124.4 (C, 
q, 1JCF 272.0 Hz), 126.6 (CH), 126.7 (CH, q, 
3JCF 3.8 Hz), 127.3 (CH), 129.7 (C, q, 
2JCF 32.3 Hz), 132.8 (CH), 135.9 (CH), 137.9 (C), 139.6 (C); m/z (CI) 225.0892 
(MH+−H2O, C13H12F3 requires 225.0891), 197 (12), 125 (3), 81 (13), 69 (15). 
(2E)-3-(3’-Allylfuran-2’-yl)prop-2-en-1-ol (61h)  
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-vinylphenyl)prop-2-en-1-ol (51a) using ethyl (2E)-3-(3’-allylfuran-2’-
yl)prop-2-enoate (59h) (0.235 g, 1.14 mmol). This gave (2E)-3-(3’-allylfuran-2’-
yl)prop-2-en-1-ol (61h) (0.180 g, 96%) as a yellow oil. max (neat)/cm
−1 3323 (OH), 
2924 (CH), 1640 (C=C), 1499, 1433, 1148, 1092, 1053, 993, 959; δH (500 MHz, 
CDCl3) 1.37–1.44 (1H, m, OH), 3.20 (2H, br d, J 6.3 Hz, 1’’-H2), 4.31 (2H, td, J 5.6, 
1.2 Hz, 1-H2), 5.02–5.09 (2H, m, 3’’-H2), 5.88 (1H, ddt, J 16.7, 10.3, 6.3 Hz, 2’’-H), 
6.23–6.29 (2H, m, 2-H and 4’-H), 6.46 (1H, dt, J 15.7, 1.2 Hz, 3-H), 7.29 (1H, d, J 
1.6 Hz, 5’-H); δC (126 MHz, CDCl3) 29.2 (CH2), 63.7 (CH2), 113.1 (CH), 115.8 
(CH2), 117.6 (CH), 120.6 (C), 126.3 (CH), 136.4 (CH), 141.6 (CH), 148.0 (C); m/z 
(CI) 147.0807 (MH+−H2O, C10H11O requires 147.0810), 137 (100%), 113 (6), 89 
(22), 73 (12). 
(2E)-3-(2’-Allylpyridin-3’-yl)prop-2-en-1-ol (61i)  
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-vinylphenyl)prop-2-en-1-ol (51a) using ethyl (2E)-3-(2’-allylpyridin-3’-
yl)prop-2-enoate (59i) (0.100 g, 0.46 mmol). Purification by column 
chromatography (elution with 40–80% diethyl ether:petroleum ether) yielded (2E)-
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3-(2’-allylpyridin-3’-yl)prop-2-en-1-ol (61i) (0.066 g, 88%) as a yellow oil. max 
(neat)/cm−1 3264 (OH), 2851 (CH), 1638 (C=C), 1572, 1429, 1091, 1018, 964; δH 
(500 MHz, CDCl3) 1.71 (1H, t, J 5.5 Hz, OH), 3.67 (2H, dt, J 6.4, 1.6 Hz, 1’’-H2), 
4.37 (2H, td, J 5.5, 1.5 Hz, 1-H2), 5.05 (1H, dq, J 17.1, 1.6 Hz, 3’’-HH), 5.11 (1H, 
dq, J 10.2, 1.6 Hz, 3’’-HH), 6.05 (1H, ddt, J 17.1, 10.2, 6.4 Hz, 2’’-H), 6.28 (1H, dt, 
J 15.8, 5.5 Hz, 2-H), 6.83 (1H, d, J 15.8 Hz, 3-H), 7.14 (1H, dd, J 7.8, 4.8 Hz, 5’-
H), 7.73 (1H, dd, J 7.8, 1.7 Hz, 4’-H), 8.45 (1H, dd, J 4.8, 1.7 Hz, 6’-H); δC (126 
MHz, CDCl3) 40.4 (CH2), 63.7 (CH2), 116.6 (CH2), 122.0 (CH), 126.7 (CH), 131.4 
(C), 132.5 (CH), 133.8 (CH), 135.4 (CH), 148.5 (CH), 156.9 (C); m/z (CI) 176.1074 
(MH+, C11H14NO requires 176.1075), 158 (33%), 130 (9), 118 (3), 81 (2), 69 (3). 
1-(2’,2’,2’-Trichloromethylcarbonylamino)-1,4-dihydronaphthalene (65a) 
 
The reaction was carried out according to the previously described procedure for 
1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54a) using (2E)-3-(2’-
allylphenyl)prop-2-en-1-ol (61a) (0.049 g, 0.28 mmol). The RCM step was 
performed at room temperature. This gave 1-(2’,2’,2’-
trichloromethylcarbonylamino)-1,4-dihydronaphthalene (65a) (0.073 g, 89%) as a 
white solid. Mp 87–89 °C; max (neat)/cm
–1 3271 (NH), 3032 (CH), 1682 (CO), 
1520, 1250, 1018, 826, 741, 648; δH (500 MHz, CDCl3) 3.39–3.54 (2H, m, 4-H2), 
5.71–5.77 (1H, m, 1-H), 5.93 (1H, ddt, J 10.0, 3.6, 2.2 Hz, 2-H), 6.20 (1H, dtd, J 
10.0, 3.6, 1.8 Hz, 3-H), 6.83 (1H, br d, J 5.7 Hz, NH), 7.18–7.23 (1H, m, ArH), 
7.27–7.31 (2H, m, 2 × ArH), 7.37–7.41 (1H, m, ArH); δC (126 MHz, CDCl3) 29.5 
(CH2), 48.0 (CH), 92.9 (C), 124.4 (CH), 127.3 (CH), 128.1 (CH), 128.4 (CH), 128.6 
(CH), 128.7 (CH), 133.2 (C), 134.1 (C), 161.6 (C); m/z (ESI) 311.9719 (MNa+, 
C12H10
35Cl3NNaO requires 311.9720). 
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6,7-Methylenedioxy-1-(2’,2’,2’-trichloromethylcarbonylamino)-1,4-
dihydronaphthalene (65b) 
 
The reaction was carried out according to the previously described procedure for 
1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54a) using (2E)-3-(2’-allyl-
4’,5’-methylenedioxy phenyl)prop-2-en-1-ol (61b) (1.96 g, 8.99 mmol). Grubbs 2nd 
generation catalyst (0.114 g, 0.135 mmol) was added and the reaction was stirred 
at room temperature for 3 h before a second portion of Grubbs 2nd generation 
catalyst (0.0763 g, 0.0899 mmol) was added and allowed to stir for a further 17 h. 
This gave 6,7-methylenedioxy-1-(2’,2’,2’-trichloromethylcarbonylamino)-1,4-
dihydronaphthalene (65b) (2.43 g, 81%) as a white solid. Mp 114–116 °C; max 
(neat)/cm−1 3334 (NH), 2894 (CH), 1699 (CO), 1502, 1482, 1233, 1038, 819; δH 
(500 MHz, CDCl3) 3.24–3.39 (2H, m, 4-H2), 5.53–5.60 (1H, m, 1-H), 5.85 (1H, ddt, 
J 10.0, 3.9, 2.2 Hz, 2-H), 5.88 (1H, d, J 1.3 Hz, OCHHO), 5.89 (1H, d, J 1.3 Hz, 
OCHHO), 6.13 (1H, dtd, J 10.0, 3.5, 1.7 Hz, 3-H), 6.55 (1H, s, ArH), 6.75 (1H, s, 
ArH), 6.87 (1H, d, J 8.8 Hz, NH); δC (126 MHz, CDCl3) 29.6 (CH2), 48.2 (CH), 92.8 
(C), 101.1 (CH2), 107.5 (CH), 107.7 (CH), 123.8 (CH), 125.9 (C), 127.6 (C), 128.5 
(CH), 146.8 (C), 147.5 (C), 161.4 (C); m/z (ESI) 355.9602 (MNa+, 
C13H10
35Cl3NNaO3 requires 355.9618), 346 (7%), 242 (100), 236 (14), 184 (18), 
173 (18), 142 (4). 
7-Fluoro-1-(2’,2’,2’-trichloromethylcarbonylamino)-1,4-dihydronaphthalene 
(65c) 
 
The reaction was carried out according to the previously described procedure for 
1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54a) using (2E)-3-(2’-allyl-5’-
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fluorophenyl)prop-2-en-1-ol (61c) (0.053 g, 0.28 mmol). The RCM step was 
performed at room temperature. This gave 7-fluoro-1-(2’,2’,2’-
trichloromethylcarbonylamino)-1,4-dihydronaphthalene (65c) (0.076 g, 76%) as a 
white solid. Mp 123–127 °C; max (neat)/cm
−1 3268 (NH), 3040 (CH), 1687 (CO), 
1503, 1249, 1226, 1023, 815; δH (500 MHz, CDCl3) 3.34–3.50 (2H, m, 4-H2), 5.66–
5.73 (1H, m, 1-H), 5.80 (1H, ddt, J 10.1, 3.5, 1.9 Hz, 2-H), 6.21 (1H, dtd, J 10.1, 
3.6, 1.9 Hz, 3-H), 6.84 (1H, br d, J 6.2 Hz, NH), 6.99 (1H, td, J 8.3, 2.6, Hz, 6-H), 
7.09 (1H, dd, J 9.6, 2.6 Hz, 8-H), 7.17 (1H, dd, J 8.3, 5.7 Hz, 5-H); δC (126 MHz, 
CDCl3) 28.9 (CH2), 48.0 (CH, d, 
4JCF 1.4 Hz), 92.8 (C), 114.5 (CH, d, 
2JCF 21.6 Hz), 
115.6 (CH, d, 2JCF 21.6 Hz), 123.8 (CH), 128.8 (CH), 129.7 (C, d, 
4JCF 3.1 Hz), 
130.2 (CH, d, 3JCF 7.8 Hz), 135.1 (C, d, 
3JCF 7.0 Hz), 161.7 (C), 161.8 (C, d, 
1JCF 
245.5 Hz); m/z (ESI) 331.9588 (MNa+, C12H9
35Cl2
37ClFNNaO requires 331.9597). 
6-Methyl-1-(2’,2’,2’-trichloromethylcarbonylamino)-1,4-dihydronaphthalene 
(65d) 
 
The reaction was carried out according to the previously described procedure for 
1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54a) using (2E)-3-(2’-allyl-4’-
methylphenyl)prop-2-en-1-ol (61d) (0.059 g, 0.31 mmol). The RCM step was 
performed at room temperature. This gave 6-methyl-1-(2’,2’,2’-
trichloromethylcarbonylamino)-1,4-dihydronaphthalene (65d) (0.078 g, 82%) as a 
white solid. Mp 118–122 °C; max (neat)/cm
−1 3253 (NH), 3036 (CH), 1685 (CO), 
1529, 1300, 1249, 1025, 823; δH (500 MHz, CDCl3) 2.34 (3H, s, 6-CH3), 3.33–3.49 
(2H, m, 4-H2), 5.65–5.73 (1H, m, 1-H), 5.92 (1H, ddt, J 10.1, 3.6, 2.2 Hz, 2-H), 
6.18 (1H, dtd, J 10.1, 3.6, 1.8 Hz, 3-H), 6.82 (1H, br d, J 8.4 Hz, NH), 7.02 (1H, s, 
5-H), 7.09 (1H, d, J 8.0 Hz, 7-H), 7.28 (1H, d, J 8.0 Hz, 8-H); δC (126 MHz, CDCl3) 
21.2 (CH3), 29.4 (CH2), 47.9 (CH), 93.0 (C), 124.4 (CH), 128.2 (CH), 128.3 (CH), 
128.7 (CH), 129.0 (CH), 130.2 (C), 134.0 (C), 137.8 (C), 161.5 (C); m/z (ESI) 
325.9864 (MNa+, C13H12
35Cl3NNaO requires 325.9877), 319 (14%), 297 (6), 236 
(10), 184 (14), 175 (14), 143 (36), 128 (7). 
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7-Methoxy-1-(2’,2’,2’-trichloromethylcarbonylamino)-1,4-
dihydronaphthalene (65e) 
 
The reaction was carried out according to the previously described procedure for 
1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54a) using (2E)-3-(2’-allyl-5’-
methoxyphenyl)prop-2-en-1-ol (61e) (0.052 g, 0.26 mmol). The RCM step was 
performed at room temperature. This gave 7-methoxy-1-(2’,2’,2’-
trichloromethylcarbonylamino)-1,4-dihydronaphthalene (65e) (0.063 g, 76%) as a 
white solid. Mp 92–96 °C; max (neat)/cm
−1 3293 (NH), 2935 (CH), 1704 (CO), 
1613, 1501, 1261, 1241, 1033, 1021, 816; δH (500 MHz, CDCl3) 3.31–3.46 (2H, m, 
4-H2), 3.77 (3H, s, OCH3), 5.67–5.74 (1H, m, 1-H), 5.89 (1H, ddt, J 10.1, 3.6, 2.3 
Hz, 2-H), 6.20 (1H, dtd, J 10.1, 3.6, 1.8 Hz, 3-H), 6.86 (1H, dd, J 8.4, 3.0 Hz, 6-H), 
6.87–6.91 (2H, m, NH and 8-H), 7.10 (1H, d, J 8.4 Hz, 5-H); δC (126 MHz, CDCl3) 
28.7 (CH2), 48.3 (CH3), 55.5 (CH), 92.9 (C), 111.8 (CH), 115.4 (CH), 123.9 (CH), 
126.1 (C), 129.1 (CH), 129.6 (CH), 134.1 (C), 158.6 (C), 161.6 (C); m/z (ESI) 
341.9811 (MNa+, C13H12
35Cl3NNaO2 requires 341.9826), 319 (83%), 307 (7), 297 
(6), 236 (10), 218 (6), 184 (11), 159 (22), 144 (4). 
1-(2’,2’,2’-Trichloromethylcarbonylamino)-1,4-dihydrophenanthrene (65f) 
 
The reaction was carried out according to the previously described procedure for 
1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54a) using (2E)-3-(1’-
allylnaphthalen-2’-yl)prop-2-en-1-ol (61f) (0.059 g, 0.31 mmol). The RCM step was 
performed at room temperature. This gave 1-(2’,2’,2’-
trichloromethylcarbonylamino)-1,4-dihydrophenanthrene (65f) (0.081 g, 84%) as a 
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white solid. Mp 150–152 °C (decomposition); max (neat)/cm
−1 3250 (NH), 3042 
(CH), 1678 (CO), 1510, 1308, 1248, 1020, 818; δH (500 MHz, CDCl3) 3.72–3.89 
(2H, m, 4-H2), 5.87–5.94 (1H, m, 1-H), 6.04 (1H, ddt, J 10.0, 3.6, 2.5 Hz, 2-H), 
6.37 (1H, dtd, J 10.0, 3.6, 1.6 Hz, 3-H), 6.85 (1H, d, J 8.3 Hz, NH), 7.46 (1H, d, J 
8.5 Hz, ArH), 7.52–7.61 (2H, m, 2 × ArH), 7.79 (1H, d, J 8.5 Hz, ArH), 7.86 (1H, 
dd, J 8.1, 0.9 Hz, ArH), 7.98 (1H, d, J 8.5 Hz, ArH); δC (126 MHz, CDCl3) 26.8 
(CH2), 48.7 (CH), 92.9 (C), 123.4 (CH), 123.7 (CH), 126.0 (CH), 126.4 (CH), 126.8 
(CH), 128.0 (CH), 128.4 (CH), 128.7 (CH), 129.7 (C), 130.1 (C), 131.3 (C), 133.0 
(C), 161.6 (C); m/z (ESI) 361.9866 (MNa+, C16H12
35Cl3NNaO requires 361.9877), 
320 (61%), 307 (10), 301 (7), 242 (7), 179 (100), 141 (3). 
1-(2’,2’,2’-Trichloromethylcarbonylamino)-6-trifluoromethyl-1,4-
dihydronaphthalene (65g) 
 
The reaction was carried out according to the previously described procedure for 
1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54a) using (2E)-3-(2’-allyl-4’-
trifluoromethylphenyl)prop-2-en-1-ol (61g) (0.061 g, 0.25 mmol). Grubbs 2nd 
generation catalyst (0.011 g, 0.013 mmol) was added and the reaction was stirred 
at 50 °C for 24 h before a second portion of Grubbs 2nd generation catalyst (0.011 
g, 0.013 mmol) was added and allowed to stir at 50 °C for a further 24 h. This gave 
1-(2’,2’,2’-trichloromethylcarbonylamino)-6-trifluoromethyl-1,4-dihydronaphthalene 
(65g) (0.065 g, 72%) as a colourless oil. max (neat)/cm
−1 3268 (NH), 2924 (CH), 
1684 (CO), 1525, 1329, 1160, 1119, 822; δH (500 MHz, CDCl3) 3.43–3.59 (2H, m, 
4-H2), 5.74–5.80 (1H, m, 1-H), 5.94 (1H, ddt, J 10.0, 3.5, 2.0 Hz, 2-H), 6.24 (1H, 
dtd, J 10.0, 3.5, 1.5 Hz, 3-H), 6.86 (1H, d, J 8.3 Hz, NH), 7.47 (1H, s, 5-H), 7.51–
7.53 (2H, m, 7-H and 8-H); δC (126 MHz, CDCl3) 29.4 (CH2), 47.6 (CH), 92.7 (C), 
124.0 (CH, q, 3JCF 3.6 Hz), 124.0 (C, q, 
1JCF 272.3 Hz), 124.1 (CH), 125.6 (CH, q, 
3JCF 3.8 Hz), 128.5 (CH), 129.0 (CH), 130.4 (C, q, 
2JCF 32.5 Hz), 134.8 (C), 137.1 
(C), 161.8 (C); m/z (ESI) 379.9581 (MNa+, C13H9
35Cl3F3NNaO requires 379.9594), 
301 (19%), 236 (26), 199 (3), 136 (2). 
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7-(2’,2’,2’-Trichloromethylcarbonylamino)-4,7-dihydrobenzo[b]furan (65h) 
 
The reaction was carried out according to the previously described procedure for 
1-(2’,2’,2’-trichloromethylcarbonylamino)-1H-indene (54a) using (2E)-3-(3’-
allylfuran-2’-yl)prop-2-en-1-ol (61h) (0.055 g, 0.33 mmol). The RCM step was 
performed at room temperature. This gave 7-(2’,2’,2’-
trichloromethylcarbonylamino)-4,7-dihydrobenzo[b]furan (65h) (0.052 g, 72%) as a 
white solid. Mp 102–104 °C; max (neat)/cm
−1 3275 (NH), 2886 (CH), 1686 (CO), 
1517, 1244, 1036, 821; δH (500 MHz, CDCl3) 3.14–3.28 (2H, m, 4-H2), 5.66–5.73 
(1H, m, 7-H), 5.88 (1H, ddt, J 9.9, 3.7, 2.1 Hz, 6-H), 6.14 (1H, dtd, J 9.9, 3.4, 1.7 
Hz, 5-H), 6.32 (1H, d, J 1.9 Hz, 3-H), 6.73 (1H, br s, NH), 7.42 (1H, d, J 1.9 Hz, 2-
H); δC (126 MHz, CDCl3) 25.1 (CH2), 44.8 (CH), 92.7 (C), 109.6 (CH), 118.4 (C), 
123.7 (CH), 129.2 (CH), 143.0 (CH), 145.3 (C), 161.5 (C); m/z (ESI) 301.9512 
(MNa+, C10H8
35Cl3NNaO2 requires 301.9513), 236 (10%), 218 (2), 184 (10). 
(1’E)-2-(Prop-1’-enyl)-3-(1’’-(2’’’,2’’’,2’’’-
trichloromethylcarbonylamino)prop-2’’-enyl)pyridine (65i) 
 
(2E)-3-(2’-Allylpyridin-3’-yl)prop-2-en-1-ol (61i) (0.055 g, 0.32 mmol) was dissolved 
in dry dichloromethane (8 mL) and cooled to 0 °C under argon with stirring. 
Trichloroacetonitrile (0.047 mL, 0.48 mmol) was added to the solution, followed by 
1,8-diazabicyclo[5.4.0]undec-7-ene (0.024 mL, 0.16 mmol) and the reaction was 
allowed to return to room temperature over 1.5 h. The reaction mixture was filtered 
through a short pad of alumina (neutral, Brockman V) with diethyl ether (150 mL) 
and concentrated in vacuo to yield the crude allylic trichloroacetimidate as a yellow 
oil which was used without further purification. The allylic trichloroacetimidate 62i 
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was transferred to a dry Schlenk tube containing a stirrer bar and potassium 
carbonate (15 mg, 3 mg/mL) to which p-xylene (5 mL) was then added. The tube 
was purged with argon, sealed and heated to 160 °C for 18 h. The reaction was 
allowed to cool to room temperature, Grubbs 2nd generation catalyst (0.013 g, 
0.016 mmol) was added and the reaction was heated to 50 °C for 20 h. The 
reaction mixture was concentrated in vacuo and purified by silica column 
chromatography (elution with 20–100% diethyl ether/petroleum ether) to yield 
(1’E)-2-(prop-1’-enyl)-3-(1’’-(2’’’,2’’’,2’’’-trichloromethylcarbonylamino)prop-2’’-
enyl)pyridine (65i) (0.041 g, 40%) as a white solid. Mp 140–143 °C 
(decomposition); max (neat)/cm
–1 3140 (NH), 2970 (CH), 1697 (CO), 1520, 1427, 
927, 941, 826, 664; δH (500 MHz, CDCl3) 1.95 (3H, dd, J 6.8, 1.7 Hz, 3’-H3), 5.29 
(1H, dd, J 17.2, 1.8 Hz, 3’’-HH), 5.42 (1H, dd, J 10.5, 1.8 Hz, 3’’-HH), 5.80–5.85 
(1H, m, 1’’-H), 6.06 (1H, ddd, J 17.2, 10.5, 4.4 Hz, 2’’-H), 6.66 (1H, dq, J 14.4, 1.7 
Hz, 1’-H), 6.87 (1H, br d, J 7.1 Hz, NH), 6.93 (1H, dq, J 14.4, 6.8 Hz, 2’-H), 7.15 
(1H, dd, J 7.8, 4.7 Hz, 5-H), 7.56 (1H, dd, J 7.8, 1.5 Hz, 4-H), 8.52 (1H, dd, J 4.7, 
1.5 Hz, 6-H); δC (126 MHz, CDCl3) 18.9 (CH3), 53.3 (CH), 92.5 (C), 118.0 (CH2), 
121.9 (CH), 126.3 (CH), 130.0 (C), 134.7 (CH), 134.9 (CH), 135.2 (CH), 149.3 
(CH), 154.4 (C), 161.0 (C); m/z (ESI) 319.0155 (MH+, C13H14
35Cl3N2O requires 
319.0166), 236 (6), 185 (8), 158 (4), 130 (3). 
6,7-Methylenedioxy-1-(2’,2’,2’-trichloromethylcarbonylamino)naphthalene 
(68) and 6,7-methylenedioxy-1,4-naphthoquinone (69) 
 
Manganese(IV) oxide (0.521 g, 5.99 mmol) was added to a solution of 6,7-
methylenedioxy-1-(2’,2’,2’-trichloromethylcarbonylamino)-1,4-dihydronaphthalene 
(65b) (0.200 g, 0.597 mmol) in chloroform (6 mL) and heated at 45 °C for 20 h. 
The crude reaction mixture was filtered through a short pad of Celite® with 
chloroform (100 mL) and then concentrated in vacuo. Purification by column 
chromatography (elution with 100% toluene) yielded 6,7-methylenedioxy-1-
(2’,2’,2’-trichloromethylcarbonylamino)naphthalene (68) (0.143 g, 72%) as a white 
solid. Further elution gave 6,7-methylenedioxy-1,4-naphthoquinone (69) (0.019 g, 
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16%) as an orange solid. Data for 68: Mp 139–140 °C; max (neat)/cm
−1 3302 (NH), 
2913 (CH), 1686 (CO), 1489, 1462, 1242, 1034, 849, 814; δH (500 MHz, CDCl3) 
6.05 (2H, s, OCH2O), 7.05 (1H, s, ArH), 7.13 (1H, s, ArH), 7.32 (1H, t, J 7.9 Hz, 3-
H), 7.55 (1H, d, J 7.9 Hz, 4-H), 7.60 (1H, d, J 7.9 Hz, 2-H), 8.47 (1H, br s, NH); δC 
(126 MHz, CDCl3) 93.1 (C), 97.6 (CH), 101.6 (CH2), 104.8 (CH), 121.4 (CH), 124.2 
(CH), 125.3 (C), 127.0 (CH), 130.0 (C), 131.6 (C), 148.1 (C), 148.9 (C), 160.6 (C); 
m/z (ESI) 353.9452 (MNa+, C13H8
35Cl3NNaO3 requires 353.9462), 301 (3%), 236 
(7), 227 (4), 159 (1); Data for 69: Mp 196–200 °C; max (neat)/cm
−1 2928 (CH), 
1655 (CO), 1586, 1485, 1316, 1026, 976, 833; δH (400 MHz, CDCl3) 6.14 (2H, s, 
OCH2O), 6.88 (2H, s, 5-H and 8-H), 7.45 (2H, s, 2-H and 3-H); δC (101 MHz, 
CDCl3) 102.8 (CH2), 106.0 (CH), 129.1 (C), 138.3 (CH), 152.5 (C), 184.1 (C); m/z 
(EI) 202.0264 (M+, C11H6O4 requires 202.0266), 174 (37%), 148 (22), 120 (29), 
105 (20), 84 (41), 77 (19), 62 (24). 
6,7-Methylenedioxy-1-aminonaphthalene (70)184 
 
6 M Hydrochloric acid (15 mL) was added to a solution of 6,7-methylenedioxy-1-
(2’,2’,2’-trichloromethylcarbonylamino)naphthalene (68) (0.330 g, 0.991 mmol) in 
methanol (20 mL) and heated with stirring to 90 °C for 60 h. The reaction mixture 
was cooled to room temperature then washed with dichloromethane (2 × 10 mL). 
The aqueous layer was basified to pH ~ 10 with 12 M sodium hydroxide solution 
and extracted with ethyl acetate (3 × 10 mL). The combined organic layers were 
dried (Na2SO4), filtered and concentrated in vacuo to yield 6,7-methylenedioxy-1-
aminonaphthalene (70) (0.182 g, 98%) as a white solid. Mp 151–152 °C (lit.184 
152–154 °C); δH (500 MHz, CDCl3) 3.85 (2H, s, NH2), 6.03 (2H, s, OCH2O), 6.69 
(1H, dd, J 6.6, 1.9 Hz, 2-H), 7.09 (1H, s, ArH), 7.13 (1H, s, ArH), 7.14–7.18 (2H, 
m, 3-H and 4-H); δC (126 MHz, CDCl3) 97.9 (CH), 101.2 (CH2), 104.8 (CH), 109.7 
(CH), 118.9 (CH), 120.3 (C), 125.0 (CH), 131.7 (C), 141.5 (C), 147.3 (C), 147.6 
(C); m/z (ESI) 188 (MH+, 100%), 158 (26), 146 (10), 130 (78). 
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6-Bromo-2,3-dimethoxybenzoic acid (72a)101 
 
2,3-Dimethoxybenzoic acid (71) (0.20 g, 1.1 mmol) was added to a stirred solution 
of sodium hydroxide (0.048 g, 1.2 mmol) in water (1.7 mL) and the solution was 
cooled to 0 °C. Dibromodimethylhydantoin (0.19 g, 0.66 mmol) was added to the 
solution in small portions and the reaction mixture was allowed to return to room 
temperature over 20 h. The reaction was quenched with 1 M hydrochloric acid (3 
mL) and extracted with diethyl ether (3 × 10 mL). The combined organic layers 
were washed with brine (30 mL), dried (MgSO4), filtered and concentrated in 
vacuo to yield 6-bromo-2,3-dimethoxybenzoic acid (72a) (0.24 g, 82%) as a white 
solid. Mp 108–110 °C (lit.,101 110–112 °C); δH (500 MHz, CDCl3) 3.87 (3H, s, 
OCH3), 3.92 (3H, s, OCH3), 6.86 (1H, d, J 8.9 Hz, 5-H), 7.27 (1H, d, J 8.9 Hz, 4-H), 
9.41 (1H, br s, CO2H); δC (126 MHz, CDCl3) 56.3 (CH3), 62.0 (CH3), 108.8 (C), 
115.1 (CH), 128.3 (CH), 130.4 (C), 147.2 (C), 152.3 (C), 170.8 (C); m/z (CI) 261 
(M+, 13%), 183 (100), 165 (24), 153 (6), 133 (5), 85 (7), 69 (8). 
2-Bromo-4,5-methylenedioxybenzoic acid (72b)102  
 
2-Methyl-but-2-ene (1.85 mL, 17.5 mmol), was added to a stirred solution of 2-
bromo-4,5-methylenedioxybenzaldehyde (52b) (0.500 g, 2.18 mmol) in tert-
butanol (10 mL). In a second flask, sodium chlorite (0.768 g, 8.73 mmol) and 
sodium dihydrogen phosphate (1.83 g, 15.3 mmol) were dissolved in water (10 
mL) with stirring. The aqueous solution was added dropwise with vigorous stirring 
to the organic solution and stirred at room temperature for 3 h. The reaction was 
quenched with 6 M hydrochloric acid (5 mL), stirred for 0.25 h and then extracted 
with dichloromethane (3 × 20 mL). The combined organic layers were extracted 
with 6 M sodium hydroxide solution (2 × 30 mL). The resulting aqueous solution 
was acidified to pH ~ 2 with concentrated hydrochloric acid and extracted with 
ethyl acetate (3 × 20 mL). The combined organic layers were washed with brine 
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(60 mL), dried (MgSO4), filtered and concentrated in vacuo to yield 2-bromo-4,5-
methylenedioxybenzoic acid (72b) (0.523 g, 98%) as a white solid. Mp 202–204 
°C (lit.,102 205–208 °C); δH (500 MHz, CDCl3) 6.08 (2H, s, OCH2O), 7.14 (1H, s, 3-
H), 7.51 (1H, s, 6-H), 11.20 (1H, br s, CO2H); δC (126 MHz, CDCl3) 102.8 (CH2), 
112.0 (CH), 115.0 (CH), 116.5 (C), 122.9 (C), 147.4 (C), 152.0 (C), 169.2 (C); m/z 
(EI) 244 (M+, 100%), 227 (39), 199 (21), 165 (8), 143 (15), 107 (10), 79 (12), 62 
(32). 
6-Bromo-2,3-dimethoxy-N-(6’,7’-methylenedioxynaphthalen-1-yl)benzamide 
(73a) 
 
6-Bromo-2,3-dimethoxybenzoic acid (72a) (0.024 g, 0.10 mmol) was suspended in 
thionyl chloride (0.5 mL) and heated with stirring to 65 °C for 1 h. The reaction 
mixture was cooled to room temperature and concentrated in vacuo to yield the 
acid chloride, which was used without further purification. In a second flask, N,N-
diisopropylethylamine (0.14 mL, 0.80 mmol) was added to a solution of 6,7-
methylenedioxy-1-aminonaphthalene (70) (0.015 g, 0.080 mmol) in 
dichloromethane (0.4 mL) and cooled to 0 °C. The crude acid chloride was 
dissolved in dichloromethane (0.4 mL) and added dropwise to the cooled, stirring 
solution of amines. The reaction mixture was stirred at 0 °C for 1 h and then 
allowed to return to room temperature over 1 h. The reaction was quenched with 1 
M hydrochloric acid (1 mL) and extracted with dichloromethane (3 × 10 mL). The 
combined organic layers were washed with a saturated solution of sodium 
hydrogen carbonate (20 mL) then brine (30 mL), dried (MgSO4), filtered and 
concentrated in vacuo. The resulting solid was washed with a minimal volume of 
ice cold chloroform to yield 6-bromo-2,3-dimethoxy-N-(6’,7’-
methylenedioxynaphthalen-1-yl)benzamide (73a) (0.031 g, 89%) as a white solid. 
Mp 227–229 °C; max (neat)/cm
−1 3235 (NH), 2918 (CH), 1664 (CO), 1543, 1463, 
1248, 1044, 997, 950, 805; δH (500 MHz, CDCl3) 3.92 (3H, s, OCH3), 3.98 (3H, s, 
OCH3), 6.05 (2H, s, OCH2O), 6.88 (1H, d, J 8.8 Hz, 4-H), 7.15 (1H, s, ArH), 7.34 
(1H, d, J 8.8 Hz, 5-H), 7.38 (1H, t, J 7.8 Hz, 3’-H), 7.47–7.52 (2H, m, NH and ArH), 
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7.61 (1H, d, J 7.8 Hz, 4’-H), 7.69 (1H, d, J 7.8 Hz, 2’-H); δC (126 MHz, CDCl3) 56.3 
(CH3), 62.5 (CH3), 99.0 (CH), 101.4 (CH2), 104.5 (CH), 110.0 (C), 114.6 (CH), 
122.1 (CH), 124.4 (CH), 126.3 (C), 126.4 (CH), 128.6 (CH), 131.4 (C), 131.7 (C), 
134.2 (C), 147.2 (C), 148.0 (C), 148.7 (C), 152.5 (C), 164.8 (C); m/z (ESI) 
452.0090 (MNa+, C20H16
79BrNNaO5 requires 452.0104), 430 (1%), 413 (3), 243 
(1). 
2-Bromo-4,5-methylenedioxy-N-(6’,7’-methylenedioxynaphthalen-1-
yl)benzamide (73b) 
 
The reaction was carried out according to the previously described procedure for 
6-bromo-2,3-dimethoxy-N-(6’,7’-methylenedioxynaphthalen-1-yl)benzamide (73a) 
using 2-bromo-4,5-methylenedioxybenzoic acid (72b) (0.031 g, 0.13 mmol) and 
6,7-methylenedioxy-1-aminonaphthalene (70) (0.020 g, 0.11 mmol). This gave 2-
bromo-4,5-methylenedioxy-N-(6’,7’-methylenedioxynaphthalen-1-yl)benzamide 
(73b) (0.039 g, 89%) as a white solid. Mp 236–238 °C; max (neat)/cm
–1 3233 (NH), 
2909 (CH), 1659 (CO), 1543, 1462, 1238, 1038, 934, 849; δH (500 MHz, DMSO-
d6) 6.15 (2H, s, OCH2O), 6.16 (2H, s, OCH2O), 7.31–7.38 (4H, m, 4 × ArH), 7.48 
(1H, s, ArH), 7.52 (1H, d, J 7.7 Hz, 4’-H), 7.65 (1H, d, J 7.7 Hz, 2’-H), 10.24 (1H, s, 
NH); δC (126 MHz, DMSO-d6) 99.7 (CH), 101.3 (CH2), 102.3 (CH2), 103.8 (CH), 
108.9 (CH), 110.2 (C), 112.5 (CH), 121.6 (CH), 123.8 (CH), 125.2 (CH), 125.6 (C), 
131.0 (2 × C), 132.6 (C), 146.9 (C), 147.3 (C), 147.6 (C), 148.8 (C), 166.2 (C); m/z 
(ESI) 435.9775 (MNa+, C19H12
79BrNNaO5 requires 435.9791), 413 (8%), 370 (4), 
236 (7), 227 (8), 198 (3). 
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6-Bromo-2,3-methylenedioxy-N-(6’,7’-methylenedioxynaphthalen-1-
yl)benzamide (73c) 
 
The reaction was carried out according to the previously described procedure for 
6-bromo-2,3-dimethoxy-N-(6’,7’-methylenedioxynaphthalen-1-yl)benzamide (73a) 
using 6-bromo-2,3-methylenedioxybenzoic acid (72c) (0.13 g, 0.51 mmol) and 6,7-
methylenedioxy-1-aminonaphthalene (70) (0.080 g, 0.43 mmol). This gave 6-
bromo-2,3-methylenedioxy-N-(6’,7’-methylenedioxynaphthalen-1-yl)benzamide 
(73c) (0.16 g, 89%) as a white solid. Mp 236–238 °C; max (neat)/cm
−1 3237 (NH), 
2905 (CH), 1655 (CO), 1543, 1493, 1451, 1238, 1038, 926, 849; δH (500 MHz, 
DMSO-d6) 6.15 (2H, s, OCH2O), 6.22 (2H, s, OCH2O), 7.01 (1H, d, J 8.3 Hz, 4-H), 
7.20 (1H, d, J 8.3 Hz, 5-H), 7.36 (1H, t, J 7.6 Hz, 3’-H), 7.37 (1H, s, ArH), 7.46 (1H, 
s, ArH), 7.47 (1H, d, J 7.6 Hz, 4’-H), 7.67 (1H, d, J 7.6 Hz, 2’-H), 10.52 (1H, s, 
NH); δC (126 MHz, DMSO-d6) 99.3 (CH), 101.4 (CH2), 102.6 (CH2), 103.9 (CH), 
110.0 (C), 110.2 (CH), 121.3 (C), 121.5 (CH), 123.9 (CH), 125.2 (CH), 125.4 (CH), 
125.4 (C), 131.1 (C), 132.1 (C), 145.7 (C), 147.2 (C), 147.4 (C), 147.7 (C), 162.2 
(C); m/z (ESI) 435.9792 (MNa+, C19H12
79BrNNaO5 requires 435.9791), 413 (13%), 
335 (13), 289 (3), 236 (8), 159 (6). 
2-Bromo-4,5-dimethoxy-N-(6’,7’-methylenedioxynaphthalen-1-yl)benzamide 
(73d) 
 
The reaction was carried out according to the previously described procedure for 
6-bromo-2,3-dimethoxy-N-(6’,7’-methylenedioxynaphthalen-1-yl)benzamide (73a) 
using 2-bromo-4,5-dimethoxybenzoic acid (72d) (0.084 g, 0.32 mmol) and 6,7-
methylenedioxy-1-aminonaphthalene (70) (0.050 g, 0.27 mmol). This gave 2-
bromo-4,5-dimethoxy-N-(6’,7’-methylenedioxynaphthalen-1-yl)benzamide (73d) 
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(0.10 g, 88%) as a white solid. Mp 231–234 °C; max (neat)/cm
–1 3217 (NH), 2934 
(CH), 1627 (CO), 1534, 1459, 1243, 1040, 951, 837; δH (500 MHz, DMSO-d6) 3.84 
(3H, s, OCH3), 3.85 (3H, s, OCH3), 6.15 (2H, s, OCH2O), 7.25 (1H, s, 3-H), 7.28 
(1H, s, 6-H), 7.36 (1H, t, J 7.7 Hz, 3’-H), 7.36 (1H, s, ArH), 7.49 (1H, s, ArH), 7.54 
(1H, d, J 7.7 Hz, 4’-H), 7.65 (1H, d, J 7.7 Hz, 2’-H), 10.22 (1H, s, NH); δC (126 
MHz, DMSO-d6) 56.0 (CH3), 56.1 (CH3), 99.8 (CH), 101.3 (CH2), 103.8 (CH), 
109.6 (C), 112.4 (CH), 115.7 (CH), 121.6 (CH), 123.9 (CH), 125.2 (CH), 125.6 (C), 
131.1 (C), 131.1 (C), 132.8 (C), 147.3 (C), 147.6 (C), 148.0 (C), 150.1 (C), 166.4 
(C); m/z (ESI) 452.0088 (MNa+, C20H16
79BrNNaO5 requires 452.0104), 413 (6%), 
381 (10), 353 (10), 301 (3), 236 (3). 
6-Bromo-2,3-dimethoxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-1-
yl)benzamide (74a)94 
 
Sodium hydride (60% dispersion in mineral oil, 0.020 g, 0.51 mmol) was washed 
with hexane (×3) under argon and dried under reduced pressure. N,N’-
Dimethylformamide (1 mL) was added to the sodium hydride followed slowly by a 
solution of 6-bromo-2,3-dimethoxy-N-(6’,7’-methylenedioxynaphthalen-1-
yl)benzamide (73a) (0.087 g, 0.20 mmol) in N,N’-dimethylformamide (1 mL). The 
reaction mixture was stirred at room temperature for 0.1 h then methyl iodide 
(0.044 ml, 0.71 mmol) was added dropwise with vigorous stirring and the mixture 
was stirred for 18 h at room temperature. The reaction was quenched by the slow 
addition of 1 M hydrochloric acid solution (3 mL), diluted with 5% lithium chloride 
solution (3 mL) and extracted with diethyl ether (3 × 5 mL). The combined organic 
layers were washed with brine (3 × 10 mL), dried (MgSO4), filtered and 
concentrated in vacuo. The crude product was washed with cold hexane (5 × 1 
mL), to yield 6-bromo-2,3-dimethoxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-
1-yl)benzamide (74a) (0.088 g, 98%) as a white solid. Mp 173–175 °C (lit.94 mp 
178–179 °C); the NMR spectra showed the presence of rotomers; for 
simplification, only signals for the major rotomer is reported: δH (500 MHz, DMSO-
d6) 3.20 (3H, s, NCH3), 3.93 (3H, s, OCH3), 4.03 (3H, s, OCH3), 6.04 (1H, d, J 1.5 
 Experimental 153 
 
Hz, OCHHO), 6.05 (1H, d, J 1.5 Hz, OCHHO), 6.87 (1H, d, J 9.0 Hz, ArH), 7.17 
(1H, s, ArH), 7.34 (1H, d, J 9.0 Hz, ArH), 7.38–7.42 (1H, m, ArH), 7.44–7.48 (1H, 
m, ArH), 7.53 (1H, s, ArH), 7.64–7.69 (1H, m, ArH); δC (126 MHz, DMSO-d6) 39.6 
(CH3), 56.2 (CH3), 61.9 (CH3), 99.7 (CH), 101.3 (CH2), 104.5 (CH), 109.4 (C), 
114.0 (CH), 123.6 (CH), 124.7 (CH), 127.4 (CH), 128.2 (C), 128.5 (CH), 131.8 (C), 
132.2 (C), 134.0 (C), 138.8 (C), 146.0 (C), 149.1 (C), 152.6 (C), 166.9 (C); m/z 
(ESI) 466 (MNa+, 100%), 446 (1), 243 (1), 227 (1). 
2-Bromo-4,5-methylenedioxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-
1-yl)benzamide (74b) 
 
The reaction was carried out according to the previously described procedure for 
6-bromo-2,3-dimethoxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-1-
yl)benzamide (74a) using 2-bromo-4,5-methylenedioxy-N-(6’,7’-
methylenedioxynaphthalen-1-yl)benzamide (73b) (0.010 g, 0.024 mmol). This 
gave 2-bromo-4,5-methylenedioxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-1-
yl)benzamide (74b) (0.010 g, 98%) as a white solid. Mp 193–196 °C;max 
(neat)/cm−1 2916 (CH), 1636 (CO), 1462, 1242, 1026, 934, 860; δH (500 MHz, 
CDCl3) 3.48 (3H, s, NCH3), 5.74 (1H, d, J 1.3 Hz, OCHHO), 5.78 (1H, d, J 1.3 Hz, 
OCHHO), 6.08 (1H, d, J 1.1 Hz, OCHHO), 6.11 (1H, d, J 1.1 Hz, OCHHO), 6.42 
(1H, s, ArH), 6.80 (1H, s, ArH), 7.09 (1H, s, ArH), 7.15 (1H, dd, J 8.1, 7.5 Hz, 3’-
H), 7.24 (1H, s, ArH), 7.34 (1H, dd, J 7.5, 1.0 Hz, 4’-H), 7.51 (1H, br d, J 8.1 Hz, 
2’-H); δC (126 MHz, CDCl3) 37.4 (CH3), 99.2 (CH), 101.6 (CH2), 101.9 (CH2), 104.7 
(CH), 107.2 (CH), 111.6 (C), 113.0 (CH), 124.2 (CH), 124.3 (CH), 127.3 (C), 127.7 
(CH), 131.6 (C), 131.8 (C), 139.1 (C), 146.4 (C), 148.2 (C), 148.5 (C), 149.2 (C), 
169.4 (C); m/z (ESI) 449.9935 (MNa+, C20H14
79BrNNaO5 requires 449.9948), 413 
(4%), 301 (7), 257 (1), 236 (4), 199 (3).  
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6-Bromo-2,3-methylenedioxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-
1-yl)benzamide (74c) 
 
The reaction was carried out according to the previously described procedure for 
6-bromo-2,3-dimethoxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-1-
yl)benzamide (74a) using 6-bromo-2,3-methylenedioxy-N-(6’,7’-
methylenedioxynaphthalen-1-yl)benzamide (73c) (0.140 g, 0.338 mmol). This 
gave 6-bromo-2,3-methylenedioxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-1-
yl)benzamide (74c) (0.138 g, 95%) as a white solid. Mp 161–163 °C; max 
(neat)/cm−1 2901 (CH), 1651 (CO), 1462, 1447, 1373, 1246, 1038, 934; the NMR 
spectra showed the presence of rotomers; for simplification, only signals for the 
major rotomer is reported: δH (500 MHz, CDCl3) 3.52 (3H, s, NCH3), 5.13 (1H, d, J 
1.5 Hz, OCHHO), 5.79 (1H, d, J 1.5 Hz, OCHHO), 6.04 (1H, d, J 1.0 Hz, OCHHO), 
6.08 (1H, d, J 1.0 Hz, OCHHO), 6.36 (1H, d, J 8.0 Hz, ArH), 6.82 (1H, d, J 8.0 Hz, 
ArH), 7.07 (1H, s, ArH), 7.13–7.17 (1H, m, ArH), 7.34 (1H, s, ArH), 7.51–7.55 (1H, 
m, ArH), 7.66–7.71 (1H, m, ArH); δC (126 MHz, CDCl3) 37.3 (CH3), 100.6 (CH), 
101.4 (CH2), 101.6 (CH2), 104.3 (CH), 109.4 (CH), 111.2 (C), 121.1 (C), 124.2 (2 × 
CH), 125.3 (CH), 125.8 (C), 127.9 (CH), 138.7 (C), 144.9 (C), 146.6 (C), 146.7 (C), 
147.9 (C), 148.1 (C), 162.X (C); m/z (ESI) 449.9935 (MNa+, C20H14
79BrNNaO5 
requires 449.9948), 430 (1%), 413 (6), 236 (1), 227 (1). 
2-Bromo-4,5-dimethoxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-1-
yl)benzamide (74d) 
 
The reaction was carried out according to the previously described procedure for 
6-bromo-2,3-dimethoxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-1-
yl)benzamide (74a) using 2-bromo-4,5-dimethoxy-N-(6’,7’-
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methylenedioxynaphthalen-1-yl)benzamide (73d) (0.085 g, 0.20 mmol). This gave 
2-bromo-4,5-dimethoxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-1-
yl)benzamide (74d) (0.083 g, 94%) as a white solid. Mp 171–174 °C; max 
(neat)/cm−1 2901 (CH), 1646 (CO), 1507, 1462, 1247, 1212, 1162, 1035, 918, 855; 
δH (500 MHz, CDCl3) 3.32 (3H, s, NCH3), 3.52 (3H, s, OCH3), 3.71 (3H, s, OCH3), 
6.07 (2H, s, OCH2O), 6.46 (1H, s, ArH), 6.79 (1H, s, ArH), 7.09 (1H, s, ArH), 7.13 
(1H, dd, J 8.1, 7.5 Hz, 3’-H), 7.29 (1H, dd, J 7.5, 1.1 Hz, 4’-H), 7.31 (1H, s, ArH), 
7.49 (1H, br d, J 8.1 Hz, 2’-H); δC (126 MHz, CDCl3) 37.2 (CH3), 55.6 (CH3), 56.1 
(CH3), 99.2 (CH), 101.6 (CH2), 104.9 (CH), 110.6 (CH), 110.8 (C), 115.4 (CH), 
124.4 (2 × CH), 127.5 (C), 127.7 (CH), 130.2 (C), 131.8 (C), 139.4 (C), 147.2 (C), 
148.0 (C), 149.1 (C), 149.5 (C), 169.7 (C); m/z (ESI) 466.0238 (MNa+, 
C21H18
79BrNNaO5 requires 466.0261), 413 (1%), 381 (4), 353 (4), 236 (1), 227 (1). 
Oxychelerythrine (44)185 (Pd(OAc)2 method) 
 
6-Bromo-2,3-dimethoxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-1-
yl)benzamide (74a) (0.020 g, 0.045 mmol), palladium(II) acetate (0.0020 g, 0.0089 
mmol), tri-o-tolylphosphine (0.0055 g, 0.018 mmol) and silver carbonate (0.025 g, 
0.090 mmol) were combined with a stirred bar in a microwave vial and placed 
under argon. Degassed N,N’-dimethylformamide (1.2 mL) was added and the vial 
was sealed and heated to 160 °C for 3 h then cooled to room temperature. 
Additional palladium(II) acetate (0.0010 g, 0.0044 mmol) and tri-o-tolylphosphine 
(0.0025 g, 0.0082 mmol) were added and the reaction was resealed and heated to 
160 °C for a further 18 h then cooled to room temperature. The reaction mixture 
was diluted with diethyl ether (4 mL) and filtered. The filtrate was the further diluted 
with diethyl ether (10 mL) and washed with 5% lithium chloride solution (3 × 15 
mL), brine (15 mL), dried (MgSO4), filtered and concentrated in vacuo. Purification 
by column chromatography (elution with 40% ethyl acetate:petroleum ether) 
yielded oxychelerythrine (44) (0.016 g, 97%) as a white solid. Mp 182–185 °C 
(lit.185 198−200 °C); δH (500 MHz, CDCl3) 3.89 (3H, s, CH3), 3.98 (3H, s, CH3), 
4.08 (3H, s, CH3), 6.09 (2H, s, OCH2O), 7.15 (1H, s, ArH), 7.38 (1H, d, J 9.0 Hz, 
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ArH), 7.52 (1H, d, J 9.0 Hz, ArH), 7.53 (1H, s, ArH), 7.97 (1H, s, ArH), 7.99 (1H, s, 
ArH); δC (126 MHz, CDCl3) 40.9 (CH3), 56.8 (CH3), 61.9 (CH3), 101.6 (CH2), 102.6 
(CH), 104.8 (CH), 117.3 (C), 117.9 (CH), 118.0 (CH), 118.6 (CH), 119.9 (C), 121.2 
(C), 123.4 (CH), 129.1 (C), 131.8 (C), 135.8 (C), 147.2 (C), 147.6 (C), 150.3 (C), 
152.9 (C), 162.8 (C); m/z (ESI) 386.0989 (MNa+, C21H17NNaO5 requires 
386.0999), 371 (4%), 227 (6). 
Oxychelerythrine (44)185 (Herrmann-Beller catalyst method) 
 
6-Bromo-2,3-dimethoxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-1-
yl)benzamide (74a) (0.020 g, 0.045 mmol), trans-bis(acetato)bis[o-(di-o-
tolylphosphino)benzyl]dipalladium(II) (0.0042 g, 0.0045 mmol) and silver 
carbonate (0.025 g, 0.090 mmol) were combined with a stirred bar in a microwave 
vial and placed under argon. Degassed N,N’-dimethylformamide (1.2 mL) was 
added and the vial was sealed and heated to 160 °C for 22 h then cooled to room 
temperature. The reaction mixture was diluted with diethyl ether (4 mL) and 
filtered. The filtrate was then further diluted with diethyl ether (10 mL) and washed 
with 5% lithium chloride solution (3 × 15 mL), brine (15 mL), dried (MgSO4), filtered 
and concentrated in vacuo. Purification by column chromatography (elution with 
40% ethyl acetate:petroleum ether) and then washing of the resulting solid with 
hexane (3 × 1 mL) yielded oxychelerythrine (44) (0.016 g, 95%) as a white solid. 
Spectroscopic data as described above. 
Oxyavicine (43)185 (Pd(OAc)2 method) 
 
The reaction was carried out according to the previously described procedure for 
the synthesis of oxychelerythrine (44) (Pd(OAc)2 method) using 2-bromo-4,5-
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methylenedioxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-1-yl)benzamide 
(74b) (0.020 g, 0.047 mmol) and a single addition of palladium(II) acetate (0.0040 
g, 0.018 mmol) and tri-o-tolylphosphine (0.010 g, 0.033 mmol). Purification by 
column chromatography (50% ethyl acetate:petroleum ether) and then washing 
the resulting solid with hexane (3 × 1 mL) yielded oxyavicine (43) (0.006 g, 23%) 
as a white solid. Mp 265−268 °C (lit.185 271−273 °C); δH (500 MHz, CDCl3) 3.97 
(3H, s, NCH3), 6.10 (2H, s, OCH2O), 6.13 (2H, s, OCH2O), 7.17 (1H, s, ArH), 7.54 
(1H, d, J 8.8 Hz, ArH), 7.60 (1H, s, ArH), 7.62 (1H, s, ArH), 7.89 (1H, s, ArH), 7.92 
(1H, d, J 8.8 Hz, ArH); δC (126 MHz, CDCl3) 41.4 (CH3), 100.8 (CH), 101.7 (CH2), 
102.1 (CH2), 102.8 (CH), 104.9 (CH), 106.8 (CH), 117.0 (C), 118.7 (CH), 121.0 
(C), 121.1 (C), 123.4 (CH), 131.2 (C), 132.1 (C), 136.0 (C), 147.2 (C), 147.7 (C), 
148.3 (C), 152.6 (C), 164.2 (C); m/z (ESI) 370.0668 (MNa+, C20H13NNaO5 requires 
370.0686), 357 (57%), 343 (100), 321 (6), 236 (6). 
Oxyavicine (43)185 (Herrmann-Beller catalyst method) 
 
The reaction was carried out according to the previously described procedure for 
the synthesis of oxychelerythrine (44) (Herrmann-Beller catalyst method) using 2-
bromo-4,5-methylenedioxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-1-
yl)benzamide (74b) (0.040 g, 0.093 mmol). Purification was performed by washing 
with hexane (5 × 2 mL), then ice cold diethyl ether (3 × 1 mL) which yielded 
oxyavicine (43) (0.025 g, 78%) as a white solid. Spectroscopic data as above. 
Oxysanguinarine (45)185 (Pd(OAc)2 method) 
 
The reaction was carried out according to the previously described procedure for 
the synthesis of oxychelerythrine (44) (Pd(OAc)2 method) using 6-bromo-2,3-
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methylenedioxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-1-yl)benzamide 
(74c) (0.020 g, 0.047 mmol). Purification by column chromatography (40% ethyl 
acetate:petroleum ether) then a second column (eluted 1% 
methanol:dichloromethane) gave oxysanguinarine (45) (0.004 g, 22%) as an off 
white solid. Spectroscopic data as below with minor impurities. 
Oxysanguinarine (45)185 (Herrmann-Beller catalyst method) 
 
The reaction was carried out according to the previously described procedure for 
the synthesis of oxychelerythrine (44) (Herrmann-Beller catalyst method) using 6-
bromo-2,3-methylenedioxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-1-
yl)benzamide (74c) (0.020 g, 0.047 mmol). The reaction was complete after 3 h. 
Purification by column chromatography (20–100% ethyl acetate:petroleum ether 
then 1% methanol:dichloromethane) and then washing the resulting solid with 
hexane (3 × 1 mL) gave oxysanguinarine (45) (0.015 g, 90%) as a white solid. Mp 
356−358 °C (lit.185 361−363 °C); δH (500 MHz, CDCl3) 3.91 (3H, s, NCH3), 6.10 
(2H, s, OCH2O), 6.27 (2H, s, OCH2O), 7.16 (1H, s, 1-H), 7.24 (1H, d, J 8.7 Hz, 
ArH), 7.53 (1H, d, J 8.7 Hz, ArH), 7.57 (1H, s, 4-H), 7.76 (1H, d, J 8.7 Hz, ArH), 
7.98 (1H, d, J 8.7 Hz, ArH); δC (126 MHz, CDCl3) 41.0 (CH3), 101.7 (CH2), 102.7 
(CH), 103.0 (CH2), 104.9 (CH), 111.1 (C), 113.3 (CH), 115.6 (CH), 117.4 (C), 
118.9 (CH), 121.3 (C), 123.7 (CH), 129.0 (C), 132.0 (C), 135.7 (C), 147.3 (C), 
147.7 (C), 147.8 (C), 147.9 (C), 162.8 (C); m/z (ESI) 370.0676 (MNa+, 
C20H13NNaO5 requires 370.0686), 354 (3%), 342 (3), 236 (6), 227 (1). 
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Oxynitidine (46)185  
 
The reaction was carried out according to the previously described procedure for 
the synthesis of oxychelerythrine (44) (Herrmann-Beller catalyst method) using 2-
bromo-4,5-dimethoxy-N-methyl-N-(6’,7’-methylenedioxynaphthalen-1-
yl)benzamide (74d) (0.019 g, 0.043 mmol) and trans-bis(acetato)bis[o-(di-o-
tolylphosphino)benzyl]dipalladium(II) (0.0080 g, 0.0086 mmol). Purification was 
performed by washing with hexane (5 × 2 mL), then ice cold diethyl ether (3 × 1 
mL), this yielded oxynitidine (46) (0.013 g, 83%) as a white solid. Mp 268−270 °C 
(lit.185 270−272 °C); δH (500 MHz, CDCl3) 3.99 (3H, s, CH3), 4.06 (3H, s, CH3), 
4.11 (3H, s, CH3), 6.11 (2H, s, OCH2O), 7.19 (1H, s, ArH), 7.57 (1H, d, J 8.7 Hz, 
ArH), 7.60 (1H, s, ArH), 7.65 (1H, s, ArH), 7.93 (1H, s, ArH), 8.00 (1H, d, J 8.7 Hz, 
ArH); δC (126 MHz, CDCl3) 41.4 (CH3), 56.3 (CH3), 56.4 (CH3), 101.7 (CH2), 102.8 
(CH), 103.0 (CH), 104.9 (CH), 108.8 (CH), 116.9 (C), 118.5 (CH), 119.4 (C), 121.2 
(C), 123.4 (CH), 129.1 (C), 132.0 (C), 136.1 (C), 147.2 (C), 147.7 (C), 149.9 (C), 
153.7 (C), 164.4 (C); m/z (EI) 363.1109 (M+, C21H17NO5 requires 363.1107), 334 
(17%), 305 (15), 290 (8), 262 (9), 182 (10), 84 (11). 
2-Allyloxybenzaldehyde (93a)117  
  
Allyl bromide (0.98 mL, 1.3 mmol) was added to a stirred solution of 2-
hydroxybenzaldehyde (92a) (0.10 mL, 0.94 mmol) and potassium carbonate (0.26 
g, 1.9 mmol) in dimethylformamide (10 mL) and warmed to 70 °C for 2 h. The 
reaction mixture was cooled to room temperature, diluted with 5% aqueous lithium 
chloride solution (20 mL) and extracted with diethyl ether (20 mL). The organic 
layer was washed with 5% aqueous lithium chloride solution (3 × 10 mL), brine (10 
mL), dried (MgSO4), filtered and concentrated in vacuo to give 2-
allyloxybenzaldehyde (93a) (0.15 g, 99%) as a colourless oil. Spectroscopic data 
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was in accordance with literature values.117 δH (400 MHz, CDCl3) 4.66 (2H, dt, J 
5.1, 1.5 Hz, 2’-H2), 5.34 (1H, dq, J 10.5, 1.5 Hz, 4’-HH), 5.45 (1H, dq, J 17.3, 1.5 
Hz, 4’-HH), 6.08 (1H, ddt, J 17.3, 10.5, 5.1 Hz, 3’-H), 6.98 (1H, d, J 8.4 Hz, 3-H), 
7.03 (1H, br t, J 7.5 Hz, 5-H), 7.53 (1H, ddd, J 8.4, 7.5, 1.9 Hz, 4-H), 7.84 (1H, dd, 
J 7.5, 1.9 Hz, 6-H), 10.54 (1H, d, J 0.7 Hz, CHO); δC (101 MHz, CDCl3) 69.4 
(CH2), 113.0 (CH), 118.2 (CH2), 121.0 (CH), 125.3 (C), 128.6 (CH), 132.6 (CH), 
135.9 (CH), 161.1 (C), 189.9 (CH); m/z (CI) 163 (MH+, 100%), 135 (34), 121 (8), 
85 (12), 79 (11). 
2-Allyloxy-5-nitrobenzaldehyde (93b)186  
  
The reaction was carried out according to the previously described procedure for 
2-allyloxybenzaldehyde (93a) using 2-hydroxy-5-nitrobenzaldehyde (92b) (0.050 
g, 0.32 mmol). Purification by column chromatography (elution with 40% diethyl 
ether in petroleum ether) gave 2-allyloxy-5-nitrobenzaldehyde (93b) (0.061 g, 
98%) as a white solid. Mp 62–64 °C (lit.186 63–65 °C); δH (400 MHz, CDCl3) 4.80 
(2H, dt, J 5.3, 1.4 Hz, 2’-H2), 5.41 (1H, ddt, J 10.7, 2.5, 1.4 Hz, 4’-HH), 5.48 (1H, 
ddt, J 17.3, 2.5, 1.4 Hz, 4’-HH), 6.08 (1H, ddt, J 17.3, 10.7, 5.3 Hz, 3’-H), 7.11 (1H, 
d, J 9.2 Hz, 3-H), 8.39 (1H, dd, J 9.2, 2.9 Hz, 4-H), 8.67 (1H, d, J 2.9 Hz, 6-H), 
10.48 (1H, s, CHO); δC (101 MHz, CDCl3) 70.3 (CH2), 113.5 (CH), 119.6 (CH2), 
124.7 (CH), 124.8 (C) 130.6 (CH), 131.1 (CH), 141.7 (C), 164.7 (C), 187.6 (CH); 
m/z (CI) 208 (MH+, 100%), 178 (45), 168 (13), 138 (16), 113 (21), 97 (18), 81 (32), 
69 (33). 
2-Allyloxy-5-chlorobenzaldehyde (93c)187  
 
The reaction was carried out according to the previously described procedure for 
2-allyloxybenzaldehyde (93a) using 2-hydroxy-5-chlorobenzaldehyde (92c) (0.500 
g, 3.18 mmol). This gave 2-allyloxy-5-chlorobenzaldehyde (93c) (0.610 g, 96%) as 
a white solid. Mp 99–101 °C (lit.187 101–102 °C); δH (400 MHz, CDCl3) 4.65 (2H, 
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dt, J 5.2, 1.5 Hz, 2’-H2), 5.35 (1H, dq, J 10.6, 1.5 Hz, 4’-HH), 5.44 (1H, dq, J 17.3, 
1.5 Hz, 4’-HH), 6.06 (1H, ddt, J 17.3, 10.6, 5.2 Hz, 3’-H), 6.93 (1H, d, J 8.9 Hz, 3-
H), 7.47 (1H, dd, J 8.9, 2.8 Hz, 4-H), 7.79 (1H, d, J 2.8 Hz, 6-H), 10.46 (1H, s, 
CHO); δC (101 MHz, CDCl3) 69.8 (CH2), 114.7 (CH), 118.7 (CH2), 126.1 (C), 126.7 
(C), 128.1 (CH), 132.1 (CH), 135.4 (CH), 159.5 (C), 188.5 (CH); m/z (CI) 197 
(MH+, 100%), 169 (13), 157 (4), 81 (11), 69 (18). 
2-Allyloxy-5-bromobenzaldehyde (93d)187  
 
The reaction was carried out according to the previously described procedure for 
2-allyloxybenzaldehyde (93a) using 2-hydroxy-5-bromobenzaldehyde (92d) (0.500 
g, 2.49 mmol). This gave 2-allyloxy-5-bromobenzaldehyde (93d) (0.591 g, 99%) as 
a white solid. Mp 35–37 °C (lit.187 37–39 °C); δH (400 MHz, CDCl3) 4.65 (2H, dt, J 
5.2, 1.5 Hz, 2’-H2), 5.35 (1H, dq, J 10.6, 1.5 Hz, 4’-HH), 5.44 (1H, dq, J 17.3, 1.5 
Hz, 4’-HH), 6.05 (1H, ddt, J 17.3, 10.6, 5.2 Hz, 3’-H), 6.88 (1H, d, J 8.9 Hz, 3-H), 
7.60 (1H, dd, J 8.9, 2.6 Hz, 4-H), 7.93 (1H, d, J 2.6 Hz, 6-H), 10.44 (1H, s, CHO); 
δC (101 MHz, CDCl3) 69.7 (CH2), 113.8 (C), 115.1 (CH), 118.7 (CH2), 126.6 (C), 
131.2 (CH), 132.1 (CH), 138.3 (CH), 160.0 (C), 188.4 (CH); m/z (ESI) 263 (MNa+, 
75%), 236 (22), 219 (70), 201 (14), 184 (27). 
2-Allyloxy-4-methoxybenzaldehyde (93e)188  
 
The reaction was carried out according to the previously described procedure for 
2-allyloxybenzaldehyde (93a) using 2-hydroxy-4-methoxybenzaldehyde (92e) 
(0.500 g, 3.29 mmol). This gave 2-allyloxy-4-methoxybenzaldehyde (93e) (0.583 
g, 92%) as a colourless oil. Spectroscopic data was in accordance with literature 
values.188 δH (500 MHz, CDCl3) 3.85 (3H, s, OCH3), 4.62 (2H, dt, J 5.1, 1.5 Hz, 2’-
H2), 5.33 (1H, dq, J 10.5, 1.5 Hz, 4’-HH), 5.45 (1H, dq, J 17.3, 1.5 Hz, 4’-HH), 6.06 
(1H, ddt, J 17.3, 10.5, 5.1 Hz, 3’-H), 6.43 (1H, d, J 2.2 Hz, 3-H), 6.54 (1H, ddd, J 
8.7, 2.2, 0.6 Hz, 5-H), 7.81 (1H, d, J 8.7 Hz, 6-H), 10.35 (1H, d, J 0.6 Hz, CHO); δC 
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(126 MHz, CDCl3) 55.8 (CH3), 69.3 (CH2), 99.2 (CH), 106.2 (CH), 118.2 (CH2), 
119.4 (C), 130.6 (CH), 132.4 (CH), 162.8 (C), 166.2 (C), 188.4 (CH); m/z (ESI) 
215 (MNa+, 100%), 187 (7), 174 (7), 159 (3). 
2-Allyloxy-5-methoxybenzaldehyde (93f)188  
 
The reaction was carried out according to the previously described procedure for 
2-allyloxybenzaldehyde (93a) using 2-hydroxy-5-methoxybenzaldehyde (92f) (0.41 
mL, 3.3 mmol). This gave 2-allyloxy-5-methoxybenzaldehyde (93f) (0.60 g, 96%) 
as a yellow oil. Spectroscopic data was in accordance with literature values.188 δH 
(400 MHz, CDCl3) 3.80 (3H, s, OCH3), 4.61 (2H, d, J 5.2 Hz, 2’-H2), 5.31 (1H, dd, J 
10.6, 1.4 Hz, 4’-HH), 5.43 (1H, dd, J 17.1, 1.4 Hz, 4’-HH), 6.06 (1H, ddt, J 17.1, 
10.6, 5.2 Hz, 3’-H), 6.93 (1H, d, J 9.1 Hz, 3-H), 7.11 (1H, dd, J 9.1, 3.3 Hz, 4-H), 
7.33 (1H, d, J 3.3 Hz, 6-H), 10.49 (1H, s, CHO); δC (101 MHz, CDCl3) 56.0 (CH3), 
70.2 (CH2), 110.4 (CH), 115.1 (CH), 118.1 (CH2), 123.6 (CH), 125.6 (C), 132.8 
(CH), 154.0 (C), 155.9 (C), 189.6 (CH); m/z (ESI) 215 (MNa+, 40%), 206 (30), 174 
(100). 
2-Allyloxy-6-methoxybenzaldehyde (93g)188  
 
The reaction was carried out according to the previously described procedure for 
2-allyloxybenzaldehyde (93a) using 2-hydroxy-6-methoxybenzaldehyde (92g) 
(0.500 g, 3.29 mmol). This gave 2-allyloxy-6-methoxybenzaldehyde (93g) (0.559 
g, 88%) as a yellow oil. Spectroscopic data was in accordance with literature 
values.188 δH (400 MHz, CDCl3) 3.90 (3H, s, OCH3), 4.63 (2H, dt, J 5.0, 1.4 Hz, 2’-
H2), 5.31 (1H, dq, J 10.4, 1.4 Hz, 4’-HH), 5.48 (1H, dq, J 17.3, 1.4 Hz, 4’-HH), 6.05 
(1H, ddt, J 17.3, 10.4, 5.0 Hz, 3’-H), 6.56 (1H, d, J 8.5 Hz, ArH), 6.58 (1H, d, J 8.5 
Hz, ArH), 7.42 (1H, t, J 8.5 Hz, 4-H), 10.56 (1H, s, CHO); δC (101 MHz, CDCl3) 
56.2 (CH3), 69.7 (CH2), 104.2 (CH), 105.3 (CH), 115.0 (C), 117.9 (CH2), 132.6 
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(CH), 135.8 (CH), 161.6 (C), 162.0 (C), 189.4 (CH); m/z (ESI) 215 (MNa+, 100%), 
187 (10), 174 (20), 137 (5). 
2-(Allyloxy)-4-diethylaminobenzaldehyde (93h)188 
 
The reaction was carried out according to the procedure described for 2-
allyloxybenzaldehyde (93a) using 4-diethylamino-2-hydroxybenzaldehyde (92h) 
(0.520 g, 2.69 mmol). This gave 2-(allyloxy)-4-diethylaminobenzaldehyde (93h) 
(0.551 g, 88%) as an orange oil. Spectroscopic data was in accordance with 
literature values.188 δH (400 MHz, CDCl3) 1.11 (6H, t, J 7.1 Hz, N(CH2CH3)2), 3.31 
(4H, q, J 7.1 Hz, N(CH2CH3)2), 4.53 (2H, dt, J 5.1, 1.5 Hz, 2’-H2), 5.22 (1H, dq, J 
10.6, 1.5 Hz, 4’-HH), 5.35 (1H, dq, J 17.3, 1.5 Hz, 4’-HH), 5.92–6.02 (2H, m, 3-H 
and 3’-H), 6.18 (1H, ddd, J 9.0, 2.3, 0.7 Hz, 5-H), 7.62 (1H, d, J 9.0 Hz, 6-H), 
10.10 (1H, d, J 0.7 Hz, CHO); δC (101 MHz, CDCl3) 12.8 (2 × CH3), 45.0 (2 × CH2), 
69.1 (CH2), 93.8 (CH), 104.6 (CH), 114.5 (C), 117.7 (CH2), 130.5 (CH), 133.1 
(CH), 153.8 (C), 163.3 (C), 187.2 (CH); m/z (ESI) 256.1312 (MNa+. C14H19NaNO2 
requires 256.1308), 215, 200, 186, 178, 150. 
Ethyl (2E)-3-(2’-allyloxyphenyl)prop-2-enoate (94a)183 
 
Lithium bromide (0.47 g, 5.4 mmol) was added to a solution of triethyl 
phosphonoacetate (21) (0.91 mL, 4.6 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-
ene (0.68 mL, 4.6 mmol) in acetonitrile (20 mL) and stirred at room temperature for 
0.5 h. 2-Allyloxybenzaldehyde (93a) (0.22 g, 1.4 mmol) was added and the 
solution was stirred at room temperature for 18 h. The reaction was quenched by 
the addition of a saturated solution of ammonium chloride (30 mL), concentrated to 
half volume in vacuo and extracted with diethyl ether (3 × 30 mL). The combined 
organic layers were washed with water (100 mL), brine (100 mL), dried (MgSO4), 
filtered and concentrated in vacuo. Purification by filtration through a pad of silica 
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(elution with 20% diethyl ether in petroleum ether) gave ethyl (2E)-3-(2’-
allyloxyphenyl)prop-2-enoate (94a) (0.30 g, 95%) as a yellow oil. Spectroscopic 
data was in accordance with literature values.183 δH (400 MHz, CDCl3) 1.34 (3H, t, 
J 7.1 Hz, OCH2CH3), 4.26 (2H, q, J 7.1 Hz, OCH2CH3), 4.62 (2H, dt, J 5.1, 1.5 Hz, 
2’’-H2), 5.31 (1H, dq, J 10.6, 1.5 Hz, 4’'-HH), 5.43 (1H, dq, J 17.3, 1.5 Hz, 4’’-HH), 
6.08 (1H, ddt, J 17.3, 10.6, 5.1 Hz, 3’'-H), 6.53 (1H, d, J 16.2 Hz, 2-H), 6.90 (1H, d, 
J 8.3 Hz, 3’-H), 6.96 (1H, td, J 7.7, 0.5 Hz, 5’-H), 7.29–7.35 (1H, m, 4’-H), 7.52 
(1H, dd, J 7.7, 1.7 Hz, 6’-H), 8.05 (1H, d, J 16.2 Hz, 3-H); δC (101 MHz, CDCl3) 
14.4 (CH3), 60.3 (CH2), 69.2 (CH2), 112.5 (CH), 117.7 (CH2), 118.8 (CH), 120.9 
(CH), 123.8 (C), 128.8 (CH), 131.3 (CH), 132.9 (CH), 139.9 (CH), 157.3 (C), 167.5 
(C); m/z (EI) 232 (M+, %), 187 (42), 158 (78), 144 (59), 129 (61), 118 (97), 84 
(100), 77 (19), 49 (99). 
Ethyl (2E)-3-(2’-allyloxy-5’-nitrophenyl)prop-2-enoate (94b)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-allyloxyphenyl)prop-2-enoate (94a) using 2-allyloxy-5-
nitrobenzaldehyde (93b) (0.049 g, 0.24 mmol). This gave ethyl (2E)-3-(2’-allyloxy-
5’-nitrophenyl)prop-2-enoate (94b) (0.060 g, 91%) as a white solid. Mp 64–65 °C; 
max (neat)/cm
–1 2986 (CH), 1690 (CO), 1631 (C=C), 1580, 1512, 1341, 1273, 
1150, 1032, 872; δH (500 MHz, CDCl3) 1.35 (3H, t, J 7.1 Hz, OCH2CH3), 4.29 (2H, 
q, J 7.1 Hz, OCH2CH3), 4.74 (2H, dt, J 5.2, 1.5 Hz, 2’’-H2), 5.39 (1H, dq, J 10.6, 
1.5 Hz, 4’’-HH), 5.45 (1H, dq, J 17.3, 1.5 Hz, 4’’-HH), 6.07 (1H, ddt, J 17.3, 10.6, 
5.2 Hz, 3’’-H), 6.61 (1H, d, J 16.2 Hz, 2-H), 6.98 (1H, d, J 9.2 Hz, 3’-H), 7.98 (1H, 
d, J 16.2 Hz, 3-H), 8.22 (1H, dd, J 9.2, 2.8 Hz, 4’-H), 8.43 (1H, d, J 2.8 Hz, 6’-H); 
δC (126 MHz, CDCl3) 14.3 (CH3), 60.7 (CH2), 70.0 (CH2), 112.2 (CH), 118.9 (CH2), 
121.5 (CH), 124.0 (CH), 124.3 (C), 126.6 (CH), 131.5 (CH), 137.3 (CH), 141.4 (C), 
161.4 (C), 166.5 (C); m/z (ESI) 300.0829 (MNa+, C14H15NNaO5 requires 
300.0842), 236 (16%), 218 (3), 210 (3). 
 Experimental 165 
 
Ethyl (2E)-3-(2’-allyloxy-5’-chlorophenyl)prop-2-enoate (94c)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-allyloxyphenyl)prop-2-enoate (94a) using 2-allyloxy-5-
chlorobenzaldehyde (93c) (0.595 g, 3.02 mmol). This gave ethyl (2E)-3-(2’-
allyloxy-5’-chlorophenyl)prop-2-enoate (94c) (0.743 g, 92%) as a yellow oil. max 
(neat)/cm–1 2982 (CH), 1705 (CO), 1632 (C=C), 1481, 1314, 1248, 1165, 1034, 
984; δH (500 MHz, CDCl3) 1.33 (3H, t, J 7.1 Hz, OCH2CH3), 4.26 (2H, q, J 7.1 Hz, 
OCH2CH3), 4.60 (2H, dt, J 5.2, 1.4 Hz, 2’’-H2), 5.32 (1H, dq, J 10.5, 1.4 Hz, 4’’-
HH), 5.41 (1H, dq, J 17.3, 1.4 Hz, 4’’-HH), 6.05 (1H, ddt, J 17.3, 10.5, 5.2 Hz, 3’’-
H), 6.49 (1H, d, J 16.2 Hz, 2-H), 6.83 (1H, d, J 8.9 Hz, 3’-H), 7.25 (1H, dd, J 8.9, 
2.5 Hz, 4’-H), 7.48 (1H, d, J 2.5 Hz, 6’-H), 7.95 (1H, d, J 16.2 Hz, 3-H); δC (126 
MHz, CDCl3) 14.5 (CH3), 60.6 (CH2), 69.7 (CH2), 114.0 (CH), 118.2 (CH2), 120.1 
(CH), 125.4 (C), 126.1 (C), 128.3 (CH), 130.8 (CH), 132.6 (CH), 138.6 (CH), 155.8 
(C), 167.2 (C); m/z (ESI) 289.0610 (MNa+, C14H15
35ClNaO3 requires 289.0602), 
247 (1%), 236 (13), 218 (1). 
Ethyl (2E)-3-(2’-allyloxy-5’-bromophenyl)prop-2-enoate (94d)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-allyloxyphenyl)prop-2-enoate (94a) using 2-allyloxy-5-
bromobenzaldehyde (93d) (0.545 g, 2.26 mmol). This gave ethyl (2E)-3-(2’-
allyloxy-5’-bromophenyl)prop-2-enoate (94d) (0.685 g, 97%) as a white solid. Mp 
<30 °C; max (neat)/cm
–1 2986 (CH), 1688 (CO), 1628 (C=C), 1489, 1300, 1275, 
1175, 986; δH (500 MHz, CDCl3) 1.33 (3H, t, J 7.1 Hz, OCH2CH3), 4.26 (2H, q, J 
7.1 Hz, OCH2CH3), 4.60 (2H, dt, J 5.2, 1.4 Hz, 2’’-H2), 5.32 (1H, dq, J 10.6, 1.4 Hz, 
4’-HH), 5.41 (1H, dq, J 17.3, 1.4 Hz, 4’-HH), 6.05 (1H, ddt, J 17.3, 10.6, 5.2 Hz, 3’’-
H), 6.49 (1H, d, J 16.2 Hz, 2-H), 6.78 (1H, d, J 8.8 Hz, 3’-H), 7.39 (1H, dd, J 8.8, 
2.5 Hz, 4’-H), 7.62 (1H, d, J 2.5 Hz, 6’-H), 7.94 (1H, d, J 16.2 Hz, 3-H); δC (126 
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MHz, CDCl3) 14.5 (CH3), 60.6 (CH2), 69.6 (CH2), 113.3 (C), 114.4 (CH), 118.3 
(CH2), 120.2 (CH), 125.9 (C), 131.2 (CH), 132.6 (CH), 133.8 (CH), 138.5 (CH), 
156.3 (C), 167.2 (C); m/z (ESI) 333.0090 (MNa+, C14H15
79BrNaO3 requires 
333.0097), 236 (7%), 218 (1). 
Ethyl (2E)-3-(2’-allyloxy-4’-methoxyphenyl)prop-2-enoate (94e)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-allyloxyphenyl)prop-2-enoate (94a) using 2-allyloxy-4-
methoxybenzaldehyde (93e) (0.580 g, 3.02 mmol). This gave ethyl (2E)-3-(2’-
allyloxy-4’-methoxyphenyl)prop-2-enoate (94e) (0.79 g, 100%) as a yellow oil. max 
(neat)/cm–1 2980 (CH), 1701 (CO), 1601 (C=C), 1505, 1300, 1252, 1155, 986; δH 
(400 MHz, CDCl3) 1.33 (3H, t, J 7.1 Hz, OCH2CH3), 3.82 (3H, s, OCH3), 4.24 (2H, 
q, J 7.1 Hz, OCH2CH3), 4.60 (2H, dt, J 5.2, 1.5 Hz, 2’’-H2), 5.32 (1H, dq, J 10.5, 
1.5 Hz, 4’’-HH), 5.43 (1H, dq, J 17.3, 1.5 Hz, 4’’-HH), 6.08 (1H, ddt, J 17.3, 10.5, 
5.2 Hz, 3’’-H), 6.43 (1H, d, J 16.1 Hz, 2-H), 6.44 (1H, d, J 2.4 Hz, 3’-H), 6.50 (1H, 
dd, J 8.6, 2.4 Hz, 5’-H), 7.46 (1H, d, J 8.6 Hz, 6’-H), 7.96 (1H, d, J 16.1 Hz, 3-H); 
δC (101 MHz, CDCl3) 14.5 (CH3), 55.6 (CH3), 60.3 (CH2), 69.3 (CH2), 99.7 (CH), 
105.6 (CH), 116.3 (C), 117.0 (CH2), 118.1 (CH), 130.3 (CH), 132.9 (CH), 140.0 
(CH), 158.8 (C), 162.6 (C), 168.0 (C); m/z (ESI) 285.1090 (MNa+, C15H18NaO4 
requires 285.1097), 244 (4%), 236 (4), 215 (93), 210 (4), 187 (4), 174 (6). 
Ethyl (2E)-3-(2’-allyloxy-5’-methoxyphenyl)prop-2-enoate (94f)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-allyloxyphenyl)prop-2-enoate (94a) using 2-allyloxy-5-
methoxybenzaldehyde (93f) (0.580 g, 3.02 mmol). This gave ethyl (2E)-3-(2’-
allyloxy-5’-methoxyphenyl)prop-2-enoate (94f) (0.792 g, 100%) as a yellow oil. 
max (neat)/cm
–1 2954 (CH), 1706 (CO), 1631 (C=C), 1494, 1214, 1165, 1042, 862; 
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δH (400 MHz, CDCl3) 1.34 (3H, t, J 7.1 Hz, OCH2CH3), 3.79 (3H, s, OCH3), 4.26 
(2H, q, J 7.1 Hz, OCH2CH3), 4.56 (2H, dt, J 5.2, 1.5 Hz, 2’’-H2), 5.29 (1H, dq, J 
10.6, 1.5 Hz, 4’’-HH), 5.41 (1H, dq, J 17.3, 1.5 Hz, 4’’-HH), 6.06 (1H, ddt, J 17.3, 
10.6, 5.2 Hz, 3’’-H), 6.49 (1H, d, J 16.2 Hz, 2-H), 6.84 (1H, d, J 8.8 Hz, 3’-H), 6.88 
(1H, dd, J 8.8, 2.9 Hz, 4’-H), 7.05 (1H, d, J 2.9 Hz, 6’-H), 8.02 (1H, d, J 16.2 Hz, 3-
H); δC (126 MHz, CDCl3) 14.5 (CH3), 55.9 (CH3), 60.5 (CH2), 70.2 (CH2), 113.0 
(CH), 114.4 (CH), 117.2 (CH), 117.8 (CH2), 119.1 (CH), 124.7 (C), 133.3 (CH), 
139.8 (CH), 151.9 (C), 153.8 (C), 167.5 (C); m/z (ESI) 285.1090 (MNa+, 
C15H18NaO4 requires 285.1097), 244 (64%), 236 (6), 217 (10), 189 (15), 176 (7). 
Ethyl (2E)-3-(2’-allyloxy-6’-methoxyphenyl)prop-2-enoate (94g)  
 
The reaction was carried out according to the previously described procedure for 
ethyl (2E)-3-(2’-allyloxyphenyl)prop-2-enoate (94a) using 2-allyloxy-6-
methoxybenzaldehyde (93g) (0.531 g, 2.76 mmol). This gave ethyl (2E)-3-(2’-
allyloxy-6’-methoxyphenyl)prop-2-enoate (94g) (0.594 g, 85%) as a yellow oil. max 
(neat)/cm–1 2979 (CH), 1701 (CO), 1622 (C=C), 1593, 1473, 1308, 1254, 1160, 
1093; δH (400 MHz, CDCl3) 1.33 (3H, t, J 7.1 Hz, OCH2CH3), 3.88 (3H, s, OCH3), 
4.26 (2H, q, J 7.1 Hz,OCH2CH3), 4.62 (2H, dt, J 5.1, 1.5 Hz, 2’’-H2), 5.30 (1H, dq, J 
10.5, 1.5 Hz, 4’’-HH), 5.43 (1H, dq, J 17.3, 1.5 Hz, 4’’-HH), 6.08 (1H, ddt, J 17.3, 
10.5, 5.1 Hz, 3’’-H), 6.54 (1H, d, J 8.4 Hz, ArH), 6.56 (1H, d, J 8.4 Hz, ArH), 6.89 
(1H, d, J 16.3 Hz, 2-H), 7.23 (1H, t, J 8.4 Hz, 4’-H), 8.17 (1H, d, J 16.3 Hz, 3-H); δC 
(126 MHz, CDCl3) 14.4 (CH3), 55.7 (CH3), 60.1 (CH2), 69.4 (CH2), 103.8 (CH), 
105.0 (CH), 112.5 (C), 117.6 (CH2), 120.8 (CH), 131.1 (CH), 132.9 (CH), 135.4 
(CH), 158.9 (C), 160.1 (C), 168.6 (C); m/z (ESI) 285.1088 (MNa+, C15H18NaO4 
requires 285.1097), 271 (1%), 236 (3), 215 (2). 
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Ethyl (2E)-3-(2’-allyloxy-4’-diethylaminophenyl)prop-2-enoate (94h) 
 
The reaction was carried out according to the procedure described for ethyl (2E)-
3-(2’-allyloxyphenyl)prop-2-enoate (94a) using 2-(allyloxy)-4-
diethylaminobenzaldehyde (93h) (0.562 g, 2.41 mmol). This gave ethyl (2E)-3-(2’-
allyloxy-4’-diethylaminophenyl)prop-2-enoate (94h) (0.698 g, 95%) as a yellow oil. 
max (neat)/cm
−1 2972 (CH), 1695 (CO), 1591 (C=C), 1514, 1144; δH (400 MHz, 
CDCl3) 1.18 (6H, t, J 7.1 Hz, N(CH2CH3)2), 1.32 (3H, t, J 7.1 Hz, OCH2CH3), 3.37 
(4H, q, J 7.1 Hz, N(CH2CH3)2), 4.23 (2H, q, J 7.1 Hz, OCH2CH3), 4.61 (2H, dt, J 
5.2, 1.5 Hz, 2’’-H2), 5.30 (1H, dq, J 10.5, 1.5 Hz, 4’’-HH), 5.44 (1H, dq, J 17.3, 1.5 
Hz, 4’’-HH), 6.05–6.14 (2H, m, 3’-H, 3’’-H), 6.26 (1H, dd, J 8.8, 2.4 Hz, 5’-H), 6.31 
(1H, d, J 16.0 Hz, 2-H), 7.37 (1H, d, J 8.8 Hz, 6’-H), 7.95 (1H, d, J 16.0 Hz, 3-H); 
δC (101 MHz, CDCl3) 12.8 (2 × CH3), 14.6 (CH3), 44.7 (2 × CH2), 60.0 (CH2), 69.3 (CH2), 
95.5 (CH), 104.6 (CH), 111.5 (C), 112.4 (CH), 117.6 (CH2), 130.6 (CH), 133.6 (CH), 140.7 
(CH), 150.7 (C), 159.4 (C), 168.7 (C); m/z (CI) 304.1916 (MH+. C18H26NO3 requires 
304.1913), 264 (4%), 218 (2), 138 (3), 71 (20). 
(2E)-3-(2’-Allyloxyphenyl)prop-2-en-1-ol (95a)183 
 
Diisobutylaluminium hydride (3.21 mL, 1 M solution in hexanes) was added 
dropwise with stirring, to a solution of ethyl (2E)-3-(2’-allyloxyphenyl)prop-2-enoate 
(94a) (0.298 g, 1.28 mmol), in diethyl ether (30 mL) at −78 °C. The solution was 
stirred at −78 °C for 3 h, then allowed to return to room temperature over 15 h. 
The reaction was quenched with 10% aqueous potassium sodium tartrate solution 
(30 mL), extracted with diethyl ether (2 × 20 mL), washed with water (100 mL), 
brine (100 mL), dried (MgSO4), filtered and concentrated in vacuo. Purification by 
column chromatography (elution with 30% diethyl ether in petroleum ether) gave 
(2E)-3-(2’-allyloxyphenyl)prop-2-en-1-ol (95a) (0.211 g, 87%) as a white solid. Mp 
44–46 °C. Spectroscopic data was in accordance with literature values.183 δH (400 
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MHz, CDCl3) 1.41 (1H, t, J 5.9 Hz, OH), 4.33 (2H, td, J 5.9, 0.8 Hz, 1-H2), 4.58 
(2H, dt, J 5.2, 1.5 Hz, 2’’-H2), 5.29 (1H, dq, J 10.5, 1.5 Hz, 4’’-HH), 5.42 (1H, dq, J 
17.3, 1.5 Hz, 4’’-HH), 6.08 (1H, ddt, J 17.3, 10.5, 5.2 Hz, 3’’-H), 6.40 (1H, dt, J 
16.0, 5.9 Hz, 2-H), 6.87 (1H, dd, J 8.2, 0.8 Hz, 3’-H), 6.91–7.02 (2H, m, 3-H and 
5’-H), 7.21 (1H, ddd, J 8.2, 7.5, 1.7 Hz, 4’-H), 7.46 (1H, dd, J 7.5, 1.7 Hz, 6’-H); δC 
(101 MHz, CDCl3) 64.5 (CH2), 69.4 (CH2), 112.5 (CH), 117.6 (CH2), 121.1 (CH), 
126.2 (C), 126.4 (CH), 127.2 (CH), 128.8 (CH), 129.3 (CH), 133.5 (CH), 156.0 (C); 
m/z (EI) 190 (57%), 149 (59), 131 (92), 121 (60), 119 (46), 91 (100), 77 (40). 
(2E)-3-(2’-Allyloxy-5’-nitrophenyl)prop-2-en-1-ol (95b)  
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-allyloxyphenyl)prop-2-en-1-ol (95a) using ethyl (2E)-3-(2’-allyloxy-5’-
nitrophenyl)prop-2-enoate (94b) (0.629 g, 2.27 mmol). This gave (2E)-3-(2’-
allyloxy-5’-nitrophenyl)prop-2-en-1-ol (95b) (0.469 g, 88%) as a yellow solid. Mp 
62–66 °C; max (neat)/cm
–1 2864 (CH), 1611 (C=C), 1508, 1335, 1246, 1078, 990; 
δH (400 MHz, CDCl3) 1.89 (1H, br s, OH), 4.37 (2H, dd, J 5.4, 1.7 Hz, 1-H2), 4.67 
(2H, dt, J 5.2, 1.5 Hz, 2’’-H2), 5.35 (1H, dq, J 10.6, 1.5 Hz, 4’’-HH), 5.43 (1H, dq, J 
17.3, 1.5 Hz, 4’’-HH), 6.05 (1H, ddt, J 17.3, 10.6, 5.2 Hz, 3’’-H), 6.49 (1H, dt, J 
16.2, 5.4 Hz, 2-H), 6.88 (1H, d, J 9.2 Hz, 3’-H), 6.92 (1H, dt, J 16.2, 1.7 Hz, 3-H), 
8.08 (1H, dd, J 9.2, 2.8 Hz, 4’-H), 8.30 (1H, d, J 2.8 Hz, 6’-H); δC (101 MHz, 
CDCl3) 63.7 (CH2), 69.8 (CH2),  111.6 (CH), 118.8 (CH2), 122.6 (CH), 123.6 
(CH), 124.5 (CH), 127.0 (C), 132.0 (CH), 132.3 (CH), 141.5 (C), 160.3 (C); m/z 
(ESI) 258.0737 (MNa+, C12H13NNaO4 requires 258.0737), 243 (33%), 236 (11), 
218 (3), 206 (3), 190 (1), 161 (1), 134 (1). 
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(2E)-3-(2’-Allyloxy-5’-chlorophenyl)prop-2-en-1-ol (95c)  
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-allyloxyphenyl)prop-2-en-1-ol (95a) using ethyl (2E)-3-(2’-allyloxy-5’-
chlorophenyl)prop-2-enoate (94c) (0.126 g, 0.472 mmol). This gave (2E)-3-(2’-
allyloxy-5’-chlorophenyl)prop-2-en-1-ol (95c) (0.101 g, 95%) as a yellow oil. max 
(neat)/cm–1 3336 (OH), 2918 (CH), 1592 (C=C), 1481, 1242, 1129, 1015, 970; δH 
(500 MHz, CDCl3) 2.24 (1H, br s, OH), 4.30 (2H, dd, J 5.7, 1.5 Hz, 1-H2), 4.51 (2H, 
dt, J 5.2, 1.4 Hz, 2’’-H2), 5.28 (1H, dq, J 10.6, 1.4 Hz, 4’’-HH), 5.39 (1H, dq, J 17.3, 
1.4 Hz, 4’’-HH), 6.03 (1H, ddt, J 17.3, 10.6, 5.2 Hz, 3’’-H), 6.34 (1H, dt, J 16.1, 5.7 
Hz, 2-H), 6.74 (1H, d, J 8.8 Hz, 3’-H), 6.87 (1H, dt, J 16.1, 1.5 Hz, 3-H), 7.11 (1H, 
dd, J 8.8, 2.6 Hz, 4’-H), 7.37 (1H, d, J 2.6 Hz, 6’-H); δC (126 MHz, CDCl3) 63.8 
(CH2), 69.6 (CH2), 113.7 (CH), 117.8 (CH2), 124.7 (CH), 126.0 (C), 126.7 (CH), 
127.8 (C), 128.1 (CH), 130.7 (CH), 133.0 (CH), 154.3 (C); m/z (EI) 224.0606 (M+, 
C12H13
35ClO2 requires 224.0604), 183 (58%), 165 (89), 155 (78), 125 (86), 91 (36), 
63 (12). 
(2E)-3-(2’-Allyloxy-5’-bromophenyl)prop-2-en-1-ol (95d)  
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-allyloxyphenyl)prop-2-en-1-ol (95a) using ethyl (2E)-3-(2’-allyloxy-5’-
bromophenyl)prop-2-enoate (94d) (0.075 g, 0.24 mmol). This gave (2E)-3-(2’-
allyloxy-5’-bromophenyl)prop-2-en-1-ol (95d) (0.058 g, 90%) as a white solid. Mp 
<30 °C; max (neat)/cm
–1 3297 (OH), 2857 (CH), 1588 (C=C), 1482, 1249, 1127, 
1016, 974; δH (500 MHz, CDCl3) 2.07 (1H, s, OH), 4.30 (2H, dd, J 5.7, 1.4 Hz, 1-
H2), 4.51 (2H, dt, J 5.2, 1.3 Hz, 2’’-H2), 5.28 (1H, dq, J 10.5, 1.3 Hz, 4’’-HH), 5.38 
(1H, dq, J 17.2, 1.3 Hz, 4’’-HH), 6.03 (1H, ddt, J 17.2, 10.5, 5.2 Hz, 3’’-H), 6.34 
(1H, dt, J 16.1, 5.7 Hz, 2-H), 6.70 (1H, d, J 8.8 Hz, 3’-H), 6.86 (1H, dt, J 16.1, 1.4 
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Hz, 3-H), 7.25 (1H, dd, J 8.8, 2.5 Hz, 4’-H), 7.52 (1H, d, J 2.5 Hz, 6’-H); δC (126 
MHz, CDCl3) 63.9 (CH2), 69.5 (CH2), 113.4 (C), 114.1 (CH), 117.9 (CH2), 124.6 
(CH), 128.3 (C), 129.6 (CH), 130.7 (CH), 131.1 (CH), 133.0 (CH), 154.8 (C); m/z 
(EI) 268.0101 (M+, C12H13
79BrO2 requires 268.0099), 229 (40%), 199 (50), 131 
(20), 118 (100), 91 (27), 63 (11), 51 (8). 
(2E)-3-(2’-Allyloxy-4’-methoxyphenyl)prop-2-en-1-ol (95e)  
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-allyloxyphenyl)prop-2-en-1-ol (95a) using ethyl (2E)-3-(2’-allyloxy-4’-
methoxyphenyl)prop-2-enoate (94e) (0.676 g, 2.58 mmol). This gave (2E)-3-(2’-
allyloxy-4’-methoxyphenyl)prop-2-en-1-ol (95e) (0.566 g, 100%) as a white solid. 
Mp <30 °C; max (neat)/cm
–1 3379 (OH), 2914 (CH), 1609 (C=C), 1576, 1500, 
1420, 1261, 1197, 1003; δH (500 MHz, CDCl3) 1.89 (1H, s, OH), 3.78 (3H, s, 
OCH3), 4.28 (2H, dd, J 6.1, 1.2 Hz, 1-H2), 4.53 (2H, d, J 5.2 Hz, 2’’-H2), 5.28 (1H, 
dd, J 10.5, 1.5 Hz, 4’’-HH), 5.41 (1H, dd, J 17.3, 1.5 Hz, 4’’-HH), 6.06 (1H, ddt, J 
17.3, 10.5, 5.2 Hz, 3’’-H), 6.27 (1H, dt, J 16.0, 6.1 Hz, 2-H), 6.42 (1H, d, J 2.4 Hz, 
3’-H), 6.47 (1H, dd, J 8.5, 2.4 Hz, 5’-H), 6.86 (1H, br d, J 16.0 Hz, 3-H), 7.35 (1H, 
d, J 8.5 Hz, 6’-H); δC (126 MHz, CDCl3) 55.4 (CH3), 64.5 (CH2), 69.2 (CH2), 99.7 
(CH), 105.3 (CH), 117.7 (CH2), 119.1 (C), 126.2 (CH), 127.1 (CH), 127.8 (CH), 
133.2 (CH), 156.9 (C), 160.4 (C); m/z (CI) 221.1177 (MH+, C13H17O3 requires 
221.1178), 203 (100%), 177 (3), 163 (2), 81 (5), 69 (7). 
(2E)-3-(2’-Allyloxy-5’-methoxyphenyl)prop-2-en-1-ol (95f)  
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-allyloxyphenyl)prop-2-en-1-ol (95a) using ethyl (2E)-3-(2’-allyloxy-5’-
methoxyphenyl)prop-2-enoate (94f) (0.126 g, 2.94 mmol). This gave (2E)-3-(2’-
allyloxy-5’-methoxyphenyl)prop-2-en-1-ol (95f) (0.534 g, 83%) as a white solid. Mp 
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41–43 °C; max (neat)/cm
–1 3387 (OH), 2915 (CH), 1585 (C=C), 1493, 1424, 1213, 
1123, 1011; δH (500 MHz, CDCl3) 1.48 (1H, br s, OH), 3.78 (3H, s, OCH3), 4.33 
(2H, br d, J 5.7 Hz, 1-H2), 4.51 (2H, dt, J 5.2, 1.5 Hz, 2’’-H2), 5.27 (1H, dq, J 10.5, 
1.5 Hz, 4’’-HH), 5.40 (1H, dq, J 17.3, 1.5 Hz, 4’’-HH), 6.06 (1H, ddt, J 17.3, 10.5, 
5.2 Hz, 3’’-H), 6.38 (1H, dt, J 16.0, 5.7 Hz, 2-H), 6.75 (1H, dd, J 8.9, 3.0 Hz, 4’-H), 
6.81 (1H, d, J 8.9 Hz, 3’-H), 6.94 (1H, dt, J 16.0, 1.3 Hz, 3-H), 7.01 (1H, d, J 3.0 
Hz, 6’-H); δC (126 MHz, CDCl3) 55.9 (CH3), 64.3 (CH2), 70.3 (CH2), 112.2 (CH), 
114.0 (CH), 114.3 (CH), 117.5 (CH2), 126.2 (CH), 127.2 (C), 129.6 (CH), 133.7 
(CH), 150.4 (C), 154.0 (C); m/z (ESI) 243.0990 (MNa+, C13H16NaO3 requires 
243.0992), 236 (19%), 202 (100), 175 (7). 
(2E)-3-(2’-Allyloxy-6’-methoxyphenyl)prop-2-en-1-ol (95g)  
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-allyloxyphenyl)prop-2-en-1-ol (95a) using ethyl (2E)-3-(2’-allyloxy-6’-
methoxyphenyl)prop-2-enoate (94g) (0.569 g, 2.17 mmol). This gave (2E)-3-(2’-
allyloxy-6’-methoxyphenyl)prop-2-en-1-ol (95g) (0.427 g, 90%) as a colourless oil. 
max (neat)/cm
–1 3372 (OH), 2953 (CH), 1584 (C=C), 1470, 1251, 1200, 1112, 
1079; δH (500 MHz, CDCl3) 1.41 (1H, t, J 5.9 Hz, OH), 3.85 (3H, s, OCH3), 4.33 
(2H, td, J 5.9, 1.0 Hz, 1-H2), 4.58 (2H, dt, J 5.2, 1.5 Hz, 2’’-H), 5.28 (1H, dq, J 10.5, 
1.5 Hz, 4’’-HH), 5.42 (1H, dq, J 17.3, 1.5 Hz, 4’’-HH), 6.08 (1H, ddt, J 17.3, 10.5, 
5.2 Hz, 3’’-H), 6.55 (1H, d, J 8.3 Hz, ArH), 6.56 (1H, d, J 8.3 Hz, ArH), 6.82 (1H, dt, 
J 16.2, 5.9 Hz, 2-H), 6.92 (1H, br d, J 16.2 Hz, 3-H), 7.13 (1H, t, J 8.3 Hz, 4’-H); δC 
(126 MHz, CDCl3) 55.8 (CH3), 65.7 (CH2), 69.6 (CH2), 104.1 (CH), 105.4 (CH), 
114.4 (C), 117.6 (CH2), 122.0 (CH), 128.3 (CH), 132.8 (CH), 133.5 (CH), 157.6 
(C), 158.7 (C); m/z (ESI) 243.0987 (MNa+, C13H16NaO3 requires 243.0992), 236 
(4%), 227 (4), 215 (4), 202 (17), 171 (1), 161 (7), 149 (1), 137 (1). 
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(2E)-3-(2’-Allyloxy-4’-diethylaminophenyl)prop-2-en-1-ol (95h) 
 
The reaction was carried out according to the previously described procedure for 
(2E)-3-(2’-allyloxyphenyl)prop-2-en-1-ol (95a) using ethyl (2E)-3-(2’-allyloxy-4’-
diethylaminophenyl)prop-2-enoate (94h) (0.676 g, 2.23 mmol). Purification by 
filtration through a silica plug (elution with 40% diethyl ether in petroleum ether) 
yielded (2E)-3-(2’-allyloxy-4’-diethylaminophenyl)prop-2-en-1-ol (95h) (0.534 g, 
92%) as an orange oil. δH (400 MHz, CDCl3) 1.17 (6H, t, J 7.1 Hz, N(CH2CH3)2), 
1.31 (1H, t, J 5.6 Hz, OH), 3.35 (4H, q, J 7.1 Hz, N(CH2CH3)2), 4.27 (2H, t, J 5.6 
Hz, 1-H2), 4.56 (2H, dt, J 5.2, 1.5 Hz, 2’’-H2), 5.29 (1H, dq, J 10.5, 1.5 Hz, 4’’-HH), 
5.43 (1H, dq, J 17.3, 1.5 Hz, 4’’-HH), 6.09 (1H, ddt, J 17.3, 10.5, 5.2 Hz, 3’’-H), 
6.16 (1H, d, J 2.5 Hz, 3’-H), 6.21 (1H, dt, J 15.9, 5.6 Hz, 2-H), 6.28 (1H, dd, J 8.6, 
2.5 Hz, 5’-H), 6.84 (1H, d, J 15.9 Hz, 3-H), 7.31 (1H, d, J 8.6 Hz, 6’-H); δC (101 
MHz, CDCl3) 12.8 (2 × CH3), 44.7 (2 × CH2), 65.1 (CH2), 69.5 (CH2), 96.6 (CH), 
104.9 (CH), 113.6 (CH), 117.3 (CH2), 124.1 (C), 127.3 (CH), 128.0 (CH), 134.0 
(CH), 148.8 (C), 157.4 (C); m/z (EI) 261.1731 (M+. C16H23NO2 requires 261.1729), 
246 (84%), 220 (32), 216 (27), 174 (65), 146 (11), 118 (7), 91 (6), 77 (4). 
7-Nitro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
benzoxepine (96b) 
 
(2E)-3-(2’-Allyloxy-5’-nitrophenyl)prop-2-en-1-ol (95b) (0.050 g, 0.21 mmol) was 
dissolved in dry dichloromethane (8 mL) and cooled to 0 °C under argon with 
stirring. Trichloroacetonitrile (0.032 mL, 0.32 mmol) was added to the solution, 
followed by 1,8-diazabicyclo[5.4.0]undec-7-ene (0.016 mL, 0.11 mmol) and the 
reaction was allowed to return to room temperature over 1 h. The reaction mixture 
was filtered through a short pad of alumina (neutral, Brockman V) with diethyl 
ether (150 mL) and concentrated in vacuo to yield the crude allylic 
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trichloroacetimidate as a yellow oil which was used without further purification. The 
allylic trichloroacetimidate was transferred to a dry Schlenk tube containing a 
stirrer bar and potassium carbonate (15 mg, 3 mg/mL) to which p-xylene (5 mL) 
was then added. The tube was purged with argon, sealed and heated to 140 °C for 
59 h. The reaction was allowed to cool to room temperature before Grubbs 2nd 
generation catalyst (0.0090 g, 0.011 mmol) and p-xylene (21 mL) were added and 
the reaction was heated to 50 °C for 6 h. Grubbs 2nd generation catalyst (0.0040 g, 
0.0055 mmol) was added and the reaction was continued at 50 °C for 17 h. The 
reaction mixture was concentrated in vacuo and purified by column 
chromatography (elution with 50% diethyl ether in petroleum ether) to yield 7-nitro-
5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (96b) (0.052 
g, 71%) as a white solid. Decomposed at 170 °C;max (neat)/cm
–1 3337 (NH), 
2841 (CH), 1694 (CO), 1522 (C=C), 1491, 1344, 1236, 1047, 820; δH (500 MHz, 
CDCl3) 4.50–4.59 (1H, m, 2-HH), 4.85–4.92 (1H, m, 2-HH), 5.57 (1H, t, J 7.5 Hz, 
5-H), 5.78 (1H, ddd, J 11.6, 3.0, 2.4 Hz, 3-H), 6.09 (1H, ddt, J 11.6, 7.5, 2.4 Hz, 4-
H), 7.24–7.30 (1H, m, 9-H), 7.45 (1H, br d, J 7.5 Hz, NH), 8.21 (1H, dd, J 9.5, 4.5 
Hz, 8-H), 8.22 (1H, d, J 4.5 Hz, 6-H); δC (126 MHz, CDCl3) 51.0 (CH), 71.4 (CH2), 
92.4 (C), 123.4 (CH), 123.8 (CH), 125.4 (CH), 125.9 (CH), 131.5 (CH), 136.4 (C), 
144.6 (C), 161.1 (C), 162.4 (C); m/z (ESI) 372.9514 (MNa+, C12H9
35Cl3N2NaO4 
requires 372.9520), 368 (3%), 320 (6), 312 (3), 301 (6), 242 (3), 236 (6), 218 (3), 
199 (7), 190 (24), 149 (3), 144 (6). 
7-Chloro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
benzoxepine (96c) 
 
The reaction was carried out according to the previously described procedure for 
7-nitro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (96b) 
using (2E)-3-(2’-allyloxy-5’-chlorophenyl)prop-2-en-1-ol (95c) (0.055 g, 0.25 
mmol), except that the Overman rearrangement was heated at 140 °C for 60 h. 
This gave 7-chloro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
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benzoxepine (96c) (0.058 g, 69%) as white solid. Mp 136–138 °C; max (neat)/cm
–1 
3260 (NH), 2943 (CH), 1708 (CO), 1687 (C=C), 1539, 1480, 1267, 1066, 825; δH 
(500 MHz, CDCl3) 4.42 (1H, br d, J 17.7 Hz, 2-HH), 4.75–4.85 (1H, m, 2-HH), 5.36 
(1H, t, J 7.9 Hz, 5-H), 5.72 (1H, ddd, J 11.7, 3.4, 2.0 Hz, 3-H), 6.07 (1H, ddt, J 
11.7, 7.9, 2.3 Hz, 4-H), 7.07 (1H, d, J 8.3 Hz, 9-H), 7.23–7.30 (2H, m, 6-H and 8-
H), 7.55 (1H, d, J 7.9 Hz, NH); δC (126 MHz, CDCl3) 51.0 (CH), 71.3 (CH2), 92.6 
(C), 123.6 (CH), 125.6 (CH), 128.3 (CH), 130.0 (CH), 130.2 (C), 131.8 (CH), 136.6 
(C), 155.9 (C), 160.8 (C); m/z (ESI) 361.9268 (MNa+, C12H9
35Cl4NNaO2 requires 
361.9280), 331 (1%), 312 (1), 301 (3), 236 (21), 218 (6), 179 (13), 164 (1). 
7-Bromo-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
benzoxepine (96d) 
 
The reaction was carried out according to the previously described procedure for 
7-nitro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (96b) 
using (2E)-3-(2’-allyloxy-5’-bromophenyl)prop-2-en-1-ol (95d) (0.10 g, 0.29 mmol), 
except that the Overman rearrangement was heated at 140 °C for 48 h. This gave 
7-bromo-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine 
(96d) (0.11 g, 79%) as white solid. Mp 147–149 °C; max (neat)/cm
–1 3267 (NH), 
2890 (CH), 1707 (CO), 1687 (C=C), 1535, 1478, 1267, 1067, 822; δH (500 MHz, 
CDCl3) 4.37–4.46 (1H, m, 2-HH), 4.81 (1H, ddd, J 17.7, 3.3, 2.3 Hz, 2-HH), 5.36 
(1H, t, J 8.2 Hz, 5-H), 5.71 (1H, ddd, J 11.7, 3.3, 2.0 Hz, 3-H), 6.07 (1H, ddt, J 
11.7, 8.2, 2.3 Hz, 4-H), 7.01 (1H, d, J 8.2 Hz, 9-H), 7.42 (1H, dd, J 8.2, 2.5 Hz, 8-
H), 7.43 (1H, d, J 2.5 Hz, 6-H), 7.54 (1H, d, J 8.2 Hz, NH); δC (126 MHz, CDCl3) 
51.0 (CH), 71.3 (CH2), 92.6 (C), 117.8 (C), 124.0 (CH), 125.6 (CH), 131.2 (CH), 
131.8 (CH), 133.0 (CH), 137.0 (C), 156.4 (C), 160.8 (C); m/z (ESI) 405.8764 
(MNa+, C12H9
79Br35Cl3NNaO2 requires 405.8774), 394 (6%), 361 (3), 342 (4), 301 
(7), 236 (18), 227 (10), 218 (6), 159 (3), 144 (3). 
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8-Methoxy-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
benzoxepine (96e) 
 
The reaction was carried out according to the previously described procedure for 
7-nitro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (96b) 
using (2E)-3-(2’-allyloxy-4’-methoxyphenyl)prop-2-en-1-ol (95e) (0.048 g, 0.22 
mmol), except that the Overman rearrangement was heated at 140 °C for 18 h. 
This gave 8-methoxy-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
benzoxepine (96e) (0.051 g, 69%) as colourless oil. max (neat)/cm
–1 3419 (NH), 
2935 (CH), 1706 (CO), 1613 (C=C), 1496, 1156, 1122, 1032, 819; δH (500 MHz, 
CDCl3) 3.79 (3H, s, OCH3), 4.43 (1H, br d, J 17.6 Hz, 2-HH), 4.79 (1H, ddd, J 17.6, 
3.6, 1.9 Hz, 2-HH), 5.33 (1H, t, J 8.3 Hz, 5-H), 5.69 (1H, ddd, J 11.5, 3.6, 1.9 Hz, 
3-H), 6.09 (1H, ddt, J 11.5, 8.3, 1.9 Hz, 4-H), 6.64 (1H, dd, J 8.3, 2.6 Hz, 7-H), 
6.68 (1H, d, J 2.6 Hz, 9-H), 7.20 (1H, d, J 8.3 Hz, 6-H), 7.53 (1H, d, J 8.3 Hz, NH); 
δC (126 MHz, CDCl3) 51.3 (CH), 55.6 (CH3), 71.2 (CH2), 92.8 (C), 108.3 (CH), 
110.0 (CH), 126.3 (CH), 127.1 (C), 129.3 (CH), 131.5 (CH), 158.4 (C), 160.7 (C), 
161.1 (C); m/z (ESI) 357.9781 (MNa+, C13H12
35Cl3NNaO3 requires 357.9775), 236 
(3%), 215 (2), 175 (100), 160 (4), 147 (6). 
7-Methoxy-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
benzoxepine (96f) 
 
The reaction was carried out according to the previously described procedure for 
7-nitro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (96b) 
using (2E)-3-(2’-allyloxy-5’-methoxyphenyl)prop-2-en-1-ol (95f) (0.064 g, 0.29 
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mmol), except that the Overman rearrangement was heated at 140 °C for 18 h. 
This gave 7-methoxy-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
benzoxepine (96f) (0.075 g, 76%) as yellow oil. max (neat)/cm
–1 3329 (NH), 2938 
(CH), 1702 (CO), 1490, 1265, 1205, 1034, 818; δH (500 MHz, CDCl3) 3.78 (3H, s, 
OCH3), 4.34–4.44 (1H, m, 2-HH), 4.76 (1H, ddd, J 17.7, 3.3, 2.3 Hz, 2-HH), 5.34 
(1H, t, J 8.0 Hz, 5-H), 5.68 (1H, ddd, J 11.6, 3.3, 2.0 Hz, 3-H), 6.09 (1H, ddt, J 
11.6, 8.0, 2.3 Hz, 4-H), 6.79 (1H, dd, J 8.3, 3.0 Hz, 8-H), 6.81 (1H, d, J 3.0 Hz, 6-
H), 7.05 (1H, d, J 8.3 Hz, 9-H), 7.66 (1H, d, J 8.0 Hz, NH); δC (126 MHz, CDCl3) 
51.6 (CH), 55.8 (CH3), 71.5 (CH2), 92.8 (C), 113.6 (CH), 114.7 (CH), 122.8 (CH), 
126.0 (CH), 131.9 (CH), 135.8 (C), 150.9 (C), 156.5 (C), 160.8 (C); m/z (ESI) 
357.9769 (MNa+, C13H12
35Cl3NNaO3 requires 357.9775), 338 (1%), 236 (2), 218 
(3), 175 (39), 147 (4). 
6-Methoxy-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
benzoxepine (96g) 
 
The reaction was carried out according to the previously described procedure for 
7-nitro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (96b) 
using (2E)-3-(2’-allyloxy-6’-methoxyphenyl)prop-2-en-1-ol (95g) (0.049 g, 0.22 
mmol), except that the Overman rearrangement was heated at 140 °C for 18 h. 
This gave 6-methoxy-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
benzoxepine (96g) (0.046 g, 61%) as colourless oil. max (neat)/cm
–1 3412 (NH), 
2938 (CH), 1710 (CO), 1602 (C=C), 1471, 1278, 1088, 818; δH (500 MHz, CDCl3) 
3.85 (3H, s, OCH3), 4.36–4.43 (1H, m, 2-HH), 4.83 (1H, ddd, J 17.6, 3.6, 2.1 Hz, 
2-HH), 5.65 (1H, ddd, J 10.7, 3.6, 1.9 Hz, 3-H), 6.00 (1H, t, J 8.1 Hz, 5-H), 6.17 
(1H, dddd, J 10.7, 8.1, 2.6, 2.1 Hz, 4-H), 6.73 (1H, dd, J 8.2, 0.7 Hz, ArH), 6.75 
(1H, dd, J 8.2, 0.7 Hz, ArH), 7.24 (1H, t, J 8.2 Hz, 8-H), 7.78 (1H, d, J 8.1 Hz, NH); 
δC (126 MHz, CDCl3) 43.0 (CH), 56.3 (CH3), 71.3 (CH2), 93.0 (C), 108.2 (CH), 
114.3 (CH), 123.9 (C), 126.7 (CH), 130.1 (CH), 131.3 (CH), 156.3 (C), 158.8 (C), 
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160.6 (C); m/z (ESI) 357.9766 (MNa+, C13H12
35Cl3NNaO3 requires 357.9775), 301 
(1%), 175 (15). 
Methyl 4-(4’-fluorophenyl)-2-hydroxybenzoate (106)121 
  
4-Fluorophenylboronic acid (0.378 g, 2.70 mmol), cesium carbonate (1.47 g, 4.50 
mmol) and [1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloride (0.0735 
g, 0.0899 mmol), were added to a degassed solution of methyl 2-hydroxy-4-
iodobenzoate (105) (0.500 g, 1.80 mmol) in 1,4-dioxane (17 mL) and water (1 mL). 
The solution was heated to 80 °C for 18 h, cooled to room temperature and 
concentrated in vacuo. The reaction mixture was purified by filtration through a 
pad of silica (elution with 20% diethyl ether:petroleum ether) to yield methyl 4-(4’-
fluorophenyl)-2-hydroxybenzoate (106) (0.442 g, 100%) as a white solid. 
Spectroscopic data was in accordance with literature values.121 Mp 110–112 
°C;max (neat)/cm
–1 3146 (OH), 2925 (CH), 1666 (CO), 1624 (C=C), 1493, 1441, 
1347, 1269, 1214, 1167, 1097, 840, 777, 703; δH (500 MHz, CDCl3) 3.97 (3H, s, 
OCH3), 7.06 (1H, dd, J 8.4, 1.0 Hz, 5-H), 7.10–7.17 (3H, m, 3-H, 2’-H and 6’-H), 
7.57 (2H, dd, J 8.4, 3JHF 5.4 Hz, 3’-H and 5’-H), 7.87 (1H, d, J 8.4 Hz, 6-H), 10.82 
(1H, br s, OH); δC (126 MHz, CDCl3) 52.4 (CH3), 111.3 (C), 115.7 (CH), 116.0 (2 × 
CH, d, 2JCF 21.6 Hz), 118.1 (CH), 129.0 (2 × CH, d, 
3JCF 8.2 Hz), 130.5 (CH), 
135.9 (C, d, 4JCF 3.2 Hz), 147.6 (C), 162.0 (C), 163.2 (C, d, 
1JCF 248.3 Hz), 170.6 
(C); m/z (EI) 246.0693 (M+, C14H11FO3 requires 246.0692), 214 (100%), 186 (45), 
157 (30), 133 (10), 93 (9), 84 (30), 49 (34). 
4-(4’-Fluorophenyl)-2-hydroxybenzyl alcohol (107)  
  
Lithium aluminium hydride (0.663 g, 17.5 mmol) was added to a solution of methyl 
4-(4’-fluorophenyl)-2-hydroxybenzoate (106) (1.72 g, 6.98 mmol) in 
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tetrahydrofuran (70 mL) and stirred at room temperature for 18 h. The reaction 
mixture was cooled to 0 °C and quenched by addition of 2 M hydrochloric acid (70 
mL). The solution was extracted with dichloromethane (2 × 70 mL), washed with 
water (2 × 50 mL) and brine (70 mL), dried (MgSO4), filtered and concentrated in 
vacuo to yield 4-(4’-fluorophenyl)-2-hydroxybenzyl alcohol (107) (1.52 g, 100%) as 
a white solid. Mp 105–107 °C;max (neat)/cm
–1 3441 (OH), 3395 (OH), 2918 (CH), 
1491, 1241, 1184, 988, 822; δH (400 MHz, CDCl3) 2.23 (1H, br s, 1-CH2OH), 4.92 
(2H, s, 1-CH2), 7.03 (1H, dd, J 7.9, 1.6 Hz, 5-H), 7.06–7.16 (4H, m, 3-H, 6-H, 2’-H 
and 6’-H), 7.40 (1H, br s, 2-OH), 7.48–7.56 (2H, m, 3’-H and 5’-H); δC (126 MHz, 
CDCl3) 64.6 (CH2), 115.3 (CH), 115.8 (2 × CH, d, 
2JCF 21.5 Hz), 118.8 (CH), 123.6 
(C), 128.4 (CH), 128.7 (2 × CH, d, 3JCF 8.1 Hz), 136.7 (C), 141.9 (C), 156.6 (C), 
162.7 (C, d, 1JCF 246.4 Hz); m/z (EI) 218.0742 (M
+, C13H11FO2 requires 218.0743), 
200 (68%), 172 (100), 133 (17), 120 (80), 85 (7). 
2-Allyloxy-4-(4’-fluorophenyl)benzyl alcohol (108)  
  
Allyl bromide (0.79 mL, 9.2 mmol) was added to a solution of 4-(4’-fluorophenyl)-2-
hydroxybenzyl alcohol (107) (1.0 g, 4.6 mmol), potassium carbonate (0.95 g, 6.9 
mmol) and sodium iodide (0.041 g, 0.28 mmol) in dimethylformamide (31 mL) and 
stirred at room temperature for 24 h. The solution was diluted with diethyl ether (60 
mL), washed with 5% lithium chloride solution (3 × 50 mL) and brine (50 mL), dried 
(MgSO4), filtered and concentrated in vacuo. Purification by column 
chromatography (elution with 20% diethyl ether:petroleum ether) gave 2-allyloxy-4-
(4’-fluorophenyl)benzyl alcohol (108) (0.95 g, 80%) as a white solid. Mp 54–56 
°C;max (neat)/cm
–1 3354 (OH), 2853 (CH), 1610 (C=C), 1496, 1221, 1001, 819; δH 
(500 MHz, CDCl3) 2.38 (1H, t, J 5.6 Hz, OH), 4.66 (2H, dt, J 5.2, 1.5 Hz, 2’’-H2), 
4.75 (2H, d, J 5.6 Hz, 1-CH2OH), 5.32 (1H, ddt, J 10.5, 2.9, 1.5 Hz, 4’’-HH), 5.44 
(1H, ddt, J 17.3, 2.9, 1.5 Hz, 4’’-HH), 6.09 (1H, ddt, J 17.3, 10.5, 5.2 Hz, 3’’-H), 
7.02 (1H, d, J 1.5 Hz, 3-H), 7.06–7.15 (3H, m, 5-H, 2’-H and 6’-H), 7.34 (1H, d, J 
7.7 Hz, 6-H), 7.44–7.65 (2H, m, 3’-H and 5’-H); δC (126 MHz, CDCl3) 61.9 (CH2), 
69.0 (CH2), 110.6 (CH), 115.8 (2 × CH, d, 
2JCF 21.4 Hz), 118.0 (CH2), 119.7 (CH), 
128.6 (C), 128.8 (2 × CH, d, 3JCF 8.0 Hz), 129.3 (CH), 133.1 (CH), 137.3 (C, d, 
 Experimental 180 
 
4JCF 3.2 Hz), 141.4 (C), 156.9 (C), 162.7 (C, d, 
1JCF 246.6 Hz); m/z (EI) 258.1054 
(M+, C16H15FO2 requires 258.1056), 228 (17%), 215 (27), 200 (57), 172 (70), 133 
(17), 120 (6). 
Ethyl (2E)-3-(2’-allyloxy-4’-[4’’’-fluorophenyl]phenyl)prop-2-enoate (109)  
  
Dimethyl sulfoxide (0.64 mL, 9.0 mmol) was added to a stirred solution of oxalyl 
chloride (0.40 mL, 4.5 mmol) in dichloromethane (15 mL) at −78 °C. The reaction 
mixture was stirred for 0.3 h then 2-allyloxy-4-(4’-fluorophenyl)benzyl alcohol (108) 
(0.78 g, 3.0 mmol) in dichloromethane (15 mL) was slowly added. The mixture was 
stirred for a further 0.3 h then triethylamine (2.1 mL, 15 mmol) was added. This 
reaction mixture was stirred for 0.5 h at −78 °C and then allowed to warm to room 
temperature and stirred for a further 2 h. Meanwhile, a solution of lithium bromide 
(1.0 g, 12 mmol), triethyl phosphonoacetate (21) (2.0 mL, 10 mmol) and 1,8-
diazabicyclo[5.4.0]undec-7-ene (1.5 mL, 10 mmol) in acetonitrile (30 mL) was 
prepared and stirred for 1 h. The Swern solution was concentrated in vacuo and 
the Horner–Wadsworth–Emmons solution was added. The reaction mixture was 
stirred at room temperature for 18 h. The reaction mixture was quenched by the 
addition of a saturated solution of ammonium chloride (20 mL) and concentrated to 
give an orange residue, which was then extracted with diethyl ether (2 × 30 mL). 
The organic layers were combined, washed with water (50 mL) and brine (50 mL) 
then dried (MgSO4) and concentrated to give a yellow oil. Purification by column 
chromatography (elution with 5% diethyl ether:petroleum ether) gave ethyl (2E)-3-
(2’-allyloxy-4’-[4’’’-fluorophenyl]phenyl)prop-2-enoate (109) (0.83 g, 84%) as a 
white solid. Mp 75–76 °C; max (neat)/cm
–1 2981 (CH), 1702 (CO), 1628 (C=C), 
1604 (C=C), 1492, 1307, 1217, 1158, 986, 811; δH (500 MHz, CDCl3) 1.35 (3H, t, 
J 7.1 Hz, OCH2CH3), 4.27 (2H, q, J 7.1 Hz, OCH2CH3), 4.69 (2H, d, J 5.2 Hz, 2’’-
H2), 5.34 (1H, dd, J 10.5, 1.4 Hz, 4’’-HH), 5.46 (1H, dd, J 17.2, 1.4 Hz, 4’’-HH), 
6.11 (1H, ddt, J 17.2, 10.5, 5.2 Hz, 3’’-H), 6.56 (1H, d, J 16.2 Hz, 2-H), 7.04 (1H, d, 
J 1.3 Hz, 3’-H), 7.09–7.18 (3H, m, 5’-H, 2’’’-H and 6’’’-H), 7.48–7.55 (2H, m, 3’’’-H 
and 5’’’-H), 7.56 (1H, d, J 8.0 Hz, 6’-H), 8.06 (1H, d, J 16.2 Hz, 3-H); δC (126 MHz, 
CDCl3) 14.5 (CH3), 60.4 (CH2), 69.4 (CH2), 111.2 (CH), 115.9 (2 × CH, d, 
2JCF 21.5 
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Hz), 118.0 (CH2), 118.8 (CH), 119.7 (CH), 122.9 (C), 128.8 (2 × CH, d, 
3JCF 8.1 
Hz), 129.3 (CH), 132.9 (CH), 136.6 (C, d, 4JCF 3.2 Hz), 139.5 (CH), 143.4 (C), 
157.9 (C), 162.9 (C, d, 1JCF 247.6 Hz), 167.6 (C); m/z (EI) 326.1316 (M
+, 
C20H19FO3 requires 326.1318), 281 (23%), 252 (20), 238 (37), 225 (17), 212 (83), 
183 (64), 165 (9), 157 (7), 133 (6), 113 (5). 
(2E)-3-(2’-Allyloxy-4’-[4’’’-fluorophenyl]phenyl)prop-2-en-1-ol (110)  
 
Diisobutylaluminium hydride (6.1 mL, 1 M solution in hexanes) was added 
dropwise with stirring to a solution of ethyl (2E)-3-(2’-allyloxy-4’-[4’’’-
fluorophenyl]phenyl)prop-2-enoate (109) (0.79 g, 2.4 mmol), in diethyl ether (50 
mL) at −78 °C. The solution was stirred at −78 °C for 3 h, then allowed to return to 
room temperature over 15 h. The reaction mixture was quenched with 10% 
aqueous potassium sodium tartrate solution (50 mL), extracted with diethyl ether 
(2 × 30 mL), washed with water (100 mL), brine (100 mL), dried (MgSO4), filtered 
and concentrated in vacuo to yield (2E)-3-(2’-allyloxy-4’-[4’’’-
fluorophenyl]phenyl)prop-2-en-1-ol (110) (0.63 g, 92%) as a white solid. Mp 84–86 
°C; max (neat)/cm
–1 3335 (OH), 2867 (CH), 1602 (C=C), 1519, 1493, 1392, 1220, 
1014, 972, 827; δH (400 MHz, CDCl3) 1.50 (1H, br s, OH), 4.36 (2H, dd, J 5.9, 1.1 
Hz, 1-H2), 4.65 (2H, dt, J 5.2, 1.5 Hz, 2’’-H2), 5.32 (1H, dq, J 10.5, 1.5 Hz, 4’’-HH), 
5.45 (1H, dq, J 17.3, 1.5 Hz, 4’’-HH), 6.11 (1H, ddt, J 17.3, 10.5, 5.2 Hz, 3’’-H), 
6.45 (1H, dt, J 16.1, 5.9 Hz, 2-H), 6.99 (1H, dt, J 16.1, 1.1 Hz, 3-H), 7.02 (1H, d, J 
1.7 Hz, 3’-H), 7.08–7.16 (3H, m, 5’-H, 2’’’-H and 6’’’-H), 7.47–7.57 (3H, m, 6’-H, 
3’’’-H and 5’’’-H); δC (101 MHz, CDCl3) 64.4 (CH2), 69.5 (CH2), 111.2 (CH), 115.8 
(2 × CH, d, 2JCF 21.4 Hz), 117.8 (CH2), 119.8 (CH), 125.2 (C), 125.9 (CH), 127.5 
(CH), 128.6 (2 × CH, d, 3JCF 8.0 Hz), 129.5 (CH), 133.4 (CH), 137.1 (C, d, 
4JCF 3.2 
Hz), 140.9 (C), 156.2 (C), 162.7 (C, d, 1JCF 246.8 Hz); m/z (EI) 284.1214 (M
+, 
C18H17FO2 requires 284.1213), 243 (49%), 225 (47), 215 (42), 196 (26), 183 (38), 
165 (19), 133 (11), 107 (6), 55 (6). 
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8-(4’’-Fluorophenyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-
1-benzoxepine (99)  
 
(2E)-3-(2’-allyloxy-4’-[4’’’-fluorophenyl]phenyl)prop-2-en-1-ol (110) (0.200 g, 0.700 
mmol) was dissolved in dry dichloromethane (32 mL) and cooled to 0 °C under 
argon with stirring. Trichloroacetonitrile (0.106 mL, 1.06 mmol) was added to the 
solution, followed by 1,8-diazabicyclo[5.4.0]undec-7-ene (0.0530 mL, 0.350 mmol) 
and the reaction was allowed to return to room temperature over 1 h. The reaction 
mixture was filtered through a short pad of alumina (neutral, Brockman V) with 
diethyl ether (300 mL) and concentrated in vacuo to yield the crude allylic 
trichloroacetimidate as a yellow oil which was used without further purification. The 
allylic trichloroacetimidate was transferred to a dry Schlenk tube containing a 
stirrer bar and potassium carbonate (60 mg, 3 mg/mL) to which degassed p-xylene 
(20 mL) was then added. The tube was purged with argon, sealed and heated to 
140 °C for 18 h. The reaction mixture was allowed to cool to room temperature 
and Grubbs 2nd generation catalyst (0.0300 g, 0.0350 mmol) and p-xylene (68 mL) 
were added. The reaction mixture was heated to 50 °C for 20 h. The reaction 
mixture was concentrated in vacuo and purified by column chromatography 
(elution with 20% diethyl ether in petroleum ether) to yield 8-(4’’-fluorophenyl)-5-
(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (99) (0.277 g, 
98%) as a white solid. Mp 115–117 °C;max (neat)/cm
–1 3416 (NH), 2932 (CH), 
1703 (CO), 1489, 1223, 907, 816, 729; δH (500 MHz, CDCl3) 4.50 (1H, br d, J 17.7 
Hz, 2-HH), 4.86 (1H, ddd, J 17.7, 3.3, 2.2 Hz, 2-HH), 5.45 (1H, t, J 8.2 Hz, 5-H), 
5.74 (1H, ddd, J 11.6, 3.3, 1.9 Hz, 3-H), 6.13 (1H, ddt, J 11.6, 8.2, 2.2 Hz, 4-H), 
7.09–7.15 (2H, m, 2’’-H and 6’’-H), 7.30 (1H, dd, J 7.8, 1.5 Hz, 7-H), 7.32 (1H, d, J 
1.5 Hz, 9-H), 7.35 (1H, d, J 7.8 Hz, 6-H), 7.50–7.56 (2H, m, 3’’-H and 5’’-H), 7.63 
(1H, d, J 8.2 Hz, NH); δC (126 MHz, CDCl3) 51.4 (CH), 71.3 (CH2), 92.8 (C), 115.9 
(2 × CH, d, 2JCF 21.5 Hz), 120.8 (CH), 123.6 (CH), 126.1 (CH), 128.7 (2 × CH, d, 
3JCF 8.1 Hz), 128.9 (CH), 131.8 (CH), 133.7 (C), 136.1 (C, d, 
4JCF 3.2 Hz), 142.5 
(C), 157.7 (C), 160.8 (C), 162.8 (C, d, 1JCF 247.2 Hz); m/z (EI) 398.9980 (M
+, 
 Experimental 183 
 
C18H13
35Cl3FNO2 requires 398.9996), 328 (59%), 294 (12), 282 (9), 252 (20), 238 
(67), 225 (18), 209 (20), 196 (23), 183 (21), 157 (8), 133 (7), 120 (6). 
7-Bromo-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-
benzoxepine (111) 
 
7-Bromo-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine 
(96d) (0.11 g, 0.29 mmol) was dissolved in ethyl acetate (6 mL) and a suspension 
of 10% palladium on carbon (0.022 g, 20% w/w) in ethyl acetate (5 mL) was 
added. The mixture was degassed, purged with hydrogen gas and left to stir at 
room temperature under a hydrogen atmosphere for 2 h. The suspension was 
filtered through Celite® with ethyl acetate (100 mL) and concentrated in vacuo to 
yield 7-bromo-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-
benzoxepine (111) (0.11 g, 100%) as a white solid. Mp 129–131 °C; νmax 
(neat)/cm–1 2921 (CH), 1709 (CO), 1530, 1476, 1223, 1165, 1038, 822; δH (500 
MHz, CDCl3) 1.74–1.93 (2H, m, 3-HH and 4-HH), 2.17–2.34 (2H, m, 3-HH and 4-
HH), 3.72 (1H, td, J 11.9, 1.7 Hz, 2-HH), 4.39 (1H, dt, J 11.9, 3.2 Hz, 2-HH), 5.08 
(1H, ddd, J 7.7, 6.5, 1.4 Hz, 5-H), 6.94 (1H, d, J 8.5 Hz, 9-H), 7.36 (1H, dd, J 8.5, 
2.4 Hz, 8-H), 7.40 (1H, d, J 2.4 Hz, 6-H), 7.44 (1H, d, J 7.7 Hz, NH); δC (126 MHz, 
CDCl3) 26.5 (CH2), 29.7 (CH2), 54.4 (CH), 74.1 (CH2), 92.7 (C), 117.2 (C), 124.4 
(CH), 132.2 (CH), 132.8 (CH), 135.6 (C), 158.7 (C), 160.9 (C); m/z (EI) 384.9042 
(M+, C12H11
79Br35Cl3NO2 requires 384.9039), 352 (100%), 322 (17), 316 (17), 239 
(11), 225 (17), 198 (10), 146 (32), 131 (14), 115 (12), 89 (6), 63 (5), 49 (4). 
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8-(4’’-Fluorophenyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-
tetrahydro-1-benzoxepine (112) and 8-(4’’-fluorophenyl)-5-(2’,2’-
dichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-benzoxepine (113)  
 
p-Toluenesulfonyl hydrazide (0.030 g, 0.16 mmol) and potassium acetate (0.016 g, 
0.16 mmol) were added to a stirred solution of 8-(4’’-fluorophenyl)-5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (99) (0.033 g, 0.082 
mmol) in butan-1-ol (0.8 mL) at 50 °C. The reaction mixture was warmed to 100 °C 
and four additional portions of p-toluenesulfonyl hydrazide (0.030 g, 0.16 mmol) 
and potassium acetate (0.016 g, 0.16 mmol) were added at 1 h intervals. After 5 h, 
the reaction mixture was cooled to room temperature and diluted with diethyl ether 
(10 mL), then washed with 1 M sodium hydroxide (10 mL), water (10 mL) and 
brine (10 mL) then dried (MgSO4), filtered and concentrated in vacuo. Purification 
by column chromatography (elution with 10% diethyl ether:petroleum ether) gave 
8-(4’’-fluorophenyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-
benzoxepine (112) (0.027 g, 81%) as a white solid. Further elution yielded 8-(4’’-
fluorophenyl)-5-(2’,2’-dichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-
benzoxepine (113) (0.005 g, 17%) as a white solid. Data for 8-(4’’-fluorophenyl)-5-
(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-benzoxepine (112): Mp 
128–130 °C;max (neat)/cm
–1 3415 (NH), 2941 (CH), 1712 (CO), 1491, 1226, 817; 
δH (400 MHz, CDCl3) 1.77–1.95 (2H, m, 3-HH and 4-HH), 2.22–2.42 (2H, m, 3-HH 
and 4-HH), 3.79 (1H, td, J 11.9, 1.7 Hz, 2-HH), 4.43–4.50 (1H, m, 2-HH), 5.18 (1H, 
ddd, J 8.1, 6.1, 1.7 Hz, 5-H), 7.09–7.17 (2H, m, 2’’-H and 6’’-H), 7.23–7.29 (2H, m, 
7-H and 9-H), 7.33 (1H, d, J 8.5 Hz, 6-H), 7.45–7.56 (3H, m, NH, 3’’-H and 5’’-H); 
δC (126 MHz, CDCl3) 26.6 (CH2), 29.8 (CH2), 54.9 (CH), 74.2 (CH2), 92.9 (C), 
115.9 (2 × CH, d, 2JCF 21.5 Hz), 121.1 (CH), 123.1 (CH), 128.7 (2 × CH, d, 
3JCF 8.1 
Hz), 130.2 (CH), 132.3 (C), 136.1 (C, d, 4JCF 3.3 Hz), 142.3 (C), 160.0 (C), 161.0 
(C), 162.9 (C, d, 1JCF 247.2 Hz); m/z (EI) 401.0150 (M
+, C18H15
35Cl3FNO2 requires 
401.0152), 366 (100%), 330 (27), 296 (15), 283 (12), 241 (38), 212 (24), 183 (22), 
170 (16), 84 (61). Data for 8-(4’’-fluorophenyl)-5-(2’,2’-
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dichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-benzoxepine (113): Mp 154–
156 °C; max (neat)/cm
–1 3246 (NH), 2928 (CH), 1669 (CO), 1492, 1208, 806; δH 
(500 MHz, CDCl3) 1.78–1.93 (2H, m, 3-HH and 4-HH), 2.23–2.34 (2H, m, 3-HH 
and 4-HH), 3.76–3.84 (1H, m, 2-HH), 4.44 (1H, dt, J 12.2, 3.4 Hz, 2-HH), 5.21 (1H, 
t, J 6.7 Hz, 5-H), 5.94 (1H, s, CHCl2), 7.08–7.15 (2H, m, 2’’-H and 6’’-H), 7.22–7.29 
(3H, m, NH, 7-H and 9-H), 7.31 (1H, d, J 8.0 Hz, 6-H), 7.49–7.55 (2H, m, 3’’-H and 
5’’-H); δC (126 MHz, CDCl3) 26.7 (CH2), 30.1 (CH2), 53.6 (CH), 66.8 (CH), 74.2 
(CH2), 115.9 (2 × CH, d, 
2JCF 21.5 Hz), 121.0 (CH), 123.0 (CH), 128.7 (2 × CH, d, 
3JCF 8.1 Hz), 130.0 (CH), 132.6 (C), 136.1 (C, d, 
4JCF 3.1 Hz), 142.1 (C), 160.0(C), 
162.8 (C, d, 1JCF 247.1 Hz), 163.2 (C); m/z (EI) 367.0545 (M
+, C18H16
35Cl2FNO2 
requires 367.0542), 332 (100%), 296 (68), 256 (10), 241 (26), 212 (23), 183 (17), 
170 (12), 133 (9), 84 (11). 
(3R*,4S*,5S*)-3,4-Epoxy-7-chloro-5-(2’,2’,2’-trichloromethylcarbonylamino)-
2,3,4,5-tetrahydro-1-benzoxepine (115) 
 
3-Chloroperbenzoic acid (0.10 g, 0.59 mmol) was added to a stirred solution of 7-
chloro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (96c) 
(0.050 g, 0.15 mmol) in dichloromethane (3 mL) at 0 °C. The reaction mixture was 
stirred from 0 °C to room temperature over 18 h then cooled to 0 °C before 3-
chloroperbenzoic acid (0.10 g, 0.59 mmol) was added. The reaction mixture was 
stirred for a further 24 h, quenched by the addition of a saturated solution of 
sodium sulfite (5 mL) and extracted with dichloromethane (2 × 5 mL). The 
combined organic layers were washed with a saturated solution of sodium 
hydrogen carbonate (3 × 10 mL), water (10 mL) and brine (10 mL), then dried 
(MgSO4), filtered and concentrated in vacuo. Purification by column 
chromatography (elution with 20% ethyl acetate:petroleum ether) gave an 
inseparable 12:1 mixture of (3R*,4S*,5S*)-3,4-epoxy-7-chloro-5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-benzoxepine (115) and its anti-
diastereomer (0.033 g, 62%) as a white solid which was used in the next step 
without further purification. Characterisation data for the major diastereomer 115: 
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max (neat)/cm
–1 3319 (NH), 2926 (CH), 1711 (CO), 1506, 1483, 1235, 1189, 1056, 
835, 823; δH (500 MHz, CDCl3) 3.19 (1H, dd, J 4.1, 1.4 Hz, 3-H), 3.72 (1H, dd, J 
6.7, 4.1 Hz, 4-H), 4.05 (1H, dd, J 14.2, 1.4 Hz, 2-HH), 4.71 (1H, d, J 14.2 Hz, 2-
HH), 5.38 (1H, dd, J 8.0, 6.7 Hz, 5-H), 7.04 (1H, d, J 8.5 Hz, 9-H), 7.29 (1H, dd, J 
8.5, 2.5 Hz, 8-H), 7.37 (1H, d, J 2.5 Hz, 6-H), 7.76 (1H, d, J 8.0 Hz, NH); δC (126 
MHz, CDCl3) 50.2 (CH), 54.8 (CH), 55.6 (CH), 69.1 (CH2), 92.5 (C), 123.8 (CH), 
129.7 (CH), 130.7 (CH), 130.8 (C), 134.0 (C), 156.1 (C), 161.1 (C); m/z (ESI) 
377.9213 (MNa+, C12H9
35Cl4NNaO3 requires 377.9229), 227 (4%), 159 (1). 
(3S*,4S*,5S*)-3,4-Dihydroxy-7-chloro-5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-benzoxepine (116)  
 
1.0 M Sulfuric acid (2 mL) was added to a solution of (3R*,4S*,5S*)-3,4-epoxy-7-
chloro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-benzoxepine 
(115) (0.017 g, 0.048 mmol) in 1,4-dioxane (2 mL) and stirred at room temperature 
for 48 h. The reaction was quenched by addition of a saturated solution of sodium 
hydrogen carbonate (3 mL) and extracted with diethyl ether (2 × 10 mL). The 
organic layer was washed with water (10 mL), brine (10 mL), then dried (MgSO4), 
filtered and concentrated in vacuo. Purification by column chromatography (elution 
with 50% ethyl acetate:petroleum ether) gave (3S*,4S*,5S*)-3,4-dihydroxy-7-
chloro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-benzoxepine 
(116) (0.016 g, 91%) as a white foam. max (neat)/cm
–1 3404 (NH and OH), 2927 
(CH), 1696 (CO), 1507, 1482, 1228, 1081, 823; δH (400 MHz, CDCl3) 2.70 (1H, d, 
J 3.7 Hz, OH), 3.33 (1H, d, J 5.3 Hz, OH), 3.76 (1H, dd, J 12.3, 8.4 Hz, 2-HH), 
3.85–3.92 (1H, m, 4-H), 4.07 (1H, ddd, J 11.7, 8.4, 3.6 Hz, 3-H), 4.35 (1H, dd, J 
12.3, 3.6 Hz, 2-HH), 5.33 (1H, dd, J 8.0, 1.5 Hz, 5-H), 7.02–7.10 (1H, m, 9-H), 
7.27–7.31 (2H, m, 6-H and 8-H), 7.35 (1H, d, J 8.0 Hz, NH); δC (126 MHz, CDCl3) 
57.1 (CH), 71.1 (CH), 73.9 (CH2), 75.8 (CH), 92.3 (C), 123.9 (CH), 129.7 (CH), 
130.5 (C), 130.6 (C), 130.7 (CH), 157.3 (C), 163.2 (C); m/z (ESI) 395.9321 (MNa+, 
C12H11
35Cl4O4NNa requires 395.9334) 363 (3%), 301 (3), 283 (4), 274 (15), 227 
(10), 159 (4). 
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(3R*,4S*,5S*)-3,4-Dihydroxy-6-methoxy-5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-benzoxepine (117)  
 
Tetramethylethylenediamine (0.019 mL, 0.13 mmol) was added to a solution of 6-
methoxy-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine 
(96g) (0.039 g, 0.12 mmol) in dichloromethane (2 mL) and cooled to −78 °C. After 
0.2 h, a solution of osmium tetroxide (0.032 g, 0.13 mmol) in dichloromethane (1 
mL) was added dropwise. The solution was stirred at −78 °C for 1 h, allowed to 
return to room temperature over 2 h, then concentrated in vacuo. The residue was 
taken up in a solution of methanol (4 mL) and 12 M hydrochloric acid (0.5 mL) and 
stirred at room temperature for 2 h. The reaction mixture was concentrated in 
vacuo. The resulting residue was purified by column chromatography (elution with 
50% ethyl acetate:petroleum ether) to yield (3R*,4S*,5S*)-3,4-dihydroxy-6-
methoxy-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-
benzoxepine (117) (0.032 g, 74%) as a colourless oil. max (neat)/cm
–1 3464 (OH), 
3417 (NH), 2928 (CH), 1711 (CO), 1505, 1473, 1249, 1086, 820; δH (500 MHz, 
CDCl3) 2.72 (1H, s, OH), 2.95 (1H, s, OH), 3.68 (1H, t, J 12.4 Hz, 2-HH), 3.85 (3H, 
s, OCH3), 4.16–4.26 (2H, m, 2-HH and 3-H), 4.50 (1H, dd, J 6.6, 4.0 Hz, 4-H), 6.01 
(1H, dd, J 8.4, 6.6 Hz, 5-H), 6.72 (1H, d, J 8.2 Hz, ArH), 6.75 (1H, d, J 8.2 Hz, 
ArH), 7.27 (1H, t, J 8.2 Hz, 8-H), 7.31 (1H, d, J 8.4 Hz, NH); δC (126 MHz, CDCl3) 
47.5 (CH), 56.4 (CH3), 68.4 (CH), 69.0 (CH), 71.2 (CH2), 92.5 (C), 107.9 (CH), 
114.4 (CH), 117.3 (C), 130.8 (CH), 158.9 (C), 160.2 (C), 161.7 (C); m/z (ESI) 
391.9818 (MNa+, C13H14
35Cl3NNaO5 requires 391.9830), 381 (1%), 279 (1). 
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3-Methyl-2,3-dihydro-inden-1-one (127a)189 and 2,3-dihydro-3-
(methylene)inden-1-ol (126a)150 
  
Allylboronic acid pinacol ester (58) (0.053 mL, 0.28 mmol) was added to a solution 
of 2-bromobenzaldehyde (52a) (0.031 mL, 0.27 mmol) and potassium carbonate 
(0.19 g, 1.4 mmol) in acetonitrile (2.7 mL) and water (0.019 mL, 1.1 mmol) at room 
temperature and stirred for 20 h. Bis(triphenylphosphine)palladium(II) dichloride 
(0.014 g, 0.020 mmol) was added to the solution followed by hydrazine 
monohydrate (0.0050 mL, 0.10 mmol). The reaction vessel was sealed and heated 
to 100 °C for 18 h then cooled to room temperature and diluted with diethyl ether 
(3 mL). The solution was filtered through a short pad of silica and concentrated in 
vacuo. Purification by column chromatography (elution with 20% diethyl 
ether:petroleum ether) yielded 3-methyl-2,3-dihydro-inden-1-one (127a) (0.002 g, 
5%) as a yellow oil. Further elution yielded 2,3-dihydro-3-(methylene)inden-1-ol 
(126a) (0.030 g, 75%) as a white solid. Data for 127a, spectroscopic data 
consistent with literature:189 δH (500 MHz, CDCl3) 1.41 (3H, d, J 7.3 Hz, CH3), 2.28 
(1H, dd, J 19.0, 3.6 Hz, 2-HH), 2.94 (1H, dd, J 19.0, 7.3 Hz, 2-HH), 3.44 (1H, 
quin.d, J 7.3, 3.6 Hz, 3-H), 7.37 (1H, t, J 7.7 Hz, ArH), 7.51 (1H, brd, J 7.7 Hz, 
ArH), 7.61 (1H, td, J 7.7, 1.2 Hz, ArH), 7.73 (1H, d, J 7.7 Hz, ArH); δC (126 MHz, 
CDCl3) 21.5 (CH3), 32.9 (CH), 45.5 (CH2), 123.6 (CH), 125.4 (CH), 127.5 (CH), 
134.9 (CH), 136.6 (C), 160.1 (C), 206.6 (C); m/z (EI) 146 (52%, M+), 131 (64), 115 
(34), 77 (31), 44 (10); Data for 126a: Mp 72–73 °C (lit.,150 71–72 °C); δH (400 
MHz, CDCl3) 1.88 (1H, d, J 7.4 Hz, OH), 2.66 (1H, ddt, J 16.9, 3.8, 2.2 Hz, 2-HH), 
3.20 (1H, ddt, J 16.9, 7.4, 2.2 Hz, 2-HH), 5.10 (1H, t, J 2.2 Hz, 1’-HH), 5.28 (1H, 
td, J 7.4, 3.8 Hz, 1-H), 5.53 (1H, t, J 2.2 Hz, 1’-HH), 7.29–7.37 (2H, m, ArH), 7.44–
7.57 (2H, m, ArH); δC (101 MHz, CDCl3) 42.7 (CH2), 73.6 (CH), 104.5 (CH2), 120.8 
(CH), 125.2 (CH), 129.0 (CH), 129.1 (CH), 140.4 (C), 146.5 (C), 147.1 (C); m/z 
(EI) 146 (100%, M+), 131 (80), 117 (57), 115 (47), 103 (28), 91 (28), 51 (20). 
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2,3-Dihydro-3-methylene-5,6-(methylenedioxy)inden-1-ol (126b)  
 
The reaction was carried out according to the previously described procedure for 
2,3-dihydro-3-(methylene)inden-1-ol (126a) using 2-bromo-4,5-
methylenedioxybenzaldehyde (52b) (0.062 g, 0.27 mmol). Purification by column 
chromatography (elution with 30% diethyl ether:petroleum ether) gave 2,3-dihydro-
3-methylene-5,6-(methylenedioxy)inden-1-ol (126b) (0.046 g, 89%) as a white 
solid. Mp 76–78 °C; max (neat)/cm
–1 3306 (OH), 2897 (CH), 1638 (C=C), 1472, 
1310, 1233, 1036, 939, 860; δH (500 MHz, CDCl3) 1.95 (1H, d, J 7.0 Hz, OH), 2.63 
(1H, ddt, J 16.8, 3.3, 2.0 Hz, 2-HH), 3.18 (1H, ddt, J 16.8, 7.0, 2.0 Hz, 2-HH), 4.94 
(1H, t, J 2.0 Hz, 1’-HH), 5.13 (1H, td, J 7.0, 3.3 Hz, 1-H), 5.28 (1H, t, J 2.0 Hz, 1’-
HH), 5.97 (2H, s, OCH2O), 6.86 (1H, s, ArH), 6.89 (1H, s, ArH); δC (126 MHz, 
CDCl3) 43.2 (CH2), 73.2 (CH), 100.5 (CH), 101.6 (CH2), 102.2 (CH2), 104.9 (CH), 
134.8 (C), 141.5 (C), 146.1 (C), 149.1 (C), 149.1 (C); m/z (EI) 190.0636 (M+, 
C11H10O3 requires 190.0630), 173 (28%), 162 (16), 143 (23), 131 (9), 115 (15), 
103 (10), 77 (8), 63 (6), 51 (5). 
2,3-Dihydro-6-fluoro-3-(methylene)inden-1-ol (126c)152  
 
The reaction was carried out according to the previously described procedure for 
2,3-dihydro-3-(methylene)inden-1-ol (126a) using 2-bromo-5-fluorobenzaldehyde 
(52c) (0.055 g, 0.27 mmol). Purification by column chromatography (elution with 
20% diethyl ether:petroleum ether) gave 2,3-dihydro-6-fluoro-3-(methylene)inden-
1-ol (126c) (0.036 g, 80%) as a colourless oil. Spectroscopic data as reported in 
literature.148 max (neat)/cm
–1 3300 (OH), 2918 (CH), 1609 (C=C), 1479, 1325, 
1252, 1130, 1088, 1042, 872, 827; δH (400 MHz, CDCl3) 1.89 (1H, d, J 7.4 Hz, 
OH), 2.68 (1H, ddt, J 16.8, 4.3, 2.1 Hz, 2-HH), 3.23 (1H, ddt, J 16.8, 7.4, 2.1 Hz, 2-
HH), 5.06 (1H, t, J 2.1 Hz, 1’-HH), 5.24 (1H, td, J 7.4, 4.3 Hz, 1-H), 5.43 (1H, t, J 
2.1 Hz, 1’-HH), 7.02 (1H, ddd, 3JHF 8.5, J 8.5, 2.4 Hz, 5-H), 7.14 (1H, dd, 
3JHF 8.5, 
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J 2.4 Hz, 7-H), 7.47 (1H, dd, J 8.5, 4JHF 5.0 Hz, 4-H); δC (126 MHz, CDCl3) 43.0 
(CH2), 73.1 (CH, d, 
4JCF 2.0 Hz), 104.0 (CH2), 111.8 (CH, d, 
2JCF 22.1 Hz), 116.5 
(CH, d, 2JCF 23.4 Hz), 122.3 (CH, d, 
3JCF 8.8 Hz), 136.3 (C, d, 
4JCF 2.6 Hz), 145.2 
(C), 149.1 (CH, d, 3JCF 7.6 Hz), 163.6 (C, d, 
1JCF 248.0 Hz); m/z (EI) 164.0635 (M
+, 
C10H9FO requires 164.0637), 149 (71%), 133 (31), 121 (19), 115 (12), 101 (12), 95 
(6), 75 (5), 51 (3). 
2,3-Dihydro-5-methyl-3-(methylene)inden-1-ol (126d)152  
 
The reaction was carried out according to the previously described procedure for 
2,3-dihydro-3-(methylene)inden-1-ol (126a) using 2-bromo-4-methylbenzaldehyde 
(52d) (0.054 g, 0.27 mmol). Purification by column chromatography (elution with 
20% diethyl ether:petroleum ether) gave 2,3-dihydro-5-methyl-3-(methylene)inden-
1-ol (126d) (0.032 g, 74%) as a white solid. Spectroscopic data as reported in 
literature.152 Mp 98–100 °C; max (neat)/cm
–1 3312 (OH), 2915 (CH), 1640 (C=C), 
1439, 1335, 1049, 818; δH (400 MHz, CDCl3) 1.93 (1H, d, J 6.1 Hz, OH), 2.39 (3H, 
s, CH3), 2.64 (1H, ddt, J 16.9, 3.5, 2.1 Hz, 2-HH), 3.18 (1H, ddt, J 16.9, 7.2, 2.1 
Hz, 2-HH), 5.07 (1H, t, J 2.1 Hz, 1’-HH), 5.17–5.26 (1H, m, 1-H), 5.50 (1H, t, J 2.1 
Hz, 1’-HH), 7.14 (1H, d, J 7.6 Hz, 7-H), 7.30–7.39 (2H, m, 4-H and 6-H); δC (126 
MHz, CDCl3) 21.6 (CH3), 43.0 (CH2), 73.3 (CH), 104.1 (CH2), 121.1 (CH), 124.9 
(CH), 130.1 (CH), 138.8 (C), 140.5 (C), 144.5 (C), 146.5 (C); m/z (EI) 160.0883 
(M+, C11H12O requires 160.0888), 145 (100%), 128 (30), 115 (40), 102 (5), 91 (19), 
77 (10), 63 (8), 51 (7). 
2,3-Dihydro-6-methoxy-3-(methylene)inden-1-ol (126e)152  
 
The reaction was carried out according to the previously described procedure for 
2,3-dihydro-3-(methylene)inden-1-ol (126a) using 2-bromo-5-
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methoxybenzaldehyde (52e) (0.058 g, 0.27 mmol). Purification by column 
chromatography (elution with 20% diethyl ether:petroleum ether) gave 2,3-dihydro-
6-methoxy-3-(methylene)inden-1-ol (126e) (0.034 g, 71%) as a white solid. Mp 
60–62 °C (lit.152 64–66 °C); max (neat)/cm
–1 3323 (OH), 2922 (CH), 1605 (C=C), 
1487, 1331, 1288, 1260, 1148, 1024, 859, 816; δH (500 MHz, CDCl3) 2.09 (1H, d, 
J 6.2 Hz, OH), 2.64 (1H, ddt, J 16.8, 4.1, 2.1 Hz, 2-HH), 3.18 (1H, ddt, J 16.8, 7.3, 
2.1 Hz, 2-HH), 3.82 (3H, s, OCH3), 4.95 (1H, t, J 2.1 Hz, 1’-HH), 5.17–5.23 (1H, m, 
1-H), 5.35 (1H, t, J 2.1 Hz, 1-HH), 6.88 (1H, dd, J 8.5, 2.4 Hz, 5-H), 6.96 (1H, d, J 
2.4 Hz, 7-H), 7.42 (1H, d, J 8.5 Hz, 4-H); δC (126 MHz, CDCl3) 43.2 (CH2), 55.6 
(CH3), 73.5 (CH), 102.1 (CH2), 108.7 (CH), 116.5 (CH), 121.9 (CH), 133.2 (C), 
145.9 (C), 148.8 (C), 160.8 (C); m/z (EI) 176.0840 (M+, C11H12O2 requires 
176.0837), 148 (42%), 133 (31), 115 (22), 103 (9), 77 (9). 
2,3-Dihydro-5-trifluoromethyl-3-(methylene)inden-1-ol (126g)  
 
The reaction was carried out according to the previously described procedure for 
2,3-dihydro-3-(methylene)inden-1-ol (126a) using 2-bromo-4-
trifluoromethylbenzaldehyde (52g) (0.040 mL, 0.27 mmol). Purification by column 
chromatography (elution with 20% diethyl ether:petroleum ether) gave 2,3-dihydro-
5-trifluoromethyl-3-(methylene)inden-1-ol (126g) (0.044 g, 78%) as a colourless 
oil. max (neat)/cm
–1 3322 (OH), 2962 (CH), 1650 (C=C), 1441, 1323, 1271, 1162, 
1120, 1060, 897, 834; δH (400 MHz, CDCl3) 1.91 (1H, d, J 7.4 Hz, OH), 2.72 (1H, 
ddt, J 16.9, 4.4, 2.2 Hz, 2-HH), 3.26 (1H, ddt, J 16.9, 7.4, 2.2 Hz, 2-HH), 5.20 (1H, 
t, J 2.2 Hz, 1’-HH), 5.32 (1H, td, J 7.4, 4.4 Hz, 1-H), 5.61 (1H, t, J 2.2 Hz, 1’-HH), 
7.56 (1H, dd, J 8.4, 1.6 Hz, 6-H), 7.59 (1H, d, J 8.4 Hz, 7-H), 7.75 (1H, br s, 4-H); 
δC (126 MHz, CDCl3) 42.8 (CH2), 73.2 (CH), 106.4 (CH2), 118.0 (CH, q, 
3JCF 4.0 
Hz), 124.3 (C, q, 1JCF 272.5 Hz), 125.8 (CH), 125.8 (CH, q, 
3JCF 3.0 Hz), 131.5 (C, 
q, 2JCF 32.1 Hz), 141.0 (C), 145.1 (C), 150.3 (C); m/z (EI) 214.0597 (M
+, C11H9F3O 
requires 214.0605), 199 (100%), 195 (25), 186 (19), 177 (13), 171 (13), 165 (18), 
151 (18), 145 (34), 128 (11), 117 (35), 115 (31), 91 (3). 
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6,7-Dihydro-7-(methylene)cyclopenta[b]pyridin-5-ol (126i)150 
 
The reaction was carried out according to the previously described procedure for 
2,3-dihydro-3-(methylene)inden-1-ol (126a) using 2-bromopyridine-3-
carboxaldehyde (52i) (0.050 g, 0.27 mmol). Purification by column 
chromatography (elution with 40% ethyl acetate:petroleum ether) gave 6,7-
dihydro-7-(methylene)cyclopenta[b]pyridin-5-ol (126i) (0.033 g, 84%) as a white 
solid. Spectroscopic data as reported in literature.1 Mp 101–103 °C; δH (500 MHz, 
CDCl3) 2.69 (1H, ddt, J 17.1, 4.0, 2.1 Hz, 6-HH), 3.19–3.23 (1H, m, OH), 3.23 (1H, 
ddt, J 17.1, 7.5, 2.1 Hz, 6-HH), 5.19 (1H, t, J 2.1 Hz, 1’-HH), 5.23–5.30 (1H, m, 5-
H), 5.99 (1H, t, J 2.1 Hz, 1’-HH), 7.17 (1H, dd, J 7.7, 4.8 Hz, 3-H), 7.77 (1H, ddd, J 
7.7, 1.5, 0.7 Hz, 4-H), 8.47 (1H, dd, J 4.8, 1.5 Hz, 2-H); δC (126 MHz, CDCl3) 40.9 
(CH2), 71.1 (CH), 108.2 (CH2), 123.4 (CH), 133.7 (CH), 140.4 (C), 145.0 (C), 150.6 
(CH), 158.3 (C); m/z (EI) 147 (M+, 78%), 130 (18), 118 (100), 104 (12), 91 (13), 79 
(12). 
2,3-Dihydro-3-methylene-6-(nitro)inden-1-ol (126j)  
 
The reaction was carried out according to the previously described procedure for 
2,3-dihydro-3-(methylene)inden-1-ol (126a) using 2-bromo-5-nitrobenzaldehyde 
(52j) (0.062 g, 0.27 mmol) and hydrazine monohydrate (0.0020 mL, 0.040 mmol). 
Purification by column chromatography (elution with 50% diethyl ether:petroleum 
ether) gave 2,3-dihydro-3-methylene-6-(nitro)inden-1-ol (126j) (0.042 g, 83%) as 
an orange solid. Mp 72–74 °C, max (neat)/cm
–1 3357 (OH), 2916 (CH), 1590 
(C=C), 1515, 1334, 1054, 900; δH (400 MHz, CDCl3) 2.17 (1H, d, J 6.8 Hz, OH), 
2.77 (1H, br d, J 16.9 Hz, 2-HH), 3.30 (1H, dd, J 16.9, 7.3 Hz, 2-HH), 5.28–5.40 
(2H, m, 1-H, 1’-HH), 5.72 (1H, br s, 1’-HH), 7.62 (1H, d, J 8.5 Hz, 4-H), 8.20 (1H, 
dd, J 8.5, 1.4 Hz, 5-H), 8.32 (1H, d, J 1.4 Hz, 7-H); δC (126 MHz, CDCl3) 42.7 
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(CH2), 72.6 (CH), 109.4 (CH2), 121.1 (CH), 121.4 (CH), 124.5 (CH), 144.6 (C), 
146.4 (C), 148.2 (C), 148.4 (C); m/z (EI) 191.0585 (M+, C10H9NO3 requires 
191.0582), 176 (100%), 144 (31), 127 (18), 115 (63), 102 (10), 91 (17), 84 (12), 77 
(10). 
6-Chloro-2,3-dihydro-3-(methylene)inden-1-ol (126k)152  
 
The reaction was carried out according to the previously described procedure for 
2,3-dihydro-3-(methylene)inden-1-ol (126a) using 2-bromo-5-chlorobenzaldehyde 
(52k) (0.059 g, 0.27 mmol) and bis(triphenylphosphine)palladium(II) dichloride 
(0.019 g, 0.027 mmol). Purification by column chromatography (elution with 20% 
diethyl ether:petroleum ether) gave 6-chloro-2,3-dihydro-3-(methylene)inden-1-ol 
(126k) (0.034 g, 69%) as a white solid. Spectroscopic data as reported in 
literature.152 Mp 85–87 °C; max (neat)/cm
–1 3321 (OH), 2923 (CH), 1641 (C=C), 
1470, 1334, 1175, 1070, 1040, 883, 826; δH (400 MHz, CDCl3) 2.02 (1H, d, J 7.4 
Hz, OH), 2.66 (1H, ddt, J 16.9, 4.1, 2.2 Hz, 2-HH), 3.20 (1H, ddt, J 16.9, 7.4, 2.2 
Hz, 2-HH), 5.10 (1H, t, J 2.2 Hz, 1’-HH), 5.23 (1H, td, J 7.4, 4.1 Hz, 1-H), 5.49 (1H, 
t, J 2.2 Hz, 1’-HH), 7.28 (1H, ddd, J 8.3, 1.9, 0.4 Hz, 4-H), 7.41–7.45 (2H, m, 5-H 
and 7-H); δC (101 MHz, CDCl3) 42.9 (CH2), 73.1 (CH), 105.2 (CH2), 122.0 (CH), 
125.4 (CH), 129.3 (CH), 134.7 (C), 138.9 (C), 145.3 (C), 148.7 (C); m/z (EI) 
180.0338 (M+, C10H9
35ClO requires 180.0342), 165 (43%), 152 (29), 145 (21), 115 
(57), 84 (55), 75 (13), 49 (42), 44 (100). 
(1R)-2,3-Dihydro-3-methylene-inden-1-ol ((R)-126a)150 
  
Allylboronic acid pinacol ester (58) (29 µL, 0.15 mmol) was added in a single 
portion to a solution of 2-bromobenzaldehyde (52a) (15 µL, 0.13 mmol) and (R)-
3,3′-bis(2,4,6-triisopropylphenyl)-1,1′-binaphthyl-2,2′-diyl hydrogenphosphate 
(0.0050 g, 0.0066 mmol) in dry toluene (1.9 mL) at −50 °C and stirred for 22 h at 
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this temperature. The solution was allowed to slowly warm to room temperature 
over 1 h then potassium carbonate (0.11 g, 0.77 mmol) and water (23 µL, 1.3 
mmol) were added and stirred for 1 h. Bis(triphenylphosphine)palladium(II) 
dichloride (0.0070 g, 0.0097 mmol) was added to the solution followed by 
hydrazine monohydrate (1.9 µL, 0.039 mmol). The reaction mixture was heated to 
100 °C for 20 h then cooled to room temperature and diluted with hexane (3 mL). 
The solution was filtered through a short pad of silica with first hexane (20 mL) 
then diethyl ether (100 mL). The diethyl ether fraction was concentrated in vacuo 
then purified by column chromatography (elution with 20% diethyl ether:petroleum 
ether) to yield (R)-2,3-dihydro-3-methylene-inden-1-ol ((R)-126a) (0.017 g, 91%) 
as a white solid. Spectroscopic data as for (126a). Enantiomeric excess was 
determined by HPLC analysis of the crude, pre-column product with a chiracel 
OD-H column (hexane:iPrOH 95:5, flow rate 1.0 mL min−1), tminor = 6.57 min, tmajor = 
7.85 min; e.r. = 86:14. [𝛼]𝐷
24 +3.2 (c 0.8, CHCl3). 
(1R)-2,3-Dihydro-6-fluoro-3-(methylene)inden-1-ol ((R)-126c) 
 
The reaction was carried out according to the previously described procedure for 
(1R)-2,3-dihydro-3-(methylene)inden-1-ol ((R)-126a) using 2-bromo-5-
fluorobenzaldehyde (52c) (0.027 g, 0.13 mmol). Purification by column 
chromatography (elution with 20% diethyl ether:petroleum ether) gave (1R)-2,3-
dihydro-6-fluoro-3-(methylene)inden-1-ol ((R)-126c) (0.019 g, 85%) as a 
colourless oil. Spectroscopic data as for (126c). Enantiomeric excess was 
determined by HPLC analysis of the crude, pre-column product with a chiracel 
OD-H column (hexane:iPrOH 98:2, flow rate 1.5 mL min−1), tminor = 7.27, tmajor = 
8.46 min min; e.r. = 92:8. [𝛼]𝐷
24 +8.5 (c 1.3, CHCl3). 
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(1R)-2,3-Dihydro-6-methoxy-3-(methylene)inden-1-ol ((R)-126e) 
 
The reaction was carried out according to the previously described procedure for 
(1R)-2,3-dihydro-3-(methylene)inden-1-ol ((R)-126a) using 2-bromo-5-
methoxybenzaldehyde (52e) (0.028 g, 0.13 mmol). Purification by column 
chromatography (elution with 20% diethyl ether:petroleum ether) gave (1R)-2,3-
dihydro-6-methoxy-3-(methylene)inden-1-ol ((R)-126e) (0.022 g, 96%) as a white 
solid. Spectroscopic data as for (126e). Enantiomeric excess was determined by 
HPLC analysis of the crude, pre-column product with a chiracel OD-H column 
(hexane:iPrOH 95:5, flow rate 1.0 mL min−1), tminor = 8.47, tmajor = 9.41 min min; e.r. 
= 90:10. [𝛼]𝐷
24 −25.4 (c 0.8, CHCl3). 
(1R)-2,3-Dihydro-5-trifluoromethyl-3-(methylene)inden-1-ol ((R)-126g)  
 
The reaction was carried out according to the previously described procedure for 
(1R)-2,3-dihydro-3-(methylene)inden-1-ol ((R)-126a) using 2-bromo-4-
trifluoromethylbenzaldehyde (52g) (20 µL , 0.13 mmol). Purification by column 
chromatography (elution with 20% diethyl ether:petroleum ether) gave (1R)-2,3-
dihydro-5-trifluoromethyl-3-(methylene)inden-1-ol ((R)-126g) (0.022 g, 76%) as a 
colourless oil. Spectroscopic data as for (126g). Enantiomeric excess was 
determined by HPLC analysis of the crude, pre-column product with a chiracel AD-
H column (hexane:iPrOH 98:2, flow rate 1.5 mL min−1), tminor = 5.86 min, tmajor = 
6.68 min; e.r. = 66:34. [𝛼]𝐷
24 −3.9 (c 1.3, CHCl3). 
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(1R)-2,3-Dihydro-3-methylene-6-(nitro)-inden-1-ol ((R)-126j)  
 
The reaction was carried out according to the previously described procedure for 
(1R)-2,3-dihydro-3-(methylene)inden-1-ol ((R)-126a) using 2-bromo-5-
nitrobenzaldehyde (52j) (0.030 g, 0.13 mmol). Purification by column 
chromatography (elution with 40% diethyl ether:petroleum ether) gave (1R)-2,3-
dihydro-3-methylene-6-(nitro)-inden-1-ol ((R)-126j) (0.022 g, 87%) as a white solid. 
Spectroscopic data as for (126j). Enantiomeric excess was determined by HPLC 
analysis of the crude, pre-column product with a chiracel AD-H column 
(hexane:iPrOH 95:5, flow rate 2.0 mL min−1), tminor = 6.46 min, tmajor = 8.37 min; e.r. 
=98:2. [𝛼]𝐷
24 −18.2 (c 1.1, CHCl3). 
(1R)-6-Chloro-2,3-dihydro-3-(methylene)inden-1-ol ((R)-126k)  
 
The reaction was carried out according to the previously described procedure for 
(1R)-2,3-dihydro-3-(methylene)inden-1-ol ((R)-126a) using 2-bromo-5-
chlorobenzaldehyde (52k) (0.029 g, 0.13 mmol). Purification by column 
chromatography (elution with 20% diethyl ether:petroleum ether) gave (1R)-2,3-
dihydro-6-chloro-3-(methylene)inden-1-ol ((R)-126k) (0.022 g, 92%) as a white 
solid. Spectroscopic data as for (126k). Enantiomeric excess was determined by 
HPLC analysis of the crude, pre-column product with a chiracel OD-H column 
(hexane:iPrOH 95:5, flow rate 1.5 mL min−1), tminor = 3.57 min, tmajor = 4.05 min; e.r. 
= 94:6. [𝛼]𝐷
24 −14.7 (c 0.7, CHCl3). 
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Appendices 
Appendix 1: Chiral HPLC traces: 
(1R)-2,3-Dihydro-3-methylene-inden-1-ol ((R)-126a)  
 
Racemic:
 
Enantioselective:
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(1R)-2,3-Dihydro-6-fluoro-3-(methylene)inden-1-ol ((R)-126c) 
 
Racemic:
 
Enantioselective:
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(1R)-2,3-Dihydro-6-methoxy-3-(methylene)inden-1-ol ((R)-126e) 
 
Racemic:
 
Enantioselective:
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(1R)-2,3-Dihydro-5-trifluoromethyl-3-(methylene)inden-1-ol ((R)-126g)  
 
Racemic:
 
 Enantioselective:
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(1R)-2,3-Dihydro-3-methylene-6-(nitro)-inden-1-ol ((R)-126j)  
 
Racemic:
 
Enantioselective:
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(1R)-6-Chloro-2,3-dihydro-3-(methylene)inden-1-ol ((R)-126k)  
 
Racemic:
 
Enantioselective:
 
 
 
